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SUMMARY 
Chapter 1 - The genesis of the testis and the male genital tract is dealt with 
including the evolution of testicular descent, followed by a description of the 
anatomical structures of the male genital system to the extent that this may 
contribute to a better understanding of the whole process of testicular descent. 
In recent years, various causative factors have been proposed for the failure of 
testicular descent whereby hormonal dysfunction has assumed increasing prom-
inence. 
According to the literature, there are various reasons WHY undescended testes 
should be treated, such as an increased risk of infertility, malignant degeneration, 
and disturbance of normal psychosexual development. The decision as to HOW 
undescended testes should be treated, hormonal or surgical, has to be carefully 
weighed. It is subject to a great deal of controversy as is the question of WHEN 
undescended testes should be treated. Recently, early treatment has been 
recommended in view of histological changes that might occur in the nonscrotal 
testis. It has also been suggested that early treatment would improve the potential 
for fertility. A divergence of patient series and other criteria complicates assess-
ment of reported results, fanning the flame of controversy. 
These aspects constituted the motivation for combined hormonal and surgical, 
clinical studies of the entity of undescended testes. An abbreviated definition and 
classification of undescended testes is given to avoid confusion of e.g. retractile 
and truly undescended testes. The aims of the various studies are supplied in 
detail. 
Chapter 2- The framework of the clinical studies is introduced stipulating the 
guidelines and various methods applied. The classification of cryptorchidism is 
further elucidated with a complete description of all aspects of incomplete 
testicular descent. 
Determination of the incidence of cryptorchidism is complicated by a lack of 
longitudinal studies of long duration and frequent inclusion of retractile testes. 
A great deal of attention is paid to the process of reaching the proper diagnosis, 
outlining the p'rocedure for physical examination and registration of the sponta-
neous and most caudal testicular position. This is illustrated with photographs 
and sample registration forms. The methods of hormonal evaluation and statis-
tical analyses are also described. 
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Chapter 3- The literature is reviewed concerning the hormonal influences on 
the development and descent of the testis, as well as the feasibility of a hormonal 
cause of the failure of testicular descent. There are indications that hormones 
play a part in testicular descent, but the nature or phase of such a hormonal action 
remains uncertain. Consequently, there is still no certainty concerning the extent 
to which cryptorchidism may be due to hormonal failure. 
In boys with normal testicular descent, elevated serum testosterone levels have 
been noted during the first months of life, followed by a decrease to normal 
prepuberal levels within the first year. Diverse basal and stimulated LH and FSH 
serum values have been reported for the first year of life. The hormonal findings 
of Job and coworkers concerning boys with undescended testes during the first 
year of life are discussed in great detail because these studies have been cited 
frequently by others. Job's group felt that the reduced LH and testosterone 
secretion, which they observed in boys with undescended testes during the first 
months of life, might furnish the explanation for the failure of testicular descent. 
The same group found in boys with delayed, spontaneous descent during the first 
months of life, LH and testosterone values similar to control values and higher 
than those for persistent cryptorchids. 
In the prepuberal period after the first year of life basal serum testosterone and 
gonadotropin values are low for boys with normal testicular descent, but a clear 
response to stimulation tests has been observed. For boys with undescended 
testes, markedly divergent results of LHRH and HCG tests have been reported. At 
a certain age level, even agonadal patients cannot be distinguished from boys 
with gonads by means of an LHRH test. Bilateral anorchia can only be demonstrat-
ed by means of an HCG test. 
The clinical and hormonal study of boys born with undescended testis during 
their first year of life revealed: 
- delayed, spontaneous descent within the first year in 40-50% of all patients, at 
times even occurring after the sixth month of life; 
- similar serum testosterone values and stimulated gonadotropin values for 
persistent cryptorchids, boys with spontaneous descent in the first year of life, 
and boys born with descended testes. 
These findings donot support the hypothesis of a (transient) insufficiency of the 
hypothalamo-pituitary-gonadal axis in boys with incomplete testicular descent. 
The hormonal evaluation was of no prognostic value for spontaneous testicular 
descent in the first year of life. No disorders in the biosynthesis of testosterone 
nor signs of enzyme inhibition were found in boys with undescended testes. 
Chapter 4- The results of hormonal treatment of undescended testes by means 
of gonadotropins, as reported in the literature, show extreme divergence in the 
percentage of success, 25-100%! There is disagreement concerning a number of 
factors that may influence the rates of success, but there is a consensus regarding 
the prominent role of testicular position; the lower the pretreatment testicular 
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position, the bigger the chance that hormonal treatment will induce descent. No 
author gives a clear explanation for the mode of action of treatment with gonad-
otropins. 
When LHRH was first used to treat undescended testes, it was administered by 
means of intramuscular injection. Once the extent of absorption in the blood 
stream of intranasally administered LHRH had been established (1-2%), LHRH 
nasal spray came into use. Diverse dosage schedules are reported with diverse 
rates of success; 13-78% in open studies and 17-38% in placebo-controlled 
studies. 
Personal experience with LHRH nasal spray therapy for boys with undescend-
ed testes is described in detail. The results of the pilot study were encouraging; 
17 of 29 testes (65%) descended completely. The results of the subsequent 
double-blind, placebo-controlled study involving 252 boys with 301 undescen-
ded testes were far less promising. During the double-blind period (eight weeks) 
a similar percentage of descent was achieved with LHRH therapy (9%) and 
placebo (8%). After the subsequent open study period, after a maximum of two 
courses of LHRH therapy, total testicular descent induced with LHRH reached 
18%. However, in the open study a placebo effect cannot be excluded. 
Logistic regression analysis confirmed the clinical observation that the most 
caudal testicular position was the major factor influencing the results of LHRH 
treatment. The lower the pretreatment position of the testis, the bigger the 
chance of induced descent. In this respect, LHRH therapy is comparable to HCG 
treatment. The dependence of the therapeutic success on pretreatment testicular 
position may explain the diversity of percentages of success for the various 
studies, including our own. In other words, the rate of success for a series of 
patients depends on the ratio of lower-positioned testes in a given series. Retro-
spective evaluation of our study population revealed a previous intrascrotal posi-
tion or retractility of testes in approximately 50% of the boys successfully treated 
with LHRH. 
Hormonal evaluation before and after LHRH treatment, gave no indication of a 
deficient hypothalamo-pituitary-gonadal axis or a reduced Leydig cell function in 
boys with undescended testes. In a number of bilateral cryptorchids higher 
stimulated FSH levels were observed. Permanent stimulation of the hypo-
thalamo-pituitary-gonadal axis could not be demonstrated. A limited auxiliary 
study served to demonstrate absorption of LHRH i.n. in the blood stream, causing 
a rise in LH levels in a number of cases. In addition, comparison of results of an 
HCG test before and after LHRH therapy, revealed elevated peak serum testoster-
one values, possibly indicating Leydig cell stimulation. Our findings did not 
explain the mode of action of LHRH treatment, although we did find some 
indications that LHRH treatment may reduce the contractility of the cremaster 
muscle. 
CHAPTERS 3 AND 4 CONSTITUTE PART A OF THE CLINICAL STUDIES, DEALING 
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WITH THE ENDOCRINOLOGICAL ASPECT OF CRYPTORCHIDISM, CON-
CLUDED WITH A GENERAL DISCUSSION OF THAT ASPECT BY THE AUTHOR 
OF THIS PART, S.M.P.F. de Muinck Keizer-Schrama. 
Chapter 5- According to the literature, failure of testicular descent may be due 
to hormonal or mechanical disturbance, while undescended testes are histologi-
cally divergent from normally descended testes. The major anomaly found in a 
non scrotal testis is a reduced number of spermatogonia per tubule. It is not clear 
whether this is a primary histological abnormality (dysgenesis) or the result of a 
higher temperature in the nonscrotal environment. There is a clear connection 
between the severity of the histological abnormality and the postion of the 
nonscrotal testis; the "higher" the arrest of testicular descent, the more severe 
the histological abnormality. In 25-60% of the boys with unilateral undescended 
testes, the contralateral, descended testes also appear to be histologically 
abnormal. Investigation of the previously undescended testis after orchiopexy, 
revealed no increase of the number of spermatogonia, but at best further matura-
tion of the existing spermatogonia. 
The clinical implications of a disturbance of testicular descent as reported in 
the literature are discussed. There is a definite link between failure of testicular 
descent and infertility, while this relationship becomes even more marked if 
cryptorchidism is bilateral. The results of numerous fertility studies are markedly 
divergent because the factors that may influence fertility, such as type or timing of 
treatment, testicular position, criteria for fertility assessment, etc. are not consis-
tently taken into account. 
Testicular tumour is a rare occurFence, but seems to be more prevalent in 
(previously) undescended testes. The premise that (early) treatment would 
prevent subsequent manifestation of a testicular tumour has not been 
substantiated. Scrotal placement oft he testis does make the testis more accessible 
to examination and treatment if malignant degeneration does occur. 
A disturbance of the psychosexual development requiring treatment will only 
occur in boys with undescended testes if there are other psychological problems, 
apart from the aspect of an abnormal appearance of the genitalia, involving the 
boys's mental stability and parent-child relationship. Regarding the psychosexual 
development, early treatment is obviously preferable, because this means that 
the child has recovered before discovering that he is "different". Surgical treat-
ment does call for special measures to reduce separation between parents and 
child to a minimum (rooming-in, day-surgery, etc.). 
The anatomical aspects of cryptorchidism are dealt with in detail, describing 
various abnormal anatomical structures related to testicular nondescent. Other 
congenital anomalies that may be associated with cryptorchidism are mentioned 
briefly. 
Following a description ofthe evolution of orchiopexy, the various techniques 
are discussed. Apart from the standard orchiopexy, generally involving fixation of 
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the testis in a subcutaneous scrotal pouch (Schoemaker technique), there are a 
number of special surgical procedures that may be required for impalpable testes 
(intra-abdominal or high-lying, inguinal testes). These special procedures includ-
ed staged orchiopexy, orchiopexy with testicular vessel transection (Fowler-
Stephens), orchiopexy using microvascular techniques, and finally, transabdom-
inal orchiopexy with abdominal wall reconstruction in a neonate with prune belly 
syndrome. 
Chapter 6 - Personal experience and results of surgical treatment of cryptor-
chidism are discussed, beginning with the management of retractile testes. Boys 
with (markedly) retractile testes have to be examined at regular intervals (e.g. 
once a year) until puberty, even though retractile testes normally do not require 
treatment. Ascent of a previously retractile testis may occur, resulting in a perma-
nent nonscrotal position of this testis. 
In contrast, the impalpable testis always requires treatment. The impalpable 
testis, usually located in the abdomen or high in the inguinal canal, always 
requires surgery, because hormonal treatment is pointless. A good scrotal posi-
tion of the testis can usually be achieved with a standard orchiopexy. Surgery of 
the impalpable testis almost always amounts to a combined diagnostic and 
therapeutic intervention, rendering separate diagnostic evaluation by means of 
frequently invasive techniques, such as CT-scan, angiography, or laparoscopy, 
superfluous. 
There are various special surgical procedures (as described in chapter 5) for the 
impalpable testis that cannot be brought to the scrotum by conventional orchio-
pexy. Personal experience with these special techniques and results are discussed 
in relation to literature data, supplying indications for the uses of each technique. 
Orchiopexy involving transsection of the testicular vessels (Fowler-Stephens 
procedure) is the method of choice for an impalpable testis with a "long loop" vas 
and epididymis, provided the decision is taken before pre-emptive retroperi-
toneal dissection has taken place. A second-stage orchiopexy is pointless unless 
there is uncertainty regarding the extent of funicular mobilization at the initial 
operation. In case the first operation did include optimal retroperitoneal dissec-
tion, a second-stage procedure may still be required, provided this involves 
autotransplantation of the testis. If the testicular vessels hamper scrotal place-
ment of the testis, these vessels may be divided to be anastomosed to the 
epigastric vessels. Based on our own results, the lower age limit for this microvas-
cular orchiopexy is set at approximately seven years. The limited need for or-
chidectomy is discussed, whereby the importance is stressed of preserving hor-
monal function. Bilateral orchidectomy should be avoided at all cost. Insertion of 
a prosthesis (after orchidectomy) depends on personal circumstances and may 
safely be postponed until the puberal period. 
A schematic presentation of the treatment protocol for impalpable testes is 
included in the general discussion following this chapter. 
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The remainder of the chapter deals with the findings and results of orchiopexy 
of 170 boys with 196 testes that failed to descend with LHRH nasal spray (see 
chapter 4). In 80% of these testicular operations anatomical anomalies were 
found explaining the failure of hormonal treatment. The most frequent finding 
was an open processus vaginal is with insufficient outgrowth into the scrotum and 
an abnormal, subcutaneous course of the fascia of Scarpa. Wound-related post-
operative complications were never severe occurring in only 5% of the opera-
tions. Practically all operations resulted in a scrotal position of the testis. At follow-
up, 4-10 months postoperatively, 2% of the operated testes appeared to have 
become atrophic. Age at operation appeared to have had no effect on the result 
(position of testis in scrotum), postoperative complications or the frequency of 
testicular atrophy. 
CHAPTERS 5 AND 6 CONSTITUTE PART B OF THE CLINICAL STUDIES, DEALING 
WITH THE SURGICAL ASPECT OF CRYPTORCHIDISM, CONCLUDED WITH A 
GENERAL DISCUSSION OF THAT ASPECT BY THE AUTHOR OF THIS PART, 
F.W.J. Hazebroek. 
Chapter 7- Based on the findings of the clinical studies in relation to literature 
data, an attempt is made to answer the question of WHY, HOW, and WHEN 
cryptorchidism should be treated. 
The risk of infertility, the rather rare occurrence of testicular tumour, and a 
disturbance of the psychosexual development, are reasons WHY the u ndescend-
e.d testis should be treated. Before treatment is initiated, the proper diagnosis has 
to be made. 
HOW the undescended testis should be treated, hormonal or surgical, 
depends entirely on the position of the testis. Although the results of our 
double-blind study period (eight weeks) were no better for LHRH than for 
placebo, the results of the entire study (maximally two LHRH courses) showed 
that LHRH nasal spray may induce descent in testes that have emerged from the 
inguinal canal and can be manipulated to at least the scrotal entrance. LHRH nasal 
spray is our hormonal treatment of choice, rather than intramuscular injections of 
HCG, because the side effects and invasiveness are least for LHRH, while the 
treatment results are similar for either modality. Surgical treatment is indicated 
for all undescended testes that have not emerged from the inguinal canal as well 
as all ectopic testes, and for those testes that failed to descend with hormonal 
therapy. 
Before any treatment can be initiated, the proper diagnosis has to be reached. 
Any documentation of previous testicular position should be traced. These data 
together with the age of the cryptorchid boy will decide WHEN treatment should 
take place. 
The treatment protocol for all types of nonscrotal testes is discussed and 
schematically presented in a comprehensive figure. 
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The chapter ends with a number of questions that can only be answered in the 
future, such as: 
- should all undescended testes be treated, or is a "wait-and-see" approach 
feasible for testes that have been documented as intrascrotal or at least 
retractile at some point in the past? 
Only a longitudinal study of long duration would supply an answer to such 
questions. 
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SAMENVAITING 
In Hoofdstuk 1 wordt de ontwikkeling van de testis en de mannelijke geslachts-
organen besproken, gevolgd door een overzicht van de testiculaire indaling en 
van die anatomische structuren van het mannelijk genitale stelsel, die bijdragen 
tot een beter begrip van het indalingsproces vah de testis. De afgelopen jaren 
worden verschillende factoren verantwoordelijk gesteld voor het niet indalen 
Van de testis, waarbij het accent steeds meer is komen te liggen op een hormonale 
dysfunctie. Hierdoor heeft tevens de hormonale behandeling van niet inge-
daalde testes opgang gemaakt. 
De red en en die aangevoerd worden WAAROM niet ingedaalde testes behan-
deld moeten worden, zijn de verhoogde kans op onvruchtbaarheid, maligne 
ontaarding en verstoring van de normale psychosexuele ontwikkeling. HOE niet 
ingedaalde testes behandeld moeten worden, hormonaal of chirurgisch, client 
zorgvuldig afgewogen te worden en ook omtrent de vraag WANNEER een 
behandeling moet worden ingesteld bestaat verschil van mening. De laatste jaren 
zijn stemmen opgegaan voor vroege behandeling, dat wil zeggen rond het 
tweede levensjaar, om histologische afwijkingen van de niet ingedaalde testis te 
voorkomen en de fertiliteit te verbeteren. Bewijs hiervoor is echter nog niet 
geleverd. 
Alvorens echter tot behandeling over te gaan zal de juiste diagnose, werkelijk 
niet ingedaalde testis, gesteld moeten worden. Hierop wordt in het volgende 
hoofdstuk uitgebreid ingegaan, maar om spraakverwarring te voorkomen 
worden nu al definities gegeven van cryptorchidisme, de retractiele testis en niet 
ingedaalde testes. Laatstgenoemden zijn te verdelen in onvolledig ingedaalde 
testes en ectopische testes. Vervolgens worden de doelstellingen van de klini-
sche studies uiteengezet. 
Hoofdstuk 2 presenteert in eerste instantie de richtlijnen voor de klinische 
studies. Classificatie en definities van de indalingsstoornissen en testisposities 
worden gegeven. Benadrukt wordt dat naast de spontane testispositie de meest 
caudale positie van groot belang is. Het vaststellen van de incidentie van de niet 
ingedaalde testis wordt gecompliceerd door het nagenoeg ontbreken van lang-
durig longitudinaal onderzoek en het niet herkennen van retractiele testes. Om 
tot de diagnose te komen moet het lichamelijk onderzoek lege artis worden 
uitgevoerd en moet niet aileen de spontane, maar ook de meest caudale testispo-
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sitie worden geregistreerd. Bovenstaande wordt in woord en beeld weergege-
ven. 
De methoden van de hormonale bepalingen en van de statistische analyses 
gebruikt bij de klinische studies worden beschreven. 
In Hoofdstuk 3 worden vanuit de literatuur de hormonale invloeden op de 
testisontwikkeling en -indaling besproken alsmede de mogelijkheid van een 
hormonale oorzaak van het niet indalen van de testis. Hoewel er aanwijzingen 
zijn dat hormonen een rol spelen bij de testiculaire indaling is nog niet met 
zekerheid vastgesteld welke hormonen in welke fase een rol spelen. Dientenge-
volge blijft ook de vraag of cryptorchidisme een hormonale oorzaak heeft 
onvolledig beantwoord. 
In het eerste levensjaar worden bij jongens met normale testiculaire indaling 
hoge serum testosteronwaarden gevonden gedurende de eerste levensmaanden 
met een daarop volgende daling. De bevindingen omtrent basale en gestimu-
leerde LH en FSH serumwaarden in het eerste levensjaar !open uiteen. De 
hormonale bevindingen van job en medewerkers betreffende jongens met niet 
ingedaalde testes in het eerste levensjaar worden uitgebreid besproken, omdat 
deze studies frequent door anderen worden aangehaald. Deze groep meende 
dat de verminderde LH en testosteronsecretie, die zij in de eerste levensmaanden 
bij jongens met niet ingedaalde testes vaststelden, een verklaring kan vormen 
voor het niet indalen van de testes. Bij jongens met spontane indaling gedurende 
de eerste levensmaanden werden LH en testosteronwaarden gevonden verge-
lijkbaar met controle waarden en hoger dan van jongens die cryptorch bleven. 
In de prepuberale periode na het eerste levensjaar zijn de serum testosteron-
en gonadotrofinenwaarden onder basale omstandigheden laag bij jongens met 
ingedaalde testes, maar zij vertonen een duidelijke response op stimulatietesten. 
Bij jongens met niet ingedaalde testes worden zeer wisselende resultaten voor 
LHRH en HCG testen opgegeven. In een bepaalde leeftijdsfase kunnen zelfs 
agonadale patienten niet door middel van de LHRH test van jongens met 
gonaden onderscheiden worden. Aileen de HCG test kan bij bilaterale anorchie 
uitsluitsel geven. 
Onze klinische en hormonale evaluatie gedurende het eerste levensjaar van 
jongens geboren met niet ingedaalde testes toonde aan dat: 
- spontane indaling voorkomt in 40-50% van de gevallen, zelfs na de zesde 
levensmaand; 
- de serum testosteronwaarden en basale en gestimuleerde gonadotrofinen-
waarden van jongens die cryptorch bleven vergelijkbaar zijn met die van 
jongens met spontane indaling in het eerste levensjaar en van jongens gebo-
ren met ingedaalde testes. 
Deze bevindingen geven geen steun aan de hypothese van een (tijdelijke) 
insufficientie van de hypothalamus-hypofyse-gonade as bij jongens met niet 
ingedaalde testes. De hormonale evaluatie bleek geen voorspellende waarde te 
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hebben voor spontane indaling in het eerste levensjaar. Wij vonden geen afwij-
kingen in de testosteron biosynthese noch tekenen van enzym inhibitie bij 
jongens geboren met niet ingedaalde testes. 
In Hoofdstuk 4 wordt vanuit de literatuur de hormonale behandeling van niet 
ingedaalde testes door middel van gonadotrofinen besproken. Hierbij vallen de 
sterk uiteenlopende indalingspercentages op: 25-100%! Omtrent een aantal 
factoren, die mogelijk var\ invloed zijn op het indalingspercentage, bestaat 
verschil van mening, maar de onderzoekers zijn unaniem van oordeel dat de 
positie van de testis voor behandeling een belangrijke rol speelt: hoe lager de 
testispositie voor behandeling, hoe hoger de kans op indaling! Voor het wer-
kingsmechanisme van de behandeling met gonadotrofinen wordt door geen 
enkele auteur een duidelijke verklaring gegeven. 
Na het isoleren en synthetiseren van het gonadoreline (LHRH) werd het 
releasing hormone aanvankelijk door middel van intramusculaire injectie toege-
past bij de behandeling van niet ingedaalde testes. Vervolgens werd, na het 
vaststellen van de absorptie in de bloedbaan na intranasaletoediening (1-2%), het 
LHRH per neusspray in verschillende doseringen toegepast met wisselende 
indalingspercentages: 13-78% in open studies, 17-38% in placebo-gecontroleer-
de studies. 
Vervolgens worden de eigen ervaringen met het intranasaal toegediende 
LHRH voor de behandeling van jongens met niet ingedaalde testes beschreven. 
De resultaten van de pilot-studie waren zeer bemoedigend: 17 van de 29 testes 
(65%) daalden volledig in. De resultaten van de daaropvolgende dubbel-blind, 
placebo-gecontroleerde studie, waarin 252 jongens met 301 niet ingedaalde 
testes werden behandeld, waren heel wat minder rooskleurig. In de dubbel-
blinde periode (na acht weken) bleek het indalingspercentage na LHRH behan-
deling (9%) niet hoger dan na placebo (8%). Na de daarop volgende open 
studieperiode, na maximaal twee LHRH kuren, bleek 18% van de testes in te 
dalen. In de open studie is echter het placebo-effect niet uit te sluiten. Met een 
logistische regressie analyse bevestigden wij de klinische observatie dat met 
name de positie van de testis voor behandeling van invloed is op het welslagen 
ervan. Hoe lager de testispositie v66r behandeling des te groter de kans op 
indalen. In dit opzicht is de LHRH behandeling vergelijkbaar met de HCG 
behandeling. De afhankelijkheid van het therapeutisch succes van de testisposi-
tie v66r behandeling kan een verklaring geven voor de uiteenlopende succes-
percentages van de verschillende studies, ook die van onze eigen studies. De 
evaluatie van testisposities in het verleden leerde dat bij ongeveer 50% van de 
jongens, die met succes op de LHRH behandeling reageerden, de testes vroeger 
ooit eens als intrascrotaal of retractiel beschreven waren. 
De hormonale evaluatie rond de LHRH behandeling gaf geen aanwijzingen 
voor een deficiente hypothalamus-hypofyse-gonade as of een verminderde Ley-
dig eel functie bij jongens met niet ingedaalde testes. Bij een aantal jongens met 
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bilateraal niet ingedaalde testes werden hogere gestimuleerde FSH waarden 
gevonden. Blijvende stimulatie van de hypothalamus-hypofyse-gonade as kon 
niet worden aangetoond. Een beperkte studie toonde echter wei aan dat het 
intranasaal toegediende LHRH in de bloedbaan wordt opgenomen en in een 
aantal gevallen LH stijging veroorzaakt. Tevens leerde de HCG test voor en na 
LHRH behandeling dat na behandeling de gestimuleerde testosteronwaarden 
significant hager waren dan voor behandeling, mogelijk een aanwijzing voor 
Leydig eel stimulatie. Bovenstaande bevindingen kunnen het werkingsmechanis-
me van de LHRH behandeling niet verklaren. Wij vonden echter aanwijzingen 
dat door de LHRH behandeling de retractiliteit van de cremasterspier afneemt. 
DE HOOFDSTUKKEN 3 EN 4 VORMEN DEEL A VAN DE KLINISCHE STUDIES, DIE 
HET ENDOCRINOLOGISCHE ASPECT BELICHTEN, HETGEEN WORDT AFGE-
SLOTEN DOOR EEN UITGEBREIDE DISCUSSIE DOOR DE AUTEUR VAN DIT 
DEEL, S.M.P.F. de Muinck Keizer-Schrama. 
Hoofdstuk 5- Allereerst wordt in dit hoofdstuk ingegaan op het feit waarom 
een testis soms niet indaalt. Zowel hormonale als mechanische stoornissen 
kunnen hiervoor een oorzaak zijn. Niet ingedaalde testes zijn histologisch gezien 
afwijkend in vergelijking met ingedaalde testes. De belangrijkste afwijking in de 
niet ingedaalde testis is het verminderd aantal spermatogonien per tubulus. Het 
is nog een onduidelijke zaak of de niet ingedaalde testis primair histologisch 
afwijkend is (dysgenesie) of dat ten gevolge van temperatuursinvlo~den de 
aanvankelijk histologisch normale testis beschadigd wordt. Er is een duidelijk 
verband tussen de ernst van de histologische afwijkingen en de ligging van de 
niet ingedaalde testis, hoe "hager" de testis is blijven liggen hoe ernstiger de 
histologische afwijkingen zijn. In 25-60% blijkt bij de unilaterale niet ingedaalde 
testis ook de ingedaalde testis afwijkend te zijn. Na orchidopexie wordt in de 
vroeger niet ingedaalde testis geen toename gezien van het aantal spermatogo-
nien, maar hooguit een verdere rijping van de reeds aanwezige spermatogonien. 
Vervolgens worden de klinische consequenties van de testiculaire indalings-
stoornissen besproken. Er is een onmiskenbaar verband tussen testiculaire inda-
lingsstoornissen en onvruchtbaarheid, waarbij dit verband des te uitgesprokener 
is indien er sprake is van bilateraal niet ingedaalde testes. Oat de resultaten van de 
vele gepubliceerde fertiliteitsstudies zo sterk wisselen, wordt veroorzaakt door-
dat in wisselende mate rekening wordt gehouden met factoren die de fertiliteit 
be"invloeden, zoals soort van behandeling, tijdstip van behandeling, testispositie, 
fertiliteitsonderzoek enz. 
Een op zichzelf zeldzame testistumor komt vaker voor in een (tevoren) niet 
ingedaalde testis. Het is nog geen vaststaand feit dat (vroege) behandeling het 
zich later manifesteren van een testistumor kan voorkomen. Wei is de testis door 
plaatsing in het scrotum beter toegankelijk voor onderzoek en behandeling van 
eventueel toch voorkomende maligniteit. 
32 
Ten aanzien van de psychosexuele aspecten van kinderen met niet ingedaalde 
testes kan gezegd worden dat psychische stoornissen, die behandeling noodza-
kelijk maken, slechts voorkomen indien er naast het probleem van de niet 
ingedaalde testis zelf nag andere psychische stoornissen voorkomen die verband 
houden met de persoonlijkheid van het betreffende kind of de relatie tussen 
ouder en kind. Ten aanzien van de psychosexuele ontwikkeling heeft vroege 
behandeling een duidelijke voorkeur, omdat dan het kind hersteld is voordat hij 
zijn "anders" zijn zou ontdekken. Rand de behandeling (orchidopexie) dienen 
wei maatregelen genomen te worden (rooming-in, dagbehandeling) die 
scheiding tussen ouders en kind zoveel mogelijk beperken. 
Nadat hierna een uitgebreid overzicht is gegeven van de anatomische afwij-
kingen die voorkomen bij de diverse vormen van niet ingedaalde testes wordt 
een korte samenvatting gegeven van andere aangeboren afwijkingen die soms 
samengaan met cryptorchidisme. 
Het hoofdstuk wordt besloten met een beschrijving van de ontwikkeling van 
de diverse vormen van orchidopexie. Naast de standaard orchidopexie, meestal 
uitgevoerd met fixatie van de testis in een subcutane scrotale ruimte (Schoe-
maker techniek) zijn er diverse speciale chirurgische technieken die hun toepas-
sing hebben voor de hoge (intra-abdominale of hoog in het lieskanaalliggende) 
testis: orchidopexie in twee tempi, orchidopexie met doornemen van de testicu-
laire vaten (Fowler-Stephens), orchidopexie gebruikmakend van microvasculaire 
technieken en ten slotte de in de neonatale periode uitgevoerde transabdomi-
nale orchidopexie met buikwandreconstructie (Prune Belly syndrome). 
Hoofdstuk 6 - ln dit hoofdstuk worden de ervaringen en resultaten van de 
eigen chirurgische studies besproken. Allereerst wordt ingegaan op het te voe-
ren beleid ten aanzien van de retractiele testis. In het algemeen behoeft de 
retractiele testis geen behandeling. Aangezien er echter een ascendens van een 
tevoren retractie!e testis kan voorkomen, met als gevolg een blijvende niet 
scrotale positie van deze testis, is het raadzaam om jongens met (sterk) retractiele 
testes met grate tussenpozen (bijv. eenmaal per jaar) te controleren. 
Vervolgens wordt het diagnostische en therapeutische beleid van de niet 
palpabele testes besproken. Hormonale behandeling van de niet palpabele testis 
is, zoals in hoofdstuk 4 is besproken, zinloos. De niet palpabele testis, die meestal 
intra-abdominaal of hoog in het lieskanaalligt, dient dan oak chirurgisch behan-
deld te worden. Meestal is door middel van een conventionele orchidopexie een 
goede scrotale positie van de testis te verkrijgen. Deze operaties zijn bijna altijd 
diagnostische en therapeutische ingrepen die aparte diagnostische, vaak inva-
sieve ingrepen zoals CT-scan, angiografie of laparoscopie, overbodig maken. 
lndien met een conventionele orchidopexie de niet palpabele testis niet in het 
scrotum gebracht kan worden, zijn er enige speciale operatietechnieken die 
ieder hun eigen indicatiegebied hebben. Eigen ervaring met deze speciale tech-
nieken worden, getoetst aan de literatuurgegevens, verder besproken. De orchi-
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dopexie met transsectie van de testiculaire vaten (Fowler-Stephens procedure) is 
een juiste chirurgische techniek indien er sprake is van een "long loop" vas en 
epididymis, mits hiertoe wordt besloten voordat retroperitoneale dissectie deze 
ingreep bij voorbaat onmogelijk maakt. Een orchidopexie in twee tempi heeft 
aileen zin, indien het onduidelijk is hoe uitgebreid bij de eerste liesexploratie de 
retroperitoneale dissectie van de funiculus heeft plaatsgevonden. Bij een tweede 
ingreep kan het noodzakelijk zijn om autotransplantatie van de testis uit te 
voeren, wanneer de dissectie bij de eerste ingreep vyel optimaal is uitgevoerd. 
lndien de testiculaire vaten een belemmerende factor zijn waardoor de testis niet 
in het scrotum geplaatst kan worden, kunnen deze vaten worden doorgenomen 
om vervolgens weer te worden geanastomoseerd met de epigastrische vaten. Op 
grand van de eigen resultaten wordt de leeftijdsgrens van deze microvasculaire 
orchidopexie gesteld op ongeveer zeven jaar. 
De beperkte indicatievoor orchidectomiewordt besproken, waarbij de nadruk 
wordt gelegd op het behoud van hormonale functie. Bilaterale orchidectomie is 
uit den boze. Het plaatsen van een prothese (na orchidectomie) hangt af van 
persoonlijke omstandigheden en kan gevoeglijk uitgesteld worden tot de 
puberale periode. 
In de uitgebreide discussie die op dit hoofdstuk volgt, bevindt zich een 
schematisch behandelingsplan van prepuberale jongens met niet palpabele tes-
tes. 
Het laatste deel van dit hoofdstuk betreft de bevindingen en resultaten van 
orchidopexie bij 170 jongens met 196 niet ingedaalde testes die zonder succes 
met de LHRH neusspray zijn behandeld. Bij ongeveer 80% van de verrichte 
operaties was het mogelijk om vanuit de gevonden anatomische afwijkingen een 
verklaring te geven, waarom de aan de operatie voorafgegane hormonale behan-
deling niet succesvol is geweest. De afwijkingen die het meest voorkomen zijn 
een onvolledige, niet tot in het scrotum uitgegroeide processus vaginalis en een 
abnormaal verlopende subcutane fascie van Scarpa. Bij 5% van de uitgevoerde 
operaties was er sprake van een meestal niet ernstige gestoorde wondgenezing. 
Bijna aile niet ingedaalde testes konden in een scrotale positie worden geplaatst. 
Bij na-onderzoek, 4-10 maanden na operatie, bleek dat 2% van de geopereerde 
testes atrofisch was geworden. De leeftijd waarop orchidopexie is uitgevoerd 
blijkt niet van invloed te zijn op het operatieresultaat (testispositie in scrotum), de 
postoperatieve complicaties of het voorkomen van testisatrofie. 
DE HOOFDSTUKKEN 5 EN 6 VORMEN DEEL B VAN DE KLINISCHE STUDIES DIE 
HET CHIRURGISCHE ASPECT BELICHTEN, HETGEEN WORDT AFGESLOTEN 
DOOR EEN UITGEBREIDE DISCUSSIE DOOR DE AUTEUR VAN DIT DEEL, F.W.J. 
Hazebroek. 
In Hoofdstuk 7 proberen wij door de bevindingen van het eigen onderzoek en 
de literatuur te integreren de vragen te beantwoorden WAAROM, HOE en 
34 
WANNEER jon gens met niet ingedaalde testes behandeld moeten worden. 
De dreiging van infertiliteit, het voorkomen van een overigens zeldzame 
testistumor en stoornissen in de psychosexuele ontwikkeling zijn redenen 
WAAROM de niet ingedaalde testis behandeling behoeft. HOE behandeld moet 
worden, hormonaal dan wei chirurgisch, wordt uitsluitend bepaald door de 
positie van de testis. Alhoewel onze stu die niet bewezen heeft dat na een behan-
delingsperiode (acht weken) LHRH beter is dan placebo, suggereren de resulta-
ten van het gehele onderzoek (maximaal twee LHRH kuren) dat de behandeling 
met LHRH per neusspray indaling kan geven van testes die het lieskanaal gepas-
seerd zijn en tenminste in de scrotumingang gebracht kunnen worden. Een pla-
cebo-effect kan echter in deze open studie niet uitgesloten worden. Bij de keuze 
van de hormonale therapie gaat onze voorkeur uit naar de LHRH neusspray 
boven de intramusculair toegediende HCG injecties, omdat de bijwerkingen en 
de belasting voor het kind minder zijn, terwijl de indalingspercentages vergelijk-
baar zijn. Chirurgische behandeling is ge"indiceerd voor aile vormen van niet 
ingedaalde testes die het lieskanaal nog niet gepasseerd zijn, voor aile ectopische 
testes en wanneer de hormonale behandeling geen indaling heeft gegeven. ·· 
Alvorens tot behandeling over te gaan moet de juiste diagnose gesteld worden 
en is het van groat belang te informeren naar de testispositie in het verleden. 
Deze gegevens bepalen samen met de leeftijd van de jongen WANNEER de 
behandeling dient plaats te vinden. Vervolgens wordt een schematisch behande-
lingsplan voorgesteld. 
Het hoofdstuk wordt afgesloten met een aantal vragen die pas in de toekomst 
beantwoord kunnen worden, zoals: 
- moeten aile niet ingedaalde testes behandeld worden of kan, wanneer de 
testis in het verleden als intrascrotaal of retractiel werd beschreven, een af-
wachtende houding aangenomen worden? 
Longitudinaal prospectief onderzoek tot na de puberteit is de enige mogelijk-
heid om deze vragen te beantwoorden. 
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CHAPTER 1 
GENERAL INTRODUCTION 
Few subjects have been so belaboured in the medical literature as the entity of 
CRYPTORCHIDISM, or undescended testis. In 1762 John Hunter first made a 
connection between undescended testes and infertility. Since then the unde-
scended testis has never ceased to be a subject for investigation. One of the main 
reasons why so many publications, frequently contradicting one another, con-
tinue to appear is that the complicated process of testicular descent is still poorly 
understood, let alone a disturbance of this process and the consequences of such 
a disturbance. 
To gain more insight into this matter we have carried out extensive clinical 
studies supported by a comprehensive review of the literature. Before going into 
the aims of our studies, it is important to define the (physical) area of research. 
1.1. THE DEVELOPMENT OF THE TESTIS 
The human testis is composed of the following elements: 
- the seminiferous tubules, containing the germ cells necessary for reproduc-
tion, and the Sertoli cells, which provide support, protection and nutrition for 
the germ cells; 
- the interstitial cells of Leydig, for the production of testosterone; 
- the peritubular cell system, supporting the germinal epithelium. 
Male gonadal development can be divided into an indifferent stage and a stage 
of testicular differentiation. 
1.1.1. Indifferent stage 
The genital glands are formed from two types of cells, the primordial germ cells 
and the coelomic epitheloid cells. Human primordial germ cells are discernable 
about three weeks after conception in the umbilical vesicle wall near the allan-
tois. The coelomic epitheloid cells line the anterior, internal side of the Wolffian 
body (= mesonephros). This epitheloid lining thickens, forming the gonadal or 
genital ridge (figure 1.1.). Early in the fourth week the primordial germ cells can 
be observed among these epitheloid cells of the genital ridge. The fusion of this 
part of the coelomic wall with the primordial germ cells eventually forms the 
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Figure 1.1. Gonadal development: indifferent stage (Tuchmann-Duplessis and Haegel, 1974; with 
permission). 
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gonadal blastema. In the fifth week after conception, changes occur in the genital 
ridge, whereby the coelomic wall gradually loses its epitheloid character and at 
this stage a proliferation of so-called primitive sexual cords can be observed. By 
the sixth week, the primordial germ cells have become embedded between the 
primitive sexual cords. Modern embryologists assume that all testicular cells 
other than the germ cells are derived from the epitheloid cells of the coelomic 
wall. 
1.1.2. Testicular differentiation 
Up till the end of the sixth week of embryonic life, the gonads of both sexes are 
identical in appearance. Subsequently, differentiation into testis or ovary takes 
place. According to Jost (1970, 1972) sex determination may be viewed as com-
prising sequential processes: 
- establishment of genetic sex (XX or XY) at fertilization; 
- translation of genetic sex into gonadal sex (ovary or testis); 
- translation of gonadal sex into body sex (female or male). 
The gonadal sex differentiation is controlled by the H-Y antigen, a cell surface 
antigen that is found in tissues of mammalian males but not in those of normal 
females. It is not yet completely clear where the genes involved in the formation 
of the H-Y antigen are located. On theY-chromosome? Or on the X-chromo-
some requiring theY-chromosome for activation? The theory of Wolf (1979) is 
that the structural testis-determining H-Y gen is located on an autosome sup-
pressed by the X-chromosome and activated by theY-chromosome. 
The testis can first be identified as such in embryos of about 17 mm crown-
rump (CR) length when the male gonadal blastema becomes subdivided into 
testicular cords. The cords, containing germ cells surrounded by the nutrient 
supporting cells (later Sertoli cells), are first noticeable in the central portion of 
the gonadal ridge near the mesonephric tubules. This is the start of formation of 
the seminiferous tubules. At a CR length of about 25 mm the tunica albuginea 
develops, a dense fibrous layer which separates the testicular tubules completely 
from the mesothelial lining of the gonad. The testicular cords extend into the 
region of the gonadal mesentery where they form a network, the rete testis. The 
cords then become canalized to form the seminiferous tubules. At a CR length of 
50-90 mm the rete testis is also canalized and in part becomes continuous with 
some of the mesonephric tubules forming the vasa efferentia. 
1.1.3. Testicular cords 
During early development, the diameter of the growing testicular cord 
depends on the intratubular situation. Rapid proliferation of germ cells or sup-
porting cells coincides with a rapid increase of the diameter of the cords. During 
late prenatal and subsequent postnatal development the process of growth 
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becomes slow and steady (Wartenberg, 1981 ). Throughout the entire prepuberal 
period, a continuous and linear increase in the tubular diameter was observed 
(Stadtler and Hartmann, 1972). The mean diameter of a given number of testicular 
cords or seminiferous tubules at a certain age can be used as a parameter for 
normal testicular growth. Another test of testicular maturation, correlating with 
the diameter of the cords, is a count of germ cells in 50 or 100 circular cross-
sections of the tubules. 
1.1.4. Germ cells 
As mentioned earlier, the male gonadal blastema becomes subdivided into 
testicular cords in the presence of the H-Y antigen at about day 42 (CR length 
17-20 mm) and the development of the germ cells commences. Various descrip-
tions of germ cell development have been reported. Hilscher (1974) followed by 
Wartenberg (1981) proposed the following sequence: primordial germ cells or 
gonocytes give rise to M-prospermatogonia which transform into T2 prosper-
matogonia or fetal spermatogonia via a transitional phase: the T1 prospermato-
gonia. The T2 prospermatogonia transform into the adult A spermatogonial stage. 
Hadziselimovic (1983a) stated that a major problem of this classification of germ 
cell development is that it does not include all types of cells observed in the 
human testis throughout embryonal life and childhood. He proposed a sequence 
of germ cell development, whereby primordial germ cells differentiate into 
gonocytes by entering the testicular cords. The gonocytes attached to the base-
ment membrane give rise to the fetal spermatogonia, while the gonocytes resting 
in the centre of the seminiferous tubules degenerate. Fetal spermatogonia thus 
transform via the transitional type of spermatogonia into A-type spermatogonia 
(AP and AD spermatogonia) and B-type spermatogonia. This transformation 
would take place after birth. From age four he also observed primary spermato-
cytes. Spermatogenesis then ceases, to recommence at puberty (Hadziselimovic 
and Herzog, 1977). Stadtler and Hartmann (1972) observed a linear increase of 
spermatogonia count in the whole prepuberal period. 
1.1.5. Sertoli cells 
The first signs of differentiation of the primitive gonad into a testis is the forma-
tion of cords of primitive Sertoli cells that encompass germ cells (Jost et al., 1974). 
There is substantial evidence that after cord formation the Sertoli cell takes an 
active part in germ cell differentiation (Wartenberg, 1978) and somatic sex differ-
entiation (anti-Mullerian hormone; see 3.1.4.). Hadziselimovic (1983a) described 
the Sertoli cell in the first year of life as the most common cell in the seminiferous 
tubule. From the first to the fourth year, a transformation takes place from fetal 
Sertoli cells into Sa- and Sb-type cells. The Sa-type cell is the most common of the 
Sertoli cells in children. In the fourth year, Sb-type Sertoli cells appear in increas-
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ing numbers simultaneous with the appearance of the 8-spermatogonia and pri-
mary spermatocytes. During puberty, increased gonadotropin and testosterone 
stimulation causes the Sertoli cells to mature and increase in size, resulting in a 
transition to the Sc-type cells. In connection with the Sertoli cell maturation, 
Ritzen and coworkers (1981) described the formation of special inter-Sertoli-cell, 
tight junctions which constitute a major component of the functional blood-
testis barrier. The adult Sertoli cells have a number of other important functions 
including the production of unique proteins that are secreted in the seminiferous 
tubular lumen (Bardin and Paulsen, 1981). The first secretory protein to be charac-
terized as deriving from the Sertoli cell was the testicular androgen-binding 
protein (ABP). ABP has been detected in various concentrations in several spe-
cies, but so far conclusive evidence for human ABP is lacking. Increased under-
standing of the hormonal control of Sertoli cells was derived from animal studies 
of this protein. The Sertoli cell is also the most likely site of origin for a water 
soluble testicular product: inhibin. The effect of inhibin is usually felt to be speci-
fic for inhibition of FSH release but it is difficult to exclude an effect of inhibin on 
LH secretion (Bardin and Paulsen, 1981). A few other specific hormones have 
been identified as secretory products of the Sertoli cell in the postnatal testis. 
Several animal studies have revealed that the Sertoli cell is a major target for FSH 
and androgens in the testis. There were indications that these two hormones, 
known to be of decisive importance for spermatogenesis, exert at least part of 
their influence through the Sertoli cells (Ritzen et al., 1981). 
1.1.6. Leydig cells 
Early development of Leydig cells and their activity in fetal human testes is 
well-documented. Among others, Holstein et al., (1971) investigated Leydig cell 
development in embryos and fetuses from the 7th to the 22nd week of gestation 
and found that the Leydig cells start to differentiate from mesenchymal cells at 
the beginning of the eighth week of gestation. These mesenchymal cells are 
derived from the coelomic epitheloid cells, which may proliferate and loose their 
epitheloid character. In the human fetal testis, the period characterized by a 
highly developed interstitial cell system lasts from the 8th to the 18th week. At 
about the 14th week, it has reached maximum expansion and constitutes more 
than 50% of the testicular volume (Holstein et al., 1971). In this period, the same 
author found a highly developed endoplasmic reticulum in fetal Leydig cells, 
characteristic for steroid-producing cells. After the 15th week, there is a gradual 
regression of Leydig cells and at birth or a few months later, the intertubular 
space in the human testis is devoid of Leydig cells (Wartenberg, 1981). However, 
Hadziselimovic observed fetal Leydig cells in human testes up till the second year 
of life. He reported that the interstitium contains mainly precursors of Leydig cells 
up till puberty but occasionally, particulary between the age of four and eight 
years, he found juvenile Leydig cells grouped around the vessels (Hadziselimovic, 
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1983•). Hayashi and Harrison (1971) also found Leydig cells in prepuberal human 
testes up till one year of age. He observed that they disappear completely by the 
fifth year of age to reappear in quantity around the eighth year. According to 
Hadziselimovic (1983•) a renewed differentiation of Leydig cells takes place at the 
onset of puberty. The puberal Leydig cells are well developed with a remarkable 
increase in the amount of smooth endoplasmic reticulum. The initial differentia-
tion of Leydig cells is an autonomous fetal occurrence, but the subsequent 
maintenance, proliferation, and regression of these cells is under gonadotropic 
control (see 3.1.). 
1.1.7. Peritubular cell system 
The peritubular cells are assumed to arise from the intertubular mesenchymal 
cells, which are derived from the coelomic epitheloid cells. Wartenberg (1978) 
described a peritubular sheet of epitheloid cells coinciding with the appearance 
of transitional prospermatogonia in the tubuli. The peritubular cells form a 
multi-layered envelope which is different from the characteristic composition in 
the lamina propria of the adult testis. According to Burgos and coworkers (1970) 
the peritubular tissue or lamina propria of the seminiferous tubules in the adult 
testis comprises a basement membrane plus a framework of fibres and cells which 
support the germinal epithelium. 
1.2. DEVElOPMENT OF THE MAlE GENITAl TRACT 
1.2.1. Upper portion of the male genital tract 
The mesonephros (or Wolffian body) is derived from the intermediate meso-
derm located on the posterior abdominal wall. Figure 1.2. is a schematic presenta-
tion of the anatomic relationship of the undifferentiated urogenital excretory 
system. Differentiation of the mesonephros, containing the Wolffian tubules, 
begins in the first week. In the cross-section, the mesonephros appears to be a 
mass projecting into the peritoneal cavity. The urogenital cord, containing the 
Wolffian or mesonephric duct, is attached to the anterolateral edge of the 
mesonephros by the urogenital mesentery. At a later stage (about 10 mm CR 
length) it also contains the Mullerian or paramesonephric duct. The gonadal 
primordium is attached to its antero-internal side by the gonadal mesentery. 
Posteriorly it is attached to the dorsal body wall by the Wolffian body mesentery. 
The inguinal ligament is formed by a band of mesenchyme from the caudal end 
of the mesonephros to the genital swellings. The urogenital mesentery and the 
Wolffian mesentery extend upward above the mesonephros to form the dia-
phragmatic or suspensory ligament. 
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Figure 1.2. Anatomic relationship of undifferentiated urogenital excretory system (modified from 
Tuchmann-Duplessis and Haegel, 1974). 
Figure 1.3. shows the differentiated male urogenital excretory system. Re-
gression of the Wollfian body starts at eight weeks, to be completed by the end of 
the fourth month. The inguinal ligament now becomes part of a whole mesen-
chymal column with the testis at the apex extending to the genital swellings, the 
gubernaculum testis. Regression of the Mullerian duct occurs at 11 weeks. The 
remaining vestiges of the Mullerian duct are the appendix testis at the cranial end 
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Figure 1.3. Differentiated male urogenital excretory system (Tuchmann-Duplessis and Haegel, 
1974; with permission). 
and the prostatic utricle at the opposite end. At 14 weeks (CR length 90 mm), the 
cranial part of each mesonephric duct becomes connected to the seminiferous 
tubules through the vasa efferentia and the rete testis. The portion of the meso-
nephric duct opposite the testis becomes greatly elongated and convoluted to 
form the epididymis. The appendix epididymis is formed at the most cranial end 
of the epididymis. Below the epididymis, certain isolated mesonephric tubules 
form the paradidymis (not shown in figure). At a later stage, the remainder of the 
Wolffian duct adopts a thick muscular coat to become the ductus deferens. The 
seminal vesicles are formed at the distal end of the ductus deferens. Caudally the 
ductus deferens becomes the ejaculatory duct. The utriculus prostaticus arises 
between the two ejaculatory ducts. 
1.2.2. Lower portion of the male genital tract 
The development of the lower portion of the male genital tract is schematically 
presented in figure 1.4. During early development, the cloacal membrane is 
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Figure 1.4. Development of the lower portion of the male genital tract. 
formed at the caudal end of the embryonic disc where the ectoderm and the 
entoderm remain in contact. The cloaca can be defined as the space into which 
the hindgut, the urogenital sinus and the tailgut end. The two Wolffian ducts 
terminate in the urogenital sinus on the dorsal side. The urogenital sinus and 
hindgut are separated by a mesenchymal column, the urorectal region, which 
erroneously has been described as a septum (Van der Putte, 1986). The genital 
tubercle develops above the cloacal membrane. The straightening of the 
embryo, the outgrowth of the genital tubeFcle and the disappearance of the 
tailgut may create the impression that the urorectal region "descends". The 
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genital folds and genital swellings develop on both sides of the cloacal mem-
brane. At approximately eight weeks, the posterior portion of the cloacal mem-
brane becomes thinner to rupture at approximately ten weeks. The urogenital 
sinus and hindgut are now open to the amniotic cavity. The perineum is formed 
from the entodermal epithelium lining the urorectal region. At ten weeks, the 
genital tubercle elongates, forming the glans penis. The urethral plate develops 
from the distal part of the ventral wall of the urogenital sinus and grows out at the 
ventral side of the genital tubercle subsequently forming the urethra. The genital 
folds form the shaft of the penis and the genital swellings develop into the 
scrotum. The orifice of the urethra shifts from the ventral side to the top of the 
genital tubercle. The raphe is then formed from the basal part of the urorectal 
region. The prostate develops from the entodermal epithelium of the dorsal wall 
of the urogenital sinus. 
1.3. TESTICULAR DESCENT 
The descent of the testis may be divided into two phases: 
- the first phase of descent or intra-abdominal descent; 
- the second phase of descent, or "true descent", during which the testis 
emerges from the inguinal canal and into the scrotum. 
1.3.1. First phase of descent 
Many authors, including Habenicht and Neumann (1983), cite the theories of 
Gier and Marion (1970) who divided this phase of descent into two stages: 
- nephric displacement; this stage is closely related to the degeneration of the 
mesonephros. The metanephros grows rapidly in size and migrates in an 
anterior direction, dorsal to the mesonephros. In the process, the meta-
nephros forces the mesonephric remnants and the gonads to move further 
caudally. In man, this stage is completed by the eighth gestational week; 
- transabdominal movement; the decisive factor for this stage of descent is the 
increase in coelomic fluid pressure and its transmission to the testis via the 
gubernaculum. 
In his differential growth theory, Hart (1909) surmised that testicular descent 
occurs as a rapid growth of the body wall in relation to the diminished growth of 
the relatively immobile gubernaculum. As a result, the testis assumes an inguinal 
position and in the second phase of descent it is drawn into the scrotum. In 
contrast, lemeh (1960) found that the gubernaculum increases in size faster than 
the body as a whole. Backhouse (1982•) described the formation of the inguinal 
gap in the first stage of testicular descent. This gap is the place where the plica 
gubernaculi meets the abdominal wall and no muscle cells are formed. This 
eventually becomes the inguinal canal. He was very explicit about the develop-
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ment of the cremaster muscle which, in his opinion, originates later and apart 
from the abdominal wall muscles. He disagreed with the theory that the cremas-
ter muscle grows up towards the testis and by contracting pulls the testis into the 
scrotum (Backhouse, 1965). He further described the developing processus vagi-
nalis as an extension of the peritoneal cavity; a diverticulum from the coelom, 
which forms a shallow gutter around the gubernacular column at its attachment 
to the anterior abdominal wall. Neither the cremaster muscle nor the processus 
continues to grow much at this stage of descent. According to Backhouse (1982•) 
the first stage of descent "is more a question of the gonad retaining its link 
through the mesonephric duct (vas deferens) and the gubernaculum with the 
bladder and the anterior wall whilst the rest of the fetus grows in length leaving 
the gonad behind." 
1.3.2. Second phase (true descent) 
In the seventh month the testis passes through the inguinal canal. Normally it 
reaches the scrotal sac by the end of the eighth month (Hamilton and Mossman, 
1978). Most investigators agree that the gubernaculum plays an important part. 
There is, however, no consensus of opinion regarding the morphological charac-
ter of the gubernaculum and the precise role in the mechanism of descent. John 
Hunter (1762) was the first person to describe the pattern of testicular descent 
with emphasis on the gubernaculum. To him we owe the name of the gubernacu-
lum (=the Latin name for shipshelm). He is very cautious in his description ofthe 
structure and function of what he called a ligament, which connects the testis 
with the scrotum and directs its course in its descent. He described the nature of 
the gubernaculum as vascular and fibrous, with the fibres running in the direction 
of the ligament itself, which is covered by the fibres of the cremaster or musculus 
testis. Backhouse (1965) described the gubernaculum as a mesenchymatous 
column, which during the time of descent increases in bulk and in the scrotum 
comes to resemble Wharton's jelly. Other authors described the gubernaculum 
as a fibromuscular or muscular cord (Sonneland, 1925; Lemeh, 1960). In animal 
studies, likewise, the gubernaculum is frequently described as having muscular 
or fibromuscular components (Eiger et al., 1977; Radhakrishnan and Donahoe, 
1981; Elder et al., 1982; Somerville et al., 1983), thus claiming that at least in some 
animals the gubernaculum is a contractile organ. On the other hand, Wensing 
and Colenbrander (1977) found that the gubernaculum in pigs and other mam-
mals had a mesenchymal structure only. It may be that some authors saw the 
cremaster muscle as part of the gubernaculum, situated peripherally, describing 
these structures as one and the same organ. Lemeh (1960), for example, observed 
that the internal abdominal oblique muscle layer gives off skeletal fibre bundles 
which surround and blend with the inguinal ligament of the mesonephros (= 
gubernaculum testis). Elder et al. (1982) stated that the muscular investment of the 
gubernaculum becomes the cremaster layer of the scrotum. Apart from the 
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confusion caused by divergent descriptions of the gubernaculum, there is con-
troversy concerning the precise role of the gubernaculum in the mechanism of 
descent. 
Backhouse (1982b) is frequently quoted in his description of testicular descent. 
In his opinion (figure 1.5.), the gubernacular mesenchyme increases in bulk 
particularly within the scrotum. There is a rapid growth and extension distally of 
the cremaster muscle close to the outer surface. The processus vaginalis also 
extends rapidly, distally in the gubernacular mesenchyme, separating this into a 
central core and a thin tube outside the processus· containing the cremaster 
muscle. The gubernacular mesenchyme shortens and the apical testis can slip 
through the canal possibly assisted by intra-abdominal pressure. The vas deferens 
and the testicular vessels grow rapidly in length. Once descent has been complet-
ed, the gubernaculum ceases to have a function and differentiates into fasciae 
found in relation to the testis and epididymis, the internal and external spermatic 
fasciae. 
Other theories were offered for the final phase of descent. Some of them were 
also suggested for the first phase of descent: 
- the traction-theory of the gubernaculum (Sonneland, 1925; Radhakrishnan 
and Donahoe, 1981; Somerville et al., 1983). This theory was already question-
ed in 1943 by Wyndham, who stated that the flimsy attachment of the 
gubernaculum to the scrotum is an obstacle exerting much traction on the 
testis; 
- the differential growth theory (Hart, 1909, see first phase of descent); 
- ACTIVE GROWTH 
- EPITHELIAL INVASION 
M. CREMASTER 
INGUINAL LIG.~~~ 
PUBIS---
Figure 1.5. A schematic representation of the patterns of growth related to testicular descent. The 
dots on the gubernaculum are an indication of cell population of the region, i.e., much 
more intercellular swelling in the scrotum than close to the testis (Backhouse, 1982b; 
with permission). 
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- the intra-abdominal pressure theory (Gier and Marion, 1970). This also applied 
to the first phase of descent; 
- the balloon theory of the gubernaculum, which was described by Wensing 
and Colenbrander (1977). In animal studies, including the pig, the extra-
abdominal or distal part of the gubernaculum increases enormously both in 
length and volume, as the intra-abdominal part decreases, which then be-
comes incorporated in the extra-abdominal part. Next, the testis is pulled into 
the inguinal canal. The subsequent gubernacular regression enables the testis 
to descend further and this can therefore be considered as the causal factor 
for the second phase of the process of descent. The degeneration and disap-
pearance of the gubernaculum was also described by others (Rajfer and 
Walsh, 1978) as cause of testicular descent. 
Some authors stress the importance of the epididymis in testicular descent 
without describing its precise role in the mechanism of descent. The need for 
migration of the cauda epididymis (the sperm-storage region) to this cooler 
location was suggested (Bedford, 1978). Another indication was the finding of a 
huge percentage of epididymal anomalies found at operation in patients with 
undescended testes, which might indicate a significant role for the epididymis in 
testicular descent (Mininberg and Schlossberg, 1983). On the other hand, it might 
be that failure of descent results in epididymal malformation or, alternatively, that 
the same agent causes failure of descent as well as epididymal malformation. 
1.4. POSTNATAL ANATOMICAL STRUCTURES 
1.4.1. Inguinal region and scrotum 
a. Subcutaneous fasciae of the inguinal region 
The subcutaneous fasciae of the inguinal region originate as a membranous 
portion of the superficial fasciae of the abdominal wall consisting of Camper's 
fascia -the superficial layer- and Scarpa's fascia- the deeper part (Anson and 
McVay, 1971). For a description of Camper's fascia we refer to the textbooks of 
anatomy. As for Scarpa's fascia, this deeper layer gradually merges into the 
subcutaneous fat in the upper abdomen where it can no longer be identified as a 
distinct membranous structure. In the lower inguinal region, Scarpa's fascia is 
attached to the inguinal ligament and to the fascia lata of the upper thigh just 
below this ligament. Passing over the superficial inguinal ring, it continues 
downward along the penis and the scrotum into the perineum. In the region of 
the perineum it is continuous with Colles' fascia. In the scrotum it becomes re-
inforced with smooth muscle fibres and because of its flayed appearance it then 
becomes known as tunica dartos (McGregor, 1929; Netter, 1961) (figure 1.6.).1n 
infancy, Scarpa's fascia is very thick and consequently falsely identified at times as 
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the aponeurosis of the musculus obliquus externus abdominis. Contraction of 
the cremasteric muscle causes the scrotal testis to retract to a recess between 
Scarpa's fascia and the external oblique muscle, lateral to the superficial inguinal 
ring. This recess is called the "superficial inguinal pouch" (Browne, 1938; Scorer, 
1962; Flach, 1977). 
B-ro'-,ef! lir-e ,r,dKCTlf~ line oF 
Ctfltlcilmcrff of Colle~· and 
So::aF,..,o·~ Fo~iot 
Figure 1.6. Fascial support of the inguinal region (Netter, 1961; with permission) 
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b. Abdominal wall and inguinal canal 
The external oblique muscle becomes tendinous as it envelops the inguina-
abdominal region. Its caudal fibres form the inguinal ligament, which is a thin 
curved structure ending in a free edge. The inguinal portion of the internal 
oblique muscle originates in the iliopsoas muscle beneath the lateral third of the 
inguinal ligament. The upper fibres have a common insertion into the linea alba. 
The caudal fibres continue down to insert into the body of the pubic bone. The 
origin of the transversus abdominis muscle is identical to that of the overlying 
internal oblique muscle, arising from the iliopsoas muscle. The transversus mus-
cle fibres combine with those of the overlying internal oblique muscle to form 
the anterior rectus sheath, while some fibres pass along the pubic crest to insert 
into the pubic bone. 
The transversalis fascia is the fascial layer of the transversus abdominis muscle 
and its aponeurosis. The term transversalis fascia applies only to the fascial lamina 
that invests the deep or inner surface of the transverse abdominal muscle and its 
aponeurosis (Anson and McVay, 1971). The inguinal canal is an oblique cleft in 
the abdominal wall above the medial half of the inguinal ligament. The inlet of 
the canal, consisting of the annulus internus or deep (internal) inguinal ring, is 
located in this transversalis fascia a little above the centre of the inguinal ligament. 
The outlet, consisting of the annulus extern us or superficial (external) inguinal 
ring, is a gap in the aponeurosis of the external oblique muscle. The superior or 
deep end of the canal is lateral to the inferior or superficial end. 
c. Scrotum 
The scrotum is a cutaneous pouch containing the testes and parts of the 
spermatic cords. On the surface it is divided into two lateral portions by a raphe, 
which continues ventrally to the undersurface of the penis and dorsally along the 
midline of the perineum to the anus. The scrotal wall consists of two layers, the 
skin and the tunica dartos. The skin is thin and falls into folds or rugae. In the 
tunica dartos a thin layer of nonstriped muscular fibres continues around the base 
of the scrotum together with the two layers of the superficial fascia of the inguinal 
region and the perineum (Scarpa's and Calles' fasciae). Internally, a septum 
divides the scrotal pouch into two cavities, one for each testis. The tunica dartos is 
closely united with the skin though separated from the subjacent parts by a fascial 
cleft upon which it glides with the greatest of ease (Spalteholtz, 1959; Gray, 1985). 
At the scrotal entrance the soft, thin and corrugated skin changes abruptly to 
become the thick elastic skin of the lower abdomen at the upper level of the 
scrotal neck. The scrotal entrance is also called the "third inguinal ring" (McGre-
gor, 1929). 
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1.4.2. Spermatic cord, testis and related structures (figure 1.7.) 
a. Spermatic cord 
The spermatic cord lies in the inguinal canal. It is composed of arteries, veins, 
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Figure 1.7. Spermatic cord, testis and related structures (Netter, 1961; with permission) 
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nerves, lymphatic vessels and the vas deferens. These structures have a common 
covering consisting of several layers: 
- the external spermatic fascia- This outer covering is a thin membrane which 
extends distally over the cord and the testis. At the superficial inguinal ring it is 
continuous with the aponeurosis of the external oblique muscle, separated 
from the tunica dartos by a fascial cleft. 
the cremasteric layer - The middle spermatic layer is called the cremasteric 
layer (Gray, 1985). It consists of scattered bundles of cremaster muscle held 
together in a continuous membrane by the cremasteric fascia. The cremasteric 
muscle itself consists of loosely arranged muscle fasciculi. The whole muscle 
may be described as forming continuous loops from the middle of the ingui-
nal ligament as far as the tunica vaginal is and then returning to insert into the 
pubic tubercle. Although striated, the fibres of the cremasteric muscle are 
generally not subject to voluntary control. 
the internal spermatic fascia- This fascia is a thin membrane which is contin-
uous with the transversalis fascia at the deep inguinal ring. 
b. Testis 
Ellipsoidal in shape, the testis holds an oblique position in the scrotum, the 
upper extremity tilting antero-laterally and the lower extremity postero-medially. 
The epididymis lies along the lateral part of the posterior border. The fibrous 
covering of the testis is called the tunica albuginea. It is a membrane composed of 
fibrous tissue. At the upper extremity of the testis there is an oval, sessile body, 
which is the appendix of the testis. It is a remnant of the upper end of the 
paramesonephric duct. 
c. Epididymis 
The epididymis consists of a central portion or body with an enlarged upper 
extremity, which is called the head or caput, and a pointed lower extremity, 
which is called the tail or cauda. At the lower extremity of the testis it turns 
upward and gradually merges into the ductus deferens. The head of the epididy-
mis is attached to the upper end of the testis (rete testis) by means of the efferent 
tubules of the gland. The tail is attached to the lower end of the testis by areolar 
connective tissue (Kroovand and Perlmutter, 1981). Between the body of the 
epididymis and the testis there is a pouch, called the digital fossa. In infants, the 
epididymis is relatively longer and larger than in adults, whereby the length of the 
epididymis far surpasses that of the testis, although it is never more than twice the 
length of the testis (Scorer, 1962). Likewise, the digital fossa, which is the space 
between testis and epididymis, is relatively larger in the infant than in the adult 
(0.3-0.45 em), while the epididymis is relatively more mobile (Cooper, 1929). The 
head of the epididymis has a small stalked appendage. 
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d. Vas deferens 
The vas deferens is the continuation of the canal of the epididymis. Commenc-
ing at the tail end of the epididymis, it is first tortuous but becomes gradually less 
twisted as it ascends along the posterior border of the testis and traverses the 
inguinal canal to reach the deep inguinal ring. Here it separates from the other 
structures of the cord and curves around the lateral side of the inferior epigastric 
vessels on its way to the seminal vesicle. 
e. Processus vagina/is peritonei 
The processus vaginalis peritonei is the serous covering of the testis and 
spermatic cord. It is a pouch of serous membrane derived from the peritoneum. 
As the testis and the epididymis descend from their retroperitoneal points of 
origin, they invaginate the cord and gradually merge into the posterior aspect of 
the processus vaginalis, thus becoming enveloped by two layers of this structure 
(Tuchmann-Duplessis and Haegel, 1974; Backhouse, 1981). After its descent, the 
portion of the processus vaginal is that extends from the deep inguinal ring almost 
to the upper part of the testis, becomes obliterated. The lower portion remains as 
a closed sac that invests the testis and may be described as the tunica vaginalis, 
consisting of a visceral and a parietal layer. The visceral layer covers the greater 
part of the testis and epididymis. The parietal layer is more extensive than the 
visceral layer. It may occasionally happen that the processus vaginalis does not 
become obliterated and as such communicates with the tunica vaginalis. This is 
called the hydrocele communicans. 
f. Gubernaculum 
In the fully descended testis, the remnants of the gubernaculum are contin-
uous with the posterior aspect of the testis and the epididymis down to the base 
of the scrotum. The descended testis with its coverings can be lifted out of the 
scrotum without dividing more than a few strands of delicate connective tissue 
(Scorer, 1962). 
g. Vascular anatomy of the testis 
The spermatic artery, which is the main source of blood for the testis, is not an 
end artery. It receives collateral twigs from the artery to the vas deferens and the 
cremasteric artery, and also from the scrotal arteries. The latter are branches of 
the internal and external pudendal arteries at the lower pole of the testis 
(Brendler and Wulfsohn, 1967). Harrison (1949) demonstrated anastomoses be-
tween the vasal artery and the spermatic artery and also showed that no anasto-
motic channels reached the testis independently, always going by way of the 
spermatic artery or its main branches. These findings were confirmed by others 
(Lee et al., 1984) (figure 1.8.). 
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Figure 1.8. Testicular artery injection of the right testis of a paediatric cadaver, 37 weeks gestation. 
Retrograde filling of small cremasteric artery and large vasal artery. CA: cremasteric 
artery; BR: origin of anastomotic branch of testicular artery; VA: vasal artery; AN: 
anastomosis; TA: testicular artery; IR: position of internal ring (Lee et al., 1984; with 
permission). 
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The testicular veins emerge from the back of the testis and unite to form a 
convoluted plexus, the plexus pampiniformis, which constitutes the chief mass of 
the spermatic cord. The vessels composing this plexus are numerous and ascend 
along the cord. On their way through the inguinal canal, they form two or three 
venous trunks at the level of the deep inguinal ring. In the iliolumbar region, 
these venous trunks are reduced to two veins to become one vein in the lumbar 
region entering the inferior caval vein (Bensussan and Huguet, 1984; Gray, 1985). 
The spermatic vessels course obliquely downward lateral from the renal area to 
exit through the internal inguinal ring. Proximal to the inguinal ring, as viewed 
from the sagittal plane, these vessels angulate exteriorly to reach the deep 
inguinal ring whereupon they course postero-medially through the inguinal 
canal. Throughout their course, the spermatic vessels are enveloped in the 
transversalis fascia. This fascia is continuous with Gerota's fascia and as such also 
envelops the ureter (Prentiss et al., 1960). In the inguinal canal it becomes the 
internal spermatic fascia. 
1.5. MOTIVATION FOR STUDYING CRYPTORCHIDISM 
1.5.1. Introduction 
In the last few decades it has been assumed that a disturbance of testicular 
descent has a multicausal genesis with a growing emphasis on the hormonal 
process that influences testicular descent. Intra-uterine hormonal dysfunction is 
considered to be a major cause of failure of testicular descent. Treatment for 
undescended testes has since long consisted of surgical intervention, but hor-
monal treatment has been gaining ground, particularly in the last ten years. 
It is by no means easy to make the correct diagnosis in case of an apparently 
undescended testis. Physical examination of prepuberal boys is particularly 
difficult where the testis is concerned due to the contractions of the cremaster 
muscle. This is one of the reasons why the incidence of undescended testes, 
generally based on transversal studies, is unclear. Longterm, longitudinal studies 
have seldom been carried out. Apart from that, there is a great deal of confusion 
concerning diagnosis and nomenclature of the undescended testis. 
Before deciding on the treatment of choice, one has to decide WHY unde-
scended testes have to be treated. Failure to treat undescended testes carries an 
increased risk of infertility, malignant degeneration, and a disturbance of the 
psychosexual development. Once the diagnosis of undescended testes has been 
reached, one has to decide HOW this should be treated. We now have a choice of 
either hormonal or surgical treatment. The pros and cons of both therapeutic 
modalities have to be weighed carefully before making a decision. And finally, 
one has to decide WHEN treatment should take place. There is still no consensus 
of opinion concerning that point. In recent years the importance of early treat-
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ment, preferably around the second year of life, has been emphasized by several 
authors. The main argument for early treatment concerns irreversible histological 
changes that might occur in the germinal epithelium of the undescended testis. 
Apart from that, early treatment is supposed to have a favourable effect on the 
potential fertility of the undescended testis. This premise has not been substan-
tiated. 
1.5.2. Definitions 
In order to avoid confusion concerning the nomenclature of cryptorchidism in 
this treatise, we have drawn up definitions for the various types of undescended 
testes. Both nomenclature and diagnosis will be dealt with in detail in chapter 2, 
but our definitions are summarized as follows: 
Cryptorchidism - This term is used as a general designation describing any 
nonscrotal testis that cannot be manipulated into a stable scrotal position. The 
word "cryptorchidism" is interchangeable with "undescended testis". 
Retractile testis - This is a completely descended and normally developed testis 
that can be lifted out of a stable scrotal position by the cremasteric reflex, 
whereby it moves over the pubic bone and into a stable subcutaneous position in 
the inguinal region. 
Cryptorchid testes (undescended testes)- These testes can be subdivided into: 
- incompletely descended testes. These testes always have a stable position 
somewhere in the path of normal descent. They may be capable of manipula-
tion into the scrotum, but if so they will never remain there of their own 
accord. 
- ectopic testes. These are testes that have assumed a position outside the 
normal path of descent, but this position is always subcutaneous. 
1.5.3. Aims of the studies 
Our interest was aroused by reports of the new hormonal treatment of boys 
with undescended testes by means of luteinizing-hormone-releasing hormone 
(LHRH) nasal spray.ln the beginning of 1982, we decided to carry out a pilot study 
to investigate the efficacy of LHRH nasal spray. The pilot study created great 
expectations for this therapeutic modality, but also posed a number of questions 
indicating the need for further investigation. Consequently, the pilot study 
formed the basis for a number of clinical studies that we initiated in prepuberal 
boys with either unilateral or bilateral undescended testes, to find answers to the 
following questions: 
1. What is the normal development and anatomy of the testis and male genital 
region in general and how does normal testicular descent proceed? This question 
was answered in the preceding paragraphs. 
2. A multiple question, concerning the diagnosis of cryptorchidism: 
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- How should the various forms of cryptorchidism be defined? 
How should the physical examination of a cryptorchid boy be carried out? 
- How should the findings of the physical examination be recorded to be of 
use at subsequent examinations? 
These aspects will be dealt with in chapter 2. 
3. Recent clinical and experimental studies reported in the literature, indicate 
that a (transient) functional insufficiency of the hypothalamo-pituitary-
gonadal axis is an important factor in the pathogenesis of cryptorchidism. 
This insufficiency, found in cryptorchid boys in the first year of life, seems to 
argue for hormonal treatment of cryptorchidism. In this connection we were 
faced with the following questions: 
Is hormonal failure a causative factor in testicular non-descent? 
- What hormonal abnormalities may be associated with cryptorchidism? 
Is there a difference in the hormonal values from birth till puberty 
between boys with undescended testes and boys with normal testicular 
descent? 
- Does spontaneous, albeit delayed, testicular descent occur during the 
(entire) first year of life? 
Is there a demonstrable (transient) functional insufficiency of the 
hypothalamo-pituitary-gonadal axis in boys with unilateral or bilateral 
cryptorchidism during their first year of life? 
- Do cryptorchid boys suffer from either a disturbance of the biosynthesis 
of testosterone or an enzymatic inhibition? 
Chapter 3 attempts to answer these questions. 
4. What kind of hormonal treatment is available for boys with undescended 
testes and which seems to be the most successful according to the literature? 
Literature data and the results of our pilot study indicated a certain measure 
of success for LHRH nasal spray. With a double-blind, placebo-controlled 
study we attempted to find an answer to the following questions: 
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- How effective is LHRH nasal spray treatment and is there a relation 
between success of treatment and age at treatment? 
- Can the mode of action of LHRH nasal spray be determined by means of 
hormonal evaluation? 
- Are the results of such hormonal evaluation of any prognostic value 
where LHRH treatment is concerned? 
Other questions arose in the course of this study: 
- Provided information can be obtained concerning previous testicular 
position (from birth), can a relationship be found between that informa-
tion and the results of hormonal treatment? 
- Would a difference in absorption of the LHRH nasal spray account for the 
reaction of this spray being less pronounced in younger than in older 
boys? 
Is there a demonstrable mode of action of LHRH nasal spray? 
All these aspects are dealt with in chapter 4. 
5. Does failure of testicular descent have a mechanical cause rather than a 
hormonal one? If so, how does the microscopical and macroscopical anat-
omy of the undescended testis (and surrounding structures) differ from that 
of a normally descended testis? Other questions in this connection are: 
Is there an increased risk of malignant degeneration of the (previously) 
undescended testis? 
- Is there a relation between infertility and cryptorchidism? 
- What are the psychosexual implications of cryptorchidism? 
- What anatomical anomalies may be associated with cryptorchidism? 
- What kind of surgical procedures can be employed in the treatment of 
undescended testes and what are the results of these procedures as 
reported in the literature? 
Chapter 5 attempts to answer these questions. 
6. Retractile testes are often incorrectly diagnosed as incompletely descended 
and unnecessarily subjected to surgery. 
- How should retractile testes be treated? 
Management of the impalpable testis merits a special place in the surgical 
treatment of undescended testes. 
- What diagnostic procedures should be employed in case of impalpable 
testes? 
- Is hormonal treatment ever indicated for impalpable testes? 
- What is the correct surgical procedure for impalpable testes? 
The boys whose testes failed to descend as a result of LHRH nasal spray in the 
abovementioned double-blind, placebo-controlled study, all underwent 
surgery. 
- Were there any anatomical anomalies in these boys that would explain the 
failure of hormonal treatment? 
- What is the procedure of choice in relation to testicular position found at 
surgery? 
- What are the specific indications for or against a certain surgical proce-
dure? 
- What complications may occur as a result of surgical treatment? 
Is there a relation between age at surgery and the occurrence of complica-
tions? 
Is there a relation between success of surgical treatment and age at 
treatment? 
The above is dealt with in chapter 6. 
7. Would the clinical studies furnish answers to the three questions posed in the 
paragraph on motivation (1.5.1.)?: 
- WHY, HOW, WHEN? 
If so, what protocol should be adopted for the treatment of undescended 
testes in the Sophia Children's Hospital? 
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Chapters 1 and 2 were written by the two authors in conjunction and both of 
them are responsible for these chapters. In contrast, chapters 3 through 6 were 
not written in conjunction, even though the clinical studies described in these 
chapters may have involved a certain measure of concerted effort. Category A of 
the clinical studies, involving chapters 3 and 4, represents the work carried out by 
S.M.P.F. de Muinck Keizer-Schrama. The general discussion that concludes this 
section is entirely her concern. Category B, involving chapters 5 and 6, represents 
the work carried out by F.W.J. Hazebroek. The general discussion at the end of 
this section is entirely his concern. Chapter 7 and the answers it attempts to 
provide once again represent a concerted effort. 
60 
CHAPTER2 
INTRODUCTION TO OUR CLINICAL STUDIES 
2.1. GUIDELINES FOR THE CLINICAL STUDIES 
The clinical studies were initiated in 1982 on the understanding that they would 
be concluded in three years. The studies would be mainly prospective with a few 
exceptions, e.g. when retrospective evaluation was required. For the double-
blind, placebo-controlled study the population would be limited to 252 patients. 
While a time limit (mid 1985) was set for the evaluation of the first year of life as 
well as the surgical studies, the follow-up would be extended to include up-to-
date information in this dissertation. 
No clinical study would be started before obtaining the approval of the 
medical-ethical commission of the University Hospital Rotterdam, Erasmus Uni-
versity School of Medicine. 
Before any procedure was initiated, every effort would be made to explain this 
procedure to the boy and his parents in as great a detail as possible, so that 
informed consent could be obtained from the parents. 
The children would always be examined by each one of us separately (to 
enable an unprejudiced opinion) following a standard diagnostic procedure (see 
2.3.). ,The boys would always be confronted by these same two doctors only in 
order to create mutual trust, which would be beneficial to the proceedings. 
Patient data would be recorded on specially designed standardized case report 
forms, in particular for the double-blind, placebo-controlled study. The first two 
pages were devoted to the medical history of the patient and his family, to be 
filled out at the boy's first visit to our outpatient clinic. The following pages served 
to record the findings at the first and subsequent physical examinations. The page 
designed for registration of the spontaneous and most caudal position of the 
testis was used for all patients in all the studies. For the surgical interventions, case 
notes would be recorded on separate, surgical report forms. Samples of all case 
report forms are included as an appendix to this chapter. 
Grants from the Sophia Foundation for Medical Research (project no 40) and 
Hoechst Holland would ensure financial support for the studies. The hormonal 
preparation Cryptocur® would be supplied free of charge by the medical 
department of Hoechst Holland. 
61 
2.2. CLASSIFICATION OF CRYPTORCHIDISM 
Identical methods of treatment for undescended testes, for example with 
LHRH nasal spray, appear to have strongly divergent results (Karpe et al., 1983; 
Hadziselimovic et al., 1984). This divergence in the results of treatment is mainly 
due to the fact that many studies fail to give a clear definition of normally 
descended or undescended testes. As a result, boys with retractile testes may 
sometimes be included in the treatment protocol (Karpe et al., 1983; Wit et al., 
1985; Rajfer et al., 1986). Uniformity in classification and diagnosis of cryptor-
chidism is essential, but this can only be achieved if the various forms of cryptor-
chidism have been clearly defined. Reporting the results of his study, Schoorl 
(1982) stressed the importance of uniformity in classification and diagnosis for the 
following pertinent reasons:"to facilitate a discussion of the identical topograph-
ical anatomy of the testis and because the treatment and prognosis will differ 
for each type of undescended testis. For the adult male, this prognosis will 
concern the ultimate location of the testis and the fertility". It is a well known fact 
that the higher the position of the testis, the greater the extent of histological 
abnormality in this testis (Dougall et al., 1974; Nistal et al., 1985). 
We drew up a system of classification and a procedure for physical examination 
of boys with undescended testes based on the following: 
1. Clinical data resulting from our pilot study of the efficacy of LHRH nasal 
spray. 
2. Data reported in the literature concerning studies carried out by others 
(Browne, 1938; Scorer and Farrington, 1971; Lipshultz, 1976; Wyllie, 1978, 
Schoorl, 1982; Wyllie, 1984). 
2.2.1. Definition of cryptorchidism 
The term "cryptorchid" comes from two Greek words, "cryptos" meaning 
hidden, and "orchis" meaning testis. In other words, cryptorchid means literally 
hidden, unperceivable testis. However, in the literature, and consequently also in 
this dissertation, the term is used in a general sense describing any nonscrotal 
testis that cannot be manipulated into a stable scrotal position. The word "crypt-
orchidism" can be used interchangeably with "undescended testis". In the light 
of normal testicular descent, the concept of testicular positions can be subdi-
vided into: 
a. scrotal testes; 
b. retractile testes; 
c. cryptorchid (undescended) testes, consisting of: 
- incompletely descended testes; 
- ectopic testes. 
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2.2.2. Definition and movability of the retractile testis 
Retractile testes are testes that have a range of movement from the scrotum to 
the inguinal region. The testes are capable of normal descent, but due to an 
overactive cremasteric reflex they are more mobile than normally descended 
testes. The cremasteric reflex enables retraction from the scrotum over the bar of 
the pubic bone and into the superficial inguinal pouch, where the testis may 
reside for lengthy periods. In newborns, the cremasteric reflex is absent and at 
that stage the retractile testis can only be moved out of the scrotum by manipula-
tion (Scorer, 1962; Farrington, 1968). After puberty, when the cremasteric reflex 
no longer exists, the testis only has a range of movement from the bottom to the 
entrance of the scrotum according to the contractility of the cremasteric muscle 
and more particularly from the dartos muscle (Browne, 1938). 
2.2.3. Definition and movability of the incompletely descended testis 
The incompletely descended testis has assumed a permanent position some-
where within the normal path of testicular descent and is either incapable of 
manipulation into the scrotum, or capable of being brought down into the 
scrotum with gentle pressure but incapable of remaining there of its own accord. 
Movability of the incompletely descended testis ranges from its position at rest to 
its most caudal position. The position at rest is the position assumed by the testis 
of its own accord when it is not being manipulated during clinical examination. 
The most caudal position is the closest the testis can be brought to the scrotum 
with gentle, never painful, pressure in a caudal direction. The movability of the 
incompletely descended testis is always limited, depending on the one hand on 
the extent to which gubernaculum and processus vaginal is reach the scrotum and 
on the other hand on the position of the testis at rest (Browne, 1938; Scorer, 1962). 
2.2.4. Definition and movability of the ectopic testis 
The ectopic testis is a testis that has assumed a position outside the normal path 
of testicular descent after having passed the inguinal canal. The differential 
diagnosis includes the extremely rare perineal, femoral, peno-scrotal or crossed-
ectopic testicular position as well as the frequently found superficial inguinal, 
ectopic testicular position, which is also referred to as the "obstructed" testis as 
this testis seems to be affixed to the inguina I region (Scorer and Farrington, 1971 ). 
The movability of all ectopic testes is always limited in the direction of the 
scrotum, while their palpability is always good due to their subcutaneous posi-
tion. 
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2.3. DIAGNOSIS OF CRYPTORCHIDISM 
2.3.1. Incidence of cryptorchidism 
According to several authors (Buemann et al., 1961; Villumsen and Zachau, 
1966; Hi rasing etal., 1982) the incidence offailure oftesticular descent in the full-term 
neonate amounts to 2-3%, while the incidence in the pre-term infant approaches 
30% (Scorer and Farrington, 1971). The smaller the size of the premature infant, 
the higher the incidence of cryptorchidism (Scorer, 1964). Those testes that will 
spontaneously descend postnatally will do so during the first year of life and by 
one year of age the incidence of cryptorchidism approximates 0.8% (Buemann et 
al., 1961; Scorer, 1964). The diagnosis of cryptorchidism can be difficult between 
the first year of life and puberty because the cremasteric reflex, which is almost 
absent in early infancy, may become very strong and a descended testis may 
retract completely out of the scrotum. Ward and Hunter (1960) found that 
approximately 6% of boys aged 5-11 years appeared to have undescended testes 
at scrupulous examination. At puberty, this figure dropped to less than 1% with 
the decrease in strength of the cremasteric reflex (Baumrucker, 1946; Cour-
Palais, 1966; Villumsen and Zachau, 1966). None of these figures should be taken 
at face value as all studies were transversal, involving a diversity of study popula-
tions and divers examiners. Longitudinal investigation, such as the recent study of 
Van Gelderen and Vermeer (1986), may provide a better insight into the true 
prevalence of cryptorchidism. 
2.3.2. Physical examination of the cryptorchid boy 
It is essential to create a certain measure of trust between examiner and child 
before the examination actually takes place. Consequently, it would be wrong to 
have the child undress before the two have become acquainted. First of all, the 
boy has to be reassured. By explaining the purpose and procedure of the 
examination in a few well-chosen words to both parents and child, much of the 
anxiety that they undoubtedly feel can be removed. The room in which the 
examination takes place should be well heated, while the examination table 
should be placed full-length against the wall. Even though the examination 
mainly concerns the genital region, the general physical and mental condition of 
the child should be considered in order not to miss other associated anomalies 
that may prove significant in reaching the diagnosis of cryptorchidism. 
The examination of the genital region should always begin with the boy in a 
supine position with at least the entire lower half of the body undressed. Both 
inguinal regions and the external genitals are subjected to a close inspection in an 
attempt to locate the spontaneous testicular position (figure 2.1.). Subsequently, 
the examiner places index finger and thumb of the right hand on the two sides of 
the inguinal canal so that it becomes impossible for testes lying distally from the 
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Figure 2.1. Spontaneous position of testes. Five year old boy with his left testis in a subcutaneous 
position outside the inguinal canal. 
inguinal canal to withdraw to the inguinal region during careful palpation of the 
scrotum. With the examiner standing to the right of the patient, the inguinal 
region is then carefully palpated with the examiner's left hand. This palpation 
should be carried out with the fingertips and the hand should be warm.lf a testis 
is not located in the scrotum, an attempt should be made to locate it in the 
inguinal region. If a palpable testis is located in the inguinal region, the movability 
of this testis is assessed, again with the tips of the finger only. As if they are playing 
a piano, the fingertips gently push the testis in the direction of the scrotum as far 
as it will go (figure 2.2.). Once the testis has reached its most caudal position, it is 
held there for a while using gentle traction in an attempt to relax the cremasteric 
muscle (figure 2.3.). 
By supporting the testis with the fingertips of the right hand during this "piano 
playing", the examiner will have reached a fair estimate ofthe volume ofthe testis 
by the time it has reached its most caudal position. This estimated testicular 
volume can then be compared with the volume of the contralateral, normally 
descended testis. A more exact estimate of the volume of the testis can be 
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Figure 2.2. As if they are playing a piano, the fingertips gently push the testis into a direction of the 
scrotum as far as it will go. 
Figure 2.3. Most caudal position oft he testis. Same boy as in figure 2.2. Fingers hold testis outside the 
external annulus of the inguinal canal. 
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Figure 2.4. Most caudal position of the testis. Four year old boy with his left testis held in the scrotal 
entrance. Volume of the testis compared with an orchiometer after Prader. 
reached using the so-called orchiometer after Prader (1966) (figure 2.4.). This 
method of measuring testicular volume was first described by Schonfeld (1943). It 
allows for assessment of testicular volume by comparative palpation; the testis is 
palpated with one hand, while models of known volume are palpated with the 
other hand. This technique is clinically easy to apply, while it is not invasive for the 
patient. 
If the testis can be brought into the scrotum without immediately shooting 
back to the inguinal region, then this is obviously a retractile testis. The examina-
tion should never be painful (avoid funicular traction) and should be repeated 
several times in a row in order to exhaust the cremasteric reflex which may 
sometimes enable a scrotal position of the testis. 
If there seems to be no palpable testis an attempt should be made to "empty" 
the inguinal canal by carrying out an ironing movement with the fingertips 
stroking in the direction of the scrotum. Sometimes this will briefly reveal a 
palpable testis at the level of the exit of the inguinal canal, which immediately 
shoots back deep into the inguinal canal. In this case estimating the volume of the 
testis will be sheer conjecture. 
Subsequently, the entire examination should be repeated with the patient in a 
squatting position, or sitting cross-legged like a tailor. For stability the child 
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should sit ·with his back against the wall. Some boys will instinctively tighten the 
muscles of their abdomen and thighs in the supine position, which complicates 
and sometimes even prohibits any examination. For these boys in particular, the 
examination in a sitting position will proceed much more smoothly. 
Retractile testes are frequently diagnosed as such at periodic physical examina-
tions of prepuberal boys (e.g. by the school physician). However, retractile testes 
are not infrequently diagnosed as cryptorchid, possibly due to the examiner 
being unfamilfar with the proper method of examining a boy with undescended 
testes.-The retractile testis can be distinguished from a 'truly undescended one in 
that it can be manipulated fully into a stable scrotal position at any time, while it 
may also descend spontaneously (figure 2.5.). The retractile testis is never found 
in front of the pubic bone because that is an unstable position. 
If no testis can be located at all using every means described above, then the 
perineum, the base of the penis, and the thigh, should be closely investigated to 
locate or exclude an ectopic testis. 
2.3.3. Registration of testicular position at physical examination 
Registration of the testicular position found at physical examination is essential 
for making a definitive diagnosis. It will also enable comparison with the testicular 
position found at subsequent examination. 
a. Registration of spontaneous position of the testis 
- testis palpable - when the testis can be felt subcutaneously either in the 
inguinal region (incompletely descended testis or superficial inguinal ectopic 
testis) or elsewhere, e.g. in the perineum (ectopic testis), or in the scrotum; 
- testis impalpable- when no testis can be felt. This does not necessarily mean 
that there is no testis, as the testis may well lie intra-abdominally or in the 
inguinal canal itself. 
In the literature, there is a great deal of confusion concerning the palpability of 
testes lying in the inguinal canal. Various publications (Illig et al., 1977; Cacciari et 
al., 1982; Klidjian, 1985; Schwarz et al., 1985) create the impression that a testis 
lying in the inguinal canal is palpable. As early as 1938, Browne proved this to be a 
fallacy: "A testis that is in the inguinal canal cannot be felt through the skin. It is a 
soft_ elongated object, sunk in the soft floor of the canal, shielded from touch by 
the tense fascia of the external oblique muscle". 
b. Registration of most caudal position of the testis 
It is essential to find the most caudal position of the testis in order to determine 
the mobility of the cryptorchid testis, which is an important factor in the choice of 
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Figure 2.5. Retractile testis. a+ b Boy in supine position. c + d Boy in standing position. 
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treatment (see chapter 4). The most caudal position of the testis should be 
registered as shown in figure 2.6., viz: 
- testis impalpable. The testis may be altogether absent or may lie high in the 
inguinal canal or intra-abdominally; 
- testis intermittently palpable in inguinal region (emergent inguinal position). 
With gentle manipulation the testis may emerge fleetingly from the inguinal 
canal and become palpable for an instant, only to shoot back to its impalpable 
position; 
- testis palpable outside the external ring. The testis seems to be lying on the 
pubic bone; 
- testis palpable in scrotal entrance. At the scrotal entrance the thick elastic skin 
of the inguinal region changes abruptly to become the thin and corrugated 
scrotal skin. In this case the testis cannot be brought down to the scrotal 
entrance permanently, as this is not a stable position. When released, the testis 
immediately returns to the spontaneous position in the inguinal region just 
above the pubic bone; 
- testis palpable high or low in scrotum. High in scrotum implies a testicular 
position beneath the scrotal entrance (under base of penis), while low in 
scrotum implies that the testis has reached the bottom of the scrotum. The 
difference between high or low scrotal position is not significant as far as exact 
location is concerned. It is much more important to determine whether the 
testis has reached a stable position and remains in the scrotum when released 
(retractile testis), or shoots back into the inguinal region immediately upon 
release (incompletely descended or ectopic testis). 
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Figure 2.6. Clinical assessment of testicular position: most caudal position at clinical examination. 
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The relation between the spontaneous position of the testis and the most 
caudal (manipulated) one is shown schematically in figure 2.7. Clinically, the 
superficial inguinal, ectopic testis cannot always be distinguished from the testis 
lying outside the external inguinal ring (Ashby, 1978). Consequently, the clinical 
classification only mentions a testis in a subcutaneous position in the inguinal 
region. 
Registration of the spontaneous and the most caudal position of the testis in the 
manner described above is obviously preferable to another method of registra-
tion, whereby the distance is measured between the upper rim of the symphysis 
and the centre of the testis in its most caudal, manipulated position (Hosli, 1971; 
Scorer and Farrington, 1971). As this measurement cannot easily be reproduced, 
the results of the registration are not dependable. 
Clinical assessment of testis position : 
most caudal position at clinical examination 
Classification Testis position at clinical examination 
I Cryptorchid testis Position at rest Most caudal position 
Incompletely 
descended testis 
Ectopic testis 
0 not palpable 
__.... 
--.. 
0 subcutaneous in / 
inguinal region ~ 
0 subcutaneous in~ 
inguinal region-._ 
0 penile. perineal~ 
femoral. crossed 
0 subcutaneous in 
0 
inguinal region y 
II Retractile testis high scrotal :r ~ 
---------------- ~ 
0 low scrotal ~ 
0 not palpable 
0 inguinal region 
0 external annulus 
0 scrotal entrance 
0 high scrotal* 
0 external annulus 
0 scrotal entrance 
0 same position 
0 high scrotal** 
0 low scrotal** 
III Scrota I testis ____.. 0 same position ____.. 0 same position 
* unstable position. ** stable position 
Figure 2.7. Clinical assessment of testicular position: spontaneous position in relation to most caudal 
position. 
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2.3.4. Clinical diagnosis 
The final diagnosis is obviously important, not only as a basis for determining 
the choice of treatment, but also because it is an important factor in any subse-
quent evaluation of the method of treatment. The follow-up is necessarily of long 
duration, frequently outlasting the working life of the doctor who made the 
initial diagnosis. This is one of the reasons why so many fundamental questions 
concerning cryptorchidism remain unanswered. 
A clear definition of the various forms of cryptorchidism, coupled with a 
properly executed physical examination and a standardized method of registra-
tion of the testicular position, will generally furnish the correct clinical diagnosis 
of retractile, incompletely descended or ectopic testes. If the examiner is not 
familiar with this kind of physical examination, or if there is uncertainty about the 
correct diagnosis (which may even happen to experienced examiners), the exam-
ination should be repeated at least once. All too frequently retractile testes are 
diagnosed as incompletely descended testes because the examination was car-
ried out with the boy standing up, or in a superficial manner (Browne, 1938; 
Cour-Palais, 1966). Retractile testes generally do not require treatment, only 
regular checkups (see 6.2.), while for true, though rare, ectopic testes, surgical 
intervention is the only correct means of treatment. 
2.4. METHODS OF HORMONAL EVALUATION 
Androstenedione2) (L:l 4) was measured by radio-immunoassay (RIA) after 
extraction with hexane-toluene 8:2 (v/v) without chromatography. The RIA was 
performed as described by Van Landeghem et al. (1981). Intra- and interassay 
coefficients of variation were 6.7% and 11% respectively. Detection limit of the 
assay: 0.35 nmol/1. 
Dehydroepiandrosterone su/fate1) (DHEAS) was measured by radio-immuno-
assay using kits from Radioassay Systems Laboratories (California). The antibody 
used in the RIA was raised in rabbits against DHEA-S-3 monohemisuccinate-HSA. 
Intra- and interassay coefficients of variation were 9% and 15% respectively. 
Detection limit of the assay: 0.02 Mmol/1. 
Dihydrotestosterone2) (DHT) was measured by radio-immunoassay after 
extraction with Extrelut columns (Merck). The extract was purified by means of 
high pressure liquid chromatography (HPLC), using a Waters HPLC apparatus 
with a Merck Lichrosorb column (5M; Si 60). Hexane-isopropanol 92:8 v/v was 
used as an eluent (0.8 ml!min). DHT was estimated using an antiserum of Radio-
assay Systems Laboratories. Intra- and interassay coefficients of variation were 9% 
and 22% respectively. Detection limit of the assay: 0.13 nmol/1. 
17 a-hydroxypregnenolone2) (17 OHPreg) was measured by radio-immuno-
assay after extraction and purification with Extrelut columns (Merck). The RIA 
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was performed using a commercial kit (Radioassay Systems Laboratories). The 
intra-assay coefficient of variation was 14%, the interassay coefficient of variation 
could not be calculated. Detection limit of the assay: 0.9 nmol/1. 
17 a -hydroxyprogesterone2) (17 OHP) was measured by radio-immuno-
assay after extraction with Extrelut columns (Merck). The RIA was performed 
using a commercial kit from lnstitut National des Radioelements (IRE). Intra- and 
interassay coefficients of variation were 12% and 18% respectively. Detection limit 
of the assay: 1.2 nmol/1. 
Luteinizing hormone1) (LH) and Follicle-stimulating hormone1) (FSH) were 
determined by radio-immunoassay, using kits from Byk-Mallinckrodt. The stan-
dards employed in these kits have been calibrated for LH versus the Medical 
Research Council (MRC) standard 68/40 and for FSH versus the MRC standard 
69/104, both expressed in IU/1. Intra- and interassay coefficients of variation for 
LH were less than 4% and 9% and for FSH less than 3% and 12% respectively. 
Detection limit for LH and FSH: 0.61U/I. 
Oestradio/3) (E2) was measured by radio-immunoassay using kits from Eidgenos-
sisches lnstitut fUr Reaktorforschung (EIR), Wurelingen, Switzerland. Intra- and 
interassay coefficients of variation were 8.2% and 18.5% respectively. Detection 
limit of the assay: 10 pmol/1. 
Progesterone4) (P) was measured by radio-immunoassay using a kit from Fari-
nos Ltd. (Finland) with a slight modification. Intra- and interassay coefficients of 
variation were 5% and 11% respectively. Detection limit of the assay: 0.5 nmol/1. 
Sex-hormone-binding globulin 3) (SHBG) was measured as described by Ham-
mond and Uihteenmaki (1983). Intra- and interassay coefficients of variation were 
10.3% and 14.6% respectively. Detection limit of the assay: 10 nmol/1. 
Testosterone4 ) (T) was determined by radio-immunoassay following extraction 
by n-hexane-diethylether without chromatography. The antibody used in the 
RIA was raised against testosterone-? a -carboxyethylthioether bovine serum 
after Pratt et al. (1975). Intra- and interassay coefficients of variation were 11% and 
22% respectively. Detection limit of the assay: 0.02 nmol/1. 
HCG test: basal and peak serum testosterone values were determined before 
and three days after the intramuscular administration of 1.500 IU HCG. 
LHRH test: basal and peak serum values of LH and FSH were determined 
before, 30 and 60 minutes after intravenous administration of 50 J.Lg LHRH. 
The hormonal analyses were carried out by: 
1 Department of Clinical Chemistry, University Hospital Rotterdam/Sophia Children's 
Hospital (Head lr. N.C. den Boer). 
2 Paediatric. Laboratory, University Hospital Rotterdam/Sophia Children's Hospital (Head 
Prof. Dr. H.J. Degenhart). 
3 Steroid Hormone Laboratory of Internal Medicine Ill, University Hospital Rotterdam/-
Dijkzigt Hospital (Head Dr. F. de Jon g). 
4 Laboratory for Endocrinological Chemistry, Bergweg Hospital Rotterdam (Heads Dr. W. 
Schopman and Dr. W.H.L. Hackeng). 
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2.5. METHODS OF STATISTICAL ANALYSIS 
For the statistical analyses we were advised and assisted by the Institute of 
Biostatistics of the Erasmus University Rotterdam (Head Prof. R. van Strik). To 
avoid any unjustifiable assumption regarding Gaussian distribution, the following 
non-parametric tests were generally applied. 
- Mann-Whitney-Utest (Wilcoxon) for comparison of two independent groups 
(Sachs, 1984: 230). 
- Wilcoxon matched pairs signed rank test for comparison of two dependent 
groups (Sachs, 1984: 244). 
- Kruskai-Wal/is test (H-test) for comparison of three or more independent 
groups (Sachs, 1984: 238). 
- Friedman test for comparison of three or more dependent groups (Sachs, 
1984: 422). 
- Sign test for comparison of medians in two groups (Sachs 1984: 247). 
- Spearman's rank correlation test for judging the correlations between two 
variables measured in the same individuals (Sachs, 1984: 308). 
- Chi-square test (2 x 2 contingency table) for comparison of two proportions 
(Sachs, 1984: 269). 
- Logistic regression analysis for multivariate analysis of the dependency of 
success rates on several study factors simultaneously (Cox, 1970). 
74 
APPENDIX 
CASE REPORT FORM 
PATIENT HISTORY 
Patient number 
Date of birth 
Birth weight 
ANAMNESIS yes no unknown 
Testis seen or felt in the scrotum ? D D D 
(by patient. parent or physician) 
Period of pain or redness of the scrotum ? D D D 
Surgical intervention in the inquinal area ? D D D 
(e.g.inquinal hernia. hydrocele) 
Infection of the urinary tract ? D D D 
If so. specify. 
Previous hormonal treatment ? D D D 
If so.specify. 
Does patient take drugs ? D D D 
If so. specify. 
Has patient had mumps ? D D D 
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CASE REPORT FORM 
FAMILY HISTORY 
yes 
MOTHER -duration of pregnancy 
-did the mother use any medication during pregnancy? 0 
If so. specify. 
-did the mother use oral contraceptives before pregnancy ? 0 
If so. for how long ? 
-did the mother use any medication to induce pregnancy ? 0 
FAMILY -has cryptorchidism ever occurred in the family ? D If so. specify. 
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no unknown 
D D 
D 0 
D D 
D D 
CASE REPORT FORM Patient number : 
Date of birth 
INVESTIGATION AT THE START 
Date: yes no 
-General impression normal D D 
dysmorphisms D D 
explanation : 
-Scrotum empty D D 
normal D D 
tight D D 
-Penis normal form D D 
normal size D D 
hypospadias D D 
-lnquinal area. scars D D 
-Testicular volume L R 
INVESTIGATION AFTER 4 WEEKS TREATMENT 
Date: 
-Scrotum empty D D 
normal D D 
tight D D 
-Penis normal form D D 
normal size D D 
-Testicular volume L R 
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CASE REPORT FORM Patient number : 
Date of birth : 
TESTICULAR POSITION AT START OF THE TREATMENT 
Date of visit : 
R L 
R L 
Position of testis : At rest D D Not palpable 
D D Palpable in inguinal region 
D D Intrascrotal 
Movability of the testis: D D Not palpable Most caudal testicular position 
D D Inguinal region. intermittently palpable 
D D External annulus 
D D Scrotal entrance 
D D High Scrotal 
Remarks: D D Scrotal 
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Surgical findings Name: 
Date of birth: 
Date of operation: 
Testis: R L both Patient number: 
No testis anorchia 0 1 
•vanishing testis• funicular remnant 0 2 
testis position intra-abdominal 0 3 
inguinal canal 0 lf 
external annulus 0 5 
superficial inguinal ectopia 0 6 
Processus vaginalis processus vaginalis wide open 0 7 
slightly open 0 B 
closed 0 g 
Vas deferens and normal vas 0 10 
epididymis blind ending vas 0 11 
no vas 0 12 
normal epididymis 0 13 
no epididymis 0 1lf 
partial separation 0 15 
complete separation 0 16 
•long loop• vas and epididymis 0 17 
atresia vas or epididymis 0 1B 
special remarks in surgical report 0 19 
Testis volume < 1 ml 0 20 
1 ml 0 21 
1-2 ml 0 22 
2ml 0 23 
2-3 ml 0 2lf 
3 ml 0 25 
Gubernacular remnant identifiable yes 0 26 
no 0 27 
Procedure and result orchidectomy 0 2B 
excision funicular remnant 0 29 
orchiopexy low scrotal 0 30 
high scrotal 0 31 
outside inguinal canal 0 32 
Fowler-Stephens procedure 0 33 
microvascular transplantation 0 3lf 
special remarks in surgical report 0 35 
Remarks 
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CHAPTER3 
HORMONAL ASPECTS OF CRYPTORCHIDISM 
Recent clinical and experimental studies reported in the literature seem to 
indicate that a (transient) functional insufficiency of the hypothalamo-pituitary-
gonadal axis is an important factor in the pathogenesis of cryptorchidism. This 
insufficiency, found in cryptorchid boys in the first year of life, argues for hor-
monal treatment of cryptorchidism. Therefore it is important to trace hormonal 
development from the embryonic phase through the first year of life and up till 
puberty. 
3.1. HORMONAL INFLUENCES ON MALE GENITAL DIFFERENTIATION 
The fundamental mechanism of sexual differentiation was clarified by Alfred 
jost between 1947 and 1952. In his classical experiments with fetal rabbits, he 
established that the castrated mammalian embryo develops into a female. Al-
though local androgen implants successfully replaced most of the masculinizing 
influences of the fetal testis, these could not bring about regression of the 
Mullerian duct (Jost, 1970; 1972). The studies of Jost demonstrated "that male 
phenotypic sexual differentiation results from two kinds of secretions from the 
fetal testis, namely steroidal androgens and a non-steroidal inhibitor of Mullerian 
duct development. 
3.1.1. Testosterone and dihydrotestosterone 
As early as the sixth week of human embryonic development (CR length 14 
mm) evidence for steroid metabolism was found in the genital ridge (Baillie et al., 
1966). From studies of human fetuses varying in age from the phenotypically 
undifferentiated stage (CR length 1-3 em) to sexually differentiated male and 
female embryos (CR length > 21 em) it was concluded that testosterone is the 
principle androgen formed by the human testis at the time of male sexual 
differentiation (Siiteri and Wilson, 1974). From the same studies it appeared that in 
the urogenital sinus and genital tubercle the capacity for dihydrotestosterone 
formation was maximal prior to the onset of male differentiation. In contrast, in 
the Wolffian ducts the ability to form dihydrotestosterone could only be demon-
strated late in male differentiation. It was concluded that testosterone itself is 
responsible for the differentiation of epididymis, vas deferens and seminal 
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vesicles while dihydrotestosterone is required for differentiation of prostate, 
phallus and scrotum. This opinion was shared by others (Bardin and Paulsen, 
1981). Another group (Reyes et al., 1973) suggested higher androgen production 
at the time of male genital differentiation. Peak concentrations of serum testoster-
one occur at 14 to 16 weeks of gestation, comparable to those of the adult male 
(Winter, 1982). At the gestational age of 16-20 weeks there is a drop in the 
testosterone concentration in the male fetus although it remains significantly 
higher than in the female fetus. After 24 weeks gestation, the serum testosterone 
levels are low and no sex-related difference is discernable. At term, however, the 
concentration of testosterone in cord blood appeared significantly higher in 
male than in female fetuses (Forest and Cathiard, 1975). Dihydrotestosterone 
levels in plasma are low in the human fetus throughout gestation (Kaplan and 
Grumbach, 1978). 
What controls the androgen production in the fetal testis? Initiation of testoster-
one production by the fetal testis might be independent of tropic hormone 
stimulation. Evidence for that was supplied by in vitro studies of fetal rat testes 
done by Picon (1976). Likewise, Siiteri and Wilson (1974) surmised that the 
initiation of male sexual differentiation by the fetal testis is not controlled by 
tropic hormones. The subsequent rise and maintenance of testosterone produc-
tion would, however, be due to gonadotropin stimulation. 
3.1.2. Pituitary and placental gonadotropins 
Luteinizing hormone (LH), follicle-stimulating hormone (FSH) and human 
chorionic gonadotropin (HCG) are glycoprotein hormones. They are composed 
of two subunits: a and {3. The a subunit of each of the glycoproteins is similar in 
structure and indistinguishable immunologically, while the biological and 
immunological specificity of the intact hormone appears to be dependent on the 
{3 subunit. LH is virtually identical to HCG except for an additional30 amino acids 
on the carboxyl terminal end of the {3 chain of HCG. The similarity in structure of 
LH and HCG undoubtedly accounts for the fact that they both stimulate testoster-
one synthesis and secretion by Leydig cells. LH and FSH are produced in the 
basophil cells of the pars distal is of the pituitary gland. The presence of gonado-
tropins in the fetal pituitary gland was demonstrated by bio-assay, immunocyto-
chemical studies, radio-immunoassay and organ cultures (for review see Gluck-
man et al., 1980). From several studies it appeared that in the male fetus LH and 
FSH has been detected in the pituitary gland as early as the tenth gestational 
week. The LH content of the pituitary gland rises sharply between the 10th and 
the 27th gestational week with little subsequent change. The peak concentration 
of LH in the pituitary gland is achieved between 20 and 24 weeks of gestation. 
There is also a striking rise in FSH content in the pituitary gland between the 10th 
and the 25th week, remaining constant thereafter. The peak concentration of FSH 
in the pituitary gland occurs between 20 and 24 weeks. During the late gestational 
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period there is a decrease in pituitary concentration of both LH and FSH. Plasma 
LH was measured by radio-immunoassay and demonstrable by 12 weeks of 
gestation (Kaplan et al., 1976). Higher concentrations were found in midgestation 
with lower levels towards term. Plasma FSH has been detected by radio-
immunoassay in fetal plasma by the 10th to 11th gestational week (Clements et al., 
1976), with peak levels in midgestation and a fall to low concentration towards 
term. In cord blood LH and FSH levels are low (Reyes et al., 1974; Kaplan and 
Grumbach, 1978). Thus, in the male fetus the pattern of plasma concentration of 
LH and FSH is similar to the changing pituitary concentration of LH and FSH with 
advancing gestation (Gluckman et al., 1980). 
Human chorionic gonadotropin (HCG) is synthesized by the syncytiotropho-
blast of the placenta and is detected in maternal circulation at seven to ten days of 
gestation. Peak levels of HCG in fetal and maternal serum coincide in time (9-12 
weeks of gestation) but the peak level is much higher in maternal than in fetal 
serum (Kaplan and Grumbach, 1978). The maximum rise in fetal serum HCG 
immediately precedes the increased synthesis and secretion of testosterone by 
the fetal testis at 10-12 weeks of gestation. After 12 weeks of gestation the HCG 
level declines. The factors that mediate the altered synthesis and secretion of 
HCG remain unknown, but in any case these factors are not under hypothalamic 
control (Kaplan et al., 1976). It appears that fetal Leydig cells acquire functional 
receptors for LH and HCG early in development (Josso, 1979). Figure 3.1. shows 
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Figure 3.1. A graphic comparison of the hormonal response to luteinizing-hormone-releasing 
factor (Takagi et al., 1977), pituitary and iJiasma FSH and LH (Kaplan and Grumbach, 
1976), plasma HCG (Kaplan and Grumbach, 1976) and plasma testosterone (Reyes et al., 
1974) during gestation (modified from Gluckman et al., 1980). 
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the temporal relationships between the concentrations of fetal serum testoster-
one, LH and HCG, suggesting that HCG plays an important role in early testoster-
one secretion which then appears to be augmented and later sustained by 
pituitary LH (Kaplan et al., 1976). Thus the pituitary LH levels rise between 12-20 
weeks of gestation (Clements et al, 1976) and may be instrumental in promoting 
androgen secretion in later stages of pregnancy during the androgen-dependent 
growth of the genital tubercle. This view is supported by the fact that congenital 
hypopituitarism is often associated with micropenis. Anencephalic and apituitary 
fetuses usually have hypoplastic and undescended testes. Consequently, Grum-
bach and Kaplan (1974) stated that it would seem that fetal serum HCG evokes 
sufficient testosterone secretion by the fetal testis to induce male sex differentia-
tion. However, owing to deficient secretion of pituitary LH and FSH in these male 
fetuses, the growth of the testes and external genitalia is impaired. 
3.1.3. The hypothalamic control of fetal LH and FSH secretion 
The human fetal pituitary gland has the capacity to respond to luteinizing-
hormone-releasing hormone (LHRH), also called gonadotropin-releasing hor-
mone (GnRH) or luteinizing-hormone-releasing factor (LRF). LHRH is a decapep-
tide with the sequence, p Glu-His-Trp-Ser-Tyr-Giy-Leu-Arg-Pro-Glu-NH 2• The 
hormone has both luteinizing-hormone-releasing factor and follicle-stimulating-
hormone releasing factor activity. The isolation and determination of the chem-
ical structure of LHRH was accomplished in the early seventies (Schally et al., 
1971). From the classic observations of Knobil and associates in the rhesus mon-
key it appeared that the arcuate nucleus is the primary structure within the medial 
basal hypothalamus mediating the hypothalamic control of gonadotropin secre-
tion: "the hypothalamic oscillator" (Knobil, 1980). GnRH secretion may be con-
trolled directly or indirectly by catecholamine, endorphin-containing and dopa 
fibres, arising from many parts of the central nervous system (CNS) (Bardin and 
Paulsen, 1981). It has been suggested that there might be a separate follicle-
stimulating-releasing hormone (for review see Sharp and Fraser, 1978). However, 
isolation of this factor has not yet been accomplished. LHRH is transported via the 
pituitary portal system to the hypophysis. The studies of Kaplan and Grumbach 
(1976) and those of Winter et al. (1974) have established the presence of immuno-
reactive GnRH in the human fetal hypothalamus early in gestation from 4-5 weeks 
after conception. This is long before the continuity of the primary and secondary 
plexus of the portal system is completed (by week 19 to week 21, Kaplan et al., 
1976). The early influence of LHRH on gonadotropin secretion occurs either by 
diffusion or via the more primitive mantle plexus of the developing portal system. 
LHRH is found almost exclusively in the hypothalamus (Winter, 1982). An absence 
of significant correlation between the concentration of LHRH in the hypothala-
mus and sex or gestational age was reported by some workers (Kaplan et al., 1976; 
Aubert et al., 1977; Gilmore et al., 1978), whereas others found an increase of the 
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LHRH content during gestation (Siler-Khodr and Khodr, 1978; Clements et al., 
1980). The following ontogenesis of the hypothalamo-pituitary-gonadal system 
was proposed for the fetal period (Reiter and Grumbach, 1982): 
- the hypothalamo arcuate GnRH neurosecretory neurons (so-called "pulse 
generator") are operative by 80 days gestation; 
- episodic secretion of LH and FSH by 80 days gestation; 
- initially unrestrained secretion of GnRH until midgestation; 
- maturation of negative sex steroid feedback mechanisms after 150 days gesta-
tion; 
- low levels of GnRH secretion at term. 
The primary role of sex steroids in the restraint of GnRH secretion ("negative 
feedback system") has been questioned. Experimental and clinical studies (Kno-
bil, 1980; Conte et al., 1980) support the hypothesis that the central nervous 
system rather than the pituitary or the gonads restrains the activation of the hypo-
thalamo-pituitary-gonadal system. This inhibition appears to be mediated 
through the suppression of GnRH synthesis and its pulsatile secretion. 
3.1.4. Anti-Mullerian hormone 
The production of anti-Mullerian hormone (AMH) or Mullerian inhibiting 
substance (MIS) by the fetal testis begins shortly before differentiation of the 
Leydig cells coinciding with the development of the seminiferous tubules, before 
30 mm CR length. josso and coworkers (1977) observed anti-Mullerian activity in 
a 20 mm fetus; it declined in late gestation and appeared to be very low at birth. 
With experimental procedures such as testicular microdissection, irradiation and 
cell cultures, she also demonstrated that the anti-Mullerian activity was limited to 
the seminiferous tubules and most probably the Sertoli cells. Although the 
biological significance of AMH has been recognized for a long time, biochemical 
analysis and purification of the hormone is still in progress. More recently, Picard 
and josso (1984) described an improved method for purification of anti-Mullerian 
hormone. The regulation of AMH production by the testis is largely unknown 
(Josso, 1979). Experiments in rats gave evidence of depression of testicular anti-
Mullerian activity, probably by FSH (Bercu et al., 1981). 
3.2. HORMONAL INFLUENCES ON TESTICULAR DESCENT 
Although the morphological process of testicular descent is a controversal 
issue in itself, there is even less agreement regarding the regulatory mechanisms. 
In animal experiments many authors have tried to answer the following ques-
tions: 
- are there hormonal influences on testicular descent? 
- if so, which hormones influence testicular descent? 
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Not having evaluated this ourselves, we can only summarize some of the 
extensive literature available on this subject. 
3.2.1. Animal studies 
The first reports of hormonal influences on testicular descent were from Engle 
(1932), who caused descent of the testis in immature Macacus monkeys by 
injecting extracts of pregnancy urine and water-soluble extracts of the anterior 
pituitary gland. Hamilton (1938) suggested that descent, produced by anterior 
pituitary-like substance, may be partially due to stimulation of the secretion of 
male hormone substances. He treated Macacus rhesus monkeys with injections 
of testosterone acetate and testosterone propionate and concluded that male 
hormone substance is actually responsible for growth processes of the reproduc-
tive system which result in descent of the testes. Subsequently, other animal 
experiments provided direct or indirect evidence of androgen dependence of 
testicular descent. Greene et al. (1939) achieved caudal displacement of the 
gonads in female fetuses by administering high doses of androgens to pregnant 
rats. From other experiments with rats it appeared that dihydrotestosterone was 
particularly responsible for testicular descent and that DHT production is 
influenced by gonadotropins (Rajfer and Walsh, 1977). In the rat gubernaculum, 
morphological alterations could be induced by DHT administration (Elder et al., 
1982). Indirect evidence of androgen dependence came from experiments with 
the anti-androgen cyproteronacetate (Neumann and Kramer, 1964). Several 
experiments involved the administration of oestrogens to developing male ani-
mals in utero: inhibition of testicular descent or cessation of gubernacular devel-
opment was achieved (Raynaud, 1958; Backhouse, 1965; Hadziselimovic et al., 
1980•). However, other experimental results attenuate or even contradict this 
androgen dependence of testicular descent (Eiger et al., 1977; Radhakrishnan et 
al., 1979). Remarkable in this respect are the observations of Wensing and Colen-
brander (1977), who questioned the influence of androgens on testicular descent 
based on their investigations in pigs. In female pigs they could not initiate a 
gubernacular reaction by androgen administration, nor could they prevent a 
gubernacular reaction in male pigs by the administration of anti-androgens. They 
even found a pronounced and prolonged gubernacular reaction in a pig with the 
androgen insensitivity syndrome. They observed normal gubernacular develop-
ment and testicular descent in fetal pigs decapitated seven weeks after concep-
tion (Colenbrander et al., 1978). Their conclusion was that testicular descent 
seems to be independent of gonadotropic stimulation, while it is not androgen-
dependent but gonad-dependent (factor X?). Moreover, administration of HCG 
or LHRH to naturally unilateral cryptorchid, prepuberal pigs could not induce 
either testicular descent or gubernacular development (Colenbrander et al., 
1978). 
Habenicht and Neumann (1983) carried out an extensive study in Wistar rats, 
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fetuses as well as adult animals, whose mothers had been treated with oestrogen 
or cyproteronacetate or a combination of both. They hoped to gain fresh know-
ledge about the regulatory mechanisms of testicular descent. They concluded 
that the regulatory mechanism of this process cannot be elucidated simply on the 
basis of androgen dependence or AMH dependence. They suggested that AMH 
is primarily responsible for differentiation of the gonads while androgens, either 
additionally or alone, are required for the final phase of descent. They added that 
the latter premise is supported by the fact that the further the testes have 
descended, the more likely the treatment of cryptorchidism with HCG or LHRH is 
to succeed. Hutson (1985; 1986) recently supported this theory of a biphasic 
hormonal control of testicular descent. He investigated the position of the testes 
in patients and mice with the androgen insensitivity syndrome (testicular femini-
zation, TFM). He found the testes of the patients with androgen insensitivity 
syndrome located at or beyond the internal inguinal ring. The testes of the male 
mice with TFM had also descended to the internal ring by the time of birth. He 
hypothesized that the first phase of descent (the transabdominal part) is not 
controlled by androgens but may be regulated by Mullerian inhibiting substance, 
whereas the second phase (the transinguinal descent) may be androgen-
dependent. 
3.2.2. Observations in humans 
The hormonal influences on testicular descent in man are as unclear as in 
animal studies. Several investigators suggested that in man the normal function of 
the hypothalamo-pituitary-gonadal axis is a prerogative for normal testicular 
descent. They hypothesized that a transient, functional impairment of this axis is 
at least a contributory factor to cryptorchidism (Canlorbe et al., 1974; Gendre! et 
al., 1977; job et al., 1977b). Hamilton (1938) was the first to show that testosterone 
was probably the active hormone, when he successfully induced descent in 
cryptorchid children with synthetic male hormone substance (see 4.1.). Well-
documented genetic disorders with abnormalities in gonadotropin production 
(Kallmann syndrome), androgen secretion (5 a-reductase deficiency) or defects 
in androgen action (androgen insensitivity syndrome) are frequently associated 
with cryptorchidism (see 3.3.). The more or less successful treatment of cryptor-
chid boys with gonadotropins or LHRH is used as an argument for gonadotropin 
and/or androgen dependence. However, the hormonal treatment of undescend-
ed testes is not based on a full understanding of the regulatory mechanisms of 
descent. Donahoe and associates (1977) speculated that next to Mullerian duct 
regression in the male embryo, MIS may influence testicular descent. They found 
that, up till the age of two years, MIS activity was lower in boys with undescended 
testes than in boys with normal testicular descent. Jasso and coworkers (1983) 
suggested that the decrease of AMH activity in ectopic testes might be the 
consequence rather than the cause of their abnormal position. However, josso 
89 
had previously questioned the role of androgens as the major factor in testicular 
descent, postulating that AMH might play a role in testicular descent (Josso, 1979). 
Hutson supported the model of a biphasic hormonal control of testicular 
descent, whereby in his opinion AMH might play an important role in the first 
phase of descent while androgens might be the major hormones in the transin-
guinal phase (Hutson, 1985; 1986; Hutson and Donahoe, 1986). 
In summary 
There is ample evidence of hormonal influence on testicular descent. The low 
levels of circulating androgens in the fetus during the last weeks of gestation 
seem tot argue against the option of androgen dependence of the transinguinal 
phase of testicular descent. However, a small amount of hormone may well be 
sufficient. 
3.3. HORMONAl FAilURE AS CAUSATIVE FACTOR IN TESTICUlAR 
NONDESCENT 
As we do not know exactly which hormones contribute to testicular descent, it 
is not surprising that it has not yet been established to what extent hormonal 
failure is the cause of testicular nondescent. Which hormones fail to play their 
part? 
3.3.1. Defects in gonadotropin/androgen secretion or action? 
Cryptorchidism is frequently found in patients with abnormalities of the 
hypothalamo-pituitary-gonadal axis. For example, Kallmann's syndrome, hypo-
gonadotropic hypogonadism secondary to deficient LHRH secretion and com-
bined with anosmia was first described by Kallmann (Kallmann et al., 1944). 
Patients with anencephaly and gross hypothalamic abnormalities also have a high 
rate of undescended testes. 
Job and associates found a (transient) functional impairment of the hy-
pothalamo-pituitary-gonadal axis in criptorchid boys from birth till puberty 
after which the condition becomes rectified (for review see Gendre! et al., 1979). 
Hadziselimovic and coworkers found atrophic Leydig cells in human unde-
scended testes in the first year of life, which in their opinion points to gonadotro-
pin deficiency as the cause of cryptorchidism (Hadziselimovic and Herzog, 1977). 
In boys with a deficiency of androgen secretion or defects in androgen action, 
cryptorchidism is associated with ambiguous genitalia. Table 3.1.1ists six enzymat-
ic defects that result in decreased androgen synthesis. Each of these six defects is 
an autosomal recessive trait and affects genitalia to a varying degree depending 
on the completeness of the defect. The degree of phenotypic abnormality varies 
from nearly normal males with hypospadias to nearly normal females. The range 
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of abnormalities is dealt with extensively in various textbooks and review articles 
(e.g. Odell and Swerdloff, 1978; Forest, 1981; Saenger, 1984). 
Patients with 5 a-reductase deficiency have previously been classified under 
defective androgen action but since the aetiology has become known they have 
been included under enzymatic defects. 5 a-reductase is the enzyme responsible 
for intracellular conversion of testosterone to dihydrotestosterone. This conver-
sion is an essential step in androgen action for tissues derived from the genital 
tubercle. At birth, patients with this deficiency present with ambiguous genitalia 
(see 5.4.3.d.). Sometimes they are being taken for females, although they have no 
female internal genitalia. The testes lie intra-abdominally or in the inguinal canal. 
Since testosterone itself is required to mediate Wolffian duct differentiation into 
epididymis, vas deferens and seminal vesicles, these tissues are normal. Similarly, 
testosterone appears to be able to act directly on hair follicles, muscle, larynx and 
bone. Farrer et al. (1985) identified a definite defect in androgen biosynthesis in 
the cryptorchid testis in mice, resulting in a diminution of the intratesticular 
testosterone contents. They surmised that cryptorchidism exerts a deleterious 
effect on the ability of the Leydig cell to synthesize testosterone, which might 
explain to a certain extent the abnormal morphology and resultant infertility seen 
in boys with cryptorchidism. In disorders of androgen action such as complete 
and incomplete androgen insensitivity syndromes, cryptorchidism is very com-
mon (Rajfer and Walsh, 1977). 
Table 3.1. Six enzymatic defects resulting in decreased androgen synthesis. 
20. 22-desmolase deficiency 
3 ~ -hydroxysteroid dehydrogenase deficiency 
17a -hydroxylase deficiency 
17. 2Q-desmolase deficiency 
17-keto reductase deficiency 
5a -reductase deficiency 
3.3.2. Deficiency in production or action of AMH or another, unidentified 
gonadal factor (factor X)? 
As described above (see 3.2.) animal studies and observations in humans have 
revealed that MIS (or factor X) may play a role in testicular descent at least in its 
initial stages (Donahoe et al., 1977; Colenbrander et al., 1978; Habenicht and 
Neumann, 1983; Hutson, 1985; Hutson and Donahoe, 1986). In the rare persistent 
Mullerian duct syndrome (Jasso et al., 1983; Beheshti et al., 1984; Van Lanschot et 
al., 1985), phenotypic males have a uterus, fallopian tubes and cryptorchidism. 
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The testes occupy the position of normal ovaries, which is consistent with the 
hypothesis that a deficiency of MIS prevents transabdominal descent (Hutson, 
1985). 
3.3.3. A combination of both deficiencies? 
A biphasic hormonal control oftesticular descent was suggested by Habenicht 
and Neumann (1983) and more recently by Hutson (1985; 1986; Hutson and 
Donahoe, 1986). It may therefore be possible that a deficiency of both hormones 
plays a part in the failure of testicular descent. 
In summary 
There are indications that incomplete testicular descent might be due to a 
hormonal deficiency, but it remains unclear which hormones fail to play their 
part. The question remains whether such a deficiency can be detected postnatally 
and, if so, whether a rational therapy is feasible. 
3.3.4. Associated genetic and dysmorphic syndromes 
Several chromosomal and non-chromosomal syndromes are associated with 
cryptorchidism. In most syndromes with abnormal sex chromosomes and in 
many syndromes with abnormal autosomes the structure of the testis is also 
abnormal. Primary gonadal anomalies are probably the major cause of cryptor-
chidism in the syndromes (for review see Odell and Swerdloff, 1978; Visser, 1982). 
Mininberg and Bingo! (1973) found chromosomal abnormalities in cryptorchid 
testes in boys with normal karyotypes. They felt that these chromosomal 
abnormalities had caused the failure to descend in the process of inhibiting a 
normal hormonal and histological testicular development. Their findings were 
not confirmed by others (Dewald et al., 1977). 
It must be emphasized that as early as 1762, Hunter wrote that the reason for its 
undescent lay in the testis itself. Much later, Johnston (1965) surmised that with 
the great majority of the undescended testes the descensive stimulus must be 
regarded as normal but that the testis fails to descend completely either because 
of an intrinsic fault that prevents its response or because of some anatomical 
hindrance to its movement (see 5.1.). 
3.4. MALE HORMONAL DEVELOPMENT UP TILL PUBERTY 
3.4.1. Introduction 
The hypothalamo-pituitary-gonadal system differentiates during fetal life and 
early infancy, declining to a low level of activity during childhood, to be re-
activated during puberty (Kaplan et al., 1976; Grumbach, 1980). According to 
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Reiter and Grumbach (1982) the regulatory systems that control human male and 
female reproduction comprise the following fundamental components: 
- the arcuate nucleus of the medial basal hypothalamus and its transducer 
neurosecretory neurons. These translate neural signals into a periodic, oscilla-
tory chemical signal, the gonadotropin-releasing hormone. There are indica-
tions that catecholaminergic and opioid neuronal networks as well as sex 
steroids modulate the release of GnRH; 
- the pituitary gonadotropes, which release LH and FSH in a pulsatile manner at 
periodic intervals in response to the GnRH rhythmic signal; 
- the gonads. 
Basal plasma levels of gonadotropins are low in prepuberal boys and thus they 
cannot be used as an index of gonadotropicfunction before the onset of puberty. 
Since the isolation and determination of the structure and synthesis of 
luteinizing-hormone-releasing hormone (Schally et al., 1971), this has been 
administered to normal prepuberal and adult human males and females (Kastin 
et al., 1972; Job et al., 1972•). It has been shown to be efficient in stimulating 
release of gonadotropins (luteinizing hormone and follicle-stimulating hor-
mone). 
The concentration of testosterone in plasma of prepuberal boys is low after the 
first months of life, but the ability of the prepuberal testis to respond to exoge-
nous human chorionic gonadotropin (HCG) is well documented. It enables an 
evaluation of Leydig cell secretory activity before puberty. 
3.4.2. The first year of life 
a. Boys with normal testicular descent 
Very striking changes of plasma testosterone occur in the male newborn. For 
the first five or six days after birth there is a rapid decrease in levels (Forest et al., 
1976). This decline is probably caused by the abrupt withdrawal of placental HCG 
(Winter et al., 1975). However, it is important to note that during this period a 
substantial amount of LH is already circulating (Hagen et al., 1974). Subsequently, 
there is an increase of plasma testosterone in the second week and the levels 
continue to rise to a maximum value between the 30th and 60th day. These values 
decrease again and between the 7th and 12th month, the concentration of plasma 
testosterone has reached prepuberal levels (Forest et al., 1976). Hammond and 
coworkers (1979) reported similar findings. 
There is also an increase in the concentration of circulating gonadotropins 
during the first year, with levels considerably higher than those of the older 
prepuberal child (Winter et al., 1975; Forest et al, 1976; Sizonenko and Aubert, 
1978). It is suggested that the rise of gonadotropins shortly after birth is caused by 
the rapid drop of circulating oestrogens, which exert a negative feedback on 
gonadotropin secretion (Forest and Cathiard, 1975). Hammond et al. (1979) noted 
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good correlations among testosterone, dihydrotestosterone and the gonadotro-
pins in the male infant population. On the other hand, the study of Forest et al. 
(1974) showed a total lack of correlation between testosterone and LH or FSH 
levels in both male and female infants. In 1976, Forest and coworkers noted that 
plasma testosterone concentrations declined from the 60th day, although blood 
LH and FSH levels remained higher than those of prepuberal children. They 
offered several explanations including the immaturity of the hypothalamo-
pituitary-gonadal axis, or low biological potency of the gonadotropins, but this 
discrepancy is still not fully understood. Previously, the same authors (Forest et 
al., 1974) had surmised that the increase in plasma testosterone levels in the 
postnatal period is likely to reflect an increase in testicular production. They 
found supportive evidence in the low androstenedione/testosterone (11 4/T) 
ratio at 1-3 months of age, similar to that of adult males with a progressive increase 
of~ 4/T ratio after the third month of life. Their view was supported by Sidling-
maier et al. (1983) who found high plasma and testicular testosterone concentra-
tions in boys from 1-3 months of age, which correlated significantly. 
Betend et al. (1975) found a higher LH response to LHRH stimulation in infants 
under six months of age than in older ones. Job et al. (1977•) found the LH 
response to LHRH (100 ~-tg LHRH i.v.) in the entire first year of life significantly 
higher in boys than in girls. The same group had previously studied boys only and 
did not find a significant difference in stimulated LH values before or after the first 
year of life up till puberty (Garnier et al., 1974). In contrast, Forest et al. (1974) 
found higher basal LH serum levels in male infants than in older prepuberal boys. 
As for basal and peak FSH serum values, two studies reported very low, 
sometimes even undetectable, levels in male infants. These levels did not vary 
with age (Garnier et al., 1974; Betend et al., 1975). Forest et al. (1974) found 
significantly higher basal FSH serum levels in male infants than in older pre-
puberal boys. 
In summary 
Most authors agree that a postnatal testosterone surge is found in male infants 
in the first three months of life with a subsequent gradual decrease. There is no 
consensus of opinion concerning basal and stimulated LH and FSH serum values 
in the male infant, although higher basal and peak LH serum values have been 
found compared to older prepuberal boys. 
b. Boys with undescended testes 
Gendre! and coworkers (1979) measured plasma testosterone in 21 cryptorchid 
infants (13 boys with unilateral and 8 boys with bilateral cryptorchidism).ln some 
of them the assay was repeated several times. Plasma levels of testosterone found 
in 14 cryptorchid boys aged 12 days to 4 months (21 samples) were compared with 
those found in 46 age-matched control subjects. They concluded that the reg res-
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sion curve (the variation of testosterone with age) in cryptorchids is at a lower 
level than the regression curve of the controls. However, it must be emphasized 
that the longitudinal and cross-sectional testosterone values were combined, 
while neither the degree of the polynomial regression curve nor the 95% con-
fidence limits were supplied. In boys aged 12-90 days, they found a statistically 
significant difference in plasma testosterone between cryptorchids and controls. 
Subsequently, when the boys were between six months and one year old there 
was no longer a difference between cryptorchid and normal boys. 
The same group collected 27 serum testosterone samples in 13 infants in whom 
spontaneous descent occurred during the first three months of life. They ob-
served that the increase in testosterone in these boys was significantly higher than 
in the boys that stayed cryptorchid throughout the first three months of life (p < 
0.05) and comparable to that of controls (Gendre! et al., 1978). Here again, the 
polynomial regression curve was based on a combination of cross-sectional and 
longitudinal values. 
Job et al. (1977b) studied 12 male infants with unilateral or bilateral undescend-
ed testes between the age of one week and 11 months. Ten ofthem underwent an 
LHRH stimulation test (0.1 mg/m2 i.v.). The mean values of basal and stimulated 
serum LH and FSH were compared with the mean and range values previously 
found in normal boys under one year of age (Garnier et al., 1974). The peak LH 
levels of the cryptorchid children appeared to be significantly lower than normal 
values (p < 0.05). Basal LH values and basal and peak FSH values were not 
significantly different from control values. No differences were found between 
unilateral and bilateral cryptorchids. In relation to our own study concerning the 
hormonal evaluation in the first year of life of boys born with undescended testes, 
it is important to note that in the aforementioned studies the first year was taken 
as a whole. Job and coworkers hypothesized that the nondescent or incomplete 
descent of the testis is correlated with a delay in pituitary LH secretion at least in 
patients without any mechanical defects of the inguinal tract or spermatic cord. In 
view of the role of androgens in the initiation and development of human 
spermatogenesis, the early defect of seminiferous tubules in cryptorchid children 
might result from a perinatal LH and testosterone deficiency (Gendre! et al., 
1980). 
In a subsequent study, the same group measured basal LH, FSH and testoster-
one values in boys with spontaneous descent during the first year of life and in 
boys that stayed cryptorchid. Serum samples were obtained during the first four 
months of life. FSH levels did not differ in the two groups but LH levels and the 
postnatal rise of testosterone were significantly lower in the persistently crypt-
orchid boys (Gendre! et al., 1980). 
Davidson et al. (1981) determined serum concentrations of /3-HCG and testos-
terone in 8 cryptorchid and 13 normal newborns in the first 24 hours of life. As the 
mean serum /3-HCG concentrations and mean serum testosterone level did not 
differ significantly between cryptorchids and controls, the author concluded that 
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at that time of life /3-HCG and testosterone do not play a decisive role in the 
mechanism of testicular descent. 
Tapanainen et al. (1982) performed LHRH stimulation tests and measured basal 
testosterone values in 14 boys with unilaterally or bilaterally undescended, 
though palpable testes. He demonstrated that in cryptorchid boys as in normal 
boys, high postnatal levels of serum testosterone are accompanied by an elevated 
response of the pituitary gland to GnRH stimulation. The basal gonadotropin and 
testosterone levels of cryptorchid infants were similar to those measured pre-
viously in the same laboratory in apparently normal newborns. He also consid-
ered the pituitary responses to LHRH in the cryptorchid boys similar to those 
found by other investigators in normal boys (Garnier et al., 1974; Betend et al., 
1975). 
In summary 
From the frequently cited studies of Job and coworkers it appeared that: 
- A lower postnatal testosterone surge was found in cryptorchid infants in the 
first three months of life compared to controls as well as to boys with sponta-
neous testicular descent in the early months of life. However, the statistical 
analysis of the results is disputable. 
- Lower stimulated LH serum values were found in cryptorchid infants com-
pared to controls, but it must be emphasized that the first year of life was taken 
as a whole. 
In boys with spontaneous testicular descent in the first year of life serum 
testosterone values and basal LH values were similar to those of controls and 
higher than those of boys with persistent cryptorchidism. Here again, the 
statistical analysis is disputable. 
Other investigators found normal testosterone and gonadotropin levels in crypt-
orchid boys in the first year of life. 
3.4.3. From the first year of life to puberty 
a. Boys with normal testicular descent 
In both human and subhuman primates the increased LH and FSH secretion in 
the fetus and during infancy is followed by a long period, approximately one 
decade, in which the reproductive endocrine system is suppressed (Kaplan et al., 
1976; Grumbach, 1980). The factors involved in this restraint of puberty are not 
well understood. Two mechanisms have been invoked to explain the prepuberal 
restraint of gonadotropin secretion: 
1. A sex steroid-dependent mechanism. In the fetal period the hypothalamic 
"gonadostat" (the arcuate GnRH neurosecretory neurons) becomes increas-
ingly sensitive to the inhibitory effects of sex steriods in the fetal circulation. 
This mechanism is not fully developed as birth. During the first two years of 
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life the hypothalamo-pituitary-gonadal axis becomes increasingly sensitive to 
the inhibitory feedback effect of small amounts of circulating sex steroids. 
2. A sex steroid-independent mechanism that can be ascribed to intrinsic CNS 
inhibitory influences. The experimental finding that the hypothalamic oscil-
lator regulates gonadotropin release (Knobil, 1980) coupled with the clinical 
observation of striking fall in gonadotropin secretion and reserve in agonad-
al children 4-11 years old (Conte et al., 1980) suggest the presence of CNS 
inhibitory influences independent of sex steroid secretion that restrain 
gonadotropin production and delay the onset of puberty. 
It is possible that both mechanisms are involved in the restraint of secretion of 
GnRH and gonadotropins until puberty. Belchetz (1983) stated that GnRH secre-
tion and steroid feedback interact, in primates principally at the pituitary level, 
although they are essentially independent. 
Basal plasma levels of gonadotropin are low in prepuberal subjects and can 
therefore not be used as an index of gonadotropic function before the onset of 
puberty. Nevertheless it was demonstrated that LH is already secreted in prepu-
beral children in a pulsatile manner (Penny et al., 1977; Waldhauser et al., 1981; 
Jakacki et al., 1982). Boyar et al. (1972) described increased pulsatile plasma LH 
levels during sleep in late prepuberal and puberal children. On the other hand, 
Beck and Wuttke (1980) could not find nocturnal variations in plasma LH and FSH 
in prepuberal boys, as is found in puberty. In later puberty, pulsatile LH secretion 
also occurs during the day. The "gonadostat theory" (Grumbach et al., 1974) 
explains the onset of puberty by a change in sensitivity of the gonadostat to the 
negative feedback action of sex steroids. On the other hand, initiation of puberty 
can also be explained by the re-activation of the arcuate nucleus of the hypotha-
lamus (Knobil, 1980; Visser, 1984). This hypothalamic oscillator controls the pulsa-
tile release (approximately one pulse per hour) of GnRH into the portal circula-
tion. What causes this activation after the prepuberal quiescence, however, 
remains to be elucidated (Knobil, 1980). 
Puberty itself is beyond the scope of this book but it appears that the earliest 
signs of sexual maturation already begin to appear around the age of six years 
with the output of the weak androgens by the adrenal cortex. This phase of 
prepuberal development is called "adrenarche" and is not under gonadotropic 
control nor does it seem to be under the direct control of ACTH (Forest et al., 
1976; Cutler and Loriaux, 1980). Evidence was given for the existence of a specific 
adrenal androgen-stimulating hormone (Parker and Odell, 1979; Sklar et al., 
1980), but so far this substance has not been isolated. 
From the early seventies it has been known that children have assayable 
gonadotropic releasable stores and their response to an intravenous injection of 
LHRH allows evaluation of their ability to secrete gonadotropins (Job et al., 1972•; 
Kastin et al., 1972; Winter and Faiman, 1972; Roth et al., 1972h). However, in 
prepuberal children there is a wide range of individual values of basal and 
stimulated gonadotropins (Job et al., 1977•). 
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From the end of the first year up till the year preceding the clinical onset of 
puberty, LH responses to LHRH are similar in boys and girls, but the mean FSH 
response is higher in girls and occasionally some normal prepuberal girls show 
high FSH releasable pituitary stores, while some normal prepuberal boys have no 
FSH response to the LHRH test (Garnier et al., 1974). In prepuberal boys no rise in 
plasma testosterone was observed after LHRH i.v. (Roth et al., 1972b). 
Thirty years ago, Leach and co-workers (1955) showed that HCG has a stimula-
tory effect on testicular steroidogenesis. Since then .it has been widely used for 
the evaluation of Leydig cell function in males of all ages. There has, however, 
been considerable variation in the dosage, duration and results of HCG stimula-
tion tests used by different groups. In adult men the response of plasma testoster-
one following a single injection of HCG is biphasic with an early rise at two hours 
and a delayed rise reaching a maximum about 3-4 days later (Saez and Forest, 
1979; Smals et al., 1979). In children (Forest et al., 1980; Tapanainen et al., 1983) 
there is no rapid testosterone response, only a delayed rise after 48-96 hours 
(mean 72 hours). There is clear evidence that in adults the maximal testosterone 
response to a specific dose of HCG remains the same after one to five daily 
injections (Smals et al., 1979; Saez and Forest, 1979; Padron et al., 1980; Okuyama 
et al., 1981). Apart from the fact that it is impractical to administer as much as three 
to five daily injections of HCG, repeated doses of HCG to adult men cause a 
down-regulation of LH/HCG receptors in Leydig cells. Repeated injections cause 
a further increase of plasma oestradiol and 170H-progesterone, which is compat-
ible with the oestrogen-mediated augmentation of a 17,20-lyase block induced 
by the first injection (Forest et al., 1979; Smals et al., 1980). 
Dunkel et al. (1985) showed that in prepuberty as well as in early puberty, the 
relative testosterone response to the first injection of HCG was much stronger 
than the response to the second and subsequent injections. He found enzyme 
inhibition in prepuberal boys after repeated HCG injections and he also advised a 
single dose of HCG for diagnostic HCG tests in prepuberal boys. 
The dose of HCG varied considerably in the different protocols. From several 
studies it appeared that the maximally stimulating dose in adult men lies between 
1,500 and 6,000 I U (Padron et al., 1980; Okuyama et al., 1981; Smals et al., 1984). It 
must be recognized that both dosages are pharmacological, leading to plasma 
HCG levels 10-300 times higher than normal endogenous LH levels (in terms of 
biological potency) for at least 24 hours (Forest, 1983). For children, Forest et al. 
(1980) proposed a dose of 50-100 IU/kg while Tapanainen et al. (1983) suggested 
giving 5,000 IU/1.7 m2, which is a some what higher dosage. 
In summary 
After the first year of life, basal testosterone and gonadotropin serum levels are 
low in the prepuberal period, although stimulation tests (LHRH tests and HCG 
tests) show clear responses. 
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b. Boys with undescended testes 
The LHRH test is also used for hormonal evaluation of prepuberal boys with 
various sexual disorders including agonadal patients and boys with undescended 
testes. In agonadal boys, Job et al. (1974a, 1976) found the same biphasic pattern in 
gonadotropin secretion and GnRH stimulated LH and FSH which was later 
observed by Conte (Conte et al., 1980) in girls with gonadal dysgenesis; high in 
infancy, low and comparable with normal prepuberal children in mid-childhood, 
and again rising to high levels in the adult castrate range at about 11 years of life. 
In other words, in mid-childhood the basal and stimulated concentrations of 
gonadotropin may not provide definitive evidence of defective or absent testes 
or ovaries. 
Koch and Rahlf (1975) and Job et al. (1974b) reported normal basal serum values 
of LH and FSH in prepuberal cryptorchid boys. Waaler (1976) also studied urinary 
secretion of LH and FSH. In prepuberal bilateral cryptorchid boys, he found 
diminished LH excretion, while he found normal FSH excretion in unilateral and 
bilateral cryptorchids under eight years of age. In bilateral cryptorchid boys in the 
age group 8-12 years, the FSH excretion was significantly increased. 
Many reports have been published concerning plasma gonadotropins in pre-
puberal cryptorchid boys after stimulation with LHRH i.v .. job and associates 
found a reduced LH and a normal FSH response to LHRH i.v. from infancy 
throughout the whole prepuberal period in unilateral and bilateral cryptorchids 
(Job et al., 1974b; 1977a; Gendre! et al., 1977). Happ et al. (1978) also found reduced 
LH response to LHRH after the first year of life up till puberty. Lee et al. (1974), 
Cacciari et al. (1976) and Van Vliet et al. (1980) found normal basal and stimulated 
LH serum levels in cryptorchidism. The accompanying FSH levels were either 
normal (Cacciari et al., 1976) or elevated in some unilateral and bilateral cryptor-
chids (Lee et al., 1974). An increased FSH response with a normal LH response in 
bilateral cryptorchids was also reported by Sizonenko et al. (1978). He performed 
testicular biopsies and found low counts of spermatogonia in both testes. He 
found a negative correlation between the FSH response to LHRH and the number 
of spermatogonia and suggested an active, selectively negative feedback mecha-
nism between inhibin and the prepuberal pituitary. Other authors did not find 
differences for LH and FSH after LHRH i.v. between unilateral and bilateral 
cryptorchids (Gendre! et al., 1977; Van Vliet et al., 1980). Some investigators found 
alternating elevated or decreased or normal basal and peak LH and FSH serum 
values (Koch and Rahlf, 1975; Illig and Werder, 1977; Skorodok et al., 1982), which 
according to Battin and Colle (1977) indicates the heterogenity of cryptorchidism. 
The HCG-stimulation test enables detecting anorchia, provided it is bilateral, in 
every age group, even in infants, because there will be no increase in plasma or 
urinary testosterone (Knorr, 1979a). Diverse results of HCG tests in cryptorchid 
boys have been reported. Some authors found no difference in testosterone 
response to HCG between cryptorchid boys and controls (Cacciari et al., 1974) or 
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between unilateral and bilateral cryptorchids (Rivarola et al., 1970; Sizonenko et 
al., 1973; Canlorbe et al., 1974). Others found lower testosterone responses in 
cryptorchid boys than in controls and/or in bilateral cryptorchids than in unilater-
al cryptorchids (Zachmann, 1972; Canlorbe et al., 1974; Cacciari et al., 1974; Walsh 
et al., 1976; Gendre! et al., 1977; Attanasio et al., 1977; Anoussakis et al., 1978; 
Hafez et al., 1983). Attanasio and coworkers (1977) found a significant difference 
in testosterone response in bilateral cryptorchids comparing the successfully 
treated boys with the unsuccessfully treated ones after HCG treatment (p < 
0.001). 
Most authors found normal basal testosterone plasma levels or urinary testos-
terone excretion in cryptorchid boys (Rivarola et al., 1970; Zachmann, 1972; 
Sizonenko et al., 1973; Cacciari et al., 1974; Canlorbe et al., 1974; Koch and Rahlf, 
1975; Illig and Werder, 1977; Dickerman et al., 1979). Waaler (1976) found elevat-
ed urinary testosterone excretion in unilateral and bilateral cryptorchid boys 
under nine years of age with a decreased urinary LH excretion. 
In summary 
In agonadal patients and in patients with a hypothalamo-pituitary-gonadotro-
pic deficiency, basal and stimulated gonadotropin levels may be in the normal 
range in mid-childhood. Elevated, normal, and decreased LH and FSH values 
have been found in cryptorchidism. Only bilateral anorchia can be detected with 
certainty with an HCG test. No uniform responses have been elicited in cryptor-
chidism. 
3.5. CLINICAL AND HORMONAL EVALUATION OF BOYS BORN WITH 
UNDESCENDED TESTES, DURING THEIR FIRST YEAR OF LIFE 
3.5.1. Introduction 
According to Scorer (1964) the incidence of undescended testes at birth 
amounts to 4.3% of male infants (2.7% for full-term and 21% for pre-term boys). 
During the first year of life, spontaneous descent may still occur, resulting in a 
reduction in the percentage of undescended testes to approximately one per 
cent for one year old boys. The conflicting reports described in section 3.4.2.b., 
prompted a clinical and hormonal study of boys born with undescended testes 
during their first year of life. This study ran parallel with our study of the effect of 
hormonal treatment of boys with undescended testes after the first year of life 
(see chapter 4). The aims of the study were: 
- to follow boys with undescended testes during their first year of life and 
observe any spontaneous testicular descent; 
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- to ascertain whether there is a (transient?) functional insufficiency in the 
hypothalamo-pituitary-gonadal axis in infants with undescended testes; 
- to investigate whether boys with undescended testes suffer from a disorder in 
the biosynthesis of testosterone or an enzyme inhibition. 
3.5.2. Patients and methods 
Between October 1982 and January 1985, a total of48 boys with 56 undescend-
ed testes were referred to the Sophia Children's Hospital within their first year of 
life (see figure 3.2.). Forty-five of these boys were born after a full-term preg-
nancy; the remaining three were born prematurely, two with a birth weight of 
2,000 g after respectively 33 and 34 weeks gestation, and one weighing 2,710 g 
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Figure 3.2. Age distribution of boys with unilateral and bilateral cryptorchidism enrolled in the study. 
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after 36 weeks gestation. All three were unilaterally cryptorchid. For the whole 
series of patients, cryptorchidism was unilateral in 40 boys (27 leftsided and 13 
rightsided) and bilateral in eight. Twenty-four boys were under three months old 
at referral, consisting of 20 unilateral cryptorchids (11 leftsided and 9 rightsided) 
and 4 bilateral cryptorchids. From the moment of referral, the boys were seen 
regularly in our outpatient clinic, if feasible, at the age of 3, 6, 9 and 12 months. At 
each visit, the spontaneous and the most caudal testicular position was deter-
mined independently by each examiner (see 2.3.). 
Hormonal evaluation consisted of an LHRH test and determination of basal 
serum testosterone at 3, 6 and 12 months of age. An HCG test was carried out at 
the start of the second year of life. Before and three days after an intramuscular 
injection of 1,500 IU HCG, we determined serum testosterone (T), dihydro-
testosterone (DHT), progesterone (P), 17 a-hydroxypregnenolone (17 OHPreg), 
17 a-hydroxyprogesterone (17 OHP), dehydroepiandrosterone sulfate (DHEAS), 
androstenedione(~ 4) (figure 3.3.). For methods of hormonal evaluation see 2.5. 
A total of 160 boys without any endocrinological anomalies served as controls 
with informed consent of the parents. Of this series, 153 were in their first year of 
life and had normally descended testes. Single blood samples were taken for 
serum testosterone determination from 144 of these boys coincident with routine 
blood tests and therefore the sampling caused no undue discomfort. Nine boys 
had an LHRH test. These boys had an indwelling catheter for other reasons and 
therefore repeat blood sampling caused no discomfort. The remaining seven 
boys were in their second year of life and their testes were retractile. These boys 
underwent an HCG test whereby testosterone, testosterone precursors and 
dihydrotestosterone were determined before and three days after the intramus-
cular administration of 1,500 IU HCG. 
For the final assessment of hormonal data, the study population was divided 
into three groups; the boys that stayed cryptorchid became group I, those that 
had delayed, spontaneous descent group II, and the control subjects formed 
group Ill. In order to avoid distribution assumption, e.g. Gaussian distribution, 
distribution-free methods were used for significance testing (see 2.6.) 
To compare the cross-sectional hormonal data of the three groups, the follow-
ing statistical procedures were carried out: 
Regarding serum testosterone. Every six boys of group Ill, equal or successive in 
age, were taken together. Their median values with respect to age and testoster-
one level were used as cross-median values (Tukey, 1977). These values were 
connected forming the cross-median curve (erne). The sign test was used for 
comparison of the testosterone values of group I and group II with the cross-
median curve of group Ill. In addition, the individual testosterone values of boys 
in group I were compared with the cross-median testosterone curve of group II. 
The cross-median testosterone values of group II were composed of four values 
determined at equal or successive ages. 
Regarding serum LH and FSH. Because of the small number of controls, cross-
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permission). 
median values of serum LH and FSH could not be determined for group Ill. 
Consequently, the individual basal and peak LH and FSH values of boys in group I 
and group Ill were compared with the cross-median curve of group II. The same 
procedure was followed for comparison of the individual LH and FSH values of 
boys in groups II and Ill with the cross-median curve of group I. The groups were 
compared with the sign test. 
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For comparison of the longitudinal hormonal data, the following statistical 
procedures were carried out: 
Regarding serum testosterone. The Kruskai-Wallis test was applied to compare 
the longitudinal testosterone values. of groups I and II and the cross-sectional 
testosterone values of group Ill at 3, 6 and 12 months of age. If the results were 
significant (p < 0.05), the Mann-Whitney-U test was carried out as well. The 
changes in the longitudinal serum testosterone values within groups I and II from 
3 to 6 and from 6 to 12 months of age, were compared using the test of Friedman. 
In case of significant results (p < 0.05), the Wilcoxon matched pairs signed rank 
test was also applied. Between the two groups these changes were compared 
using the Mann-Whitney-U test. 
Regarding serum LH and FSH. The longitudinal basal and peak LH and FSH values 
of groups I and II at 3, 6 and 12 months of age were compared with the 
Mann-Whitney-U test. The changes in the longitudinal LH and FSH values within 
groups I and II from 3 to 6 and from 6 to 12 months of age were compared using 
the test of Friedman. If the results were significant (p < 0.05), the Wilcoxon 
matched pairs signed rank test was applied. Between the two groups these 
changes were compared using the Mann-Whitney-U test. 
Correlations. Wei nvestigated the correlations of basal and peak LH values with 
testosterone values as well as the correlation of the ratio basal LH/T and peak 
LH/T with age for groups I and II. The rank correlation coefficients were calcu-
lated according to Spearman. 
HCG test. The results of the HCG tests were compared between the three 
groups using the Kruskal-Wallis test. In case of significant result (p < 0.05), the 
Mann-Whitney-U test was applied. In addition, the basal versus peak values of 
the testosterone precursors, testosterone and dihydrotestosterone were compa-
red within each group using Wilcoxon matched pairs signed rank tests. 
Upon reaching the age of one year, 19 boys of group I (22 undescended testes) 
were enrolled in our concurrent double-blind, placebo-controlled study of the 
efficacy of LHRH nasal spray, where they became part of age group A (see 4.3.2.). 
The protocol for the double-blind study being completed at that stage, hormonal 
treatment for the remaining nine cryptorchid one year olds was deferred. 
The foldout at the end of this book gives an explanatory survey of patient 
groups and age periods as well as symbols used in figures and tables. 
3.5.3. Clinical results 
Table 3.2. shows the frequency of spontaneous descent during the first year of 
life in our study population. Such delayed, spontaneous testicular descent oc-
curred in 19 boys altogether (20testes). Fifteen of them had unilaterally undescend-
ed testes (ten leftsided and five rightsided) while four were bilateral cryptor-
chids. Of these four boys only one had spontaneous descent of both testes. In the 
other three boys only one testis descended (two leftsided and one rightsided) 
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Table 3.2. Spontaneous testicular descent during the first year of life. 
spontaneous descent 
cryptorchidism boys boys testes 
unilateral left 27 10 10 
unilateral right 13 5 5 
bilateral B 4* 5 
total 48 19* 20 
* three boys with bilateral cryptorchidism had unilateral 
spontaneous descent 
Table 3.3. Spontaneous testicular descent during the first year of life in boys enrolled in the study 
within the first three months of life. 
spontaneous descent 
cryptorchidism boys boys testes 
unilateral left 11 6 6 
unilateral right g 4 4 
bilateral 4 2* 2 
total 24 12* 12** 
* two boys with bilateral cryptorchidism had unilateral 
spontaneous descent 
** six testes descended before the 3rd month 
and they remained unilaterally cryptorchid. Subsequently, this condition will be 
referred to as "hemi-descent". Spontaneous, delayed descent did not occur in 
any of the prematurely born boys. 
Table 3.3. shows the frequency of spontaneous descent in the 24 boys with 28 
undescended testes, who entered the study within the first three months of life. 
Spontaneous descent occurred in 12 of them, consisting of 10 with unilaterally 
undescended testes (6 leftsided, 4 rightsided) and 2 boys with bilaterally unde-
scended testes who had hemi-descent (one leftsided, one rightsided). In six of 
these boys the spontaneous descent occurred within the first three months of life, 
four with unilaterally undescended testes (three rightsided and one leftsided) 
and two boys with bilaterally undescended testes who had hemi-descent. The 
remaining 12 boys (including one pre-term baby) stayed cryptorchid. In 6 of 
altogether 19 boys that had delayed, spontaneous descent, this occurred after the 
sixth month. Five of them had unilaterally undescended testes (four leftsided and 
one rightsided) while the remaining boy, a bilateral cryptorchid, had sponta-
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neous descent of both testes. At the end of the first year, 10 of the 20 testes that 
had descended spontaneously, had assumed a permanent scrotal position, includ-
ing the six testes that had descended within the first three months of life. The 
other ten testes were retractile. 
Table 3.4. shows the results of LHRH nasal spray treatment in 19 boys (22 
undescended testes) without spontaneous descent during the first year of life, 
who were enrolled in the double-blind, placebo-controlled study (see 4.3.). The 
hormonal treatment was only successful in one boy with a righsided undescend-
ed testis and in one boy with bilaterally undescended testes in whom one testis 
descended only. Both these testes became retractile. 
Table 3.4. Results of LHRH nasal spray treatment. 
success failure 
cryptorchidism boys boys testes boys testes 
unilateral left 10 0 0 10 10 
unilateral right 6 1 1 5* 5 
bilateral 3 1** 2 5 
total 19 2 2 17 20 
* one drop-out: ectopia 
** only one testis descended 
3.5.4. Hormonal evaluation 
There were no significant differences in hormonal values between boys with 
unilaterally or bilaterally undescended testes in group I or group II, possibly due 
to the small number of bilateral cryptorchids. Consequently, in the statistical 
analyses no distinction was made for unilateral or bilateral cryptorchidism in 
either group. Boys with bilateral cryptorchidism who had spontaneous descent of 
one testis only (hemi-descent) were assigned to group II. 
Cross-sectional data. Cross-sectional studies should be based on one sample 
per patient. Therefore for the boys in groups I and II we used the first determina-
tion. For the control group we only had single samples. Figure 3.4. shows the 
individual serum testosterone values in the first year of life of boys in group I (n = 
29), group II (n = 18) and group Ill (n = 144). For group I unilateral and bilateral 
cryptorchids are shown separately, while for group II differentiation also involves 
boys with spontaneous hemi-descent. 
Figure 3.5. shows the individual testosterone values of boys in groups I and II in 
comparison with the cross-median testosterone curve of group III. The sign test 
revealed no significant differences comparing groups I and II with group III from 
the age of 80 to 180 days, 180 to 360 days, or at any time during that whole period. 
Figure 3.6. shows the individual testosterone values of boys in group I in 
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comparison with the cross-median testosterone curve of group II. The sign test 
revealed no significant differences comparing groups I and II from the age of 80 
days to 300 days. 
Figures 3.7. and 3.8. show the individual basal and peak LH serum values (after 
LHRH i.v.) of boys in group I (n = 29), group II (n = 18) and group Ill (n = 9). For 
group I unilateral and bilateral cryptorchids are shown separately while for group 
II differentiation also involves boys with spontaneous hemi-descent. 
Figure 3.9•. compares the individual basal LH serum values of boys in groups I 
and Ill with the cross-median curve of group II, while figure 3.9b. compares the 
individual basal LH serum values of boys in groups II and Ill with the cross-median 
curve of group I. The sign test revealed no significant difference for basal LH 
between groups I and II or between groups I and Ill (p > 0.05), whereas basal LH 
appeared to be higher in group II than in group Ill. 
Figure 3.10•. compares the individual peak LH serum values of boys in groups I 
and Ill with the cross-median curve of group II, while figure 3.10b. compares the 
individual peak LH serum values of groups II and Ill with the cross-median curve 
of group I. No significant differences were found for peak LH between groups I 
and Ill, between groups I and II or between groups II and Ill. 
Almost all (41 of 55) basal FSH serum values of boys in the three groups fell 
below the detection limit of the FSH assay (0.61U/I). Consequently, no evaluation 
of basal FSH was carried out. 
Figure 3.11. shows the individual peak FSH values of boys in group I (n = 28), 
group II (n = 18) and group Ill (n = 9). For group I unilateral and bilateral 
cryptorchids are shown separately, while for group II differentiation also involves 
boys with spontaneous hemi-descent. 
Figure 3.12•. shows the individual peak FSH values for boys in groups I and Ill in 
comparison with the cross-median peak FSH curve for group II. The sign test 
revealed no significant differences between group I or Ill and group II. The same 
procedure was followed for comparison of the individual peak FSH values of boys 
in groups II and Ill with the cross-median peak FSH curve of group I (figure 3.12b.). 
Here again, there were no significant differences. 
Longitudinal data. Figure 3.13. shows the longitudinal testosterone values of 
groups I and II and the cross-sectional testosterone values of group Ill after 
logarithmic transformation. These values were determined at approximately 3 
months (age period X, range 80-126 days), 6 months (age period Y, range 169-236 
days) and 12 months (age period Z, range 330-410 days). Table 3.5. shows the mean 
and SEM serum testosterone values for the three groups in the three age periods. 
In groups I and II the number of boys in age period Z was smaller than in either 
age period X or Y for technical reasons and in two cases because the parents 
refused another test (one in each group). The Kruskai-Wallis test revealed no 
significant differences between the three groups in any of the three age periods 
(p>0.05). 
Table 3.6. shows the change in serum testosterone values (mean ± SEM) in 
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groups I and II. The change of serum testosterone within groups I and II from age 
period X toY was statistically significant (p < 0.05). From age period Y to Z there 
was no significant difference in the change within group I. While the pattern of 
change within group II from age period Y to Z was the same as for group I, the 
small number of boys did not allow for significance testing. Comparing group I 
with group II, there was no difference in the change in serum testosterone levels 
(p >0.05). 
Figures 3.14. and 3.15. give the longitudinal basal and peak LH serum values for 
groups I and II at approximately 3, 6 and 12 months of age. The mean and SEM 
basal and peak LH values of the two groups in age periods X, Y and Z are given in 
table 3.7. No significant differences were found between groups I and II for any 
one of the three age periods. 
Table 3.8. shows the change in basal and peak LH serum values in groups I and 
II. In group I, the changes in basal and peak LH values from age period X toY and 
from Y to Z were statistically significant (p < 0.05). In group II the change in basal 
and peak LH from age period X to Y was statistically significant but the change 
from age period Y to Z could not be tested for significance (small number of 
boys), although it did show the same pattern as in group I. A comparison of the 
two groups revealed no difference in the change in basal and peak serum LH (p > 
0.05). 
Figure 3.16. shows the longitudinal peak FSH values of groups I and II in the 
three age periods. The mean and SEM peak FSH values of the two groups are 
given per age period in table 3.9. A comparison of groups I and II per age period 
revealed no significant differences (Mann-Whitney-U test, p > 0.05). Peak FSH 
serum values did not change significantly from age period X toY or to Z within 
groups I and II (test of Friedman, p > 0.05). 
Correlations. No significant correlations were found between cross-sectional 
basal or peak LH and testosterone serum levels from the age of 80 days in the first 
year of life either in group I or in group II. The Spearman test revealed a highly 
significant positive correlation between the ratio basal LH/T or peak LH/T and 
age in the first year of life in groups I and II (p < 0.005). In figures 3.17~, 3.17~, 3.17s 
and 3.17~, the least square regression lines are presented of the ratios in groups I 
and II. An increase of the ratio basal LH/T or peak LH/T with age was found in 
both groups. 
Table 3.10. gives the basal and peak serum testosterone values (mean± SEM) 
before and three days after intramuscular administration of 1,500 IU HCG at the 
start of the second year of life for 22 boys in group I and 7 each in groups II and Ill. 
It was not possible to carry out an HCG stimulation test in the whole study 
population. Many parents would not allow another blood test, particularly con-
cerning the boys in whom spontaneous descent had occurred. No statistically 
significant differences were found in basal and peak serum testosterone values 
comparing the three groups (Kruskai-Wallis test, p > 0.05). 
Table 3.11. shows basal and peak serum values (median and range) oftestoster-
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one, dihydrotestosterone and several steroid precursors of the ~ 4, and ~ 5 
pathway before and after intramuscular administration of 1,500 IU HCG in the 
second year of life in the three groups. Group 1: 11 boys; group II: 7 boys and 
group Ill: 7 boys. For technical reasons, 17 OHPreg was only determined in the 
boys of group I and in two boys of group II. After HCG stimulation a significant 
increase of serum T and DHTwas found in all three groups (p<0.05), whereas no 
significant changes could be observed for P and 17 OHP in any of the three 
groups and for 17 OHPreg in groups I and II. A small but statistically significant 
increase was found for DHEAS in groups I and Ill and for ~4 in groups I and II (p< 
0.05). A comparison of the three groups revealed no significant differences for 
basal17 OHP, ~ 4, T and DHT between the three groups or for basal17 OHPreg 
between groups I and II (small number of boys). Basal P and DHEAS were slightly 
higher, but with statistical significance, in group II than in group I. There were no 
statistically significant differences between the three groups for peak values of P, 
17 OHP, DHEAS, T and DHT. Peak values of~ 4 were slightly higher, albeit with 
statistical significance, in group II than in group Ill. There was no difference in the 
peak values of 17 OHPreg for groups I and II. 
Pages 110-136 contain figures and tables illustrating the hormonal evaluation. 
Foldout page 330 gives an explanatory survey of patient groups and age periods 
as well as symbols used in figures and tables. 
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Table 3.5. Longitudinal testosterone serum values (mean± SEM) of boys of groups I and II and cross-sectional testosterone serum values (mean ±SEM) of 
boys of group Ill in age period X, Y and Z. See foldout page 330. 
age period X age period Y age period Z 
80-126 days 16g-236 days 330-'1 10 days 
age testosterone age testosterone age testosterone 
boys [days] nmol/1 boys [days] nmol/1 boys [days] nmol/1 
group N mean mean~ SEM N mean mean~ SEM N mean mean~ SEM 
persistent 12 101 3.63 ~ 0.73 12 188 0.15 ~ 0.05 8 385 0.06 ~ 0.02 
cryptorchidism 
II 
delayed spontaneous 6 10'1 3.83 ~ 0.9'1 6 192 0.30 ~ 0.11 3 388 0.12 ~ 0.08 descent 
Ill 
controls 15 109 '1.03 ~ 0.75 17 212 0.20 ~ 0.06 9 35'1 0.07 ~ 0.02 
....1 
N No significant differences for serum testosterone comparing groups I. II and Ill per age period [Kruskai-Wallis test. p > 0.05] w 
-' 
~ Table 3.6. Change in serum testosterone values (mean± SEM) of boys of groups I and II from age period X toY andY to Z. See foldout page 330. 
age period X ---+ y age period Y ---+ z 
change of testosterone change of testosterone 
boys nmol/1 boys nmol/1 
group N mean~ SEM N mean~ SEM 
persistent 12 -3.ljB ~ 0.69* B -0.13 ~ o.os•• 
cryptorchidism 
II 
delayed spontaneous fi -3.5lj ~ 0.91* 3 -0.19 ~ 0.09 descent 
• significant change from age period X toY [Wilcoxon matched pairs signed rank test. p <0.05] 
•• no significant change from age period Y to Z [Wilcoxon matched pairs signed rank test. p >0.05] 
no significant differences in the change of serum testosterone between groups I and II 
[Mann-Whitney-U test] 
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Table 3.7. Longitudinal basal and peak LH serum values (mean± SEM) of boys of groups I and II in age period X, Y and Z. See foldout page 330. 
age period X age period Y age period Z 
B0-126 days 169-236 days 330-'110 days 
age LH IU/1 age LHIU/1 age LHIU/1 
boys [days) mean.:!:.SEM boys [days) mean.:!:.SEM boys [days) mean.:!:.SEM 
group N mean basal peak N mean basal peak N mean basal peak 
persistent II 102 '1.55 33.'13 II 1BB 2.50 1B.'I6 g 3B5 t.B1 7.57 
cryptorchidism + 0.'1'1 + 3.00 + 0.20 + 2.30 + 0.20 + 0.75 
II 
delayed spontaneous 6 10'1 5.g3 36.62 6 1g2 2.62 20.3B 3 3BB 2.07 10.27 descent + 1.32 + 3.33. + 0.25 + 2.73 + 0.'17 + 2.0B 
...l 
t:::J no significant differences for basal or peak LH serum values comparing groups I and II per age period [Mann-Whitney-U test. p > 0.05) 
--' 
N 
o:> 
Table 3.8. Change in basal and peak LH serum values (mean± SEM) of boys of groups I and II from age period X toY andY to Z. See foldout page 330. 
group 
persistent 
cryptorchidism 
II 
delayed spontaneous 
descent 
boys 
N 
11 
6 
age period X -+ Y 
change of LH IU/1 
mean~ SEM 
basal peak 
- J.g6* - 14.g6• 
+ 0.29 + 2.64 
-
- 3.27° - 16.23° 
+ 1.10 + 4.55 
-
age period Y - Z 
boys 
N 
g 
3 
change of LH IU/1 
mean~ SEM 
basal peak 
- 0.66° 
+ 0.34 
- 0.63 
+ 0.46 
- 10.64° 
+ 2.61 
- 10.57 
+ 3.62 
• significant change from age period X to Y and Y to Z [Wilcoxon matched pairs signed rank test. p < 0.05] 
no significant differences in the change of basal or peak serum LH between groups I and II 
[Mann-Whitney-U test. p > 0.05] 
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-' Figure 3.16. Individual longitudinal peak FSH values of boys of groups I (lower line) and II (upper line) at approximately 3, 6and 12 months of age(-= mean (:g value). See foldout page 330. 
-' Table 3.9. Longitudinal peak FSH serum values (mean± SEM) of boys of groups I and II in age period X, Y and Z. See foldout page 330. w 
0 
age period X age period y age period z 
80-126 days 169-236 days 330-1H 0 days 
age peak FSH age peak FSH age peak FSH 
boys [days) IU/1 boys [days) IU/1 boys [days) lUll 
group N mean mean 2:. SEM N mean mean 2:. SEM N mean mean 2:. SEM 
persistent 10 101 2.86 2:. O.IJ2 10 187 I • 98 2:. 0 • 37 9 385 3.70 2:. 0.70 
cryptorchidism 
II 
delayed spontaneous 6 IOIJ 2.77 2:. 0.87 6 192 2.27 2:. 0.67 3 388 3.80 2:. 2.20 descent 
no significant change from age period X to Y and Y to Z within groups I and II [test of Friedman. p > 0.05) 
no significant differences for peak serum FSH comparing groups I and II per age period [Mann-Whitney-U test. p > 0.05) 
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~ Figure 3.17•. Correlations between the ratio basal LH/T and age in the first year of life for boys of group I. See foldout page 330. 
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Figure 3.17b. Correlations between the ratio peak LH/T and age in the first year of life for boys of group I (n = 29). See foldout page 330. 
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Figure 3.17c. Corr,elations between the ratio basal LH/T and age in the first year of life for boys of group II (n = 17). See foldout page 330. 
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Figure 3.17d. Correlations between the ratio peak LH/Tand age in the first year of life for boys of group II (n = 17). See foldout page 330. 
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Table 3.10. Results of HCG tests for serum testosterone of boys of group I (n = 22), group II (n = 7) and group Ill (n = 7). 
serum testosterone 
boys nmol I I • mean .:!:. SEM 
group N basal* peak* 
22 0.10 .:!:. 0.02 13.51.:!:. 1.00 
II 7 0.10 .:!:. 0.03 16.00 .:!:. 2.56 
Ill 7 0.07.:!:. 0.01 10.90 .:!:. 1.24 
* comparison between group I. II and Ill: N.S. 
[Kruskal Wallis test. p > 0.05) 
-" Table 3.11. Results of HCG tests for testosterone precursors, testosterone and dihydrotestosterone for boys of group I (n = 11), group II (n =7) and group Ill w 
0"\ (n=7). 
p 17 DHPreg 17DHP OHEAS 
,:\ " T DHT 
N nmol/1 N nmol/1 N nmo1/l N umol/1 N nmol/1 N nmol/1 N nmo1/l 
--- -
~ 
basal median 11 1.1 B 2.3 11 < 1.2 11 0.0'1 11 0.38 11 0.05 11 < 0.13 
range < 0.5 - 2.2 1.1-g.o < 1.2 - J.g < 0.02 - 0.58 < 0.35 - 0.8'1 0.02 - o.:m < 0. 13 -< 0. 13 
peak median 11 1.3 8 3.5 11 1.5 11 0.12° 11 1.1g0 11 15.0 11 1.83° 
range 0.7 - 3.0 1.3 - 5.B < 1.2 - 2.2 0.07- 1.20 0.52 - 1.5'1 5.5 - 20. 0.78 - 2.73 
~ 
basal median 7 2.1• 2 5.7 7 < 1.2 7 0.20° 7 0.55 7 0.07 7 < 0.13 
range 1.0 - '1.2 1.'1 - g_g <1.2-1.5 0.0'1- 1.20 < 0.35- 1.30 0.02 - 0.28 < 0.13 - 0.25 
peak median 7 2.1 2 
"·" 
7 2.1 7 0.30 7 1.31°. 7 1'1. 0 7 1.55° 
range 0.7 - 2.8 o.g- 7.8 < 1.2 - "·" 0.11 - 1.'10 0.87 - 2.20 8.8 - 30. 1.13 - 2.32 
group Ill 
basal median 7 1.3 N.D. 7 < 1.2 7 0. 1g 7 0.5g 7 0.05 7 < 0.13 
range 1.1-3.0 <1.2-1.5 0.03 - 0.5g < 0.35 - 0.80 0.03 - o. 13 < 0.13 - 0.1'1 
peak median 7 1.3 N.D. 7 1.5 7 0.35° 7 0.73 7 11.0 7 1.57° 
range < 0.5 - 2.7 < 1.2 - 2.3 0.12- 0.'15 0.52 - o.glf 5.8 - 15. 1.00 - J.g5 
o significantly higher than basal values [Wilcoxon matched pairs signed rank test. p < 0,05) 
• significantly higher than basal P of group I [Mann-Whitney-U test, p < 0.05) 
o significantly higher than basal DHEAS of group I [Mann-Whitney-U test. p < 0.05) 
• significantly higher than peak/\ If of group Ill [Mann-Whitney-U test. p < 0,05) 
N - number of boys 
N.D. - not done 
3.5.5. Discussion 
Delayed, spontaneous descent of the testis occurred in 50% of the boys that 
were enrolled in the study within the first three months of life. In 50% of these 
cases, the descent occurred before the third month. All boys that had delayed, 
spontaneous descent during the first year of life were born after a full-term 
pregnancy. In 6 of altogether 19 boys that had spontaneous descent during the 
first year of life, this occurred after the sixth month. In contrast, Scorer (1964; 
1981) as well as Forest and coworkers (1984) stated that spontaneous testicular 
descent practically never occurs after the sixth month of life. Villumsen and 
Zachau (1966) were unable to time the occurrence of spontaneous descent in the 
first year of life, because they only saw the subjects at the fifth day of life and at 
one year of age. 
Nineteen boys with 22 testes that had failed to descend spontaneously by the 
end of their first year of life, were enrolled in the double-blind, placebo-
controlled study of the efficacy of LHRH nasal spray treatment (age group A, see 
chapter 4). Conforming with the overall low rate of success, this hormonal 
treatment resulted in the descent of only 2 of these 22 testes. Consequently, the 
other seven boys whose testes had failed to descend spontaneously by the end of 
the first year, were not subjected to such hormonal treatment. 
In agreement with Forest and coworkers (1973; 1974), the cross-sectional 
testosterone serum analysis revealed elevated testosterone levels in the first six 
months of life in boys with descended testes. Noteworthy is the wide range, 
particularly in the first three months of life (see figure 3.4.). 
Neither a cross-sectional nor a longitudinal evaluation of serum testosterone 
levels during the first year of life revealed significant differences from the age of 
80 days, between boys that stayed cryptorchid and boys that had spontaneous 
descent or controls. These findings do not agree with those of Gendre! and co-
workers (1980) who reported that up till the age of four months, plasma testoster-
one was significantly lower in boys who remained cryptorchid than in boys with 
spontaneous testicular migration. 
Cross-sectional and longitudinal basal and peak LH and peak FSH serum 
values, likewise, showed no significant difference between boys that stayed 
cryptorchid and boys with delayed spontaneous descent in the first year of life. 
The small number of controls did not allow for a definite conclusion, although 
the levels of basal and peak LH and peak FSH were comparable with those of 
cryptorchid boys and boys with delayed, spontaneous descent. Basal LH values 
were even higher for boys with delayed spontaneous descent than for controls. 
Consequently, there were no signs of a (transient) functional insufficiency of 
the hypothalamo-pituitary-gonadal axis in infants with undescended testes. This 
lack of a pituitary-gonadal disturbance in the boys that stayed cryptorchid 
through the first year of life is in conformity with our findings in the double-blind, 
137 
placebo-controlled study concerning cryptorchid boys aged 1 to 12 years (see 
chapter4). 
Neither serum testosterone values nor the results of the LHRH tests were of any 
prognostic value for spontaneous testicular descent in the first year of life. 
We did not find any significant correlations between basal or peak serum LH 
and serum testosterone levels from 80 days through the first year of life in boys 
that stayed cryptorchid or in boys that had delayed, spontaneous descent. This 
contrasts with the positive correlations found by Gendre! et al. (1980) between 
testosterone and LH levels in infants that remained cryptorchid and in those that 
had delayed, spontaneous testicular descent. Hammond and coworkers (1979) 
found good correlations between serum T and gonadotropins in the male infant 
population, while Forest et al. (1974) found no correlations between serum T and 
gonadotropins. On the other hand, we did find a statistically significant correla-
tion between the ratio basal LH/T and age as well as the ratio peak LH/T and age 
in the first year of life for boys who remained cryptorchid as well as for those with 
delayed spontaneous testicular descent. Towards the end of the first year of life, 
the ratio of basal LH/T and peak LH/T increased in the two groups. It emerged 
from the cross-sectional testosterone and LH values of our study that serum 
testosterone declined earlier to prepuberal levels than basal and peak LH values. 
Forest and coworkers (1976) described the same observations for basal LH and 
testosterone. The following explanations can be offered: 
- High levels of maternal oestrogens drop rapidly after birth. Likewise, serum 
testosterone falls rapidly in the first week of life, probably due to the removal 
of HCG from cord blood. These two events may contribute to the rise of 
circulating gonadotropins, which may be responsible for the subsequent rise 
of serum testosterone after birth (Forest et al., 1973). 
- The fall of oestrogens after birth may also provide an explanation for the 
subsequent rise of serum testosterone, because there is ample evidence that 
oestradiol directly inhibits testosterone production by enzyme inhibition 
(Yanaihara et al, 1972; Jones et al., 1978). 
- The decrease of serum testosterone after the second month of life may be 
caused by a decreased response of the testes to endogenous gonadotropins. 
The decline of fetal Leydig cells in the infant testis after the first postnatal 
months may well be responsible for this decreased response. 
- The decrease of basal and GnRH stimulated LH secretion in the first year of life 
might be due to the following mechanisms (see 3.4.): 
1. A sex steroid-dependent mechanism. In the first years of life the sensitiv-
ity of the gonadostat to circulating sex steroids increases ("low setpoint") 
subsequently resulting in suppression of gonadotropins by low amounts 
of circulating steroids. 
2. A sex steroid-independent mechanism. Intrinsic CNS inhibitory influ-
ences suppress the secretion of gonadotropins. 
In our opinion, the lack of correlations between basal and stimulated serum lH 
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and testosterone values in the first year of life in boys with delayed spontaneous 
descent and boys that stayed cryptorchid favours the second theory. Our premise 
is in agreement with the suggestion of Winter (1982) that the reduced childhood 
secretion of gonadotropins might be the result of central inhibition of GnRH 
secretion. 
Table 3.12. shows the changes in the plasma concentration of the precursors of 
testosterone in the five enzymatic defects affecting testicular testosterone biosyn-
thesis as described by Forest (1981). The first three defects concern enzymes 
required for the formation of cortisol as well as testosterone. Consequently, each 
is associated with a more or less severe adrenal insufficiency and a compensatory 
increase in ACTH secretion resulting in a secondary increase in steroids situated 
above the enzymatic block. The enzymes 17,20-desmolase and 17 a-hydroxy-
steroid dehydrogenase (= 17-keto reductase) are only involved in the biosyn-
thesis of testosterone. Therefore, patients with these enzymatic defects have 
intact glucocorticoid and mineralocorticoid secretion.ln genetic males suffering 
from any one of these five enzymatic defects, insufficient secretion of testoster-
one by the fetal Leydig cells results in an absent or incomplete masculinization of 
the external genitalia ranging from a nearly male appearance with hypospadias to 
a nearly normal female appearance. 
The boys of our study showed no clinical indications of a defect in the testoster-
one biosynthesis. All boys had a normally developed scrotum and a normal penis 
without hypospadias. None of them had bilaterally impalpable testes. Nor were 
there any clinical signs of adrenal insufficiency. 
Table 3.12. Pattern of changes in the plasma concentrations of the precursors of testosterone in the 
five enzymatic defects affecting testicular testosterone biosynthesis (Forest, 1981; with 
permission). 
Pregnen- Progester- 17 -Hydroxy- 17 -Hydroxy- DHA Androstene- Testosterone 
Enzyme defect alone one pregnenolone progesterone diane 
20-22 Desmolase \ \ \ \ \ \ \ 
17 a -Hydroxylase // // \ \ \ \ \ 
3 p -oi-Dehydro- /// / //// // //// ±/ <i?Vcr\ genase 
17-20 Desmolase // // // /// \ \ \ 
17-Keto- n 
Reductase 
n ±/ ±/ ±/ //// \ 
Basal testosterone, dihydrotestosterone and steroid precursors were very simi-
lar for boys that stayed cryptorchid and boys that had spontaneous testicular 
descent in the first year of life, in comparison with boys that were born with 
normally descended testes. HCG stimulation resulted in a clear and identical rise 
of serum testosterone values in all three groups. In adult men, a clear rise of 17 
a-hydroxyprogesterone level can be observed 24 hours after one single injection 
of HCG, and this level is still elevated at 72 hours, indicating inhibition of 
17,20-lyase activity (Forest and Roulier, 1984). In our study, the steroid precursors 
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showed at best only a very small increase (.:14 and DHEAS) in the entire study 
population. Consequently, our hormonal data did not suggest enzymatic defects 
or enzyme inhibition in any of the boys, while their physical appearance and the 
normal stimulated DHT values excluded a 5 a-reductase deficiency. 
3.5.6. Conclusions 
Forty to fifty per cent of the testes that were undescended at birth descended 
spontaneously during the first year of life. Such delayed, spontaneous descent 
may even occur after the sixth month of life. 
Our hormonal findings do not support the hypothesis of a (transient) function-
al insufficiency of the hypothalamo-pituitary-gonadal axis in infants with unde-
scended testes. 
Serum testosterone values and the results of the LHRH tests were of no 
prognostic value for spontaneous testicular descent in the first year of life. 
No disorders in the biosynthesis of testosterone nor enzyme inhibition were 
found in our study population. 
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CHAPTER4. 
HORMONAL TREATMENT OF CRYPTORCHIDISM 
4.1. THE HISTORY OF HORMONAL TREATMENT 
4.1.1. Introduction 
Hormonal treatment of undescended testes dates from the early thirties. 
Ascheim and Zondek (1928•; 1928b) noted the presence of a substance that 
stimulated the sex glands in the urine of pregnant women. Shortly afterwards, 
Shapiro (1930) reported genital growth and testicular descent by injections with 
Hypophysenvorderlappen Hormone (HVH) in a large percentage of boys and 
young men with hypogenitalism and cryptorchidism. Hamilton (1938; Hamilton 
and Hubert, 1938) induced descent in monkeys as well as in humans with testos-
terone propionate administered subcutaneously. They surmised that descent of 
previously retained testes obtained by anterior-pituitary-like (APL) substances 
might to some extent be due to the production of male hormone substances. The 
year before, Thompson et al. (1937) had published a literature review of APL 
treatment results. The success rate varied from 25 to 100%, but some studies 
involved very small numbers of patients. In his own study, descent occurred in 
only 4 of 21 undescended testes. None of the impalpable testes descended. Of 
the descended testes, two were of the migratory type, one testis could be pushed 
into the upper end of the scrotum before treatment and the fourth down to the 
lower end of the inguinal canal. He stated that in three of the four successful 
cases, the testes were of the type that commonly descends at puberty! He further 
stated that the findings at operation in several of the unsuccessful cases would 
suggest that anatomical factors were responsible for failure of descent. The dose 
and duration of the administration of APL substance varied but generally approx-
imated 200 rat units three times a week by intramuscular injection for an average 
of five months. In most of the patients growth of penis, increase of testicular size 
and of pubic hair, higher erection frequency, more active, particularly masculine 
behaviour was reported. 
In a study of 71 boys with 91 undescended testes, Bigler et al. (1938) evaluated 
the treatment of undescended testes with injections of either the gonadotropic 
substance of the urine of pregnant women or the gonadotropic substance of the 
anterior lobe of the pituitary gland. The success rate was 48% in the first group and 
25% in the second group. Return to the former, undescended position occurred 
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in both groups. He thought that the better result in the first group was due to the 
greater number of rat units administered. Treatment was equally successful at any 
age after the first year but in view of the side effects was not recommended 
before the age of seven years. The APL substance of urine of pregnant women 
was advocated because of its higher potency (100 rat units/cm3) so that smaller 
amounts could be used. 
Almost 20 years later, Deming (1952) again evaluated the percentage of success 
of hormonal therapy for cryptorchidism with APL substance derived from preg-
nancy urine (chorionic hormone). He found extremes of 0% to 90% with many 
variations in between. He stated that if one testis descends while another one 
remains cryptorchid there must be some factor other than hormonal which 
influences the retention of the testis along the canal. The success rate in his own 
group was only five per cent and he advocated using chorionic hormone primari-
ly adjuvant to surgery. 
4.1.2. Human chorionic gonadotropin (HCG) 
Human chorionic gonadotropin (HCG), which came into use at a later,stage 
and is still being used today, is also derived from the urine of pregnant women. 
This product possesses mainly LH activity. Some investigators employed human 
menopausal gonadotropin (HMG) which chiefly possesses FSH activity. How-
ever, the results of treatment with HMG either alone or in combination with HCG 
seemed no better than those of HCG alone (Bergada and Mancini, 1973; Confa-
lonieri et al., 1979). 
Diverse schedules have been proposed for HCG treatment, varying in dosage 
as well as duration. In 1975, the International Health Foundation recommended 
an HCG dosage scheme related to age: 
3-12 months 
1- 6 years 
6 years and over -
250 IU I 
500 IU 
1,000 IU 
per i.m. injection 
two times a week 
for five weeks 
Forest and coworkers (1984) found no fault with the total dose of this scheme, 
ranging from 2,500 IU to 10,000 IU, but they questioned both dosage and dura-
tion. They tried out various schemes, starting with seven intramuscular injections 
over a period of two weeks and eventually reached an optimal dosage scheme of 
four injections at intervals of either four or five days. It appeared that four HCG 
injections given at five day intervals generated similar testosterone secretion as 
seven injections over the same period of time, while circulating levels of HCG 
remained elevated in terms of LH equivalent biopotency and in the puberal 
range for about four days. The dose they used was 100 IU/kg or approximately 
2,500 IU/m2 per injection, twice the amount recommended by the International 
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Health Foundation, but their total dose was not much different, ranging from 
4,000 to 15,000 I U. 
Many studies have been published over the years concerning the results of 
HCG treatment and the various factors that may influence the success of hormon-
al therapy. In a study of more than 1200 patients, Bergada (1979) found that 
30-40% of the testes responded satisfactorily to HCG. The group of job (Canlorbe 
et al., 1979) reported complete descent in 40% of more than 300 cryptorchid boys. 
In a review of three large European studies, Bierich (1982) described the indi-
vidual rates of success as being very similar. The overall success rate amounted to 
a good 50% with HCG treatment, resulting in the descent of 753 of 1400 testes. 
Dickerman and coworkers (1983) reported a success rate of 25% in 128 prepuberal 
boys. With their diverse protocols, the group of Forest et al. (1984) achieved an 
overall success of 36% in the treatment of 558 undescended testes. 
All authors agreed that the position of the testis before treatment is of the 
utmost importance for successful hormonal therapy. The lower the pretreatment 
location of the testis, the better the treatment results. For prescrotal or gliding 
testes, Knorr (1970) reported a success rate of 99%. Bierich (1982) felt that of all 
undescended testes, the prescrotal ones would benefit most from hormonal 
therapy. He suggested that the lower success rate reported by Bergada compared 
with the three European studies was due to the fact that the Argentine author had 
not included prescrotal testes. The rate of success reported for impalpable testes 
contrasts shrilly with that for prescrotal testes, ranging from 32% (Knorr, 1970) to 
zero (Dickerman et al., 1983). 
The age of the patients also seemed to play an important part in the outcome of 
hormonal therapy. Most authors stated that the success of hormonal treatment 
was lower in the first years of life (Knorr, 1970; Dickerman et al., 1983; Forest et 
al., 1984). Garagorri et al. (1982) found only nine per cent success in patients 
treated from 6 to 35 months of age. Bierich (1982) found lasting success in 20% of 
the boys treated before their sixth year against 70% for older children. He felt that 
the difference in response was due to the age-related increment of Leydig cells. 
The increase of plasma testosterone after HCG treatment in the age group of 10 to 
13 years was twice as high as that found in infancy (Bierich, 1979). 
Bierich (1979) found significantly higher post-treatment testosterone values in 
successfully treated than in unsuccessfully treated boys. In contrast, Canlorbe et 
al. (1979) found a lower testosterone response in successfully treated patients. 
Forest (1979) found no differences in end-treatment testosterone values from six 
months to puberty. 
Bierich (1979) observed approximately the same treatment results in unilateral 
and in bilateral cryptorchidism. Others found a higher success rate in bilateral 
than in unilateral cryptorchidism (Bergada, 1979; Canlorbe et al., 1979), or just the 
opposite (Garagorri et al., 1982; Dickerman et al., 1983). 
A second HCG course was advocated by several investigators if the first HCG 
treatment had partial success (Bierich, 1979; Dickerman et al., 1983; Forest et al., 
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1984). Pagliano Sassi (1979) felt a second HCG course was useless. 
A return of the testis to the former, undescended position was reported by 
several groups (Bierich, 1979; Forest et al., 1984). Therefore, these authors 
recommended that the therapist follows the child for a considerable length of 
time after cessation of HCG administration and, if necessary, repeats the 
treatment. 
Whatever protocol was used, a clear reaction was usually observed in the 
genitalia, such as increased size of penis and testes, increased frequency of 
erection, roseate oedema of the scrotum as well as psychic alterations, (Forest et 
al., 1984). The symptoms generally disappeared soon after cessation of treatment. 
Two large prospective studies have been reported concerning the fertility of 
cryptorchid boys treated with HCG in the prepuberal period. Knorr (1979b) 
examined the ejaculate of 138 boys over 17 years of age, who were treated for 
undescended testes at the age of 6 to 13 years. The treatment consisted of HCG 
alone, surgery alone or unsuccessful HCG treatment followed by surgery. He 
concluded that only 39% of the patients treated for whatever type of undescend-
ed testis presented with a normal spermatogram and that the prognosis for 
fertility is no poorer after HCG treatment than after surgery. Fertility was 
significantly lower in bilateral (29%) than in unilateral (46%) cryptorchidism. The 
age at treatment, ranging between 6 and 13 years seemed to have no significant 
influence on the results. Therefore, he felt that placing the undescended testis in 
the right position at school age in no way guaranteed a normal spermatogenesis 
in later life. Zamudio-Aibescu (1979) examined 66 men who had all been treated 
with HCG at the age of 6 to 14 years followed by surgery if the hormonal 
treatment was unsuccessful. Fertility was evaluated by means of serial studies of 
sperm. The fertility rate for the whole group was 59%. The fertility rate was higher 
for the patients cured with HCG alone (74%) than for the patients submitted to 
complementary orchiopexy (51%). Furthermore, he also found that the post-
treatment fertility rate was higher for unilateral cryptorchidism (81%) than for 
treated, bilateral cryptorchidism (38%). 
Few authors described the mode of action of treatment with gonadotropins for 
undescended testes. Deming (1952) studied pre-adolescent macaque monkeys 
before and after injection of gonadotropic hormone. He found a 50% increase in 
testicular size, consisting mainly of an increase in the diameter of the tubules with 
some increase in interstitial tissue. The vas deferens had enlarged and elongated 
and the vascularity of the whole cord was greatly accentuated. The cremaster 
muscle fibres were twice the size of the control fibres. He surmised that the same 
changes may be produced by the hormonal therapy in the human male child 
causing testicular descent unless mechanical obstructive factors or structural 
abnormalities are present. Bierich (1979) assumed that the high local concentra-
tion of testosterone produced by the interstitial cells under the influence of HCG 
exerts a strong effect on the germinal epithelium and thus on growth and 
development of the gonad. However, he did not suggest in what way the actual 
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descent of the testis might be influenced. Forest and coworkers (1984) stated that 
the mode of action of HCG in postnatal testicular descent is still poorly under-
stood, but that both HCG itself and testosterone, produced in response to HCG, 
play a role. Here again, remarks concerning the actual descent of the testis were 
lacking. 
4.1.3. luteinizing-hormone-releasing hormone (LHRH) 
The effect of intranasally administered LHRH on gonadotropin secretion was 
first evaluated in 1973. London et al. (1973) showed that in adult men the response 
of LH and FSH to 5 mg LHRH, administered intranasally, is comparable to the 
gonadotropin response to 100 J.Lg LHRH, administered intravenously. Therefore it 
was concluded that 2% of the intra nasally administered LHRH was absorbed. Of 
the various doses of LHRH administered intranasally (1.25, 2.5, 5 mg) 2.5 mg was 
the minimal amount of LHRH required to produce the maximal LH response. The 
minimal amount required to produce the greatest change in FSH levels remained 
to be determined, since there was no significant difference between the mean 
response to 1.25, 2.5 or 5 mg. Evaluating gonadotropin release after intranasally 
administered LHRH in adult men and women, Dahlen et al. (1974) found a 
dose-dependent LH release after 0.5-2.0 mg LHRH. FSH release was not apparent. 
Furthermore, he found the LH release after 2.0 mg LHRH in the same range as 
seen after i.v. injection of 25 f..Lg indicating that approximately 1% of the intranasal 
LHRH reaches the circulatory system. 
Bourguignon et al. (1974) measured serum levels of LHRH by radio-
immunoassay in four young men following the intranasal administration of 2 mg 
synthetic LHRH. The initial rise of serum LHRH was seen at 2.5 minutes and the 
peak was reached at 15 minutes. A rapid response in serum LH was observed, the 
peak occurring between 30 and 45 minutes, while FSH levels did not change 
significantly. It was calculated that 1.25% of the dose was absorbed. 
Hagberg and Westphal (1982) made a dose response curve for LH and FSH 
release in five prepuberal boys with undescended testes, after i.n. administration 
of a total of 1.2 mg LHRH in three doses over a period of eight hours. Only a small 
increase of LH was found at the end of the period. Hocht, likewise, showed 
profiles of gonadotropin secretion after the administration of 400 f..Lg LHRH i.n. in 
three doses without clear results (Von der Ohe, 1982). Rajfer and coworkers 
(1984) demonstrated that in adult male volunteers 200 f..Lg LHRH was the minimal 
intranasal dose capable of achieving a significant LH response, which usually 
occurred within 30 minutes after insufflation. In cryptorchid boys, the same 
group found a significant increase of serum LH levels at 30 and 60 minutes after 
intranasal administration of 200 f..Lg LHRH (Rajfer et al., 1986). No reports have 
appeared concerning serum levels or urinary excretion of LHRH after intranasal 
administration of LHRH in prepuberal boys. 
The first successful attempt to treat cryptorchid boys with LHRH was reported 
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by Bartsch and Frick in 1974. By administering 20 J.Lg LHRH intramuscularly once a 
day for 14 days, they achieved complete descent in 14 of 16 undescended testes 
(87.5%). 
Happ and coworkers (1975) were the first to report the effect of intranasal 
LHRH therapy in boys with undescended testes. Subsequently, LHRH nasal spray 
treatment has been used in open and placebo-controlled studies with a success 
rate varying from 9-78% (table 4.1.). Dosage and duration of the LHRH intranasal 
administration differed in the various studies. Happ et al. (1978) treated their 
patients with 200 J.Lg LHRH six times daily (before and after meals, one puff of 100 
J.Lg in both nostrils) for a duration of ten weeks at most. They concluded that 
distinctly increased gonadotropin serum levels could be attained in prepuberal 
cryptorchid boys with as little as 200 J.Lg of LHRH i.n. The repeat stimulation after 
an interval of one hour was performed to take advantage of the priming effect of 
an initial dose, as previously suggested by Beck and coworkers (1976). Other 
workers subsequently reported the administration of 400 J.Lg LHRH, three times a 
day for a period of four weeks with similar results (Hagberg and Westphal, 1982; 
Hadziselimovic et al., 1982; Borkenstein et al., 1983). It is suggested that more 
frequent LHRH stimulation may lead to down regulation (Hadziselimovic, 1983b). 
Table 4.1. Success rates reported for LHRH nasal spray treatment. 
complete 
LHRH nasal spray patients testes descent % 
author dose/2'1 h duration [wks) -t+• N age [yrs) patients testes 
Happ et al .. 197B 6x200ug 1-10 25 1-11 36 6q 
Pirazzol i et a I .. 197B 6x200ug 9 5-12 9 22 22 
2x500ug 13 5-12 13 39 39 
Zabransky. 19B1 6x200ug qo 1-1q 50 7B 
Cacciari et al . • 19B2 6x200ug 23 3-12 23 22 22 
2x500ug 2q 3-12 2q 3B 3B 
Hagberg and Westphal. 19B2 3xqooug qg 2-10 56 61 
Hadziselimovic et al .• 19B2 3xlJOOug 60 IOmos-14 B1 62 
Borkenstein et al .. 19B3 3x"tOOug 53 median 5.6 6B qg 57 
Van der Meijden et a I •• 19Bq 6x200ug 29 2-12 39 13 
Schwarz et a I •• 19B5 3xl.f00ug 119 1-12 171 37 
De Muinck Keizer et at • • 19B6 3xl.f00ug 2x q 227 1-13 271 1B 
Illig et al .. 1977 6x200ug q q6 1-12 61 3B 
Bertelsen et al .. 19B1 6x200ug 23 5-12 Jq 26 2q 
Hagberg and Westphal. 19B2 6 x 100 ug q7 2-10 61 2B 
Karpe et al .• 19B3 6x200ug 25 3- B 25 2o 20 
Wit et al ... 19B5 3x'I00ug 26 1-12 35 17 
De Muinck Keizer et al .• 19B6 3 x lJOO ug 121 1-13 151 9 
. 
- open study. + placebo controlled study 
4.1.4. Discussion 
Reviewing the literature regarding treatment for undescended testes with 
gonadotropic hormones (APL and HCG) reveals a remarkable divergence in the 
rates of success reported for this modality. In the early years, involving treatment 
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protocols of long duration, percentages of testicular descent varying from 25% to 
100% were reported. For human chorionic gonadotropin, which subsequently 
came into use, the rate of success varied from 25% to 50% in a number of large 
series. Several factors may have influenced the divergent results: 
1. All authors agree that the pretreatment testicular position is a determining 
factor. The lower the pretreatment location of the testis, the better the results 
of treatment. This is illustrated by the fact that the percentage of success for 
impalpable testes has been reported as being zero, while a success rate of 99% 
has been reported for prescrotal testes. 
2. Most authors agree that the age at treatment plays an important role. The suc-
cess rate of hormonal therapy was lower in the first years of life. 
3. Most authors agree that a repeat course of HCG enhances the final rate of suc-
cess if the first treatment course had partial success, or in case the testis returns 
to its former, undescended position after complete descent had been 
achieved. 
4. There is less agreement concerning the influence of laterality on the success of 
hormonal treatment (unilateral vs. bilateral, leftsided vs. rightsided). 
5. The importance of an optimal, minimal dose of HCG is not disputed. Too small 
a dose may be ineffective, while large doses result in considerable side effects. 
However, it appears to be extremely difficult to determine the optimal dosage 
scheme. The percentages of success are no yardstick, as these percentages are 
influenced by many factors as listed above. Forest's final protocol alleviates the 
burden of treatment as it reduces frequency and duration compared with the 
schedule suggested by the International Health Foundation, while the rate of 
success appears to be similar. The higher dose per injection caused obvious 
side effects. 
6. There is no consensus of opinion regarding any correlation between testos-
terone response to HCG treatment and the rate of success. Most authors do 
not mention the mode of action of hormonal treatment or merely state that 
the mechanism is poorly understood. 
In the discussion and conclusions of our own study of LHRH treatment for 
cryptorchidism (see 4.3.), the clinical and hormonal data reported in the literature 
for this hormonal treatment will be discussed and, if feasible, compared with the 
results of HCG treatment. 
4.2. LHRH NASAl SPRAY TREATMENT FOR CRYPTORCHIDISM; 
A PILOT STUDY 
In view of the good results reported by some authors for LHRH treatment of 
cryptorchidism, we decided to carry out a clinical investigation of this modality. 
We first initiated a pilot study, lasting from tune to October 1982, involving 22 
prepuberal boys with either unilateral or bilateral undescended testes. 
147 
4.2.1. Patients and methods 
Twenty-two healthy, prepuberal boys aged 3 to 13 years, with 26 undescended 
testes, were treated with LHRH nasal spray (Cryptocur®) after informed consent 
had been obtained from the parents. For a period of four weeks, one puff(= 200 
J.Lg) LHRH was sprayed into each nostril three times a day before meals. If the 
results were insufficient, the procedure was repeated after an interval of four 
weeks. Before, during, and after the therapeutic regimen, the children were 
examined independently by both authors as described in chapter 2. Utmost care 
was taken to ensure exclusion of retractile testes. 
4.2.2. Results 
As shown in table 4.2., LHRH nasal spray therapy resulted in the complete 
descent of 17 testes (65%) in 13 boys (59%). Figure 4.1. shows the most caudal 
position of the testis before and after LHRH treatment. It appeared that 13 (76%) 
of the 17 testes that descended completely could be manipulated to at least the 
scrotal entrance before treatment. Return of the testis to the former, undescend-
ed position occurred in one boy with unilateral cryptorchidism, three months 
after successful treatment. He underwent another course of LHRH therapy, 
which once again resulted in complete descent. No adverse effects of the hor-
monal treatment were observed in any of the boys. No compliance problems 
occurred. 
Table4.2. Results of pilot study. 
patients testes complete descent 
age [years) patients testes 
N range mean~ SO n N [%) n [%) 
22 3-13 8.9 ~ 2.8 26 13* [59) 17 [65) 
*eight boys needed two LHRH courses and one relapse also 
required a second LHRH course 
4.2.3. Discussion 
The results of this pilot study seemed to indicate that LHRH nasal spray therapy 
was indeed an effective modality for treating boys with undescended testes. The 
patient series was too small to draw definite conclusions, but the results did 
warrant further investigation. 
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Figure 4.1. Most caudal testicular position before e and after 0 LHRH treatment in the pilot study. 
4.3. LHRH NASAL SPRAY TREATMENT FOR CRYPTORCHIDISM; 
DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY 
4.3.1. Aims of the study 
The positive results achieved with LHRH nasal spray in the pilot study, prompt-
ed a double-blind, placebo-controlled clinical investigation, involving a large 
series of prepuberal boys of various ages, with unilateral or bilateral cryptor-
chidism. We also wanted to determine whether hormonal analysis might indicate 
the mode of action of LHRH and provide a prognostic aid. 
4.3.2. Patients and methods 
Between October 1982 and April1985, a total of 252 prepuberal, cryptorchid 
boys were enrolled in the double-blind, placebo-controlled study and treated 
with LHRH nasal spray. Cryptorchidism was unilateral in 203 boys (104 rightsided, 
99 leftsided) and bilateral in 49. The study population was divided into three age 
groups: A= 1-2 years (52 boys); B = 2-6 years (100 boys); and C = 6-12 years (100 
boys). Table 4.3. gives the particulars for each age group. Our study population 
did not include boys who had previously undergone either hormonal or surgical 
treatment for cryptorchidism; boys with retractile testis; boys with truly ectopic 
testes (perineal, penile, etc.); boys with concomitant inguinal hernia; or boys 
with chromosomal or dysmorphic syndromes. 
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Table4.3. Classification of study population. 
cryptorchidism 
age [years] unilateral bilateral 
age 
group boys range mean~ SO right left 
A 52 1- 2 1.5 ~ 0.3 16 30 6 
B 100 2- 6 lf.3 ~ 1.2 lf5 lf1 1lf 
c 100 6-12 g_o ~ 1.7 lf3 26 2g 
total 252 1-12 5.6 ~ 3.3 10lf gg qg 
The children were all examined independently by both authors, following a 
standard procedure and using standardized case report forms as described in 
chapter 2. 
After obtaining informed consent from the parents, we allocated the patients 
randomly and blindly to treatment with either synthetic LHRH (Cryptocur®) or 
placebo. The daily intranasal dose amounted to 1.2 mg, one puff of 200 llg in each 
nostril three times a day before meals. After four weeks of treatment followed by 
another four weeks without treatment, the code was broken and the results 
evaluated. If treatment proved unsuccessful, LHRH-treated subjects were given a 
second course of treatment, while the boys that had been on placebo received 
one or two courses of LHRH, as required. For a schematic presentation of the 
study protocol excluding follow-up period, see figure 4.2. 
Treatment was considered successful if the testis was either spontaneously 
intrascrotal, or capable of being manipulated fully into the scrotum without 
retracting immediately. If so, the patient was re-examined after 3, 6 and 12 
months, and subsequently once a year. In case of withdrawal of the testis to the 
former, undescended position, the patient was given another course of LHRH 
nasal spray. 
Testicular volume was determined before and after the double-blind period 
with an orchiometer after Prader (see 2.3.2.). In view of the limited accuracy of 
Double-blind ~ open 
>------~\------=..<:..:..-----< 
!! 1--P..;;;!a ... r c•R-~o;......-4-----------1-l __ R_x _ (-4+-~---------l RX 
weeks lf lf lf lf 
~ LHRH test 50 J.Jg i.v. 
! HCG test 1500 U i.m. 
RX: 200 J.Jg LHRH t.i.d. in each nostril [-1200 J.Jg/d] 
Figure 4.2. Study protocol. 
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this measuring technique, we only recorded an increase of testicular volume if 
this amounted to at least 1 mi. 
Basal and stimulated LH and FSH levels were determined with two LHRH tests, 
one carried out before and one immediately after the first four weeks. The 
placebo group had a third LHRH test after their first true treatment course. An 
HCG test was only carried out once, before treatment. After treatment, basal 
testosterone values were determined in the course of the LHRH test. The proce-
dure for hormonal evaluation is described in detail in chapter 2. 
Sixty-one, age-matched, healthy prepuberal boys served as controls for the 
hormonal analyses, with informed consent from the parents. These boys had 
been referred to us for evaluation of their testicular position; the testes were 
found to be fully descended. Divided for age, there were 10 boys in group A (1-2 
yrs), 28 in group B (2-6 yrs), and 23 in group C (6-12 yrs). The age distribution for 
control subjects and cryptorchid boys is given in figure 4.3. Frequency calculation 
is relative to total. 
Relative 
Frequency 
% 
24 
22 
20 
18 
16 
14 
12 
10 
B 
6 
4 
2 
0 
2 3 4 
- Cryptorchid boys N-237 
• Controls N-61 
5 6 7 B 9 10 11 12 
Age [years] 
Figure 4.3. Age distribution of study population (minus dropouts) and controls. 
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Statistical analysis of the results was carried out using methods described in 
chapter 2. The success rate for the double-blind period was evaluated on the basis 
of both individual patients and individual testes. When the outcome proved 
identical, subsequent analysis was based on the testes only, as usually reported in 
the literature. The chi-square test was used to compare the percentages of tes-
ticular descent. The same test was used for comparison of an increae 2:: 1 ml in 
testicular volume after either LHRH therapy or placebo. In order to evaluate the 
dependency of the success rates on several study factors simultaneously, a logistic 
regression analysis was performed. 
4.3.3. Results 
For a small number of patients data were incomplete because of poor 
compliance (13 boys, 18 undescended testes). These patients were excluded from 
the analyses except for success of treatment, in which case an analysis based on 
intention-to-treat was performed as well. In addition, two boys (two undescend-
ed testes) were excluded because of anomalies (inguinal hernia, ectopic testicu-
lar position) found during treatment. 
Standardized success rates were included in our presentation of this study in 
The Lancet (De Muinck Keizer-Schrama et al., 1986). However, we have since 
learned that a condition for the application of standardization is that the ratio of 
the percentages within two (or more) populations should be constant over 
categories of the stratification factor (i.e. the factor that might influence the rate). 
This condition was not met in our study, which may explain why the outcome of 
standardization contradicted the outcome of the logistic regression analysis. 
Consequently, all further mention of standardized success rates was excluded 
from this presentation of the results. 
a. Patient history 
According to information supplied at the start of the investigation, none of the 
undescended testes had ever been seen or felt in the scrotum. No episodes of 
pain or redness of the scrotum were reported. None of the patients had previous-
ly undergone surgery in the inguinal region, nor had anyone ever had hormonal 
treatment. Urinary tract infection was reported for 11 of the 237 boys (5%) 
included in the evaluation. Seventy-one boys had suffered from mumps, 157 
never had mumps, and in nine cases it was not known. Medication was used 
during the study by 17 of the 237 boys: antihistamine (two boys); antibiotics (three 
boys); laxatives (three boys); iron and vitamin supplements (three boys); homeo-
pathic remedies (six boys). The incidence of a gestational age under 37 weeks and 
a birth weight under 2,500 g was 11% and 15% respectively.ln 39 cases the mother 
took medication during pregnancy, such as antibiotics (six cases); iron and 
vitamin supplements (nine cases); anti-emitics and antipruritics (six cases); drugs 
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to prevent miscarriage (seven cases); diuretics (two cases); drugs to prevent 
premature labour (two cases); insulin (one case); sedatives (two cases); antihis-
tamine (one case); unknown drug (three cases). Fifty-nine per cent of the 
mothers used oral contraceptives before pregnancy. Familial incidence of crypt-
orchidism (1st and 2nd degree of relationship) was reported by the parents of 79 
boys (33% of study population). We did not inquire further into the exact 
incidence and nature of this familial cryptorchidism. 
b. Physical examination 
At the first physical examination, the general impression of all boys was normal, 
with one exception. This was a ten year old, mentally retarded boy, who had been 
born prematurely and small for gestational age. He had suffered from hypogly-
caemia in the neonatal period. His physical appearance was normal and his 
scrotum and penis were normally developed. Both testes (volume 2.5 ml) were 
palpable in the inguinal region and capable of being manipulated to the scrotal 
entrance. Dysmorphisms were noted in three boys: epicanthus and hypertelo-
rism in one of them, congenital ptosis in the second boy, and clinodactyly in the 
remaining one. A tight and small scrotum was observed in eight boys; five of 
them had bilateral undescended testes. Three boys had hypospadias. In all other 
boys the penis was normal in size and shape. There were no scars in the inguinal 
region of any one of the boys. 
Physical examination after four weeks of LHRH treatment or placebo (double-
blind period) revealed no changes in either scrotum or penis, except for the fuller 
aspect of the scrotum in case of testicular descent. This will be dealt with later. 
Table 4.4. gives the testicular volume of the palpable testes (descended as well 
as undescended) of the study population before treatment. In 30 boys (43 testes) 
the testicular volume was2:2.5 mi. In two boys of group A with unilateral absence 
of testis, the contralateral, descended testis had a volume of 2.5 mi. In four boys of 
group B with unilateral cryptorchidism, the volume of the contralateral, de-
scended testis was 2: 2.5 mi. In one of them, the undescended testis also had a 
volume of 2.5 mi. In 24 boys of group C with unilateral or bilateral undescended 
Table 4.4. Volume of palpable testes before treatment. 
volume testes [n] per age group total 
ml A B c testes [n] 
25 lf5 7 77 
1.5 35 61f 30 12g 
2 16 50 101 167 
2.5 2 If 27 33 
3 0 1 7 B 
3.5 0 0 1 
If 0 0 1 
total 76 161f 171f lf16 
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testes, the testicular volume was:::::: 2.5 ml in 17 incompletely descended testes as 
well as in 19fullydescended testes. In general, a testicularvolume:::::3 ml was only 
observed in contralateral, descended testes (ten testes). The volume of the con-
tralateral, descended testis in boys with unilateral testicular absence was variable: 
age group A: 1-2.5 ml; age group B: 1-2 ml; and age group C: 2.5-3.5 mi. 
Table 4.5. shows the increase of testicular volume:::::: 1 ml after LHRH treatment 
or placebo during the double-blind period. After LHRH therapy, an increase was 
observed in 13 boys (18 testes, 9%) and after placebo in five boys (five testes, 2%). 
This difference was statistically significant (chi-square test, p < 0.002 ). In eight 
boys (eight testes) the increase in volume was observed in the descended testis, 
while in six boys (seven testes) the volume of the undescended testis increased. 
In four boys (eight testes) the volume of both testes increased. In most of the 
patients, with an increase of testicular volume the treatment was without success. 
Complete descent was never achieved in boys of age group A that had an 
increase of testicular volume. In group B there was one boy with an increased 
testicular volume and complete descent after placebo. In group C the volume of 
the contralateral, descended testis increased in one successfully treated boy. In 
another boy of this same age group, with bilateral cryptorchidism, the volume of 
both testes increased while complete descent was achieved in both of them. 
Table 4.5. Number(%) of testes with volume increase 2:1 ml during double-blind period. 
age placebo LHRH 
group total increase total increase 
A :JB 0 [OJ :19 :J [B) 
B go IJ [IJ) 72 5 [7] 
c 85 1 [1] BIJ 10[ 12] 
total 21:1 5 [2]* 1g5 18 [9]* 
* increase significantly more frequent with LHRH than with placebo 
[chi-square test. p <0.002] 
c. Success of treatment 
Table 4.6. shows the comparative rates of success for placebo and LHRH treat-
ment during the double-blind period (eight weeks). Figures are given for the 
entire study population (a) involving 252 patients with 301 undescended testes 
and subsequently for the study population minus drop-outs (b) involving 237 
patients with 281 undescended testes. The success rate is itemized per age group 
for 237 patients in table 4.7., which shows testicular descent achieved with either 
placebo or LHRH per patient (unilateral or bilateral) and per testis. Regarding 
these two tables, there was no significant difference in the success rate for either 
placebo or LHRH. Nor was there a siginificant difference between placebo and 
LHRH in connection with the percentages of descent for individual patients or 
individual testes. Consequently, further analysis of the percentages of descent 
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Table4.6. Success rates during double-blind period. 
complete descent 
type of patients testes patients 
[N [%) testes 
treatment N n inclusive* exclusive** n[%) 
a) 
entire study placebo 126 143 10 [H) 9 [7) 10 [7) population 
252 boys LHRH 126 15H 11 [9) 7 [6) 14 [9) 301 testes 
b) 
study 
population placebo 116 130 10 [9) 9 [H) 10 [H) 
minus drop outs 
237 boys LHRH 121 151 11 [9) 7 [6) 14 [9) 2H1 testes 
* inclusive of bilateral cryptorchids in whom one testis only descended 
** exclusive of bilateral cryptorchids in whom one testis only descended 
Table 4.7. Itemized success rates in 237 patients, 281 testes, during the double-blind period. 
complete descent 
patients [N) testes [n) patients [N) testes [n) 
uni- bi- uni- bi- uni- bi- uni- bi-
lateral lateral lateral lateral lateral lateral lateral lateral 
placebo A 23 1 23 2 0 0 0 0 
B 42 5 42 10 6 0 6 0 
c 37 H 37 16 3 1* 3 
total 102 14 102 2H 9 1 9 
LHRH A 20 5 20 10 0 1* 0 
B 39 H 39 16 1 0 1 0 
c 32 17 32 34 3 6** 3 9 
total 91 30 91 60 4 7 4 10 
* only one testis descended completely 
•• in three patients only one testis descended completely 
concerned testes only, in agreement with similar analyses in the literature, even 
though the patients were randomized. 
Figure 4.4. is a schematic presentation of the treatment results beginning with 
the entire study population in the double-blind period through follow-up. Even 
though no placebo was given in the open study period, we continued to refer to 
"placebo patients" and "LHRH patients" for identification purposes. In the 
placebo group, 13 testes descended after one LHRH course during the open 
study period. In both placebo and LHRH patients together, 21 testes descended 
after a second LHRH course, resulting in the complete descent of 48 testes (18%) 
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Drop-outs-
Success-
Failure-
Failure-
Failure-
Failure-
PLACEBO 
D Patients 
OTestes 
LHRH 
Double-Blind Period 
One LHRH Course 
Open Period 
Two LHRH Courses 
Follow-up Period 
20g 
Figure 4.4. Results of treatment from start through follow-up. 
Table 4.8. Final results of treatment of 237 boys (281 testes). 
complete descent of testes: number 
patients (N) testes (n) double-blind period two LHRH age 
group placebo LHRH placebo LHRH placebo LHRH courses• 
A 2'1 25 25 30 0 ( OJ ( 3) 
" 
(7) 
B '17 '17 52 55 6 (11) I ( 2) 12 (12) 
c '15 ljg 53 66 
" 
( 71 12 (16) 32 (26) 
total 116 121 130 151 10 B) 1'1 ( g) 'IB (16) 
• complete descent of testes in combined placebo and LHRH groups. excluding placebo descent 
(%] 
late 
descent 
3 [5) 
I (I] 
10 (g) 
1'1 [5) 
after two LHRH courses (placebo descent excluded). Another 14 testes descend-
ed at a later stage during the follow-up period. These were classified as "late 
descent". The final results of the entire study period, including follow-up, are 
given in table 4.8. concerning 237 patients, 281 testes. 
156 
Figure 4.5. gives the most caudal testicular positions before and after treatment 
for the three age groups, excluding placebo descent. Of the 48 testes that 
descended completely with LHRH treatment, 36 (75%) could at least be manipu-
lated to the scrotal entrance before treatment. The same applies to eight of ten 
testes (80%) that descended with placebo. 
Table 4.9. gives the comparative rates of success for unilateral and bilateral 
cryptorchidism after two courses of LHRH treatment, excluding late descents. 
The percentages for complete testicular descent were identical for bilateral and 
rightsided unilateral cryptorchidism, while the success rate for leftsided crypt-
orchidism lagged far behind. 
We investigated to what extent the various study factors had influenced the 
rates of success. For the double-blind period this involved age at treatment, type 
of treatment (LHRH or placebo), laterality (leftsided vs rightsided vs bilateral), and 
pretreatment testicular position. It appeared that the rate of success was inde-
Not Palpable 
Inguinal Region. 
Intermittently 
Palpable 
External Annulus 
Scrotal Entrance 
High Scrotal 
Scrotal 
Figure 4.5. Most caudal testicular position before e and after 0 LHRH treatment (excluding 
placebo descent). 
Table 4.9. Success of LHRH treatment in unilateral and bilateral cryptorchidism (excluding late 
descents). 
patients testes 
complete descent of testes: number (% 1 
N n right left both 
unilateral right glf glf 21 (221 
unilateral left go go B (g1 
bilateral lflf B7* If ( 51 3 (31 12 [1'11 
* one testis descended with placebo during double-blind period 
** significantly lower than for right sided or bilateral cryptorchidism 
[chi-square test. p < 0.051 
total 
21 (221 
B [ g1** 
1g (221 
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pendent of age at treatment, type of treatment, and laterality (p > 0.05), but highly 
dependent on pretreatment testicular position (p < 0.001). For the open study 
period (after two LHRH courses), the factors involved age at treatment, laterality, 
and pretreatment testicular position. Here again, it appeared that the rate of 
success depended mainly on pretreatment testicular position (p < 0.001). There 
was no dependence on either age at treatment or laterality of the undescended 
testis (p > 0.05). 
d. Findings in exceptional cases 
The one mentally retarded patient had a late descent of testes. Despite two 
courses of LHRH treatment, his testes had not fully descended at the end of the 
study period. Surgery was postponed in view of his mental condition. Almost two 
years later puberty had started and both testes were in the scrotum. 
One of the eight boys with small, tight scrotums, a bilateral cryptorchid, was 
found to have no testes at surgery. Of the remaining seven only one achieved 
complete descent. This was a unilateral cryptorchid and one of three boys with 
dysmorphisms. The other two boys with dysmorphisms did not respond to 
treatment. 
One of three boys with hypospadias had complete testicular descent after two 
LHRH courses. Late descent occurred in another one, but hormonal therapy 
failed altogether in the third boy. 
Minor adverse reactions were reported by the parents of some boys, indis-
criminately for placebo or LHRH treatment during the double-blind period (table 
4.10.). 
Table 4.10. Adverse reactions reported during double-blind period. 
placebo LHRH 
A B c A B c 
more erections 0 0 0 
epistaxis 0 0 2 I 0 0 
sneezing 0 0 0 0 0 1 
acne 0 0 0 0 0 1 
appetite increase 0 1 1 0 0 1 
headache 0 0 0 0 0 
more aggressive 0 0 1 0 
e. Follow-up period 
The boys were followed for six months to three years after treatment. In group 
A, late descent occurred in three boys (three testes) two to six months after LHRH 
treatment. No return of the testis to the former, undescended position occurred 
in this age group. At follow-up examinations, none of the successfully treated 
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testes were spontaneously intrascrotal; all these testes appeared to be retractile. 
The testicular volume was 1-2 mi. 
In age group B, late descent occurred in one boy (one testis) three months after 
LHRH treatment. Five patients (five testes) had a relapse 3-12 months after 
treatment, including one placebo descent. A repeat course of LHRH was success-
ful in four of them. Orchiopexy was required in the remaining one. Of the 18 
testes, that descended with LHRH treatment in this age group, two were sponta-
neously intrascrotal six months to two years later. All the others were retractile. 
The testicular volume was 1-3 mi. 
In age group C, late descent was observed 3-20 months after LHRH treatment in 
seven boys (ten testes). In three patients (five testes) complete descent coincided 
with the start of puberty. Relapse occurred in five patients (six testes) 6-12 months 
after treatment. A repeat course of LHRH was successful in three of them (three 
testes), but failed in one patient (two testes). The parents of the fifth patient 
refused another course of LHRH. During the follow-up period of the successfully 
treated testes, totalling 43 for this group, the spontaneous position of 29 testes was 
in the scrotum. The other testes were retractile. In 11 boys (with 17 successfully 
treated testes) puberty had started. In all these boys the testes were sponta-
neously intrascrotal. In three boys who were successfully treated for unilateral 
cryptorchidism, puberty had started but the previously undescended testis 
remained smaller than the contralateral one. Testicular volume of the whole age 
group was between 2-16 mi. 
f. Hormonal evaluation 
The pretreatment hormonal data for cryptorchid boys and age-matched con-
trol subjects are given in table 4.11. The figures for one boy (aged 2 yrs, group B) 
were excluded when surgery revealed bilateral gonadal aplasia in this patient. 
Serum LH levels were slightly higher in cryptorchid boys than in control subjects, 
which was significant for basal LH in all age groups, and for peak and delta LH in 
groups Band C (p < 0.05). Serum FSH levels were identical for cryptorchids and 
controls. Basal and stimulated serum testosterone values in cryptorchids were 
similar to those in controls or even higher (basal testosterone age group B, p < 
0.05). 
Comparing the three age groups, stimulated LH values were higher in age 
group A than in B orCin both cryptorchids and controls. Regarding the values for 
basal LH, as well as basal and peak FSH, there were no differences between the 
three age groups in cryptorchid boys or control subjects. In patients as well as 
controls, basal testosterone was significantly higher in boys of age group C, than 
in boys of groups A or B. There were significant falls with age in peak and delta 
testosterone levels in both patients and controls. 
Tables 4.12•. and 4.12b. give the hormonal data for cryptorchid boys only, 
before and after the double-blind period, enabling a comparison between a 
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change in values after LHRH treatment or placebo. There was a small but statis-
tically significant decline in basal and peak LH after LHRH and placebo in age 
group A, while age group B showed a similarly significant decline in peak and 
delta LH after placebo only. A decline in peak FSH was noted after LHRH therapy 
in age groups Band C, while age groups A and B showed a statistically significant 
decline in peak FSH after placebo. Rather than an increase in basal testosterone 
levels after LHRH therapy, we observed a significant decrease in age groups A and 
B. A decrease of basal testosterone level was even found after placebo in age 
group B. Comparing the total results of LHRH therapy with those of placebo, 
there was a similar change of peak LH in all age groups and of peak FSH in groups 
A and B. Conversely, there was a significant difference (p <0.05) in the change of 
peak FSH in age group C and of basal testosterone in age group A. 
When the hormonal data were compared for unilateral or bilateral cryptor-
chidism, serum LH levels were the same in the three age groups before treatment 
(table 4.13•.) as well as after treatment (table 4.13h.). Before treatment, peak and 
delta FSH were significantly higher in bilateral than in unilateral cryptorchids of 
age group B only. After treatment, peak and delta FSH were higher in bilateral 
than in unilateral cryptorchids of group A as well as group B.In group C there was 
no difference in FSH values between unilateral and bilateral cryptorchids after 
treatment. Compared with pretreatment values, a significant decline of peak and 
delta LH was observed after treatment in unilateral cryptorchids of age groups A 
and B, but not in bilateral cryptorchids. Peak and delta FSH showed a decline in 
unilateral cryptorchids of all age groups and in bilateral cryptorchids of age 
groups Band C. Basal testosterone levels only declined in unilateral cryptorchids 
of age groups A and B. Finally, comparing the changes of hormonal values after 
LHRH therapy in either unilateral or bilateral cryptorchids, there was a significant 
difference in peak FSH values of age group A only. 
Table 4.14. gives the comparative pretreatment hormonal values for boys that 
subsequently responded fully to two courses of LHRH treatment and for boys that 
had total failure of treatment (involving results of either placebo or LHRH 
treatment beginning with the double-blind period and on through the entire 
follow-up period). Regardless of age group, there was no difference in pre-
treatment values comparing the successfully treated boys with the nonrespond-
ers. 
The final evaluation of hormonal values before and after LHRH therapy in 
relation to subsequent success or failure, involved a comparison of boys that had 
complete testicular descent after one course of LHRH with boys that had total 
failure oftreatment (tables4.15•. and 4.15h.). Consequently, the so-called "succes-
ses" do not include patients that had complete testicular descent after two 
courses of LHRH, nor patients with "late" testicular descent. Before treatment, 
there was no significant difference in hormonal values between success and 
failure, except for basal LH in group A. After treatment, peak and delta FSH 
differed significantly between success and failure in age group C. Comparing 
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Table 4.11. Hormonal data in patients before treatment and in control subjects. 
Mean~ SEM 
A 
patients controls patients 
LH [IU/Il 
basal 2.13~0.11* 1.51 ~ 0.16 2.26 ~ 0.13* 
peak g.g1 ~ 0.63° 8.38~1.15° 7 .g8 ~ 0.37. 
delta 7.78 ~ 0.60° 6.87 ~ 1.12° 5.73 ~ 0.32. 
FSH [lUll) 
basal 0.72 ~ O.OIJ 0.60 ~ 0.00 0.7LJ ~ 0.02 
peak 3.g7 ~ O.LJg 3.15 ~ 0.7g 3.3g ~ 0.23 
delta 3.25 ~ O.LJg 2.55 ~ 0.7g 2.66 ~ 0.22 
Testosterone [nmol/1 1 
basal 0.10 ~ 0.01 0.07 ~ 0.01 0.12 ~ 0.01 * 
peak 12.67 ~ 0.86• 11.73 ~ 1.77° 7.1o ~ o.38• 
delta 12.57 ~ 0.86• 11.66 ~ 1. 77° 6.g8 ~ o.38• 
Number of boys ljg 10 g2 
• significantly higher than control value [p <0.05) 
o significantly higher than the same determination in groups B and C [p <0.051 
• significantly higher than the same determination in groups A and B [p <0.05) 
B 
controls 
1.71J ~ 0.11 
6.00 ~ O.IJ2 
IJ.27 ~ O.IJ1 
0.65 ~ 0.03 
3.11 ~ O.IJ7 
2.LJ6 ~ O.IJ7 
0.07 ~ 0.01 
7 .gg ~ o.go 0 
7.g2 ~ o.go 0 
28 
patients 
2.63 ~ 0.11* 
8.25 ~ 0.31. 
5.62 ~ 0.27. 
0.81J ~ 0.02 
2.72 ~ 0.17 
1.88 ~ 0.17 
o.27 ~ o.o3• 
5.1J5 ~ 0.31. 
5.18 ~ 0.30. 
g3 
peak and delta testosterone group A > group B > group C in patients [ • ) and controls [ o 1 [p <0 .05) 
Mann-Whitney-U test 
c 
controls 
1.g7 ~ 0.11J 
6.16 ~ 0.61 
IJ.1g ~ 0.58 
0.81J ~ 0.15 
2.8LJ ~ O.IJ2 
2.00 ~ 0.33 
0.22 ~ o.o3• 
IJ.51 ~ 0.31° 
IJ.2g ~ 0.31° 
23 
..... 
O"l 
N 
Table 4.12". Hormonal data in patients before LHRH treatment or placebo. 
A 
LHRH Placebo 
LH [IU/1) 
basal 2.23.:!:. 0.17 2.03 .:!:. o. 15 
peak 10.'16.:!:. 0.96 9.3'1 .:!:. O.BO 
delta B.23 .:!:. 0.9'1 7.32.:!:. 0.73 
FSH [IU/11 
basal 0.77.:!:. 0.06 0.66 .:!:. 0.03 
peak '1.6B .:!:. O.B6 3.22.:!:. 0.'13 
delta 3.91 .:!:. O.B'I 2.55 .:!:. 0.'13 
Testosterone [nmol/11 
basal 0.13.:!:. 0.02 0.07.:!:. 0.01 
peak 12.36.:!:. 1.35 13.02.:!:. 1.05 
delta 12.23.:!:. 1.35 12.9'1.:!:. 1.0'1 
Number of boys 25 23 
Mean.:!:. SEM 
B c 
LHRH Placebo LHRH Placebo 
2.30.:!:. 0.17 2.21 .:!:. 0.19 2.67.:!:. 0.15 2.5B .:!:. 0.16 
B.52 .:!:. 0.61 7.'15.:!:. 0.'13 B.66 .:!:. 0.52 7.B3.:!:. 0.3'1 
6.22.:!:. 0.55 5.2'1 .:!:. 0.33 5.99 .:!:. 0.'15 5.25 .:!:. 0.2B 
0.72.:!:. 0.02 0.75.:!:. 0.0'1 O.B5 .:!:. 0.03 O.B'I .:!:. 0.03 
3.'19 .:!:. 0.33 3.30 .:!:. 0.32 2.85 .:!:. 0.26 2.5B .:!:. 0.21 
2.77.:!:. 0.33 2.55 .:!:. 0.31 2.01 .:!:. 0.27 1.75.:!:. 0.22 
0.11.:!:. 0.01 0.12.:!:. 0.02 0.2B.:!:. 0.03 0.26.:!:. 0.0'1 
6.'1B ~ 0.53 7.71.:!:. 0.55 5.60 .:!:. 0.'10 5.2B .:!:. 0.'17 
6.37 .:!:. 0.53 7.59.:!:. 0.55 5.32 .:!:. 0.'10 5.02 .:!:. 0.'16 
'16 '16 '17 '15 
....I 
~ 
w 
Table 4.12b. Hormonal data in patients after LHRH treatment or placebo. 
LH [IU/1] 
basal 
peak 
delta 
FSH [lUll] 
basal 
peak 
delta 
Testosterone [nmoi/IJ 
basal 
Number of boys 
A 
LHRH 
1.98 ~ O.l!l• 
8.81 ~ 0.92. 
6.83 ~ 0.8"1. 
0.71 ~ 0.0"1 
"1.67 ~ 1.01 
3.96 ~ 1.00 
o.o"' ~ o.o1••o 
25 
Placebo 
1.79 ~ 0.12. 
8.23 ~ 0.82. 
6."10 ~ 0.75 
0.7"1 ~ 0.08 
2.20 ~ 0.31. 
1."16 ~ 0.32. 
0.07 ~ 0.01 
23 
Mean~ SEM 
B 
LHRH Placebo 
2.39 ~ 0.21 2.06 ~ 0.15 
7.63 ~ 0.36. 6.37 ~ 0."11. 
5.21 ~ 0.37 "1.31 ~ 0.31. 
0.76 ~ 0.03 0.72 ~ 0.02 
2.21 ~ 0.31. 2.3"1 ~ 0.28. 
1."15 ~ o.3o• 1.61 ~ 0.28. 
o.o7 ~ o.o1• 0.07 ~ 0.01• 
"16 "16 
• significantly different from placebo value [Mann-Whitney-U test. p <0.05] 
• significantly different from starting value [Wilcoxon matched pairs signed rank test. p <0.05] 
c 
LHRH 
3.36 ~ 0.37 • 
8.73 ~ 0.53. 
5.37 ~ 0."13 
0.88 ~ 0.05 
1.61 ~ 0.17 .. 0 
0.73 ~ 0.15 •• o 
0.25 ~ 0.0"1 
"17 
o change after LHRH significantly different from change after placebo [Mann-Whitney-U test. p <0 .05] 
Placebo 
2.27 ~ 0.12 
7.2"1 ~ 0.37 
"1.97 ~ 0.33 
0.82 ~ 0.03 
2.29 ~ 0.18 
1."17 ~ 0.19 
0.19 ~ 0.02 
"15 
_. 
~ Table 4.13•. Hormonal data in unilateral and bilateral cryptorchids before LHRH treatment. 
Mean~ SEM 
A B c 
unilateral bilateral unilateral bilateral unilateral bilateral 
LH [lUll) 
basal 2.11 ~ 0.12 2.30 ~ 0.26 2.30 ~ 0.1'1 1.96 ~ 0.19 2.70 ~ 0.11 2.'1lf ~ 0.26 
peak 9.9lf ~ 0.6B 9.70 ~ 1.77 7.9'1 ~ O.lfl B.26 ~ 0.69 6.06 ~ 0.2B 6.76 ~ O.B9 
delta 7.6lf ~ 0.65 7.lf0 ~ 1.56 5.6lf ~ 0.35 6.2B ~ 0.76 5.36 ~ 0.2lf 6.32 ~ 0.75 
FSH [IU/11 
basal 0.6B ~ 0.02 0.97 ~ 0.2lf 0.75 ~ 0.03 0.66 ~ 0.05 0.62 ~ 0.02 0.69 ~ 0.05 
peak 3.69 ~ 0.50 5.93 ~ 1.76 3.llf ~ 0.23 5.13 ~ 0.76. 2.72 ~ 0.21 2.72 ~ 0.29 
delta 3.01 ~ 0.51 lf.97 ~ 1.59 2.39 ~ 0.22 lf.lf6 ~ 0.77. 1.90 ~ 0.21 l.B3 ~ 0.26 
Testosterone [nmol/11 
basal 0.11 ~ 0.02 0.05 ~ 0.01 0.12 ~ 0.01 0.13 ~ O.Olf 0.27 ~ 0.03 0.26 ~ 0.06 
peak 12.9lf ~ 0.92 10.62 ~ 2.lfl 6.96 ~ O.lf1 7.9lf ~ 1.06 5.33 ~ 0.33 5.77 ~ 0.73 
delta 12.63 ~ 0.92 10.77 ~ 2.lf2 6.86 ~ O.lfl 7.61 ~ 1.05 5.06 ~ 0.32 5.lf9 ~ 0.71 
Number of boys lf3 6 BO 12 6B 25 
• significantly different from unilateral value [Mann-Whitney-U test. p <0.05) 
-' 
0'1 
U1 
Table 4.13b. Hormonal data in unilateral and bilateral cryptorchids after LHRH treatment. 
Mean~ SEM 
A B c 
unilateral bilateral unilateral bilateral unilateral 
LH [lUll] 
basal 1.69 ~ 0.10 1.67 ~ 0.1!7 2.16~0.12 2.61! ~ 0.62 3.01 ~ 0.26 
peak 6.36 ~ 0.62. 9.66 ~ 2.36 6.67 ~ 0.31. 7.76 ~ 0.51 7.76 ~ 0.37 
delta 6.1!5 ~ 0.56. 7.62 ~ 2.03 1!.69 ~ 0.26. 5.13 ~ 0.66 1!.75 ~ 0.25 
FSH [lUll] 
basal 0.72 ~ O.OIJ 0.60 ~ 0.13 0.73 ~ 0.02 0.60 ~ 0.06 0.65 ~ O.OIJ 
peak 2.69 ~ 0.1!9. 7.52 ~ 2.1!6 •O 2.06 ~ 0.20. 3.56 ~ 0.79 •• 2.01 ~ 0.15. 
delta 2.17 ~ o.5o• 6.72 ~ 2.36 •o 1.35 ~ 0.20. 2.76 ~ 0.61 •• 1.17 ~ 0.15. 
Testosterone [ nmo 1/1] 
basal 0.06 ~ 0.01• 0.03 ~ 0,01 o.o7 ~ o.ot• 0.06 ~ 0.01 0.21 ~ 0.02 
Number of boys 1!3 6 60 12 66 
• significantly different from unilateral value [Mann-Whitney-U test. p <0.05] 
• significantly different from starting value [Wilcoxon matched pairs signed rank test. p <0.05] 
o change after LHRH therapy in bilateral cryptorchids significantly different from that in unilateral cryptorchids 
[Mann-Whitney-U test. p <0.05] 
bilateral 
2.29 ~ 0.16 
6.61! ~ 0.72 
6.35 ~ 0.70 
0.66 ~ 0.06 
1.76 ~ 0.25: 
0.69 ~ 0.25 
0.25 ~ 0.05 
25 
..... 
0"'> 
0"'> 
Table 4.14. Hormonal data before treatment in boys with complete descent after two LHRH courses (success) and in boys with total failure of treatment 
(failure). 
Mean~ SEM 
A B c 
success failure success failure success failure 
LH [lUll) 
basal 2.70 ~ 0.51 2.10 ~ 0.12 2.12 ~ 0.32 2.26 ~ 0.15 2.6'-1 ~ 0.16 2.56 ~ 0.1'-1 
peak 11.73 ~ 0.7'-1 9.69 ~ 0.66 6.36 ~ 0.91 6.31 ~ 0.'-12 7.76 ~ 0.72 6.35 ~ 0.3'-1 
delta 9.02 ~ 0.53 7.59 ~ 0.65 '-1.26 ~ 0.62 6.03 ~ 0.36 5.11 ~ 0.61 5.79 ~ 0.29 
FSH [IU/1) 
basal 0.65 ~ 0.09 0.73 ~ 0.0'-1 0.71 ~ 0.06 0.75 ~ 0.03 0.62 ~ 0.0'-1 0.6'-1 ~ 0.02 
peak 3.66 ~ 1.53 '-1.02 ~ 0.56 2.96 ~ 0.66 3.'-19 ~ 0.26 2.'-11 ~ 0.2'-1 2.67 ~ 0.2'-1 
delta 3.03 ~ 1.52 3.29 ~ 0.55 2.25 ~ 0.6'-1 2.75 ~ 0.25 1.59 ~ 0.25 2.0'-1 ~ 0.25 
Testosterone [ nmol/1) 
basal 0.06 ~ 0.02 0.11 ~ 0.02 0.10 ~ 0.03 0.11 ~ 0.01 0.39 ~ 0.06 0.22 ~ 0.02 
peak 15.50 ~ 1.71 12.22 ~ 0.9'-1 5.60 ~ 0.96 7.25 ~ 0.'-13 5.50 ~ 0.70 5.'-16 ~ 0.36 
delta 15.'-1'-1 ~ 1.71 12.11 ~ 0.9'-1 5.50 ~ 0.96 7.1'-1 ~ 0.'-13 5.12 ~ 0.65 5.26 ~ 0.36 
Number of boys 
" 
'-11 11 75 27 57 
.... 
O'l 
'l 
Table 4.15a. Hormonal data before treatment in boys with complete descent after one LHRH course (success) and in boys with total failure of treatment 
(failure). 
Mean~ SEM 
---
A B 
success failure success failure 
LH [IUIIJ 
basal 3.50 ~ 0.50 2.10 ~ 0.12. 2.30 ~ 0.62 2.28 ~ 0.15 
peak 12.30 ~ 0.70 g.6g ~ 0.68 5.86 ~ 0.83 8.31 ~ O.Lf2 
delta 8.80 ~ 0.20 7.5g ~ 0.65 3.56 ~ 0.56 6.03 ~ 0.36 
FSH [IU/11 
basal 0.70 ~ 0.20 0.73 ~ O.Olf 0.72 ~ 0.07 0.75 ~ 0.03 
peak 2.Lf5 ~ 1.Lf5 Lf.02 ~ 0.56 2.12 ~ O.Lflf 3.Lfg ~ 0.26 
delta 1.75 ~ 1.25 3.2g ~ 0.55 1.Lf0 ~ O.Lf3 2.75 ~ 0.25 
Testosterone (nmol/1) 
basal 0.07 ~ O.Olf 0.11 ~ 0.02 o.og ~ 0.03 0.11 ~ 0.01 
peak 17.00 ~ 3.00 12.22 ~ o.gLf 7.18 ~ J.3g 7.25 ~ O.Lf3 
delta 16.gLf ~ 3.0Lf 12.11 ~ o.glf 7.og ~ 1.Lf0 7.1Lf ~ O.Lf3 
Number of boys 2 Lf1 5 75 
• significantly different from success group [Mann-Whitney-U test. p <0.05) 
success 
2.60 ~ 0.26 
8.Lf3 ~ 1.08 
5.83 ~ 0.88 
0.7g ~ 0.05 
2.30 ~ 0.2g 
1.51 ~ 0.32 
O.Lf7 ~ 0.11 
6.06 ~ 1.03 
5.60 ~ o.g5 
17 
c 
failure 
2.56 ~ 0.1Lf 
8.35 ~ 0.3Lf 
5.79 ~ 0.29 
0.8Lf ~ 0.02 
2.87 ~ 0.2Lf 
2.0Lf ~ 0.25 
0.22 ~ 0.02 
5.Lf8 ~ 0.36 
5.26 ~ 0.36 
57 
....I 
O"l 
00 
Table 4.15b. Hormonal data after treatment in boys with complete descent after one LHRH course (success) and in boys with total failure of treatment 
(failure). 
LH [lUll] 
basal 
peak 
delta 
FSH [IU/1] 
basal 
peak 
delta 
Testosterone [nmol/1] 
basal 
Number of boys 
success 
2.15 ~ 0.65° 
11.75 ~ 3.25 
g.60 ~ 2.60 
0.75 ~ 0.15 
2.80~ 1.70 
2.05 ~ 1.85 
O.OLJ ~ 0.02 
2 
A 
failure 
J.8g ~ 0.12 
8.1LJ ~ 0.61• 
6.23 ~ 0.55. 
0.7LJ ~ 0.05 
3.53 ~ 0.66 
2.78 ~ 0.66 
o.o5 ~ o.o1• 
41 
Mean~ SEM 
success 
1.68~0.47 
7.06 ~ 1.38° 
5.38 ~ 1.1g 0 
0.7LJ ~ 0.08 
1.8LJ ~ 0.55 
1.10 ~ 0.60 
0.07 ~ 0.02 
5 
B 
failure 
2.26 ~ 0.15 
7.15 ~ 0.32. 
4.88 ~ 0.28• 
0.74 ~ 0.02 
2.39 ~ 0.25. 
1.65 ~ 0.2LJ. 
o.o7 ~ o.o1• 
75 
• significantly different from success group [Mann-Whitney-U test. p <0.05] 
• significantly different from starting value [Wilcoxon matched pairs signed rank test. p <0.05] 
success 
2.53 ~ 0.26 
8.70 ~ 1.07 
6.17 ~ 0.97 
c 
0.83 ~ O.OLJ 
1.67 ~ 0.35. 
0.8LJ ~ 0.35• 
0.28 ~ 0.07 
17 
failure 
2.92 ~ 0.31 
7.85 ~ O.LJ1 
LJ.9LJ ~ 0.28 
0.85 ~ O.OLJ 
2.21 ~ 0.17 •• 
1.36 ~ o. 16 •• 
0.21 ~ 0.02 
57 
o change after LHRH therapy in success group significantly different from that in failure group [Mann-Whitney-U test. p <0.05] 
values before and after treatment, peak and delta LH differed in age group A and 
B for nonresponders only. Peak and delta FSH differed for failure in age group B 
and C, and for success in age group C. The only significant differences between 
success and failure in the changes of hormonal values after LHRH therapy were 
observed in basal LH of group A and in peak and delta LH of group B. 
A comparison of the hormonal values before and after treatment of boys with 
placebo descent, which occurred in age groups Band Conly, with the values for 
boys with complete descent after one course of LHRH or nonresponders, reveal-
ed no significant differences. 
4.3.4. Discussion 
For a proper evaluation of our results, we had to ascertain whether the criteria 
for excluding patients from the study had been adhered to. According to the 
information supplied at referral for all 252 boys, none of the undescended testes 
had ever been seen or felt in the scrotum. As the study progressed, we felt the 
need to verify this information, particularly in view of the number of placebo 
descents. Consequently, every effort was made to trace any documentation of 
previous testicular positions in our patients from birth to referral. This retrospec-
tive evaluation of testicular position was carried out as a separate study (see 4.3.5.). 
Approximately one third of the study population was reported to have had 
mumps. However, orchitis is unlikely to have occurred as none of the patients 
had experienced pain or redness of the scrotum. 
Seventeen of the 237 boys included in the evaluation used some kind of 
medicine during the study. There were no signs of drug interaction or adverse 
reactions. 
In the Netherlands, the incidence of births with a gestational age under 37 
weeks or a birth weight under 2,500 g amounts to 12.3% and 10.3% respectively 
(Personal communication from "Stichting lnformatiecentrum voor de Gezond-
heidszorg" regarding National Registration of Births for 1983). The difference 
between the study population and the general Dutch populace is only statistically 
significant for low birth weight (chi-square test, p < 0.05). The higher frequency 
of low birth weight in these 237 cryptorchid boys might indicate an association. 
However, no conclusion can be drawn as this was not a case-control study. Scorer 
(1964) found that 21% of boys with a birth weight of 2,500 g or less were born with 
undescended testes, but he noted spontaneous descent after the first three 
months of life in 70% of these cases. His data do not reveal a higher frequency of 
cryptorchidism after the first year of life in boys with a low birth weight. Villumsen 
and Zachau (1966) also found a higher frequency of undescended testes at birth 
in boys with a birth weight of 2,500 g or less. They estimated that 2.3% of 
premature boys versus 0.8% of full-term boys have undescended testes at the age 
of three years. Depue (1984) concluded from case-control studies of cryptor-
chidism and inguinal hernia that there was a significantly higher risk of cryptor-
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chidism in case of low birth weight or shortened gestation. Nevertheless, Mau 
and Schnakenburg (1977) did not find an increased frequency of undescended 
testes in premature babies once they had reached the age of nine months. In 
another case-control study of the aetiology of cryptorchidism, Swerdlow et al. 
(1983) found only a slightly higher risk for the low-birth-weight boys. He surmised 
that the higher risk for boys of low birth weight and below normal gestational age 
might reflect the absence of maternal hormonal stimulus for descent in babies 
born before the normal time of testicular descent. However, this explanation 
would only apply to the higher frequency of cryptorchidism at premature birth, 
rather than to any higher frequency at a later stage. 
The maternal use of oral contraceptives before and sometimes during the first 
weeks of pregnancy reported for our series of boys with undescended testes did 
not differ in frequency from the general use of oral contraceptives in the Nether-
lands (Van Vliet and Hofman, 1982). The study carried out by Depue (1984) did not 
reveal any connection between cryptorchidism and the use of oral contracep-
tives. Mau and Schnakenburg (1977) reached the same conclusion. 
Familial incidence of cryptorchidism has been reported in the past and again 
more recently, suggesting that hereditary factors are involved in cryptorchidism 
(Corbus and O'Conner, 1922; Minehan and Touloukian, 1974; Rezvani et al., 
1976; Czeizel et al., 1980; Jones and Young, 1982; Savion et al., 1984). In this 
respect no conclusion can be drawn regarding our study population, because the 
exact incidence and nature of the familial cryptorchidism reported by the parents 
was not investigated. 
The only conclusion we dare draw from the initial clinical findings is that boys 
with a tight and small scrotum are not likely to respond to hormonal therapy. 
Many authors report a normal prepuberal testicular volume of 1-2 ml (Schon-
feld and Beebe, 1942; Rundle and Sylvester, 1962; Dooren et al., 1963; Laron and 
Zilka, 1969; Kleinteich, 1979). It has also been shown that testicular volume may 
increase from age 10-11 years (Prader, 1975; Kleinteich, 1979). Dooren and 
coworkers (1963) found a testicular volume of 1-5 ml in 114 boys with normally 
descended testes aged 10-12 years. A volume of 4-5 ml was only noted in 12% of 
the boys aged 11-12 years. In our boys with undescended testes we generally 
found normal testicular volumes before treatment. Of the 30 boys in whom we 
registered a testicular volume of 2.5-4 ml, 13 were 10-12 years old and therefore 
the testicular volume may have been normal for age. In the remaining 17 boys 
(aged 1-10 years) it may have been a case of compensatory hypertrophy of the 
contralateral, descended testis, although in a number of these boys (particularly 
in those aged 9-10 years) the unilateral, undescended testis also measured 2.5 mi. 
In the literature there is no consensus of opinion regarding the incidence of 
compensatory hypertrophy of the contralateral, descended testis in unilateral 
cryptorchidism (Laron and Zilka, 1969; Kleinteich, 1979). For our study population 
we estimated that the incidence of compensatory hypertrophy was at most 9% 
(17 of 184 unilateral cryptorchids included in the evaluation). Furthermore, the 
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great diversity in volume of the contralateral testis in boys with unilateral absence 
of testis argues against the assumption that unilateral cryptorchidism is always 
associated with hypertrophy of the contralateral, descended testis. 
After LHRH treatment, we noted that 18 of 195 testes (9%) had increased in 
volume. In the age group 6-12 years this occurred in 10 of 84 testes (12%). Karpe 
and associates (1983) found an increase of testicular volume (< 1 ml) in a 
significant number of patients during LHRH therapy, while they observed no 
such increase in the placebo group. Dijkstra and coworkers (1986) reported an 
increase in the number of spermatogonia and spermatocytes in addition to an 
increase in the diameter ofthe seminiferous tubules after four weeks of pulsatile, 
intramuscular administration of LHRH in pigs. Hadziselimovic and coworkers 
(1980b) found no difference in spermatogonia count per tubule in testicular 
biopsies, taken at operation, comparing cryptorchid boys that had undergone 
hormonal treatment with those that had not. On the other hand, he did find 
evidence of stimulation of Leydig cells after LHRH treatment. He reported an 
increase in size and number of Leydig cells and signs of increased secretory 
activity. The increase in testicular volume observed in our patients after LHRH 
treatment is more likely to have been caused by an increase of germinal epithe-
lium than by an increase in the number of Leydig cells, particularly in view of the 
fact that the tubular compartment of the testis takes up more room than the cells 
of Leydig (Prader, 1966). Moreover, we also found an increased volume in 5 of 213 
testes in the placebo group. Success of treatment did not coincide with increase 
of testicular volume. 
The success rate reported in the literature for LHRH nasal spray varies from 
9-38% for double-blind studies and from 13-78% for open studies as shown in 
table 4.1. In our double-blind period, the success rate for LHRH treatment (9%) 
did not differ from that for placebo (8%). Two courses of LHRH treatment were 
required for 43% of the testes that eventually descended with this treatment and 
therefore the success rate for the double-blind period is not comprehensive. 
However, one cannot exclude a placebo effect during the open study period.lllig 
and coworkers (1980•) found that a second trial of intranasal LHRH in patients 
with little or no response to the initial LHRH treatment was ineffective, regardless 
whether it immediately followed the initial course or was given weeks or months 
later. The same authors reported that HCG treatment after LHRH treatment had 
no effect on testicular position. This is contrary to the findings of Hadziselimovic 
(1982) who reported that a short course of intramuscular HCG immediately 
following intranasal LHRH treatment, enhanced its rate of sucGess. 
Dosage and duration of treatment varied in the various studies (see 4.1.3.). In 
general, the choice of treatment schedule will be based on a comparison of the 
rates of success achieved with the various schedules. However, the rates of 
success may well have been influenced by other factors. In our study, the age of 
the patient affected the results of LHRH treatment. Our highest success rate was 
in the oldest age group. This contrasts with the results of several other studies in 
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which the greatest success was achieved in boys of 2 to 5 years (Zabransky, 1981; 
Hagberg and Westphal, 1982) or where there was no relation between age and 
descent (Happ et al., 1975; Illig et al., 1977; Pirazzoli et al., 1978; Schwarz et al., 
1985). Garagorri and coworkers (1982) reported a lower success rate for HCG 
treatment in the younger age groups. Regarding the LHRH treatment, we won-
dered whether the difference in the rates of success achieved in the different age 
groups might be due to an age-related divergence in the resorption of the nasal 
spray. A separate, small-scale investigation was carried out to test this premise 
(see 4.3.6.). 
Most authors agree that the more caudal the location of the testis before 
treatment, the better the result (Kiidjian et al., 1985; Schwarz et al., 1985). Some 
authors reported a higher success rate for bilateral undescended testes (Cacciari 
et al., 1982; Hadziselimovic, 1982; Borkenstein et al., 1983), while others found a 
higher percentage of descent in cases of unilateral cryptorchidism (Illig et al., 
1977; Happ et al., 1978). Our results of the logistic regression analysis indicate that 
the most caudal position of the testis before treatment is far more important for a 
successful outcome of LHRH therapy than either age of the boy or laterality ofthe 
undescended testis. 
A lower testicular position (scrotal entrance and high scrotal) was far more 
frequent in the older age group than in the younger boys, for which we can offer 
several explanations. It may be that younger boys with undescended testes in 
relatively low positions were not referred to our outpatient clinic ("selection 
bias"). Or, testicular descent may continue during the entire prepuberal period. 
Alternatively, a previously fully descended testis may be capable of ascending to a 
prescrotal position, or give the impression of having ascended ("pseudo-
ascent"). The second premise can only be substantiated by a longitudinal study 
from birth to puberty. No such study has been reported. The third premise was 
substantiated to some extent by Privat in 1978. She found undescended testes in 
boys at preschool- or school-age that had been in a scrotal position during the 
first years of life. Several explanations for the apparent ascent of the testes have 
been proposed (see 5.8.). In boys with a persistent processus vaginalis, ascent of 
the testis may occur with growth (Atwell, 1985). Alternatively, the traction of the 
cremaster muscle may be so strong at a certain point in childhood, that it is 
impossible to differentiate between retractile and truly undescended testes, 
despite skillful, repeated examination ("pseudo-ascent"). According to Karpe 
and associates (1983), the descent achieved with LHRH treatment might be 
related to reduced testicular retraction by the cremaster muscle. The results of 
our retrospective evaluation of previous testicular positions (see 4.3.5.) indicate 
that both explanations for the ascent or pseudo-ascent of the testis are feasible. 
Several parents of boys with one undescended and one retractile testis reported 
that during LHRH therapy the retractile testis seemed to be more frequently 
intrascrotal than before. All these findings substantiate Karpe's premise. To gain 
more insight, we initiated a search for binding sites or receptors for androgens, 
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LH and FSH or LHRH in the cremaster muscle. The preliminary results revealed 
LH-binding sites in the cremaster muscle of prepuberal boys and pigs. 
A number of workers reported they saw no adverse reactions to LHRH treat-
ment (Illig et al., 1977; Happ et al., 1978; Pirazolli et al., 1978; Cacciari et al., 1982; 
Van der Meyden et al., 1984), while others did observe a few adverse reactions, 
such as behavioural changes (Hagberg and Westphal, 1982; Wit et al., 1985). It is 
interesting to note that in our study adverse reactions were reported by the 
parents of some boys that had placebo! 
The phenomenon of late descent was also reported by Schwarz and coworkers 
(1985). In their collaborative study, late descent amounted to 6% (10/171 testes), 
which they blamed on the diversity in clinical assessment. In our study, 14 initially 
nonresponding testes (5%) were either located in the scrotum or capable of 
manipulation into the scrotum at follow-up. In three patients complete descent 
coincided with the start of puberty. However, since late descent also occurred in 
the younger age groups, puberty offers only a partial explanation. 
The recurrence of incomplete testicular descent some time after complete 
descent has been achieved with hormonal therapy (time lapse in our study was 3 
to 12 months) has been reported by others, varying from 5-60% (Happ et al., 1978; 
Illig et al., 1980•; Zabransky, 1981; Hagberg and Westphal, 1982; Hadziselimovic, 
1982; Karpe et al., 1983; Schwarz et al., 1985). 
An improved position or complete descent oftestes with placebo has also been 
reported (Illig et al., 1977; Hagberg and Westphal, 1982; Karpe et al., 1983; Klidjian 
et al., 1985). These observations confirm the difficulty of diagnosis and may be 
explained in part by the extent to which the child is able to relax at repeat 
examinations. 
As described in chapter 3, literature data concerning pre-existing hormonal 
anomalies in cryptorchid boys are highly conflicting (Sizonenko et al., 1973; job 
et al., 1974b; Lee et al., 1974; Cacciari et al., 1974; 1976; Gendre! et al., 1977; Illig 
and Werder, 1977; Happ et al., 1978; Sizonenko et al., 1978). Our comparative 
hormonal evaluation of cryptorchid boys and control subjects did not suggest a 
deficient hypothalamo-pituitary-gonadal axis or deficient Leydig cell function in 
cryptorchid boys. Mean basal and peak FSH values were the same for all 
cryptorchids and controls. We only found a higher mean peak FSH in bilateral 
cryptorchids aged 2 to 6 years. Sizonenko and coworkers (1978) correlated 
increased FSH response in bilateral cryptorchids to low counts of spermatogonia 
in both testes. 
The higher stimulated LH levels observed in both cryptorchids and controls of 
age group A compared with age groups Band C, demonstrate maturation of the 
prepuberal restraint of gonadotropin production in the older boys (see 3.4.3.). 
The higher basal testosterone levels in boys over six years old may be due to the 
increase in adrenal steroids towards puberty (adrenarche). The decrease with age 
of peak and delta testosterone may indicate that at a younger age the testes are 
more responsive to a single high dose of HCG. Forest (1979) did not find a 
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significant difference in post-HCG levels of testosterone in prepuberal1-12 year 
old boys. However, HCG stimulation in that study consisted of repeated HCG 
injections. Another explanation may lie in the dosage of HCG. In our study, the 
same dose of HCG was administered to boys of all ages, amounting to 1,500 IU. 
Consequently, the younger boys received a relatively higher dose. However, 
since the maximally stimulating dose of a single HCG injection for adult men lies 
between 1,500 and 6,000 IU (Forest, 1983), one may assume that in the entire 
prepuberal period maximal stimulation is achieved with 1,500 IU HCG. 
The mode of action of LHRH treatment is still unclear. Some investigators 
surmised that after LHRH stimulation LH and FSH co-operate to potentiate the 
local action of testosterone (Illig et al., 1980b) or to increase local testosterone 
secretion and thereby testicular descent due to differentiation of epididymis and 
ductus deferens (Hadziselimovic et al., 1980b). However, we found no evidence of 
stimulation of the hypothalamo-pituitary-gonadal axis. There were identical, 
slight changes in basal and peak LH and FSH, as well as basal testosterone levels 
after LHRH treatment and after placebo. We wonder whether the slight differen-
ces in the change of peak FSH in group C and of basal testosterone levels in group 
A are of clinical significance. Several workers have reported similar findings 
(Pirazolli et al., 1978; Cacciari et al., 1982; Hagberg and Westphal, 1982). Others 
have described a fall in peak FSH levels combined with increased, decreased, or 
unchanged peak LH levels (Happ et al., 1978; Spona et al., 1979; Illig et al., l980b; 
Hadziselimovic, 1982; Hocht, 1983; Karpe et al., 1983). Comparing the success-
fully treated boys with the nonresponders in our study, there were only small and 
clinically insignificant differences in the change of a few hormonal values. There-
fore, this evaluation did not explain the mode of action either, nor did it provide a 
prognostic aid. Our failure to determine the mode of action of LHRH nasal spray 
prompted us to carry out an additional investigation of this aspect, towards the 
end of the study period (see 4.3.7.). 
There is great similarity between hormonal treatment with HCG and with 
LHRH as far as results and contributive factors are concerned: 
- For both modalities divergent percentages of testicular descent have been 
reported. 
- For both modalities the best rate of success involved lower positioned testes. 
In case of impalpable testes, success is at best minimal. 
- For both modalities a higher success rate has been reported interchangeably 
for unilateral and bilateral cryptorchidism, for younger and for older boys. 
- For both modalities return of the testis to its former, undescended position has 
been reported. 
- For both modalities the mode of action is still unclear. 
Adverse reactions to hormonal treatment, particularly signs of androgenic 
stimulation, are more frequently reported for HCG than for LHRH. No studies 
have been reported of placebo-controlled HCG treatment, but the efficacy of 
HCG and LHRH were recently compared in a double-blind study (Rajfer et al., 
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1986). In this study involving 33 boys aged 1-5 years, the frequency of testicular 
descent was equally low for either modality, 1 of 20 testes after HCG versus 3 of 17 
after LHRH. They concluded that hormonal treatment is practically useless for 
truly undescended testes. 
4.3.5. Retrospective evaluation of testicular position before referral 
a. Introduction 
In order to decide whether a boy with unilateral or bilateral cryptorchidism 
qualified for our double-blind, placebo-controlled study of the efficacy of LHRH 
nasal spray, the parents were asked a number of questions and particularly 
whether the undescended testis had ever been seen or felt in the scrotum. The 
boy was only admitted to the study if this question was answered in the negative. 
As the study progressed, results seemed to cast a doubt on the information 
supplied by the parents. Apart from the finding that the lower the initial testicular 
position the better the response to hormonal treatment, it emerged that some 
testes descended with placebo. Consequently, we felt the need for a retrospec-
tive evaluation of our patients, tracing all available documentation of testicular 
position from birth up till the time of referral. Collecting these data and reviewing 
the anamnesis was essential for answering the following questions: 
- Is the anamnesis supplied by the parents correct as regards their son's previous 
testicular position? 
- Is there a connection between the anamnestic evaluation and the result of 
hormonal therapy? 
- Does the anamnestic evaluation provide an explanation for the testicular 
descent achieved with placebo? 
b. Patients and methods 
After obtaining parental consent, we requested information concerning our 
patients, regardless of treatment results, from Child Health Care institutions 
(well-baby clinics and school medical officers), general practitioners and any 
other doctors that had examined these boys at one stage or another. We spe-
cifically asked for any documentation of testicular position. The information we 
received was classified as follows: 
response - merely indicating information was received, which was then quali-
fied as: 
positive - indicating that the cryptorchid testis or testes of that particular 
patient had been documented at least once as retractile or intra-
scrotal; 
negative - indicating that the undescended testis or testes had never been 
documented as retractile or intrascrotal; or 
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unknown- indicating that no documentation concerning testicular position 
was available. If there was no response whatsoever, the patient 
concerned was also grouped in this category. 
c. Results 
Table 4.16. gives the data, often collected with great difficulty, per age group 
according to success or failure of treatment and classified as described above. 
This concerns the testicular position in 237 boys included in our final assessment. 
We received a response for 213 of them, supplying pertinent information regard-
ing 195 patients. Positive information was received significantly more often (p < 
0.05) for boys that had success with LHRH treatment (43%) than for boys with 
failure of treatment (17%). 
Table 4.17.lists the age at which testicular position was first documented in the 
195 boys for whom pertinent information was received, per age group and again 
Table4.16. Information concerning previous testicular position in 237 cryptorchid boys; number 
(%)of boys. 
age treatment information 
group result total response positive negative unknown 
A success 7 6 [86] [ 14] 5 [72] 1 [ 14] 
failure 42 40 [95] [ 2] 39 [93] 2 [ 5] 
B success 18 17 [94] g [50]* 5 [28] 4 [22] 
failure 76 64 [84] Hi [21]* 42 [55] 18 [24] 
c success 36 34 [94] 16 [44]* 13 [36] 7 [20] 
failure 58 52 [90] 13 [23]* 35 [60] 10 [ 17] 
A+ B + C success 61 57 [93] 26 [43]* 23 [38] 12 [20] 
failure 176 156 [89] 30 [ 17]* 116 [66] 30 [17] 
total 237 213 [90] 56 [23] 139 [59] 42 [ 18] 
* success significantly different from failure [chi-square test [2 x 2 table]. 
p < 0.05] 
Table4.17. Age at first documentation of testicular position in 195 boys. 
age treatment total at birth 0-1 yr 1-4 yr 4-12 yr 
group result pos neg pos neg pos neg pos neg pos neg 
A success 5 0 0 1 5 0 0 0 0 
failure 39 1 5 0 34 0 0 0 0 
B success g 5 0 4 3 1 2 2 
failure 16 42 0 6 10 33 5 2 1 1 
c success 16 13 0 0 6 1 3 4 7 B 
failure 13 35 2 4 22 3 3 4 g 
A+ B + C success 26 23 0 1 11 7 6 5 g 10 
failure 30 116 3 12 14 89 B 5 5 10 
total 56 139 3 13 25 96 14 10 14 20 
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in relation to success or failure of treatment. The information concerning testicu-
lar position at birth, in the first year of life, and from age 1-4, was generally 
supplied by well-baby clinics or infant health centres, while the information 
concerning age 4-12 generally came from school medical officers. Information 
regarding testicular position at birth was received for a small number of boys 
only. Particularly for the older boys (age group C), little information was available 
concerning their testicular position at birth or in the first year of life. 
Table 4.18. lists the information received concerning the previous testicular 
position in boys whose testes descended during the double-blind period. Ten 
boys (ten testes) had testicular descent with placebo (table 4.18•.). Positive infor-
mation was received regarding four of these boys. Unfortunately, no information 
was available for another four. Eleven boys (14 testes) had testicular descent with 
LHRH therapy (one course) as shown in table 4.18b. As with placebo decents, 
positive information was received regarding four boys, while no information was 
available for five of them. 
At the time of writing, 170 of 176 boys that had no success of hormonal 
treatment have been operated upon. Table 4.19. shows the previous testicular 
position in these 170 boys (196 undescended testes). This table lists 62 boys in 
group C, while table 4.16. of this retrospective evaluation listed only 58 boys in 
group C with failure of treatment. The difference is due to four bilateral cryptor-
chids in this group who had hemi-descent with hormonal treatment. These boys 
were added to the success group, as mentioned before, even though their 
contralateral, undescended testis required surgery. In none of these four cases 
did we receive positive information. 
Table 4.18. Information concerning previous testicular position of boys whose testes descended 
during the double-blind period. 
a] 10 boys. whose testes descended with placebo 
placebo information age 
group descent positive negative unknown 
A 0 0 0 0 
B 6 2 2 2 
c 4 2 0 2 
total 10 4 2 4 
b) 11 boys. whose testes descended with LHRH [one course] 
LHRH information age 
group descent positive negative unknown 
A 0 0 
B 1 1 0 0 
c 9 3 1 5 
total 11 4 2 5 
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Table4.19 Information concerning previous position of 196 operated testes in 170 boys; number 
(%)of boys. 
information 
age 
testes group boys response positive negative unknown 
41 A 36 36 [100) 1 [ 3) 33 [92) 2 [ 5) 
82 B 72 62 [ 86) 15 [21) 41 [57) 16 [22) 
73 c 62 50 [ Bl) 13 [21) 38 [61) 11 [ 1 B) 
196 total 170 148 87) 29 [17) 112 [66) 29 [17) 
Table 4.20. summarizes the findings at surgery of 196 undescended testes in 
relation to the information received concerning previous position. The informa-
tion was positive for 32 (16%) of the 196 testes that required surgery. In two of 
these cases (concerning unilateral cryptorchids) the surgical findings invalidated 
the positive information received in that there was no testis! In addition, ten 
testes were found in a subcutaneous position on top of the aponeurosis of the 
external oblique muscle (superficial inguinal ectopia), while according to the 
positive information these testes had been documented at least once as intrascro-
tal or retractile. We also received positive information regarding ten testes that 
were located in the inguinal canal and another ten just outside the inguinal canal 
in the external annulus. These 20 testes were somewhat mobile in a wide open 
processus vagina lis. An open processus vaginalis was a frequentfinding concern-
ing 139 testes in all. 
Table 4.20. Surgical findings in relation to information concerning previous position of 196 testes; 
number(%) of testes. 
peroperative position of testes -+--total_____,.. processus vaginal is 
superficial 
intra- inguinal external inguinal 
information absent abdominal canal annulus ectopia open obliterated 
positive 2 (13) 0 ( 0) 10 (21) 10 (15) 10 (17) 32 (\6) 22 (16) 10 (17) 
negative 11 (74) 8 !100) 28 (60) 36 (55) 46 (76) 129 (66) 91 (65) 38 (67) 
unknown 2 (13) 0 ( 0) 9 (19) 20 (30) 4 ( 7) 35 (18) 26 (19) 9 (16) 
total 15 (100) 8 (100) 47 (100) 66 (100) 60 (100) 196 (100) 139 (100) 57 (100) 
d. Discussion 
The response to our request for information concerning previous testicular 
position was very good, amounting to 90%. Unfortunately, information concern-
ing testicular position at birth or during the first year of life was unavailable in 
many cases, particularly for age group C, because the early records for these boys 
had often been discarded. This meant that very important information was 
lacking, because in early infancy an undescended testis is easily distinguished 
from a descended one. There is practically no cremasteric reflex in a boy of that 
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age and therefore there is no retractility to confuse the examiner. It stands to 
reason that we received positive information for only two patients in the youn-
gest age group, one with success and one with failure of treatment. 
As shown in table 4.16., positive information was significantly more frequent 
for boys with success than for those with failure of treatment. This may indicate 
that a number of successfully treated testes, viz. those with positive information, 
should actually have been designated as descended or retractile testes, although 
it was definitely impossible to make such a diagnosis before treatment. It is 
remarkable that positive information was received regarding four of ten boys 
with placebo descent and four of eleven boys with descent aher LHRH in the 
double-blind period. Pertinent information was not available for four boys in the 
placebo group nor for five in the LHRH group. Therefore we cannot draw any 
conclusions, but the similarity between the two groups is striking. 
Regarding the information we received, this could not always be taken at face 
value. Just how dependable are these early data? In two cases we received 
positive information when the testes were absent! A number of times the leh and 
right side had changed places. Sometimes it was not clear whether the testis had 
been truly undescended or retractile. 
It seems logical that the percentage of positive information was lower for testes 
with failure of treatment than for the successfully treated ones. In actual fact this 
percentage should have been zero! The fact that this was not the case, might 
suggest that a number of testes that were operated upon were actually retractile. 
However, this is highly unlikely as none of the operated testes were ever capable 
of manipulation into the scrotum at repeated examinations before and during 
the LHRH treatment, nor at an examination under general anaesthesia before 
surgery was commenced. Provided the positive information supplied in these 
cases is correct, these testes must have ascended at one stage or another. 
The occurrence of testicular ascent has previously been reported by Privat 
(1978) and Atwell (1985). Both authors describe boys they themselves had exam-
ined and diagnosed as having normally descended testes, whose testes at a 
follow-up examination years later were no longer in the scrotum nor could they 
be manipulated into a scrotal position. Atwell in particular, describes the surgical 
findings in a number of testes he operated upon personally. In these cases he 
consistently found a wide open processus vaginalis. Part of such a wide open 
vaginal process will disappear into the peritoneum as the boy grows, which may 
result in a relative shortening of this process whereby the testis is lifted out of the 
scrotum (testicular ascent is described in more detail in chapter 5). 
In agreement with these data from the literature, testicular ascent may possibly 
have occurred in the 20 cases where we found a testis floating in a wide open 
processus vaginalis. It is difficult to say whether there was testicular ascent 
regarding the ten testes that were found in a superficial inguinal, ectopic position 
at surgery while the information for these testes was positive. 
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e. Conclusions 
The questions that prompted this retrospective evaluation can be answered as 
follows: 
- The anamnesis supplied by the parents was not always correct as regards their 
son's previous testicular position. In 56 boys of the entire study population 
(23%) the testis had been seen in the scrotum at least once, of which the 
parents were totally unaware. 
- There was a connection between the anamnestic evaluation and the results of 
hormonal treatment. Positive information was received significantly more 
often for boys in whom the treatment was successful than for those in whom 
the treatment failed. 
- Due to a lack of pertinent information, the anamnestic evaluation could not 
provide an explanation for the testicular descent achieved with placebo. In 
this respect, there was a remarkable similarity between boys whose testes 
descended with placebo and boys whose testes descended with LHRH in the 
double-blind period. 
4.3.6. Serum levels of lHRH and gonadotropins after intranasal administration 
oflHRH 
a. Introduction 
During the double-blind, placebo-controlled study it seemed as if the reaction 
to hormonal treatment was less pronounced in boys of the younger age groups 
than in those of the oldest age group. We wondered if this could be due to a 
difference in absorption ofthe LHRH nasal spray. Therefore we decided to carry 
out a substudy in a small number of boys representative of the three age groups 
to investigate the absorption of LHRH administered intranasally, by measuring 
LHRH, LH and FSH serum levels in timed blood samples. 
b. Patients and methods 
Nine boys with unilaterally undescended testes were selected for age, three 
boys per age group (A = 1-2 yrs; B = 2-6 yrs; C = 6-12 yrs) with a similar 
distribution of most caudal testicular position. They were treated for four weeks 
with LHRH (Cryptocur®) intranasally, one puff in each nostril three times a day 
before meals, one puff amounting to 200 Mg. If this did not result in testicular 
descent, they underwent a second course of treatment. On the 15th day of the 
initial treatment, the boys came to the outpatient clinic at midday, before their 
second daily dose of LHRH had been administered. An indwelling catheter was 
inserted and after the first blood sample was taken at 0 minutes, 400 Mg of LHRH 
was administered intranasally as described above. Subsequently, blood was taken 
at 5, 15, 30 and 60 minutes. 
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Dr. j. Sandow of Hoechst Aktiengesellschaft, Frankfurt, measured the LHRH 
serum levels by radio-immunoassay without extraction. The antiserum (HF39) 
used in the test was developed by Nett and coworkers (1973). Detection limit of 
the assay: 100 pg/ml. A control experiment was carried out by measuring LHRH 
plasma levels likewise at 0, 5, 15, 30 and 60 minutes in three adult men who were 
given 100 p,g LHRH intravenously. LH and FSH serum levels were also determined 
by radio-immunoassay, using RIA-gnost® hLH and hFSH from Behringwerke 
A. G. The standards employed in these kits have been calibrated for LH versus the 
MRC standard 68/40 and for FSH versus the MRC standard 69/104, both express-
ed in mU/ml. Detection limit of the assay was 2mU/ml for LH and 1 mU/ml for 
FSH. 
c. Results 
One boy (age group B) was excluded from the study because of poor com-
pliance. The result of the LHRH treatment is given in table 4.21. The serum levels 
of LHRH, LH and FSH before and after 400 p,g LHRH intranasally are depicted in 
figure 4.6 .. Although the LHRH serum levels were low, they could be measured 
shortly after the LHRH administration, at 5-30 minutes in all three age groups. In 
age groups A and B serum LHRH was higher in the boys that did not respond to 
hormonal treatment. Serum LH increased markedly in two boys of age group C, 
but showed little response in the younger boys. There were practically no 
changes in serum FSH after the LHRH administration in anyone of the three age 
groups. For comparison, figure 4.7. shows the LHRH serum levels in three adult 
men before and after intravenous administration of 100 p,g LHRH.In all three men 
the peak response occurred five minutes after LHRH administration. 
Table4.21. Results of LHRH therapy. 
age age pretreatment most caudal 
group patient yrs/mos testicular position 
A I 1/3 external annulus 
II 1/B external annulus 
Ill 1/3 scrotal entrance 
B yg scrotal entrance 
II 213 external annulus 
Ill 3/3 external annulus 
c I 6/11 external annulus 
II B/7 external annulus 
Ill 7/1 scrotal entrance 
* withdrawn from study because of poor compliance 
** two LHRH courses were needed 
+-yes 
--no 
complete 
descent 
+ 
+ 
0 * 
+ ** 
+ 
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Figure 4.6. Serum levels of LHRH, LH and FSH before and after 400 J.l.g LHRH per nasal spray in eight 
boys (age group A: N = 3; age group B: N = 2; age group C: N = 3). 
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Figure 4.7. Serum levels of LHRH before and after 100 11g LHRH administered intravenously to 
three adult men. 
d. Discussion 
The auxiliary study showed that LHRH can be detected in blood 5-30 minutes 
after intranasal administration of 400 p,g LHRH in prepuberal boys. The small 
number of boys did not allow for a clear differentiation between age groups, 
although the study did show that even in the younger age groups relatively high 
serum levels can be obtained, comparable to LHRH serum levels in adult men 
after the intravenous administration of 100 p,g LHRH. 
The absorption of LHRH nasal spray as well as the gonadotropin response to 
various doses of intranasally administered LHRH in adults is described in section 
4.1.3. The absorption of LHRH nasal spray in prepuberal boys has not previously 
been determined, but the gonadotropin response to LHRH nasal spray in prepu-
beral boys was measured recently by Rajfer and coworkers (1986). They found a 
significant increase in serum LH levels at 30 and 60 minutes after the intranasal 
administration of 200 p,g LHRH. Serum FSH did not change significantly. They did 
not measure the LHRH serum levels. To our knowledge, our study is the first one 
in which serum levels of LHRH as well as gonadotropins were measured in 
prepuberal boys after intranasal administration of LHRH. 
In our limited study, a clear LH response ocGurred at 30 minutes after intranasal 
administration in age group Conly, particularly in the two boys that responded 
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successfully to LHRH therapy. We can find no easy explanation for the fact that 
the response of serum LH to an intranasal dose of LHRH was most marked in boys 
of the oldest age group. Those boys had not yet reached the peri puberal period 
during which the response of gonadotropins to exogenous GnRH increases 
(Reiter and Grumbach, 1982). It is remarkable that in our double-blind, placebo-
controlled study identical changes were observed in basal and peak levels of LH 
after four weeks of either LH or placebo, both administered intranasally, in all age 
groups. It is possible that in prepuberal boys the effect of intranasally adminis-
tered LHRH on LH release is too short and therefore does not result in a lasting 
stimulation of gonadotropins. 
No relationship could be established between serum LHRH and LH after 
intranasal administration of LHRH. As in studies in adult males, no response of 
FSH was observed after the intranasal administration of LHRH 
e. Conclusion 
This supplemental study did not reveal a difference in absorption of the intra-
nasally administered LHRH between the three age groups which might explain 
the difference in success of hormonal treatment. However, a clear LH response to 
LHRH nasal spray was only observed in boys of age group C and these same boys 
responded successfully to this form of treatment. 
4.3.7. Supplementary endocrinological studies before and after LHRH nasal 
spray treatment 
a. Introduction 
The obligatory precursor for the biosynthesis of testosterone in the testes of 
mammals appears to be cholesterol, which can be converted intramitochon-
drially to pregnenolone (figure 3.3.). The conversion of pregnenolone to testos-
terone can occur via several A 5 intermediates- involving pregnenolone (Preg), 
17 a-hydroxypregnenolone (17 OHPreg), dehydroepiandrosterone (DHEA) and 
androstenediol (A 5)- as well as via several A 4 intermediates- involving proges-
terone (PL 17 a-hydroxyprogesterone (17 OHP) and androstenedione (A 4). Ac-
cording to Yanaihara and Troen (1972), the A 5 pathway appears to be the most 
significant in the human testis. In contrast, Zachmann (1972) stated that it is still 
controversial whether under physiological conditions the A 4 or the A 5 pathway 
is preferred for the biosynthesis of testosterone from pregnenolone, even 
though both pathways require the same enzymes, albeit in a different sequence. 
Forest and coworkers (1975) suggested that the prepuberal testis may also con-
tribute to the plasma pool of metabolites of the A 4 pathway (A4 and 17 OHP). The 
same group found evidence of testicular production of DHEAS in childhood (De 
Peretti and Forest, 1978). 
The kinetics of the plasma level response of steroid hormones to a single 
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intramuscular injection of HCG was studied by Forest and Bertrand (1984) in 
normal prepuberal boys. They observed a progressive increase of plasma T with 
peak levels usually occurring at the 100th hour. The kinetics of dihydrostestoster-
one (DHT) were quite similar, although the extent of the response was modest. 
There was no significant change in 17 OHP or~ 4. Toscana and coworkers (1983) 
likewise found an increase in plasma T and DHT, but no change in 17 OHP, ~ 4 
and oestradiol (E2), after a single dose of HCG in prepuberal boys. Untreated hypo-
gonadotropic, hypogonadic adult men showed an almost similar reaction to a 
single intramuscular HCG injection, consisting of a progressive and substantial 
rise in plasma T, maximal at 96-120 hours, as well as a modest, late rise in E2, but no 
significant change in ~ 4 or 17 OHP (Forest and Roulier, 1984). This contrasted 
with a biphasic T response to a single intramuscular injection of HCG observed in 
normal adult males; the first one after four hours and a second, delayed reaction 
with a more pronounced peak between 72-96 hours (Saez and Forest, 1979). 
Furthermore, there is ample evidence that in adult men HCG acutely stimulates 
the testicular aromatase, while it inhibits 17 a-hydroxylase and even more so 
17,20-lyase activity, resulting in the accumulation of 17 a-hydroxylated steroids 
and progesterone - so-called HCG-induced testicular desensitization (Forest et 
al., 1979; Martikainen et al., (1980). Peak levels of E2 and 17 OHP are obtained in 
adult men after one intramuscular injection of HCG, but these levels are still 
elevated at 72 hours (Forest and Roulier, 1984). The finding that an HCG-induced 
steroidogenic desensitization would occur in normal adult men and puberal boys 
as well as in HCG-treated hypogonadotropic, hypogonadic adult men, but not in 
prepuberal boys, prompted Forest to suggest that HCG-induced steroidogenic 
desensitization is present in patients previously exposed to a certain level of 
gonadotropic stimulation (Forest and Roulier, 1984). 
Mercier and coworkers (1966) clearly demonstrated the existence of a separate 
human sex hormone-binding globulin (SHBG or TEBG = testosterone-oestra-
diol-binding globulin). SHBG is a beta-globulin secreted by the liver. The protein 
binds reversibly and with affinity the main biologically active, circulating 
androgen testosterone and, to a lesser extent, dihydrostestosterone and the 
active oestrogen oestradiol (E2). Serum concentrations of SHBG are partially 
dependent on the hormonal milieu; androgens cause a reduction and oestro-
gens a rise in SHBG level (Anderson, 1974). The concentration of SHBG is higher 
in children than in adults; after the onset of puberty there is a slight fall in the 
female and a marked drop in the male (Anderson, 1974). Belgoroski and Rivarola 
(1982) suggested the use of SHBG as a parameter for the determination of 
gonadotropin-induced androgen secretion in prepuberal boys. They measured a 
decrease of SHBG concentration after five days of HCG stimulation. 
These diverse findings prompted us to carry out a supplementary investigation 
to determine the mode of action of LHRH nasal spray in a separate series of 16 
cryptorchid boys. 
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b. Patients and methods 
Sixteen boys with either unilateral or bilateral cryptorchidism were studied 
with the informed consent of the parents. There were four boys in age group A 
(1-2 yrs), three in age group B (2-6 yrs) and nine in age group C (6-12 yrs). All16 
boys underwent an HCG test at the start and at the close of four weeks of LHRH 
nasal spray treatment, amounting to 200 p.g in each nostril three times a day 
before meals. Before and three days after the intramuscular injection of 1,500 IU 
HCG, the serum levels of the steroid hormones T, DHT, P, 17 OHP, DHEAS and 
il 4, were determined in all three age groups. In addition, SHBG and E2 were 
determined in age groups A and B only. For methods of steroid determinations 
see chapter 2. A second course of LHRH treatment was administered if the initial 
treatment was unsuccessful. 
Age group matched, healthy prepuberal boys were used as control subjects. 
These boys had been referred to us for evaluation of their testicular position; the 
testes were found to be fully descended in all cases. With the informed consent of 
the parents, serum levels of steroid hormones and SHBG were determined 
before and after an HCG challenge as described above. There were seven boys in 
age group A, ten in age group B, and ten in age group C. 
Statistical analysis of the results was carried out by means of Wilcoxon matched 
pairs signed rank tests and Mann-Whitney-U tests. Because of the small number 
of cryptorchid boys in age groups A and B, the results of these two age groups 
were combined for statistical analysis, regarding the cryptorchid boys as well as 
control subjects. This is justifiable in view of the fact that the results of hormonal 
evaluation of the two age groups were comparable in cryptorchids as well as 
controls. 
c. Results 
The results of the LHRH nasal spray treatment are given in table 4.22. Complete 
descent occurred in five unilateral cryptorchids only; in two of them after two 
courses of LHRH treatment. 
Table 4.22. Results of LHRH nasal spray treatment in 16 boys with unilateral or bilateral 
cryptorchidism. 
patients [N) 
age unilateral bilateral 
yrs right left 
1- 2 2 2 0 
2- 6 3 0 0 
6-12 5 2 2 
total 10 4 2 
* two boys needed two LHRH courses 
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complete descent 
[patients. N) 
unilateral bilateral 
right 
0 
0 
3* 
3 
left 
1 
0 
1 
2 
0 
0 
0 
0 
Tables 4.23•. and 4.23b. give the median and range serum values of P, 17 OHP, 
DHEAS, ~ 4, T, DHT, SHBG and E2, obtained during the HCG tests before and after 
the initial course of LHRH nasal spray treatment in patients of age groups A and B, 
in comparison with age-matched control subjects. Table 4.23c. gives the com-
bined figures for age groups A and B that were used in the statistical analysis. 
Before LHRHtherapy, basal and peak values of P, 17 OHP, DHEAS, ~4, T, DHT, E2, 
and SHBG of cryptorchid boys did not differ from control values (p > 0.05). In 
cryptorchid boys as well as control subjects, peak values of T and DHT were 
considerably higher than basal values, while the DHEAS and~ 4 peak values were 
slightly (but statistically significant) higher than basal values. In comparison with 
pretreatment values, the values after LHRH therapy showed an increase in indi-
vidual peak T levels in all but one boy, although no statistical significance was 
obtained (p > 0.05). BasalT values did not change after LHRH therapy. The basal 
and peak values of the steroid precursors, DHT, E2, and SHBG, did not change 
significantly either. In general, the basal values of the steroid precursors and DHT 
were low and in many cases even fell below the detection limits of the assays. 
Table 4.23d. gives the median and range serum values of steroid precursors, 
testosterone and dihydrostestosterone likewise obtained during HCG tests 
before and after the initial course of LHRH treatment, in boys of age group C in 
comparison with age-matched control subjects. In these older boys, cryptorchids 
as well as controls, the basal and peak values of P, 17 OHP, DHEAS, and ~4, as well 
as basal T values, were significantly higher than the values found in the two 
younger age groups (1-6 yrs). Peak testosterone values in control subjects and 
peak DHT values in cryptorchids and controls were significantly lower than in the 
younger boys. Comparing the values for cryptorchid boys before treatment with 
control values, there was no difference in basal or peak values of P, DHEAS, ~ 4, T 
or DHT (p > 0.05). Basal and peak values of 17 OHP were slightly, but significantly 
higher in control subjects than in cryptorchid boys (p < 0.05). In cryptorchids as 
well as controls, peak values ofT and DHT were considerably higher than basal 
values. In cryptorchids, peak DHEAS values were slightly, but significantly higher 
than basal values. In control subjects, peak ~ 4 values were slightly, but 
significantly higher than basal values (p < 0.05). In comparison with pretreatment 
results, the values after LHRH therapy showed an increase in the individual peak 
serum T values in all boys of this age group and this was statistically significant (p < 
0.05). Basal Tvalues did not change, nor was there a significant change in basal or 
peak values of the steroid precursors or DHT. 
For the boys of all three age groups together (1-12 yrs), the increase in peak T 
and DHT values observed after LHRH therapy was statistically significant (p < 
0.05). 
d. Discussion 
Compared with control values, basal and peak values of the steroid precursors 
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-' Table 4.233 • Results of HCG tests in cryptorchid boys of age group A (1-2 yrs) before and after one course of LHRH nasal spray therapy, in comparison with CXl 
CXl age-matched control subjects. 
AGE GROUP A 
Cryptorchids (N - 4) 
age ( yrs) mean .:!:. SO p 17 OHP DHEAS A 4 T DHT E2 SHBG 
1.5.:!:. 0.4 nmol/1 nmol/1 umol/1 nmol/1 nmol/1 nmol/1 pmol/1 nmol/1 
basal median 0.9 < 1.2 0.06 < 0.35 0.06 < 0.13 13 166.9 
range <0.5 - 1.4 <1.2 - 3.3 <0.02 - 0.12 <0.35 - 0.76 0.02 - 0.11 <0.13 - <0.13 6 - 14 125.6 - 24B.O 
before LHRH 
peak median 0.6 1.4 0.25 O.B9 9.65 1.3B 15 193.2 
range <0.5 - 0.9 <1.2 - 2.2 0.17- 0.31 0.72-1.04 4.90 - 14.70 1.09 - 1.56 10 - 22 101.7 - 216.0 
basal median 0.7 < 1. 2 0.09 < 0.35 0.06 < o. 13 14 165.6 
range <0.5-1.3 <1.2 - 1.9 <0.02 - 0.1B <0.35 - 0.45 0.05 - O.OB (0.13 - (0.13 9 - 16 123.9- 247.9 
after LHRH 
peak median 1.0 1.6 0.31 1.10 14.70 2.04 16 160.9 
range <0.5 - 3.4 <1.2 - 4.6 0.21 - 0.46 0.90- 1.36 7.60- 21.00 1.16- 2.99 13 - 20 110.2- 241.6 
Controls (N - 7) 
age (yrs) mean .:!:. SO 
1.6 .:!:. 0.3 
basal median 1.3 < 1.2 0.19 0.46 0.06 < 0.13 11 170.0 
range 1.1- 3.0 <1.2 - 2.6 0.03 - 0.59 <0.35 - 0.60 0.03 - 0.13 <0.13- 0.14 7 - 16 116.6- 215.9 
peak median 1.3 1.5 0.35 0.73 11.00 1.63 15 162.6 
range (0.5- 2.7 <1.2 - 2.3 0.12 - 0.45 0,52 - 0.94 6.60 - 15.00 0.65 - 1.96 9 - 24 20.1 - 166.0 
Table 4.23b. Results of HCG tests in cryptorchid boys of age group B (2-6 yrs) before and after one course of LHRH nasal spray therapy, in comparison with 
age-matched control subjects. 
AGE GROUP B 
Cryptorchids [N - ;I] 
age [yrs) mean~ SO p 17 DHP OHEAS A Lj T DHT E2 SHBG 
3.0 ~ 1.1 nmol/1 nmol/1 umol/1 nmol/1 nmol/1 nmol/1 pmol/1 nmol/1 
basal median < 0.5 < 1.2 0.13 < 0.35 0.03 < 0.13 12 136.3 
range <0.5 - 0.7 <1.2 -<1.2 0.06 - 0.31 <0.35 - 0.66 0.02 - 0.0'1 <0. 13 - <O. 13 6 - 13 130.3 - 138.1 
before LHRH 
peak median < 0.5 < 1.2 0.37 1.15 11.80 1.31 20 1'12.9 
range <0.5 - 0.6 <1.2-1.7 0.36 - 0.'18 0.97- 1.3B 3.30 - 13.00 0.57 - 1.71 9 - 31 125.7 - 180.8 
basal median < 0.5 < 1.2 0.18 < 0.35 0.09 < 0.13 11 176.0 
range <0.5 - O.B <1 .2 -<1.2 0.09 - 0.32 <0.35 - 0.55 0.02 - 0.12 <0. 13 - <O. 13 11 - 12 109.1 - 199.8 
after LHRH 
basal median 1.0 1.91 0.51 1.0'1 19.00 1.65 18 16'1.5 
range 1.9 - 1.3 <1.2 - 3.'1 0.'13 - 1.00 0.59 - 2.02 5.10 - 28.00 1.03 - 2.'1'1 12 - 22 127. 1 - 197. 1 
Centro Is [N - I OJ 
age [yrs) mean~ SO 
3.7 ~ 1.2 
basal median 0.6 < 1.2 0.13 0.5'1 0.05 < 0.13 10 126.6 
range <0.5 - 2.0 <1.2 - 3.1 0.02 - 0.'19 <0.35 - 1.01 0.02 - 0.1'1 <0.13 - 0.30 5 - 16 80.9 - 232.5 
peak median 0.6 < 1.2 0.31 0.89 9.85 0.92 13 135.1 
range <0.5 - 3.0 <1.2- 3.5 0.10 - 0.99 0.62 - 1. 7'1 '1.30 - 19.00 0.82 - 1.96 6 - 2'1 8'1.2 - 183.5 
.... 
~ 
..... Table 4.23c . Results of HCG tests in cryptorchid boys of age groups A and B combined (1-6 yrs) before and after one course of LHRH nasal spray therapy, in 
<.0 
0 comparison with age-matched control subjects. 
AGE GROUP A + B 
Cr~~torchids (N - 7) 
age ( yrs) mean .! SO p 17 OHP OHEAS Ll " T OHT E2 SHBG 
2.1 .! 1.1 nmo1/1 nmo1/1 umol/1 nmol/1 nmo1/l nmol/1 pmo1/l nmol/1 
basal median < 0.5 < 1.2 0.06 < 0.35 0.0'1 < 0.13 13 13B.1 
range <0.5- 1.'1 <1.2- 3.3 0.02 - 0.31 <0.35 - 0.76 0.02 - 0.11 <0. 13 - <0. 13 6 - 1'1 125.6 - 2'16:o 
before LHRH 
peak median < 0.5 1.3 0.31 • 1.01 • 11.60. 1.31 • 17 176.6 
range <0.5 - 0.9 <1.2- 2.2 0.17 - 0.'16 0.73- 1.36 3.30 - 1'1.70 0.57 - 1.71 9 - 31 101.7- 216.0 
basal median < 0.5 < 1.2 0.12 < 0.35 0.07 < 0.13 12 176.0 
range <0.5 - 1.3 <1.2- 1.9 0.02 - 0.32 <0.35 - 0.55 0.02 - 0.12 <0.13 - <0.13 9 - 16 109.1 - 2'17.9 
after LHRH 
peak median 1.0 1.9 0.'13 • 1.0'1. 19.00 • 1.97 • 17 16'1.5 
range <0.5 - 3.'1 <1.2 - '1.6 0.21- 1.00 0.59 - 2.02 5.10 - 26.00 1.03 - 2.99 12 - 22 110.2 - 2'11.6 
Controls (N - 17l 
age ( yrs) mean .! SO 
2.9.! 1.'1 
basal median 1.1 < 1.2 0. 1'1 0.52 0.05 < o. 13 10 1'16.7 
range <0.5 - 3.0 <1.2 _- 3.1 0.02 - 0.59 <0.35 - 1.01 0.02 - 0.1'1 <0.13 - 0.30 5 - 16 60.9 - 232.5 
peak median 1.1 < 1.2 0.32 • 0.67. 10.00. 1.16. 1'1 136.0 
range <0.5 - 3.0 <1.2- 3.5 0.10- 0.99 0.52 - 1. 7'1 '1.30 - 19.00 0.62 - 1.96 6 - 2'1 6'1.2 - 166.0 
• significantly higher than basal values (Wilcoxon matched pairs signed rank test. p < 0.05) 
-' 
I.D 
-' 
Table 4.23d. Results of HCG tests in cryptorchid boys of age group C (6-12 yrs) before and after one course of LHRH nasal spray treatment, in comparison 
with age-matched control subjects. 
AGE GROUP C 
Cryptorchids (N - 9) 
age (yrs) mean.:!. SO p 17 OHP DHEAS A 4 T OHT 
9.5.:!. 2.1 nmol/1 nmol/1 umol/1 nmol/1 nmol/1 nmol/1 
basal median 2.2• 2.4• o.e7• 1.60. 0.16. < 0.13 
range 1.4 - 3.1 2.4 - 2.9 0.36 - 2.BO 0.35- 3.10 O.OB - 0.64 < 0.13 - 0.64 
before LHRH 
peak median 1.9• 2.4• 1.2e•0 1.35. 5.300 0.39° 0 
range 1.4 - 2.6 2.4 - 3.7 0.42 - 3.48 0.60 - 2.70 1.40-6.60 < o. 13 - 1.20 
basal median 1.7 2.4 1.42 1.40 0.12 < 0.13 
range 1.1 - 2.4 2.4 - 3.1 0.52 - 2.82 0.40 - 2.00 0.03 - 0.26 (0.13-2.00 
after LHRH 
peak median 2.1 2.4 1.98° 1.950 6.60 0. 0.820 
range 1.2 - 3.9 2.4 - 3.8 0.48 - 3.26 1.40- 2.50 4.30 - 15.00 < o. 13 - 6.50 
Controls (N - 10) 
age (yrs) mean .:!. SO 
9.g .:!. 2.0 
basal median 1.8• 3.7•• 1.18• 1.49. 0.13. 0.20 
range 1.1 - 3.6 2.4 - 6.0 0.58 - 5.90 0.40 - 3.90 0.05 - 0.42 < o. 13 - 0.43 
peak median 2.2• 4.4•• 1.4o• 1.75.0 4.65°0 0.50 OD 
range 1.2- 2.5 2.4 - 5.3 0.66 - 6.41 0.90 - 4.10 3.30 - 6.50 0.26 - 0.69 
• significantly higher than the same determinations in younger boys (1--fi yrsl (Mann-Whitney-U test. p < 0.05) 
o significantly lower than the same determinations in younger boys (1--fi yrs) (Mann-Whitney-U test. p < 0.05) 
• significantly higher than the same determinations in cryptorchid boys (Mann-Whitney-U test. p < 0.05) 
o significantly higher than basal value (Wilcoxon matched pairs signed rank test. p < 0.05) 
• significantly higher than peak value before LHRH treatment (Wilcoxon matched pairs signed rank test. p < 0.05) 
revealed by the HCG tests performed before and after LHRH treatment, did not 
suggest pre-existing disorders in the testosterone biosynthesis in the cryptorchid 
boys. Nor did any evidence emerge of an inhibition of enzymes involved in the 
biosynthesis of testosterone, as a result of either the intramuscular injection of 
HCG or one course of LHRH nasal spray treatment. 
The higher basalT and testosterone precursors observed in boys over six years 
old suggest an increase of adrenal steroids before puberty (adrenarche), as 
described by Forest (1979). The peak testosterone values were higher in younger 
boys (1-6 yrs) than in boys of age group C (6-12 yrs). This is in conformity with the 
results of the HCG test carried out in our double-blind, placebo-controlled study 
(see 4.3.4.), although in the auxiliary study statistical analysis showed a significance 
for controls only. 
We did find an increase of peak testosterone values after LHRH therapy in all 
age groups. This may have been partly due to the HCG injection prior to 
treatment. This increase in peak T values supports the observations of Hadziseli-
movic and coworkers (1979; 1980b). In testicular biopsies, taken from boys with 
undescended testes that had undergone LHRH treatment, they found an increase 
in size, number and differentiation of Leydig cells, as well as recruitment of 
precursor cells from fibroblasts. 
No significant changes of serum SHBG were found, either after HCG stimula-
tion or after LHRH treatment, contrasting with the findings of Belgoroski and 
Rivarola (1982) and Dunkel (1985). In agreement with our observations, Chaussain 
and coworkers (1979) did not find a change in the binding capacity of SHBG after 
HCG stimulation in cryptorchid prepuberal boys. 
In summary 
The results of the HCG tests performed before and after four weeks of LHRH 
nasal spray therapy, support the hypothesis that LHRH treatment stimulates the 
Leydig cells. Under basal conditions, this stimulation cannot be detected in 
blood; basal serum testosterone values did not increase after LHRH therapy (see 
4.3.). 
We did not find any indication of a defect in the biosynthesis of testosterone in 
prepuberal boys with undescended testes. Nor did we find any evidence of 
inhibition of the enzymes involved in the biosynthesis of testosterone, either by 
intramuscular injection of HCG or by four weeks of LHRH nasal spray treatment. 
4.3.8. Conclusions 
In the double-blind period, the rate of success for LHRH treatment did not 
differ from that for placebo, while the results of the open study seemed to 
indicate that LHRH therapy does influence the position of the testis. However, 
the placebo effect of treatment during the open period should not be over-
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looked. LHRH nasal spray may be effective in boys with incompletely descended 
testes that can be manipulated to the scrotal entrance. 
Our hormonal data did not indicate the presence of hormonal anomalies in 
cryptorchid boys, although higher stimulated FSH serum values were found in 
bilateral2-6 year old cryptorchids. 
Nor did the hormonal data substantiate the premise that the mode of action 
involves activation of the pituitary-gonadal axis, although the results of the HCG 
test after LHRH nasal spray therapy did indicate stimulation of Leydig cells. 
Hormonal evaluation did not provide a diagnostic aid regarding success of 
hormonal treatment. 
The retrospective evaluation of testicular position before referral disclosed a 
previous intrascrotal position or retractility of testes in more than 40% of the boys 
in whom complete descent was achieved. Consequently, it is feasible that the 
mode of action of LHRH treatment involves a decline in retractility of the 
cremaster muscle and that a number of the testes that responded successfully to 
LHRH therapy would have been spontaneously intrascrotal at puberty. 
The lower success rate for LHRH treatment in the younger age groups cannot 
be explained by a difference in resorption of the LHRH nasal spray. The explana-
tion may lie in the relatively small number of low testicular positions before 
treatment in younger boys compared to the 6-12 year olds. This indicates that only 
pretreatment testicular position significantly influences the rate of success. 
GENERAL DISCUSSION OF HORMONAL ASPECTS 
AND TREATMENT OF CRYPTORCHIDISM 
A (transient) deficiency of the hypothalamo-pituitary-gonadal axis would 
explain the pathogenesis of cryptorchidism and argue for its hormonal treatment. 
This hypothesis is based on the observation of relatively lower serum testosterone 
values during the early months of life in boys with undescended testes, compared 
to boys with normal or delayed spontaneous descent (Gendre! et al., 1978; 1979). 
The same group found peak LH values of cryptorchid boys significantly lower 
than those of boys with delayed spontaneous descent (Gendre! et al., 1980). In 
contrast, other workers found normal values for serum testosterone as well as 
basal and stimulated gonadotropins in cryptorchid boys during the early months 
of life (Davidson et al., 1981, Tapanainen et al., 1982). In view of these conflicting 
data we decided to study the clinical and hormonal aspects of boys born with 
undescended testes during the first year of life. 
Clinically, we observed spontaneous, delayed testicular descent in fullterm 
infants. The frequency amounted to 50% for boys enrolled in the study within the 
first three months of life, half of whom had this spontaneous descent before they 
were three months old. Contrary to the reports of Scorer (1964; 1981) and Forest 
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and coworkers (1984), we did observe spontaneous testicular descent after the 
sixth month of life. 
Our hormonal evaluation of boys with normal testicular descent showed a 
clear postnatal testosterone surge rising to peak levels at approximately two 
months. The values decreased again and after approximately the sixth month, the 
concentration of plasma testosterone had reached prepuberal levels. These data 
are in agreement with those of Forest et al. (1976) and Hammond et al. (1979). 
Comparing the cross-sectional serum testosterone values of persistently crypt-
orchids and boys with delayed spontaneous descent with those of control 
subjects, we found no significant differences. Nor did we find significant differ-
ences comparing the cross-sectional and longitudinal serum testosterone values 
of boys with delayed spontaneous descent with the values of boys that stayed 
cryptorchid. The fact that Gendre( and coworkers (1978) did not evaluate cross-
sectional and longitudinal data separately, may to some extent explain the diver-
gence between our findings and theirs. The difference in results may also be 
influenced by the fact that the French workers did not expect spontaneous 
descent after the fourth month of life, while we observed spontaneous descent 
even after the sixth month. A drawback of our study might be that testosterone 
values of persistently cryptorchid boys and of those with delayed, spontaneous 
descent were not measured before 80 days of age. On the other hand, we did 
measure these values before 80 days in control subjects and found a markedly 
wide range throughout the firstthree months. Our results are in conformity with 
those of Tapanainen et al. (1982) who found testosterone levels of cryptorchid 
infants similar to those of infants with normal testicular descent. 
In our study, cross-sectional and longitudinal basal LH and stimulated LH and 
FSH serum values showed no significant differences from the age of 80 days 
through the first year of life between boys with delayed, spontaneous descent 
and persistently cryptorchid boys. The small number of control subjects did not 
allow for a definite conclusion, although the levels of basal and peak LH and FSH 
serum values of the controls were comparable to those of cryptorchids and boys 
with delayed spontaneous descent. Basal LH values were even higher for boys 
with delayed, spontaneous descent than for controls. The longitudinal basal and 
stimulated LH serum values in cryptorchids and boys with delayed, spontaneous 
descent showed a significant decrease from 3 to 6 and from 6 to 12 months of age. 
Job and coworkers (1977b) found lower stimulated LH serum values in cryptorchid 
infants compared to control subjects. However, the fact that they considered the 
first year of life as a whole may account for the discrepancy. In our study, we 
observed an age-related decrease in stimulated LH values during the first year of 
life. Our findings were in agreement with those of Tapanainen and coworkers 
(1982), who also found initially increased basal and stimulated LH levels in crypt-
orchid boys, which declined to prepuberal levels towards the end ofthe first year 
of life, comparable to those of boys with normal testicular descent. 
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Our hormonal evaluation during the first year of life did not support the hypothe-
sis of a deficient hypothalamo-pituitary-gonadal axis in cryptorchid infants. 
Spontaneous testicular descent in the first year of life occurs in 40-50% of all cases, 
even after the sixth month of life. 
There were no hormonal differences between boys with persistent cryptor-
chidism and boys with spontaneous testicular descent in the first year of life. 
The lack of correlations between basal or stimulated LH serum values and 
testosterone serum values in the first year of life favours the theory that intrinsic 
CNS inhibitory influences suppress the secretion of gonadotropins in childhood 
and that this mechanism is independent of sex steroids. A deficiency of gonado-
tropic and androgenic hormones has also been suggested as causal to cryptor-
chidism. Provided that such hormonal deficiency can be determined postnatally, 
our findings of normal testosterone and gonadotropin levels in cryptorchid boys 
during the first year of life do not support this premise. In actual fact, our results 
question the role of gonadotropic and androgenic hormones in testicular de-
scent. 
Our hormonal evaluation favours the theory that intrinsic CNS inhibitory 
influences, independent of sex steroids, suppress the secretion of gonadotropins 
in childhood. 
Our findings did not support the premise that cryptorchidism is caused by a 
deficiency of gonadotropic and androgenic hormones. 
The levels of testosterone, dihydrotestosterone and steroid precursors before 
and after HCG stimulation at the start of the second year of life were very similar 
for boys that stayed cryptorchid and boys with delayed spontaneous descent in 
the first year of life compared to boys with normal testicular descent. After HCG 
stimulation, a clear and identical rise of serum testosterone and DHTwas found in 
the three groups. The steroid precursors showed no or only small increases. In 
conformity with the physical appearance of our boys with undescended testes, 
these hormonal data contra-indicate disorders in the biosynthesis of testosterone 
or enzyme inhibitions. 
The results of the HCG tests gave no indication of disorders in the biosynthesis of 
testosterone in boys with undescended testes, in conformity with the physical 
appearance of our study population. Moreover, we found no signs of enzyme 
inhibition. 
The results of the pilot study of LHRH nasal spray treatment for boys with 
undescended testes after the first year of life were encouraging; 17 out of 26 (65%) 
testes descended with LHRH therapy. However, in our double-blind, placebo-
controlled study, the percentage of descent with LHRH treatment (9%) was not 
better than with placebo (8%). After two LHRH treatment courses, complete 
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descent was achieved for 48 out of 271 undescended testes (18%). Comparing the 
success rate of our double-blind period with the results of other double-blind, 
placebo-controlled studies in the literature (see table 4.1.), it appeared that our 
rate of success (9%) was similar (chi-square test, p > 0.05) to that of Karpe et al., 
1983 (20%) and Wit et al., 1985 (17%). The success rates of the studies of Illig et al., 
1977 (38%), Bertelsen et al., 1981 (24%) and Hagberg and Westphal, 1982 (28%) 
were significantly higher (chi-square test, p < 0.05) than ours in the double-blind 
period. Comparing the percentage of success after two LHRH courses in our 
study (18%) with that of other, uncontrolled studies, including our own pilot 
study, it appeared that the results of Pirazolli et al., 1978 (32%), Cacciari et al., 1982 
(22%), Van der Meyden et al., 1984 (13%), and Rajfer et al., 1986 (18%) were 
comparable to ours (chi-square test, p > 0.05). The success rate of our pilot study 
(65%) was significantly higher and so were the percentages of complete descent 
achieved in the studies of Happ et al., 1978 (64%),Zabransky, 1981 (78%), Hagberg 
and Westphal, 1982 (61%), Hadziselimovic et al., 1982 (62%), Borkenstein et al., 
1983 (57%), and Schwarz et al., 1985 (37%). Even when we added the placebo 
descents to the success group in the open study period (surmising that in an 
uncontrolled study these descents would have been considered as success of 
hormonal therapy) the comparison with the other studies did not vary. 
Which factors are responsible for these divergent success rates? 
Although the results of our study suggested that success of treatment was 
dependent on age at treatment (a lower success rate in the younger age groups) 
as well as laterality of the undescended testes (a lower success rate in leftsided 
cryptorchidism), the influence of pretreatment testicular position and success of 
hormonal therapy seemed paramount. From the logistic regression analysis it 
emerged that success of treatment was indeed highly dependent on pretreat-
ment testicular position and not on age at treatment or laterality of the unde-
scended testes. In our study more than 50% of the testes that could be manipulat-
ed at least to the scrotal entrance before treatment, descended after two LHRH 
courses. Therefore it is very likely that the treatment results will be better for a 
study population that includes more boys with testes in a lower, albeit undescend-
ed position. In this respect, it appeared that our own pilot study involved 
significantly more undescended testes that were capable of manipulation to at 
least the scrotal entrance before treatment, than our double-blind, placebo-
controlled study (54% versus 26%). This may explain the difference in success 
between these two studies. Some investigators did not mention pretreatment 
testicular position at all (Bertelsen et al., 1981; Borkenstein et al., 1983), while 
others merely specified "inguinal" or "inguinal canal" without mentioning the 
most caudal testicular position before treatment (Illig et al., 1977; Pirazolli et al., 
1978; Cacciari et al., 1982). In contrast, Happ and coworkers (1978) reported that 
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28 of the 36 undescended testes in their series could at least be manipulated to the 
scrotal neck before treatment. It is not surprising that the success rate in this study 
was 64%! Hadziselimovic et al., (1982) reported that in their series more than 60% 
of the inguinal testes responded successfully to LHRH therapy, but the most 
caudal testicular position before treatment was not mentioned. Some investiga-
tors (Happ et al., 1978; Van der Meyden et al., 1984) included so called gliding 
testes or "gleithoden" (i.e. testes that can be manipulated into the upper part of 
the scrotum with immediate return to the undescended position}, which had 
been excluded by others (Karpe et al., 1983). 
Success of LHRH treatment for nonscrotal testes is highly dependent on pre-
treatment testicular position. The diversity, or lack of description of the pretreat-
ment testicular positions in the various study populations, complicates compari-
son of treatment results. 
The placebo descents in our own study and in other placebo-controlled 
studies have demonstrated that it is impossible to exclude retractile testes with 
absolute certainty. Hadziselimovic et al., (1982) claimed that in his study only true 
cryptorchids were selected for treatment (hormonal or surgical). In testicular 
biopsies from all surgically treated boys he found histological changes typical for 
a cryptorchid gonad. However, animal studies have revealed histological changes 
in testes that were located extrascrotally for a certain length of time, which were 
reversible in many cases (Moore, 1924; Clegg, 1963; Frankenhuis and Wensing, 
1979). 
Inclusion of retractile testes may have influenced the percentages of success of all 
studies of hormonal treatment for undescended testes. 
We also wondered whether our dosage schedule might have caused our lower 
success rate for LHRH therapy compared to other studies. It appeared that the 
same dosage was used in most other studies, including the studies with higher 
success rates. Some workers attributed higher success rates to double stimulation 
(administration before and after meals one nostril at a time}, whereby the effect 
of the second dose is enhanced by the priming effect of the preceding dose (Illig 
et al., 1977; Happ et al., 1978). However, similarly good results were achieved with 
single, binasal LHRH administration three times daily (Hagberg and Westphal, 
1982; Hadziselimovic et al., 1982; Borkenstein et al., 1983). Hadziselimovic (1983b) 
even surmised that LHRH treatment administered six times daily, leads to down 
regulation or exhaustion of the pituitary gland. 
In our study, a repeat course of LHRH treatment enhanced the success rate. 
This may indicate that the success of treatment depends on duration of the 
therapy, although a placebo effect in the open study cannot be excluded. In most 
studies LHRH was administered for four weeks only and the results were the same 
or even better than after our second courseof LHRH. A repeat course of LHRH 
has been called useless by some (Illig et al., 1980•), while others claimed high 
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success rates with prolonged treatment (Happ et al., 1978). 
Enhancement of the rate of success after two LHRH courses in our study may 
indicate that success of treatment depends on duration of therapy, although a 
placebo effect in the open study cannot be excluded. 
The mode of action of LHRH nasal spray treatment is unclear. Illig and co-
workers (1980b) suggested that FSH has a key function in inducing testicular 
descent, without offering an explanation for the way in which testicular descent 
takes place. Hadziselimovic surmised that the epididymis has a primary role in 
testicular descent and that high local testosterone concentrations are necessary 
to induce differentiation and outgrowth of the epididymis and thereby testicular 
descent (Hadziselimovic et al., 1980b). Our observation of statistically significant 
differences in hormonal values before and after placebo administration indicates 
that factors other than LHRH treatment may influence gonadotropic release after 
exogenous GnRH stimulation. The results of the LHRH tests before and after 
LHRH therapy gave no signs of a lasting stimulation of the hypothalamo-pituitary-
gonadal axis, although we did find some clinical and hormonal indications of 
stimulatory influences of the LHRH therapy: 
In some boys we observed an increase in testicular volume after LHRH 
therapy. This increase may be caused by stimulation of the germinal epithe-
lium as found in pigs after LHRH administration (Dijkstra et al., 1986). 
In some boys we observed a rise of LHRH and LH serum levels after intranasal 
LHRH administration. Increase of LH serum levels in prepuberal boys after 
LHRH administered intranasally was also found by others (Rajfer et al., 1986). 
However, the results of the LHRH tests before and after LHRH treatment in 
our double-blind, placebo-controlled study indicated that the LH release after 
LHRH nasal spray is of short duration and that LHRH nasal spray treatment 
does not result in a lasting stimulation of gonadotropins. 
- We observed a significant increase of HCG-stimulated serum testosterone 
values after LHRH treatment compared to pretreatment results. These find-
ings support the testicular biopsy findings of Hadziselimovic et al. (1979), 
consisting of an increase in size, number and differentiation of Leydig cells 
and Leydig cell precursors after LHRH treatment. Animal studies have shown 
that in rats, LHRH may directly stimulate the activity of gonadal cells, while 
evidence is still lacking for a direct stimulation of human gonadal cells by 
LHRH (For review, see Rommerts and Themmen, 1986). 
We found some clinical and hormonal indications of stimulatory influences of 
LHRH intranasal therapy, although we wonder whether these findings really 
explain the mode of action of LHRH nasal spray therapy. 
Karpe and coworkers (1983) suggested that the descent occurring during LHRH 
treatment was the result of decreased retractility of the cremaster muscle. Our 
retrospective evaluation of previous testicular position indicated that a relatively 
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larger number of testes that descended with LHRH treatment had at one point 
occupied a scrotal position than of testes that failed to descend. Apart from that, 
the parents of some boys with unilaterally undescended testes mentioned several 
times that during LHRH therapy the contralateral descended, albeit retractile 
testis was more frequently intrascrotal. These findings suggest that LHRH therapy 
may have some effect on the cremaster muscle. It remains to be seen whether 
LHRH, LHRH-mediated LH and FSH, or testosterone influence this process. In 
order to gain more insight, we have initiated a study in humans and pigs to 
evaluate whether the cremaster muscle contains binding sites or receptors for 
androgens, LH and FSH or LHRH. The preliminary results reveal binding sites for 
LH in the cremaster muscle of humans and pigs. If the assumption of decreased 
cremaster retractility as a result of LHRH treatment is true, this might also explain 
the return of the testes to the former undescended position (relapse), frequently 
observed after cessation of LHRH therapy and the positive reaction to a repeat 
course of LHRH. Nevertheless, placebo descent, which occurs in virtually all 
double-blind studies, illustrates that factors other than hormonal therapy may 
influence the relaxation of the cremaster muscle. 
We support Karpe's premise that the mode of action of LHRH therapy might be 
explained by a decrease in retractility of the cremaster muscle. 
Our results did not indicate hormonal anomalies in cryptorchid boys. The only 
hormonal abnormality we could find was the relatively higher stimulated FSH 
levels after the first year of life in some boys with bilateral cryptorchidism. 
Hormonal evaluation did not provide a prognostic aid regarding success of 
hormonal therapy. 
Our hormonal evaluation during and after the first year of life did not support the 
assumption that a deficiency of the hypothalamo-pituitary-gonadal axis is 
responsible for cryptorchidism, contra-indicating that LHRH treatment might 
stimulate such a deficient axis. 
The hormonal data did not provide a prognostic aid regarding success of hormon-
al therapy. 
Having compared the results of our study of LHRH treatment for undescended 
testes with literature data, we conclude that there is no evidence that age at 
treatment, laterality of the undescended testes, or frequency of LHRH adminis-
tration, influence the success of LHRH therapy. 
We consider LHRH spray treatment useless for undescended testes that are not 
palpable. Complete descent may be achieved in some cases when the undescend-
ed testis can be manipulated to the scrotal entrance. It is feasible that a number of 
testes that descend with LHRH treatment, would have descended spontaneously 
at puberty. 
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CHAPTERS. 
SURGICAl ASPECTS OF CRYPTORCHIDISM 
5.1. FAILURE OF TESTICULAR DESCENT 
5.1.1. Aetiology of cryptorchidism 
Our knowledge of the normal mechanism of testicular descent being incom-
plete subject to many contradictory theories, it is not surprising that our compre-
hension of the pathogenesis of cryptorchidism is also limited. According to 
Backhouse (1981) failure of testicular descent is likely to stem from one of two 
major causes, (1) a failure of the hormonal environment or (2) mechanical failure. 
Hormonal failure is usually believed to produce a state of incomplete descent, 
while mechanical failure leads to an ectopic testis position. 
5.1.2. Hormonal failure 
Cryptorchidism is frequently found in patients with abnormalities of the 
hypothalamo-pituitary gonadal axis. For example, Kallmann's syndrome, which 
is secondary to deficient LHRH secretion, and anencephaly, are both associated 
with cryptorchidism. lntratesticular steroid enzymatic defects, causing disorders 
of testosterone production, are likewise associated with a high incidence of 
cryptorchidism (Kogan, 1985; Farrer et aL, 1985). Farrer and coworkers identified 
a definite defect in androgen biosynthesis in the cryptorchid testis in mice, 
·resulting in a diminution in the intratesticular testosterone contents. They sur-
mised that cryptorchidism exerts a deleterious effect on the ability of the Leydig 
cell to synthesize testosterone, which might explain to a certain extent the abnor-
mal morphology and resultant infertility seen in boys with cryptorchidism. In dis-
orders of androgen utilization such as 5 a-reductase deficiency and androgen 
insensitivity syndrome, cryptorchidism is very common (Rajfer and Walsh, 1977). 
The finding of atrophic Leydig cells in cryptorchid newborns (Hadziselimovic and 
Herzog, 1976) points to a gonadotropin deficiency as the cause of cryptorchidism. 
According to Job and coworkers (1974b), cryptorchid boys suffer from an LH 
deficiency which lasts till puberty, after which the condition becomes rectified 
(Canlorbe, 1974). In Leydig cells of young cryptorchid boys, secretion of testoster-
one is impaired (Gendre! et aL,'1978). The premise that the LH deficiency causes 
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cryptorchidism due to a low testosterone level, led to treatment with gonado-
tropins (see chapter 4). 
It is generally believed that Mullerian Inhibiting Substance (MIS) is considered 
to stimulate testicular descent, at least its initial stage (Donahoe et al., 1977; 
Hutson, 1985; Hutson and Donahoe, 1986). In the rare persistent Mullerian duct 
syndrome (Josso et al., 1983; Beheshti et al., 1984; V~n Lanschot et al., 1985) 
phenotypic males have a uterus, fallopian tubes and cryptorchidism. In these 
cases the testes occupy the position of normal ovaries, which is consistent with 
the hypothesis that a deficiency of MIS prevents transabdominal descent (Hut-
son, 1985). Mininberg and Bingo! (1973) found chromosomal abnormalities in 
cryptorchid testes in boys with normal karyotypes, which according to them had 
caused the failure to descend, because these chromosomal abnormalities inhibit-
ed a normal hormonal and histological testicular development. Their findings 
were not confirmed by other authors (Dewald et al., 1977). 
5.1.3. Mechanical failure 
John Hunter (1762) drew attention to the descent of the testis during late 
intra-uterine life and he described the gubernaculum as a fibromuscular cord 
connecting the testis to the scrotum. The discovery of this gubernaculum led to 
considerable controversy concerning its role in the descent of the testis. Lock-
wood (1888) described five so-called gubernacular tails terminating in the scro-
tum, at the pubic bone, in the perineum, in the femoral, and in the superficial 
inguinal area. Sometimes these nonscrotal gubernacular tails were strongly devel-
oped, pulling the testis out of the scrotum into an ectopic position. Lockwood's 
theory was questioned by Sonneland (1925), who was unable to find any embry-
ologic or anatomic evidence for the existence of gubernacular tails. McGregor 
(1929) was also unable to demonstrate such a subdivision of the gubernaculum 
and suggested that an ectopic testicular position was due to other anatomic 
abnormalities. He described an orifice in the inguinal region which he called "the 
third inguinal ring". This ring is distal to the external inguinal ring of the inguinal 
canal and serves as the entrance to the scrotum. If it is absent or underdeveloped, 
because of an abnormal subcutaneous fascia (Scarpa's fascia), the gubernaculum 
which guides the testis in its descent fails to make further progress and becomes 
adherent to the surrounding fasciae and pubic bone, whereby the testis remains 
only partially descended. Charny and Wolgin (1957) stated that McGregor's 
theory appears acceptable for those cryptorchid testes which have passed 
beyond the external inguinal ring but which have either stopped short of the 
scrotum or have been directed into other directions. However, the theory does 
not take into account those testes which are located intra-abdominally or high in 
the inguinal canal. Browne (1938) followed by Scorer and Farrington (1971), 
mentioned a fascial barrier at the scrotal entrance obstructing further descent, 
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which was the factor responsible for the testis assuming a pubic or superficial 
inguinal, ectopic position. 
The present concept of the structure and mode of action of the gubernaculum 
described by Backhouse (1965, 1981) is that of an undifferentiated mesenchymal 
band which paves the way for the testis and guides it to its position. He described 
fibrous encroachment on the gubernaculum which may similarly divert it, partly 
causing an ectopic testis position. To quote Backhouse: 
"In the developing state, the gubernaculum must remain as an undifferenti-
ated mesenchymatous mass into which the processus vagina/is and the cremaster 
muscle can grow and differentiate. It is important that as the body wall and scrotal 
fasciae differentiate in the fetus, the fibrous tissue and abdominal muscles not 
encroach on the gubernaculum. Encroachment of the developing fibrous tissue 
into the gubernacular mesenchyma will effectively prevent the downward 
growth of the processus vagina/is and the cremaster muscle at that site (figure 
5.1.). In the remaining part of the gubernaculum, without invasion, their growth 
will occur normally. Although we have not found such invasion in human fetuses, 
we have observed it in pigs. Because the pig is remarkably like man with respect 
to the overall pattern of the process, it appears reasonable to assume that the 
mechanism also is similar. It is easy to recognize that the pattern observed in the 
pig fetus leads to the morphological pattern of the human ectopic testis, which is 
comparable morphologically to the essential anatomy of a pig ectopic testis. 
A B 
c D E 
Figure 5.1. Schematic presentation of normal cremasteric muscle and processus vaginalis growth 
(A, B) and how this can be limited by fibrous invasion of the gubernacular mesenchyme 
to produce an ectopic testis (C, D and E) (Backhouse, 1982; with permission). 
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A small invasion of fibrous tissue at one site will set up the fibrous band shown by 
Lockwood to form the necessary anchor for one or another of the peripheral sites 
of ectopia. These peripheral sites also provide the attachments of normal fascia. 
As the normal cremaster and processus vagina/is develop elsewhere in the 
gubernaculum (and with other changes such as normal swelling), the normal 
descent process is limited only by the fibrous band and the deficient processus 
vagina/is at that point. Thus the testis is free to descend normally but only as far as 
the anchor point. Because of this and the pattern of development of the proces-
sus vagina/is, the testis will swing out of the norma/line of descent in much the 
same way as a boat tethered to the bank of a stream will be carried into the shore 
by the current. From time to time cases are seen in which there is complete 
barrier across the external ring, a continuation of the abdominal wall fascia below 
which there may be a relatively small, wrinkled, albeit empty scrotum. Such a 
condition can be explained as an extension of the small fibrous invasion of the 
ectopic testis entirely across the gubernaculum. The distal mesenchyma may still 
exist as a pocket that will allow normal scrotal development but the testis will be 
totally blocked in its descent." 
That an increase of intra-abdominal pressure might be the primary force 
causing the testis to leave the abdomen and enter the inguinal canal was men-
tioned by Gier and Marion (1969). This theory was recently revived by Mickel in 
1982. He stated that the three months delay between internal testicular descent 
and transit through the inguinal canal into the scrotum (external descent) is 
determined by the need for the abdominal wall to develop the ability to increase 
intra-abdominal pressure. This results from fetal movements, respiratory excur-
sion, and increase in intestinal volume. When the abdominal wall musculature is 
absent, as in prune-belly syndrome, or inadequate, as in bladder extrophy or 
gastroschisis, inability to increase intra-abdominal pressure may result in crypt-
orchidism. It is obvious that intra-abdominal pressure is one of the factors, but 
certainly not the main factor in testicular descent. 
In summary 
Many theories have been proposed to explain failure of testicular descent, all 
of which have some merit, but no single one covers every aspect. Failure of 
testicular descent is likely to stem from two major causes: 
-mechanical failure- A disturbance in the outgrowth of the gubernaculum and 
processus vaginalis are the main causes for the occurrence of an abnormal 
testicular position. Apart from that, an abnormal course of Scarpa's fascia may 
obstruct the path of testicular descent into the scrotum. Another mechanical 
factor that may inhibit normal testicular descent is the absence of intra-
abdominal pressure. 
- hormonal failure - Failure in secretion or action of gonadotropin, androgen, 
AMH, or another gonadal factor may play a part in the disturbance of testicular 
descent. It is not yet clear which hormones, nor at what time these play a part. 
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Consequently, hormonal failure as a cause for incomplete testicular descent 
raises many questions that remain unanswered. · 
5.2. HISTOPATHOLOGY OF THE UNDESCENDED TESTIS 
5.2.1. Aetiology of histopathological anomalies in cryptorchid testes 
In the eighteenth century John Hunter wrote: "When one or both testes 
remain throughout life in the belly, they are exceedingly imperfect and probably 
incapable of performing their natural function". Two centuries later Bland-
Sutton (1923) stated that, in his experience: "The imperfections of the cryptorchid 
testis are the cause, not the consequence of its failure to reach its goal in the 
scrotum. Surgical efforts to preserve a retained or partially descended testis may 
be described as supererogation". Not every surgeon today would be so out-
spoken, but many have a suspicion that there is considerable truth in these words. 
It remains uncertain to what degree hormonal or mechanical defects are 
responsible for the situation in which an otherwise normal boy has one or two 
testes which failed to descend. likewise, there is no consensus concerning the 
observed histologic features, which may be partly or entirely based on a congeni-
tal deficiency (Sohval, 1954; Charny and Wolgin, 1957) or, alternatively, to a 
derangement of normal structures produced by a higher temperature in the 
abnormal location (Mengel et al., 1974; Hadziselimovic et al., 1975; Hedinger, 
1979). A number of investigators (Moore and Quick, 1924; Harrenstein, 1928; 
Badenoch, 1945) have demonstrated that the temperature in the scrotum is some 
degrees lower than in the inguinal canal or in the abdominal cavity. Cooling 
experiments of abdominal testes in adult, naturally cryptorchid pigs indicate that 
spermatogenic arrest in abdominal testes is not due to an inborn defect, but is 
caused solely by maintenance of the testis at abdominal temperature (Franken-
huis et al., 1979). Hence the hypothesis that a nonscrotal position would in due 
course result in degenerative anomalies of the germinal epithelium because of 
the higher temperature. In other words, these degenerative anomalies would 
occur in primarily normal testes which had failed to descend sufficiently. 
5.2.2. Histopathology of unilateral and bilateral cryptorchidism 
Various histological studies, with divergent outcome, have been carried out to 
establish basic anomalies that would render the cryptorchid testis less capable of 
spermatogenesis. Cooper (1929) correlates the degenerative changes in crypt-
orchid testes with the age of the boy and with the degree of incomplete descent. 
Her first observation was that the younger the age at which the cryptorchid testis 
was examined histologically, the closer the appearance approximated normality. 
The second observation she made was that the further the testis had descended 
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the more closely it corresponded histologically to the scrotal testis of boys of the 
same age. Comparing biopsies taken of both the retained cmd the contralateral, 
normally descended testis, Nelson (1951) noted that in terms ofthe mean diame-
ters of the seminiferous tubules, the retained testis keeps pace with its normally 
descended mate up till age 6 or 7, thereafter showing retardation of develop-
ment. Robinson and Engle (1954) came to a similar conclusion, setting the age 
limitatS rather than 6 or?. With increasing age he noted a lag in tubular growth, 
reduction in the number of spermatogonia and thickening of the peritubular 
connective tissue. Charny and Wolgin (1957) reported a form of testicular dysge-
nesis in about 20 per cent of the retained testes which they examined. Of the 
remainder, no sustained difference was observed between the scrotal and the 
retained testes up to the tenth year, the spermatogonia and Sertoli cells being 
similar in number in both groups. Progressive degeneration of retained testicular 
tissue, beginning at age S-6, was mentioned by Hecker and Hienz (1967) and 
Numanoglu et al. (1969). The premise that the cryptorchid testis would remain 
stable to at least the fifth year of life was re-evaluated in the light of new 
histological data reported since 1972. 
By examination of testicular weight, diameter of seminiferous tubules and 
spermatogonia count, Stadtler and Hartman (1972) showed that gonads of pre-
puberal boys have ali near pattern of development. This was contrary to previous 
beliefs. Hadziselimovic (1981) described similar findings and noted that the 
seminiferous tubular diameter increased continuously up till puberty, when 
there is a sudden increase in the tubular diameter and the formation of lumina 
becomes apparent. 
As mentioned before, there used to be considerable controversy regarding the 
age at which damage to a cryptorchid testis begins. It is now apparent that 
damaging influences causing morphologic changes in the cryptorchid testis 
begin at the end of the second year. Hosli, 1971; Mengel et al., 1974; Hedinger, 
1979 believed that the spermatogonia count in seminiferous tubules (apart from 
tubular maturation and tubular diameter) is the crucial parameter when assessing 
the impairment of function of the cryptorchid testis. In their experience, the 
method of Mancini et al. (1964) which relies on the germ cell count of 50 
transverse sections of seminiferous tubules proved to be very useful. Based on 
spermatogonia count as well as on qualitative examination ofthe ultrastructure of 
interstitial tissue, Mengel et al. (1974) reported several significant features. They 
carried out a histologic investigation of biopsy specimens of 515 retained and 237 
unilaterally descended testes. Determination of spermatogonia content and 
tubular diameter showed that during the first and second year of life no morpho-
logic changes occurred in the retained testes. After the second year, however, the 
spermatogonia count decreased significantly. Hedinger (1982) evaluated 619 
unilaterally or bilaterally undescended testes of 450 boys, from several months to 
ten years old. His controls were normal testes of children with sudden death or 
children who had died accidentally. The mean spermatogonia count during the 
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first year of life was equal to that found in normally descended testes. A differ-
ence in spermatogonia count between descended and undescended testes was 
observed during the second and third year of life, stabilizing after the third year 
with the mean spermatogonia value of the cryptorchid testes remaining 
significantly lower than normal until puberty (figure 5.2.). In the same study, the 
mean values of spermatogonia were nearly identical for unilateral and bilateral 
cryptorchidism (figure 5.3.). Early, ultrastructural, morphologic changes in cryp-
torchid testes have been demonstrated in the second year of life (Hadziselimovic 
et al., 1975) and even in the first year (Mininberg et al., 1982). It remains unclear 
whether the underlying mechanism is a primary diminution of spermatogonia, 
accompanied by either atrophy of the seminiferous tubules with a secondary 
thickening and fibrosis, or atrophy of the germinal epithelium due to diminished 
vascularization caused by primary expansion of the connective tissue (Mengel et 
al., 1981). 
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Figure 5.2. Number of spermatogonia per 50 transverse sections of seminiferous tubules in all 
cryptorchid testes and in normal controls, mean values per age group (Hedinger, 1982; 
with permission). 
209 
SPERM ./50 TUB, 
180 
170 
160 
150 
140 
130 
120 
110 
100 
90 
80 
70 
60 
so 
40 
30 
20 
10 
21 16 
··•······· 
10 
bilateral biopsies: 
-- cryptorchid testis 
·-··· scrotal 
testis 
/'\.1 
·-.. t ... ···· 
·········· ....... ···•·····••·· •···•······ ... . 
I 
T 
j 
I 
1 
r J-~1r-T I 
10 11 YEARS 
16 11 10 11 13 n CASES 
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and scrotal testes (Hedinger, 1982; with permission). 
5.2.3. Histopathology of the undescended testis as compared with the contra-
lateral, descended testis 
It is of considerable clinical interest that not only the cryptorchid testis but also 
the contralateral, descended testis shows morphologic changes during the early 
years of childhood. The morphologic changes in the descended testis in boys 
with unilateral cryptorchidism have been reviewed by several authors since 
biopsies have been routinely done on both testes. Mack et al. (1961), Hecker and 
Hienz (1967), Bay et al. (1968), Mengel et al. (1974), Nistal et al. (1980), Schindler 
(1982) and Yunis etal. (1984) found damage in the germinal epithelium of the de-
scended testes in 25-60% of their patients with unilateral cryptorchidism. The 
marked divergence in outcome of the various studies shoud be interpreted in the 
light ofthe divergence in investigative criteria and not taken at face value. In 1985, 
Kirby and coworkers proposed the premise of damage to the contralateral 
descended testis. They performed bilateral testicular biopsies on 66 boys with 
unilateral cryptorchidism and determined the tubular fertility index (TFI = 
number of tubules containing spermatogonia counted and expressed as a value 
per 100 tubules for each testis). The results were compared with those previously 
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reported for a group of boys with normally descended testes (Farrington, 1969). 
Kirby's group found no significant differences comparing the germ cell activity of 
the scrotal testes in unilateral cryptorchidism with that of controls. In contrast, the 
mean TFI of the cryptorchid testes was significantly lower than that of control 
patients of all ages. In neither group was there evidence of a progressive loss of 
germ cell activity during childhood. 
5.2.4. Histopathology of the undescended testis in relation to its position 
As mentioned before, nonscrotal testes fall into three categories, (1) retractile 
testes, (2) incompletely descended testes, and (3) ectopic testes. This classification 
is not only based on the spontaneous location of the testis, but also on the 
testicular lesions involved. Mack et aL (1961) regarded the presence of germ cells 
in the seminiferous tubules as evidence of potential spermatogenesis in their 
series of testicular biopsies. In the normal testis, germ cells are usually found in 80 
to 100% of the tubules. They assessed the number of tubules containing germ 
cells in 20 ectopic testes and 12 incompletely descended testes. Defective germ 
cells were frequent in both types, but much more so in the incompletely de-
scended testes. The defect is present before puberty and they found no evidence 
of an increase with age. 
Dougall et aL (1974) examined 107 testicular biopsies of boys with either 
unilateral or bilateral cryptorchidism. No spermatogonia were found in 6 of the 
10 abdominal testes (60%), 9 of the 27 testes lying in the inguinal canal (33%), or 3 
of the 69 testes lying in a superficial inguinal, ectopic position (4%). 
In addition, the investigations of Farrington (1969), Scorer and Farrington (1971) 
and Nistal et aL (1985) have shown that, despite a deficiency of germinal cells in all 
cryptorchid testes, the prognosis appears best for the boy whose testes have 
progressed furthest along the path of descent as the germinal cell content is 
dependent upon the position of arrest. 
5.2.5. Testicular histology after orchiopexy 
Little is known about the evolution of testicular lesions in cryptorchid testes 
after orchiopexy. Histological proof of further differentiation of germ cells in 
testes brought down surgically, was obtained in seven clinical cases reported by 
Hecker and Hienz in 1967. In 1969 Kiesewetter and coworkers studied 29 boys 
with bilateral undescended testes to determine what effect scrotal placement had 
on the structure of the testis. Fifteen of 29 repeat biopsies (52%) after orchiopexy 
showed moderate or marked improvement when compared to the original 
biopsy. An additional 34% showed slight improvement, while in only 14% the 
second biopsy showed no change. Compared to the unoperated fellow, only 7 of 
23 repeat biopsies (30%) after orchiopexy showed moderate or marked improve-
ment, 39% showed slight improvement and 31% were unchanged. Unfortunately, 
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the criteria for improvement in Kiesewetter's study are not clearcut. In their own 
words, it was not always possible to quantitate exactly the improvement in the 
second biopsy. In this study "it was not possible to draw conclusions concerning 
the influence that the time between biopsies had or ultimate histologic im-
provement." 
Diagnostic biopsies were taken by Kleinteich and Schickedanz (1977) from 74 
unilateral and 78 bilateral cryptorchid testes surgically corrected two to ten years 
previously, as well as from 74 contralateral, descended testes. They concluded 
that in the surgically treated testes, the amount of extratubular connective tissue 
was greater than in the contralateral, descended testes, while a morphological 
improvement of the germinal epithelium had occurred in comparison with 
untreated, undescended testes of boys of the same age. In contrast, Francavilla 
and coworkers (1979) concluded from their study that neither spontaneous nor 
induced descent of the testis before puberty, seems to modify the development 
of the lesions which are already present in the seminiferous tubules. 
Another important study was published by Nistal and coworkers in 1980. They 
studied a second biopsy of testes from boys whose ages ranged between 11 and 20 
years, who had undergone orchiopexies with biopsies during previous years. 
Comparing the first and second histologic pattern, they found that 3 out of 5 high 
scrotal testes showing marked germinal hypoplasia in the first biopsy specimen 
revealed incomplete arrest of maturation at the level of the first spermatocyte 
stage in the second specimen, while the remaining two showed severe hypo-
spermatogenesis in the second specimen. Of 16 testes initially located in the 
inguinal canal, seven showed severe germinal hypoplasia in the first biopsy 
specimen, while the second specimen revealed only Sertoli cells. Eight testes with 
marked germinal hypoplasia later showed seminiferous tubules with only Sertoli 
cells or isolated spermatogonia and spermatocytes. One testis with Sertoli cell 
hypoplasia showed only mature Sertoli cells in the second biopsy specimen. They 
also took second biopsies from another series of six testes, initially located 
intra-abdominally. One of these testes, presenting with severe germinal hypo-
plasia in the first biopsy specimen, showed only Sertoli cells and severe thickening 
of the basement membrane in the second one. In the other five, initially diagnos-
ed as Sertoli cell hypoplasia, the second biopsy specimens all revealed that most 
of the seminiferous tubules contained only immature Sertoli cells. All second 
biopsy specimens in these testes showed variable thickening of the basement 
membrane. The final conclusion of this study was that testes do not show spec-
tacular increases in germinal cell numberfollowing orchiopexy. More or less the 
same conclusions were drawn by Schindler and coworkers (1982). With repetitive 
biopsies in 12 patients they clearly showed that maturation does progress after 
orchiopexy, but without improvement of cellularity. 
In summary 
Undescended testes are histologically abnormal. This histological abnormality 
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may be due to both a hormonal and a mechanical disturbance caused by the 
nonscrotal postion of the testis (temperature influence). Based on microscopical 
as well as qualitative examination of the ultrastructure of undescended and 
descended testes, the following features are reported: 
- In comparison with a normally descended testis, the undescended testis 
shows a normal development until approximately the second year of life. 
- The same histological anomalies that are found in the undescended testis are 
found in 25-60% of normally descended testes. 
- Although there is a deficiency of germinal cells in all undescended testes after 
the first year of life, the prognosis appears best for the boys whose testes have 
progressed furthest along the path of descent, as germinal cell content is 
dependent on the position of arrest. 
- After complete descent achieved with orchiopexy, the previously unde-
scended testis does not show improvement of germinal cells. 
5.3. CLINICAL IMPLICATIONS OF CRYPTORCHIDISM 
5.3.1. The nonscrotal testis and fertility 
It has been known for a long time that there is a definite relationship between 
cryptorchidism and infertility. Therefore it is hardly surprising that most authors 
have focussed their attention on this aspect. In most studies the aspect of fertility 
is referred to as "fertility percentage", indicating the percentage of men out of 
the study population with a sperm density (or sperm count) over 20 x 106 sperma-
tozoa/ml, which has generally been accepted as the lower limit of normal values 
(Freund, 1966; Scorer and Farrington, 1971). 
Fertility of untreated cryptorchids 
Few studies have appeared in the literature that include fertility rates for men 
with unilateral or bilateral undescended testes that were left untreated. The rare 
publications that do deal with this entity clearly show that if bilateral cryptor-
chidism is left untreated, this always leads to infertility (Mack, 1963; Scott, 1962; 
Schirren, 1966). Lipshultz (1976) studied 212 men with unilateral undescended 
testes that were never operated upon, and found that 142 (64%) of them were 
infertile. 
Fertility of cryptorchids after hormonal and surgical treatment 
Numerous studies have been published analyzing the incidence of infertility in 
cryptorchid boys after hormonal or surgical treatment. Cywes and coworkers 
(1981), Kogan (1983), as well as Gilhooly and coworkers (1984) compiled fertility 
data from the literature, concerning altogether 958 bilateral and 1273 unilateral 
cryptorchids, who had been treated in the prepuberal period. Only 28-40% of the 
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subjects with initially bilateral undescended testes appeared to be fertile, butthis 
percentage was considerably higher (51-70%) for the men with initially unilateral 
undescended testis. 
Very recently, Chilvers and coworkers (1986) published the results of an exten-
sive review of the literature concerning the long-term effect of cryptorchidism on 
fertility. Twenty-seven papers that considered adult fertility in terms of sperm 
density following treatment for undescended testes were identified. Here again, 
it appeared that the fertility percentage after successfully treated, unilateral 
undescended testes (343 out of 600 or 57%) was considerably higher than that for 
bilateral cryptorchidism (82 out of 331 or 25%). The relatively higher fertility rate 
for treated, unilateral undescended testes still falls far short of the often-quoted 
figure of 90% fertility common among couples, for half of which the male partner 
may be a primary or contributing cause (WHO Statistics, 1969). 
Evaluation of the results cited in the numerous retrospective studies is difficult 
because here again there is considerable diversity. According to Kogan (1983) and 
Chi Ivers et al. (1986) the most important factors complicating direct comparison 
are: 
- Composition of study population 
For some studies the patient source is not mentioned, or the series may include 
patients from infertility clinics, which obviously has a negative influence on the 
results. In most studies, the men providing semen specimens represented only a 
small fraction of the case series originally presenting with cryptorchidism and it is 
more than likely that they comprise a self-selected group whose characteristics 
vary. 
- Definition of fertility and methods of fertility evaluation 
Interpretation of data on fertility in published series of cryptorchid patients 
requires a common definition of fertility. Most studies use the accepted defini-
tion of more than 20 x 106 spermatozoa/ml by semen analysis. However, there is a 
further source of diversity in the various methods of semen collection and 
analysis (documentation of motility and morphology is seldom mentioned), 
duration of abstinence, number of semen specimens examined, and repetition of 
low sperm count. In some studies, fertility has been determined on the basis of 
paternity, but paternity tells very little about semen quality other than negating 
azoospermia (Bramble et al., 1974; Lipshultz, 1976). Apart from that, the paternity 
percentage of a study population may be influenced adversely by a number of 
men that either did not marry or may not (yet) have wanted children (Gilhooly 
et al., 1984). On the other hand, semen analysis alone does not provide a clear-cut 
distinction between fertility and sterility, while a number of so-called subfertile 
men may become fathers. 
- Hormonal versus surgical treatment 
Studies that include successful and unsuccessful hormonal treatment (HCG) 
seem to indicate that, at least in bilateral cryptorchidism, those testes that de-
scend with HCG treatment are more fertile than those that do not (Aibescu et al., 
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1979b). For most series of boys successfully treated with HCG, subsequent semen 
analysis shows fertility to surpass that of surgically treated patients. It would 
appear then, that the method of treatment influences fertility results, while 
inclusion of varying numbers of patients that were either sucessfully or unsucess-
fully treated with hormones affects analysis of fertility results (Kogan, 1983). In this 
respect one should bear in mind that the testes that seemed to descend as a result 
of hormonal treatment may in actual fact have been retractile and therefore 
normal testes with potentially normal fertility, while the testes that did not 
respond to hormonal treatment were on the whole truly cryptorchid and more 
likely to be associated with abnormal anatomical structures. Regarding surgical 
treatment, very few authors mention the occurrence of testicular atrophy after 
orchiopexy in connection with fertility results. From the literature it appears that 
the incidence of postoperative testicular atrophy varies from 2 tot 40% (Charny 
and Wolgin, 1957; Gross and Replogle, 1963; Fahlstrom, 1963). A high percentage 
of testicular atrophy will obviously have a negative influence on subsequent 
fertility rates. 
- Pre-operative testicular position 
Few studies cite the pre-operative testicular position and then correlate the 
results of treatment with subsequent fertility. It is a wellknown fact that high 
inguinal or intra-abdominal testes are more difficult to bring into the scrotum and 
that results in terms of fertility are worse in this group. Consequently, series that 
include either fewer or greater numbers of patients with high-lying testes, cannot 
be meaningfully compared (Kogan, 1983). Apart from that, many studies fail to 
elucidate the criteria for excluding retractile testes. Particularly concerning the 
studies with large series of bilateral cryptorchids, it is not unlikely that retractile 
testes were included. As mentioned above, retractile testes are generally normal 
in development and consequently their fertility is in no way reduced (Puri and 
Nixon, 1977). 
Age of treatment 
In almost all published studies of cryptorchidism and fertility, treatment was 
carried out between the 4th and 14th year of life, while the results are presented 
as a totality for the entire group without any division for age. The question 
whether early treatment has a favourable effect on subsequent fertility, has not 
been answered convincingly. The study of Ludwig and Potempa (1975) is fre-
quently cited in support of the premise that early treatment (orchiopexy) is 
conductive to subsequent fertility. However, their study carries no statistical 
significance as the number of patients that were under four years of age at 
operation amounted to no more than 15 out of 71 (21%). The aforementioned 
literature review of Chi Ivers et al. (1986) included fertility assessment in five series 
of bilateral cryptorchids whereby the age at operation was taken into account. 
They found no difference in fertility percentages related to age at treatment. In 
addition, the same group analyzed five similar studies concerning unilateral 
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cryptorchidism and found a slight (and statistically insignificant) effect of early 
treatment, which appeared to be entirely attributable to one of the five studies, 
namely the study of Ludwig and Potempa (1975). 
One study that did take all aforementioned criteria into consideration is the 
one carried out by Schoorl (1983). His patient series consisted of 285 bilateral 
cryptorchids that had all undergone surgery at 11-12 years, performed by the 
author himself in over 85% of the cases. Schoorl drew up a classification for 
fertility and subfertility based on semen quality and he also looked at paternity. 
He obtained sperm analyses for 141 of these initially bilateral cryptorchids, 
revealing fertility in only 20%, subfertility in 55% and azoospermia in 25%. In 108 
of these men the testes had been palpable in the inguinal region before opera-
tion; fertility fell below the lower limit in 84 (77.8%) of them, with azoospermia in 
18 (16.7%). The results were much poorer for the men whose testes had been 
impalpable before operation (intra-abdominal or high inguinal). Altogether 29 of 
33 (87.9%) were subfertile, with azoospermia in 17 (51.5%) of them, while the 
sperm count in the remaining 4 men (12%) just reached the lower limit (20 x 106). 
Schoorl's study would be an excellent basis for comparison with a similar retro-
spective study, involving a series of bilateral cryptorchids that had undergone 
surgery at an earlier age. Such a comparison would furnish conclusive evidence 
regarding the effect of age at treatment on subsequent fertility. 
In summary 
Drawing conclusions from published assessments of fertility after treatment for 
cryptorchidism is a precarious exercise, because comparison of results is com-
plicated by great diversity. The main areas of diversity concern patient source, 
methods of fertility evaluation, lack of specification of pre-operative conditions 
(diagnosis, position of testis, age), etc. Schoorl's retrospective study stands out 
because of a very succinct recital of most of the factors that may contribute to or 
detract from post-orchiopexy fertility. Unfortunately, very few if any studies are 
comparable. No hard evidence has been furnished for the premise that early 
treatment favourably affects subsequent fertility, although it does seem best to 
treat cryptorchidism before puberty. Failure to treat cryptorchidism almost cer-
tainly leads to infertility. 
5.3.2. The nonscrotal testis and malignancy 
It has been known for more than a hundred years that there is a link between 
the nonscrotal testis and malignancy and this has been investigated extensively by 
many authors. A review of large series of testicular tumours described in the 
literature (Campbell, 1944; Wobbes et al., 1980; Martin, 1981; Whitaker, 1981) 
revealed that 3 to 12% of these tumours occurred in undescended testes. A 
testicular tumour is a very rare occurrence; the annual incidence in the Nether-
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lands is estimated to amount to 2 to 3 of 100,000 men (Soebhag, 1982). However, 
the nonscrotal testis appears to be 10 to 48 times more prone to tumour formation 
than a normally descended testis (Gilbert and Hamilton, 1940; Martin, 1979; 
Wobbes, 1981; Welvaart and Thijssen, 1981). The tumours occurring in nonscrotal 
testes are mostly germ cell tumours, generally seminoma. Other tumours that 
may occur in the cryptorchid testis are embryonic cell carcinoma, chorio-
carcinoma and teratocarcinoma (Martin, 1979). 
It is not entirely clear what causes this increased risk of malignant degeneration 
of the nonscrotal testis. According to Fergusson (1962), testicular trauma is a major 
cause of the occurrence of a testicular tumour. According to Cromie (1983), any 
correlation between trauma and tumour lies mainly in the fact that medical 
treatment for, say a minor trauma, will reveal the existence of a testicular tumour. 
Others (Ash lay and Mostofi, 1959; Hausfeld and Schrand, 1965) feel that damage 
to the germinal epithelium as a result of a higher than scrotal temperature, is a 
major cause of malignant degeneration. Hadziselimovic and Girard (1977) sug-
gested that suppression of both the hypothalamus and hypophysis in cryptorchid 
boys during intra-uterine development, would result in incomplete develop-
ment of not just the Leydig cells, but also the germinal epithelium, which in its 
turn would eventually lead to malignant degeneration. 
Provided that a nonscrotal testis is a potential source of malignancy (third or 
fourth decade after birth), one may well wonder whether treatment of a nonscro-
tal testis makes sense. Would it not be better to carry out a preventive orchidec-
tomy? To answer that question, we first have to elucidate several aspects related 
to the link between nonscrotal testis and malignity. 
Is there a relationship between the incidence of testicular tumour and the 
location of the nonscrotal testis, be it in the abdomen or in the inguinal region? 
Campbell (1944) described a series of 2119 nonscrotal testes, 302 (14.3%) of 
which were located in the abdomen and 1807 (85.7%) in the inguinal region. A 
tumour presented in 68 of the altogether 2119 testes, but 33 (48.5%) of these 69 
tumours occurred in the initially intra-abdominal testes. This assessment seems to 
lead to the obvious conclusion that intra-abdominal testes are six times more 
prone to malignant degeneration than nonscrotal testes lying in the inguinal 
region. Cromie (1983) reached the same conclusion in his investigation. 
Does orchiopexy reduce the risk of subsequent malignant degeneration? 
No hard evidence has as yet been furnished in the literature for the assumption 
that orchiopexy would prevent the subsequent occurrence of a testicular tumour 
(Krabbe et al., 1979; Martin, 1981; Whitaker, 1981). What does happen is that 
bringing the testis into a scrotal position makes it more accessible to examination, 
enabling early diagnosis and treatment of a testicular tumour if it does occur. 
Is there a relationship between age at orchiopexy and malignant degeneration? 
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a. Would early treatment reduce the risk of malignant degeneration of the 
initially undescended testis? 
There is no definite answer to this question, although some reports do indicate 
that a testicular tumour is less likely to occur if orchiopexy has been carried out 
before the sixth year of life (Gehring et al., 1974; Martin, 1979; Pattern et al., 1985). 
b. Is there an upper age limit for orchiopexy in relation to malignant degene-
ration? 
Nonscrotal testes presenting with histologically obvious degenerative anomalies 
around puberty, will not contribute to a normal process of spermatogenesis 
(Nistal et al., 1980). This concerns mainly testes that have remained in a high 
inguinal or abdominal position until puberty and are frequently also macroscop-
ically abnormal (smaller and softer). Examining 50 male adults a number of years 
after they had undergone orchiopexy around the age of puberty, Krabbe and 
coworkers (1979) found a carcinoma in situ in the operated testis of 4 (8%) of 
them. In 2 of 35 (6%) patients that underwent surgery for unilateral undescended 
testis after the 11th year of life, Zwierstra and coworkers (1984) diagnosed 
malignancy in a macroscopically normal testis (once seminoma and once carci-
noma in situ). Both patients had undergone orchiopexy at a very late stage (at the 
age of 23 and 42 respectively) and in both cases it concerned a high-lying testis 
(intra-abdominal and high inguinal respectively). Based on the histological data 
and the relative frequency of malignant degeneration, these authors, in agree-
ment with others (Martin and Menck, 1975; Hinman, 1979), advocate orchidectomy 
for unilateral cryptorchids with a high-lying testis first presenting for treatment at 
or even after puberty. 
It is far more difficult to give guidelines for the treatment of bilateral unde-
scended testes first presenting after puberty. Bilateral orchidectomy as a preven-
tive measure against malignancy amounts to castration of the patient with all that 
entails. Consequently, there is some controversy as to the treatment of choice in 
these cases. There is no hard evidence for the assumption that orchidectomy 
coupled with hormone substitution would be preferable to bilateral orchiopexy 
(Martin, 1981). Individual factors, such as age of the patient, surgical possibilities, 
macroscopic aspect of the testes, etc. will have to indicate the treatment of choice 
(e.g. orchidectomy for one testis and orchiopexy for the other one). If orchiopexy 
is decided upon, a testicular biopsy is mandatory. 
In summary 
- Compared with a normally descended testis, the nonscrotal testis is more 
prone to subsequent malignant degeneration. 
- A testis remaining in the abdomen is more prone to malignant degeneration 
than a testis remaining in the inguinal region. 
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- There is no proof that orchiopexy would prevent malignant degeneration, 
although there are indications that testicular tumours occur less frequently in 
nonscrotal testes that are operated on at an early age. 
- Orchiopexy is rarely indicated if the testis has remained in the abdomen past 
the age of puberty; unless this condition is bilateral, orchidectomy is the 
treatment of choice. 
5.3.3. Psychosexual aspects of cryptorchidism 
Psychosexual development is undoubtedly a consequence of many influences, 
including biologic factors such as hormones; situational and social factors (rea-
ring as well as imitation and identification); cognitive maturation with genital 
awareness and concepts of self-image; and probably more subtle innate drives as 
well. Gender identity, or self-concept of being male or female, is well established 
by the age of two to three years (Money et al., 1955; Dewurst, 1975; Ladee-Levy, 
1986). Psychiatric studies have revealed that at or even before three years of age, a 
cryptorchid boy may become aware of the fact that his genitalia appear different 
from those of his friends. This awareness is not considered significant until the 
cryptorchid boy is exposed to peer scrutiny taking a shower in an environment 
such as the school locker room. An empty scrotum may be a source of consider-
able anxiety and embarrassment, often causing feelings of physical inferiority and 
concern about virility (Gross and Replogle, 1963; Smith and Lattimer, 1975). 
Psychological consequences of having undescended testes 
Reported psychotherapy of boys whose lack of testicular descent has contrib-
uted to a disturbance of their psychological development, often reveals that in 
the eyes of these boys their genitalia constitute one whole entity. At play and 
fantasizing, they reveal their feeling of having a defective penis in every possible 
way (Bloss, 1960; Schiffman, 1978). Evaluation of cryptorchid boys that did not end 
up at the psychiatrist or psychologist, revealed that many of them thought of their 
body as being damaged (Bloss, 1960; Druss, 1978). The figures that these boys 
drew were often equipped with long rifles, or they had long noses, or there were 
other phallic symbols executed in great detail (Cytren et al., 1967). These boys 
often suffer from irrational anxiety, while the realisation of their parents fear 
concerning their masculinity adds to their feelings of inferiority. They often 
attempt to keep their abnormal genitalia a secret from their peers, which may 
cause problems at sports events or other group activities involving the locker 
room (Meyer-Bahlburg et al., 1974; Smith and Lattimer, 1975; Ladee-Levy, 1986). 
This is probably due to a sense of shame. It is significant that in Dutch the genitals 
are commonly referred to as "shame parts". 
In general, these boys do not present with real psychological problems unless 
there are other contributive factors, such as mental instability; family stress; 
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parents that doubt their son's ability to function as a man when he grows up; etc. 
(Finemann, 1959). The longer the boy has to live with one or two undescended 
testes, the bigger the risk of psychological problems (Finemann, 1959; Bloss, 1969; 
Manley, 1982). If psychological problems do occur, these are generally not 
related to specifically sexual areas, but affect other aspects of the boy's persona-
lity instead, consisting of learning problems; behavioural disturbance; anxiety; 
gender identity crises; etc. (Bloss, 1960; Ladee-Levy, 1986). Successful surgical 
correction of the undescended testes results in a rapid recovery of the psycholog-
ical disturbance. 
Optimal timing of orchiopexy 
In determining the optimal time for surgery, one must consider the child's 
general reaction to hospitalization as well as the specific reaction to an operation 
of the genitalia. According to Manley (1982), there are several basic influences 
that must be considered, such as a) separation anxiety, and b) the hospital 
experience. 
re a) separation anxiety: 
Separation anxiety affects children of various ages (Kelalis et al., 1975; Manley, 
1982). From birth to age six months there should be little concern about brief 
episodes of separation, but from the age of six months, the infant begins to be 
aware of and increasingly upset by separation from the mother. From age one to 
three years, separation from the mother is traumatic, particularly during the early 
phase of the episode. From three to six years of age, separation from the mother is 
more tolerable because with increasing age, the child is increasingly able to 
comprehend the necessity and nature of the operation. 
reb) the hospital experience: 
Much has been done to humanize children's hospitals in recent years. One 
aspect that can be influenced to a great extent by the physician is the preparation 
of the child for the hospital procedure for surgical patients. Above all, a realistic 
and honest explanation of what the child and his parents should expect will go a 
long way towards preventing any postoperative psychological disturbance. Allow-
ing the parents to be with the child right up till the operation and immediately 
afterwards is important in this respect. Other benefits relate to a shorter stay in 
hospital or day-care surgery (Manley, 1982). 
In summary 
Having undescended testes may be associated with a sense of anxiety and 
shame. In general, an obvious psychological disturbance requiring proper care 
generally does not occur unless there are other contributive factors related to the 
child's personality or parent-child relationship. The psychological disturbance 
which then occurs mainly affects behavioural aspects of personality rather than 
sexual ones. 
From a psychological or psychiatric point of view there is no optimal age at 
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which a child is most able to cope with the operation, because every age is beset 
by its own specific fears. Separation anxiety reaches a peak in the age period 6 
months to 3 years and consequently, if orchiopexy has to be performed during 
that period (as indicated by the correct diagnosis), rooming-in or day-care sur-
gery will do much to forestall problems connected with an operation in the first 
years of life. An operation at that age has the advantage that the child never 
reaches the point of comparison with other boys so that he will not have to go 
through the agony of feeling different. 
5.4. ANATOMICAl ASPECTS OF CRYPTORCHIDISM 
A disturbance of testicular descent is usually associated with a severe distur-
bance of the anatomical proportions. The location of the undescended testis 
appears to be directly related to any anatomical anomalies of the testis itself and 
particularly to any anomalies of the surrounding structures. Consequently, the 
anatomical anomalies often associated with a disturbance of testicular descent, 
should be discussed in relation to the position of the testis (incompletely de-
scended or ectopic). 
5.4.1. Anatomy of the undescended tesis 
a. The testis 
In prepuberal boys the volume of the normally descended testis varies from 
approximately 1-3 ml (Zachman et al., 1974; Cassorla et al., 1981; Takihara et al., 
1983). The volume of the incompletely descended testis is usually small compared 
with the contralateral, descended testis or, in case of bilateral cryptorchidism, in 
comparison with the testicular volume of descended testes of boys of the same 
age (Scorer and Farrington, 1971; lipshultz, 1976). These differences in volume 
increase with age. In case of unilateral absence of testis, or severe underdevel-
opment of testis, compensatory hypertrophy of the contra lateral, descended 
testis may occur. Compensatory testicular hypertrophy can be defined as a 
progressive testicular enlargement beyond the normal size for age (laron and 
Zilka, 1969; Tato et al., 1979; Laron et al., 1979). 
b. Testicular absence 
Sometimes inguinal exploration for incompletely descended testes will reveal a 
vas deferens with testicular vessels only, ending in a tissue remnant, which 
appears to consist of epididymal tissue. This finding has been reported unilate-
rally as well as bilaterally and has been described as "the vanishing testis syn-
drome" (Abeyaratne, 1969). The fetal testis is of primary importance in the 
development of the Wolffian duct (male) and the degeneration of the Mullerian 
duct (female). In the absence of the testis, the female system will develop and the 
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Wolffian ducts will degenerate. A female system will even develop ifthe testes are 
initially present but disappear early in fetal life. If the testes disappear after a 
critical gestational phase (about 16 developmental weeks), a male system will 
persist. Consequently, in case of a phenotypic and genotypic male with proved 
bilateral anorchidism, we must assume that testes were present through 16 weeks 
of embryologic development but have subsequently vanished. 
Why the fetal testis subsequently "vanishes" is obscure in most cases. Intra-
uterine torsion, infarction, infection or impairment of vascular supply during 
testicular descent have all been proposed as mechanisms (Abeyaratne, 1969; Tosi 
and Morin, 1976; Honore, 1978). In these cases indentifying the testicular vessels 
is of the utmost importance; if these vessels accompany the vas into the inguinal 
canal to terminate with the vas into the knob of epididymal tissue, the presence of 
a separate intra-abdominal testis can safely be excluded. If, however, exploration 
reveals a vas deferens only in the inguinal canal or retroperitoneally at the deep 
inguinal ring, then the intra-abdominal presence of a testis is feasible and cannot 
be excluded (Lythgoe, 1961; Nowak, 1972; Levitt et al., 1978; Bergdahl and 
Andersson, 1981). 
It is extremely rare for testis, epididymis, vas or testicular vessels to be totally 
absent, either unilaterally or bilaterally, in an otherwise normally developed boy. 
Such a rare finding is frequently associated with anomalies of the urinary tract 
(Bergmeyer and Meradji, 1977). As compensatory testicular hypertrophy does not 
solely occur in the absence of a contralateral testis, inguinal exploration is always 
required to trace a non palpable, albeit present testis (La ron and Zilka, 1969; La ron 
et al., 1979). 
c. Epididymis and vas deferens 
Epididymal deformities are frequently seen in association with cryptorchid 
testes and tan vary in extent from total agenesis of the epididymis (Lazarus and 
Marks, 1947) to failure of union, complete or imcomplete, between the testis and 
the epididymis (Marshall and Shermeta, 1979; Mininberg and Schlossberg, 1983; 
Heath et al., 1984). The most common deformity of the epididymis is slight or 
gross extension in relation to the testis (Scorer and Farrington, 1971). 
Occasionally, when the testis is located intra-abdominally, the epididymis dips 
down with the open processus vaginal is through the inguinal canal into the top of 
the scrotum and returns as the vas deferens into the abdomen (Moschcowitz, 
1912; Fowler and Stephens, 1959; Brendler and Wulfsohn, 1967). While the 
functional significance of epididymal deformities is uncertain, with the exception 
of complete separation between testes and epididymis, the surgical implication is 
obvious. If the possibility of an extended or loosely attached epididymis is not 
considered, the descended tissue may be injured during surgical dissection. It 
may be mistaken for the tunica vaginalis or for an atrophic testis and as such 
excised, leaving a retained testis intra-abdominally. Alternatively, the testis may 
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be considered absent and no further exploration undertaken (Dean et al., 1952; 
Lythgoe, 1961; Nowak, 1972). Figure 5.4. gives an overview ofthe more common 
types of epididymal deformities (Scorer and Farrington, 1971). 
Partial absence of either the epididymis or the vas deferens also occurs in 
association with cryptorchidism, although such anomalies are more frequently 
found in boys with a congenital rubella infection or cystic fibrosis (Priebe et al., 
1979; Kroovand and Perlmutter, 1981; Wingerden and Franz, 1984). 
1 +2 Normal epididymis 
3+4 Partial separated epididymis 
5+6 Complete separated epididymis 
7 Long loop epididymis 
Figure 5.4. Overview of the more common types of epididymal deformities. 
d. Processus vagina/is peritonei 
During the descent from their retroperitoneal points of origin, the testis, 
epididymis and spermatic cord invaginate the posterior aspect of the processus 
vaginalis, thus becoming enveloped by two layers of this structure. Following 
testicular descent, the layers of the processus vaginal is around the spermatic cord 
normally close except around the testis and epididymis, where they form the 
tunica vaginal is. These normal conditions are found when the processus vaginalis 
continues to the bottom of the scrotum, but if development is arrested before this 
has occurred, the testis will be unable to reach its normal position and only a 
partial descent of the testis results. In these partially descended testes, however, 
the processus vaginalis usually persists as a wide open sac in which the testis is 
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"floating freely" (Kroovand and Perlmutter, 1981; Heath et al., 1984). This wide 
open processus vaginal is is a precursor of an inguinal hernia or hydrocele (Curtis 
and Staggers, 1960). 
Traversing the inguinal canal, the processus vaginalis sometimes persists at the 
level of the annulus intern us to such an extent as to cause folds in the peritoneum, 
frequently resulting in adhaesions. According to Hunter (1926), the peritoneal 
folds that remain after closure oft he processus vaginal is, may well lead to the type 
of inguinal hernia that is not readily apparent (figure 5.5.). 
1. vas deferens 
2. peritoneum 
~1l~tl------ 4. processus vaginalis 
closed 
5. external annulus 
1 .. --\--,~-- 8. tunica vaginalis 
Figure 5.5. Diagram illustrating various types of hernial sacs 
a. wide open processus vaginal is 
b. closed processus vaginalis 
9. inguinal hernia 
10. processus vaginalis 
wide open 
c. excess of peritoneum in which case the funicular portion may become completely 
obliterated. 
e. The scrotum 
In case of unilaterally undescended testis, the scrotum is generally normal 
although on one side somewhat flattened compared with the other half contain-
ing a normally descended testis. An underdeveloped scrotum, poor in rugae, is 
uncommon and if it does occur this is usually associated with high-lying (inguinal 
or abdominal) testes, or with atrophic or absent testes. In these cases, there is 
usually an endocrinologic disturbance often associated with genetic or dysmor-
phic syndromes. 
5.4.2. Anatomical anomalies in relation to ectopic testes 
a. Introduction 
Considerably fewer anatomical anomalies of testes and surrounding structures 
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are found in case of ectopic testes as compared with the incompletely descended 
testes described above. The ectopic testis and epididymis are generally normal 
with the processus vaginalis generally closed. The spermatic cord, likewise, is 
generally of normal or near-normal length. In these cases any and all anomalies 
are usually related to the mechanical failure that has obstructed the path of 
descent of an otherwise normally developed and descending testis (McGregor, 
1929; Backhouse, 1982•). 
b. Anatomical anomalies in relation to truly ectopic testes 
True ectopia (perineal, peno-dorsal testis, etc.) rarely occurs. In case of ectopia, 
a developmental disturbance of the gubernaculum (see 1.3.2. and 1.4.2.) may 
cause the testis to descend into, for example, the perineum, as shown in figure 
5.6. At operation, the testis is capable of being brought down to the scrotum once 
the fascial barrier preventing descent, has been dissected (Backhouse, 1982•). 
Figure 5.6. Perineal ectopic testis in a one year old boy. 
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c. Anatomical anomalies in relation to superficial inguinal_ ectopic testes 
This abnormal position finds the testis in the superficial inguinal pouch (see 
1.4.1.a.). To arrive there, it has turned sharply upwards and outwards upon leaving 
the external annulus of the inguinal canal. This is due to an abnormal attachment 
of Scarpa's fascia to the pubic bone and scrotal entrance, preventing passage of 
the gubernaculum and testis into the scrotum. The anatomy of this area has been 
fully described by McGregor in 1929. Sprawling almost like a tent to shelter the 
testis in its abnormal position in the superficial inguinal pouch, Scarpa's fascia can 
be clearly identified in these cases right down to the pubic bone. At that level, its 
abnormal attachment to the pubic bone narrows the scrotal entrance, blocking 
gubernaculum and testis (Browne, 1938; jones, 1966; Scorer and Farrington, 1971; 
Flach, 1977). In these cases, the gubernacular remnants generally present as a 
fibrous cord extending to the pubic bone. 
5.4.3. Associated anatomical anomalies 
a. Cryptorchidism and anomalies of the abdominal wall 
Bilateral cryptorchidism is a common feature of several anomalies involving the 
abdominal wall. In the so-called prune belly syndrome, bilateral undescended 
testes are frequently located in the abdomen. The syndrome is characterized by a 
defect of the abdominal wall musculature, giving it the wrinkled appearance of a 
dried prune, and multiple severe anomalies of the urinary tract (Hendren and 
Ginsburg, 1981). Exstrophy of the bladder, gastroschisis and omphalocele are 
other anomalies of the abdominal wall with which bilateral cryptorchidism is 
frequently associated (Kaplan et al., 1986). 
b. Cryptorchidism and anomalies of the urinary tract 
In the general population, the incidence of major urological abnormalities is 
less than 2% (Felton, 1959; Leary et al., 1972). In boys with cryptorchidism, a higher 
than normal incidence of urinary tract malformations has been reported (Gross-
man and Ririe, 1968; Farrington and Kerr, 1969; Donahoe et al., 1973; Watson et 
al., 1974; White et al., 1973; Tveter and Fjaerli, 1975). 
Bergmeyer and Meradji (1977) reviewed the literature in comparison with their 
own data concerning cryptorchidism and associated urological abnormalities 
and found 13 cases with a major abnormality in 579 patients (2.2%). Five ofthese 13 
cases required surgical intervention. There appeared to be a slightly increased 
prevalence for minor abnormalities such as duplication of the upper urinary tract, 
ureteral dilatation, renal malrotation and uretero-pelvic junction obstruction. 
Hendren and Ginsburg (1981) routinely carried out intravenous pyelography 
(IVP) in all boys with bilateral cryptorchidism. Others advocate limiting an IVP or 
other radiologic investigations to boys with undescended testes that have urolo-
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gic symptoms or congenital abnormalities outside the urinary tract (Watson et al., 
1974; Tveter and Fjaerli, 1975; Bergmeyer and Meradji, 1977). 
c. Cryptorchidism and abnormal paratesticular structures 
Persistence of Mullerian duct structures may be revealed by chance at surgery 
(frequently at operation for inguinal hernia). A uterus, vagina, and Fallopian 
tubes may be found in combination with a vas deferens and undescended, 
frequently intra-abdominal testes (Snow et al., 1985; Van Lanschot et al., 1985). 
d. Cryptorchidism and ambiguous genitalia 
Cryptorchidism is frequently found in infants with ambiguous genitalia (Visser, 
1982). Adrenogenital syndrome, mixed gonadal dysgenesis, feminizing testes 
syndrome, and true hermaphroditism are intersex disorders in which cryptor-
chidism is combined with other genital abnormalities. Drop and coworkers (1984) 
published a comprehensive description of ambiguous genitalia and all that this 
entails. 
5.5. THE HISTORY OF ORCHIOPEXY 
5.5.1. Conventional orchiopexy 
Surgical placement of an incompletely descended testis into the scrotum was 
first attempted by Rosenmerkel in 1820. The first work of merit in this line was 
done by Schuller in 1tl81. He recognized the processus vaginalis as the chief factor 
hampering the natural course of the testis down to the scrotum. In 1899, Bevan 
first described division of the processus vaginal is with extended funicolysis. Four 
years later, he published the results of an improved technique (Bevan, 1903). 
Bevan's technique was based on principles that govern orchiopexy to this day 
(figure 5.7.). In 1909, Torek described a new technique which is essentially the 
same as Bevan's, but the testis is fixed to the fascia on the inner surface of the thigh 
for two or three months. The testis is then released from the thigh in a second 
procedure. Davison (1911) recommended division of the deep epigastric vessels 
to permit the cord to pass in a more direct line to the scrotum. Ombredanne 
(1927) perfected Bevan's technique, adding fixation of the testis by placing it in 
the opposite scrotal compartment. La Roque (1931) introduced the principle of 
retroperitoneal dissection to free the cord structures. Cabot and Nesbit (1931) 
introduced the use of a rubber band attached at one end to a testicular suture and 
at the other end to the inner surface of the thigh, by means of adhesive tape, in 
order to maintain the new position of the testis. Refining the fixation technique 
by positioning the testis between the tunica dartos and the scrotal skin was 
recommended in 1932 by the Dutch surgeon Schoemaker (figure 5.8.). Gross 
(1953) advocated extended retroperitoneal dissection freeing the vas down to the 
227 
Figure 5.7. Original drawings of the first publication of orchiopexy (Bevan, 1903; with permission). 
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Figure 5.8. Original drawings of the Schoemaker orchiopexy (Schoemaker, 1932; with permission). 
base of the bladder and the vessels up to the inferior pole of the kidney. Prentiss 
and coworkers (1960) further shortened the distance from the deep inguinal ring 
to the scrotum by transplanting the cord structures to the medial end of the 
posterior wall of the inguinal canal. Their report affirmed the mathematic princi-
ple that the shortest distance between two points is a straight line. Another new 
anchoring technique, the window septopexy, was described by Welch in 1972. 
His surgical technique consists of anchoring the orthopic testis permanently to a 
window in the elastic membrane that divides the scrotal compartments. Saha 
(1978) introduced "cordopexy", a technique which is based on fixation of the 
spermatic cord and not the testis. All these modifications of the original tech-
nique designed by Bevan depend on two main factors, mobilization and fixation, 
while it has become evident that undue traction or fixation of the testis with 
tension on the cord vessels will contribute to testicular atrophy and loss of 
function. Table 5.1. gives the results of conventional orchiopexy. 
A revised approach to the inguinal region using diverse incisions was described 
by Lipton, as well as by Chambless and Florence in 1961. They advocated either a 
tranverse or a midline preperitoneal approach to the imcompletely descended 
testis. Both procedures incorporated many technical principles common to con-
ventional inguinal orchiopexy and the incision originally described for inguinal 
hernia by Cheatle (1921) and Henry (1936). This approach afforded excellent 
Table 5.1. Results of conventional orchiopexy; number(%) of testes. 
authors 
Gross and Replogle [1963) 
Daum et al. [1969) 
Scorer and Farrington [ 1 971 ) 
Cywes et al. [1981) 
Lynch et al. [1982) 
Thorup et al. [198q) 
Total 
clinical results 
operations 
1767 
295 
125 
587 
233 
695 
3702 
success 
1537 [87) 
26q [89) 
96 [77) 
q57 £781 
193 [83) 
572' [82) 
3119 (8q) 
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exposure of the high-lying testis and allowed extensive dissection of spermatic 
vessels and vas deferens. Furthermore, their approach gave adequate exposure 
for bilateral orchiopexy at one and the same operation. Good results of this 
midline preperitoneal approach are described by Hunt and coworkers (1981). 
They recommended a more frequent use of this operation technique. jones and 
Bagley (1979) described another modification of the standard orchiopexy. They 
used a high inguinal incision combined with an abdominal extra- and retroperi-
toneal approach using a muscle-splitting incision. Exploration of the retroperito-
neal area enables extensive mobilization of the testicular vessels and vas deferens. 
5.5.2. Staged orchiopexy 
The majority of incompletely descended or ectopic testes can be brought 
down into the scrotum with the conventional orchiopexy procedure, but in some 
cases the length of the spermatic cord is not adequate to reach the scrotum. A 
"staged orchiopexy" is one where the testis is mobilized to its maximum extent at 
the first operation and fixed at a site as distal as possible, usually outside the 
external inquinal ring or at the pubic tubercle. After at least one year, a second 
operation is performed involving inguinal and retroperitoneal dissection. Staged 
orchiopexy for the treatment of the high-lying testis was first described by Snyder 
and Chaffin in 1955 and has since been advocated by many other surgeons (table 
5.2.). 
Most surgeons encounter difficulty in the dissection of the testis and cord 
during the second procedure. In 1975 Corkery described a technique to protect 
the testis and the spermatic cord at the first-stage operation by temporarily 
encasing these structures in silastic sheeting. This allows for a safer second-stage 
procedure by preventing adherence of the testis and cord structures. The role of 
the staged orchiopexy is controversial. Redman (1976) sees no rationale for a 
staged procedure. In his highly critical review he suggested that a successful 
second stage is most likely an indication of inadequate dissection during the first 
stage and that there is no documentation of further elongation of the spermatic 
cord after operation. 
Table 5.2. Results of staged orchiopexy; number(%) of testes. 
authors clinical results 
follow-up in years 
operations success after second stage 
Snyder and Chaffin ( 1 g55) 7 6 ( B6) not mentioned 
Gross and Replogle ( I g53) 24 24 (100) not mentioned 
Persky and Albert ( I g71 ) 13 g ( 6g) not mentioned 
Firor (lg71) 32 30 ( 94) not mentioned 
Corkery (I g75) 6 5 ( B3) not mentioned 
Zer et al. (lg75) 41 32 ( 7B) 2-10 
Kiesewetter et al. (lgBI) 40 33 ( B2l 1-24 
Steinhardt et al. (1gB5) 12 10 ( B3) •adequate• 
Total 175 1'/g ( B5) 
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5.5.3. Orchiopexy with testicular vessel transection 
The concept oftesticularvessel transection was first described by Bevan in 1903. 
He recommended dividing all the structures of the spermatic cord, except the vas 
deferens and its associated deferential artery and vein, in case the internal 
spermatic vessels were too short to permit scrotal placement. Because of the poor 
results with this procedure, it quickly fell into disfavour. Interest was renewed by 
Fowler and Stephens in 1959. They observed that in patients with high-lying 
testes, the vas deferens was often elongated, frequently extending down through 
the external inguinal ring and then looping back to rejoin the testis. The testicular 
vessels are short, but the vas deferens and its companion vessels are long. Using 
peroperative angiography, they demonstrated vascular collateral anastomoses 
between the vasal and the spermatic arteries. Under such anatomical conditions, 
high ligation and division of the main vascular pedicle to the testis may be 
feasible, allowing the testis to be placed in an intrascrotal position. To assure the 
adequacy of blood supply from the vasal artery, Fowler and Stephens recom-
mended temporary occlusion of vessels followed by incision of the tunica albugi-
nea of the testis which should observed for fresh bleeding. Although the Fowler-
Stephens procedure is particularly applicable in case of a high-lying testis with a 
long vas, several authors used this procedure with high-lying testes without a long 
loop vas deferens (table 5.3.). Analysis of the various results demonstrates that the 
procedure must be decided upon early in the course of dissection, since retro-
peritoneal dissection damages the perivasal circulation, which forms the collateral 
blood supply.ln the normal testis, the division of the main spermatic vessels does 
not necessarily lead to testicular atrophy, provided the collateral channels in the 
cord and scrotum are left undisturbed. 
Table 5.3. Results of Fowler-Stephens procedure; number(%) of testes. 
authors 
Moschcowitz [1910] 
Mac Collum (1g35] 
Fowler and Stephens [ 1959] 
Brendler and Wulfsohn [ 1 967] 
Clatworthy et al. [1972] 
Datta et al. [1977] 
Gibbons et al. [1979] 
Total 
5.5.4. Microvascular orchiopexy 
clinical results 
operations success 
22 21 [ 95] 
5 0 [ 0] 
12 8 [ 67] 
5 5 [ 100] 
32 2'1 [ 75] 
3 3 [100] 
27 22 [ 81] 
106 83 [ 78] 
long loop vas 
present 
not mentioned 
no long loop vas 
7 long loop vas 
[5 success] 
no long loop vas 
all long loop vas 
no long loop vas 
not mentioned 
The short vascular pedicle of the intra-abdominal or high-lying, inguinal testis 
poses a major surgical problem. Staged orchiopexy and reliance on the vessels of 
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the vas deferens for testicular vascularization (Fowler-Stephens procedure) have 
not given consistently satisfactory results. The last ten years have seen a general 
advance in the clinical application of microsurgery. With the improvement of 
microvascular techniques, testicular autotransplantation has become feasible. In 
1976, Silber and Kelly reported successful autotransplantation of an intra-
abdominal testis in a child with prune belly syndrome and since then testicular 
autotransplantation has gained in popularity. Using a surgical microscope, the 
intra-abdominal testis is transplanted to the scrotum with re-anastomosis of the 
divided testicular vessels to the inferior epigastric artery and vein. Subsequently, 
many authors have described their experience with this technique and the 
overall results demonstrate the feasibility of such microvascular surgical orchio-
pexy (table 5.4.). The rationale of this new operation is based on the assumption 
that the restoration of an optimal vascular supply represents the best guarantee 
for a possible functional recovery of the testis. 
Table 5.4. Results of microvascular orchiopexy; number(%) of testes. 
authors 
Silber and Kelly [1976] 
Silber [1978) 
Romas et al. [1978) 
MacMahon et al. [ 1 980) 
Martin and Salibian [1980) 
Rossignol et al. [1981) 
~acksman et al. [1982) 
Silber [1982) 
O'Brien et al. [1983) 
Giuliani and Carmignani [ 1 983) 
Upton et al. [1983) 
Garibyan and Hazebroek [ 1 984) 
Bianchi [ 1984) 
Shioshvili [ 1 985) 
Total 
operations 
4 
8 
2 
1 
7 
5 
11 
5 
10 
g 
10 
6 
80 
5.5.5. Neonatal transabdominal orchiopexy 
clinical results 
success 
1 [100) 
1 [100) 
4 [100) 
6 [ 75) 
2 [ 100) 
1 [100) 
6 [ 86) 
5 [ 100) 
6 [ 54) 
5 [100) 
6 [ 60) 
8 [ 89) 
8 [ 80) 
6 [100) 
65 [ 811 
follow-up 
period in months 
? 
8 
6-15 
6-48 
3-12 
12 
6-36 
>6 
12-72 
>3 
>6 
9-18 
1-24 
2-12 
In patients with prune belly syndrome, one expects intra-abdominal testes 
lacking the potential for spontaneous descent. Woodard and Parrott (1978) 
demonstrated that the testis of prune belly patients can be brought down into the 
scrotum with their vascular pedicle intact, by means of a transabdominal, transpe-
ritoneal orchiopexy carried out during the first weeks of life, either in conjunc-
tion with urinary tract reconstruction or as a primary procedure. The cord is 
mobilized transperitoneally to the origin of the spermatic vein and artery, after 
which the testis is passed through the abdominal wall at the site of the external 
inguinal ring and into the scrotum. The results achieved in these patients support 
the view that orchiopexy, performed very early in life, offers the best chance of 
obtaining viable testes in the scrotum. 
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5.5.6. Orchiopexy procedures applied in the Sophia Children's Hospital 
At the Sophia Children's Hospital the surgical procedure for undescended 
testes has since long consisted of funiculolysis followed by orchiopexy with testis 
fixation in a subcutaneous pouch after Schoemaker. Staged orchiopexy, the 
Fowler-Stephens procedure, and neonatal transabdominal orchiopexy are carried 
out on occasion. From 1981, microvascular orchiopexy has become one of our 
standard procedures. An extensive description of all these surgical procedures 
and their fields of application is given in chapter 6. 
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CHAPTER6 
SURGICAL TREATMENT OF UNDESCENDED TESTES 
6.1. INTRODUCTION 
The hormonal studies described in chapters 3 and 4 have demonstrated 
unconditionally that surgical intervention is the only therapeutic modality for the 
majority of truly undescended testes. Retractile testes generally do not require 
any treatment (see below), while a// undescended testes that are impalpable, 
require surgical therapy. Incompletely descended testes that are capable of 
manipulation to at least the scrotal entrance, may descend with hormonal treat-
ment. A great deal depends on the diagnostic findings. It is essential that the 
diagnostic examination of boys with any form of testicular nondescent is carried 
out by someone with anatomic insight and with expertise in the examination of 
infants and children (Spitz, 1983). 
6.2. MANAGEMENT OF THE RETRACTILE TESTIS 
The retractile testis differs from the normally descended testis in that it is a great 
deal more mobile. It can readily be pulled out of the scrotum over the bar of the 
pubic bone by the active cremaster muscle (cremasteric reflex). Farrington (1968) 
studied the position and retractility of the testes of 594 boys in the age range of 0 
to 16 years. He found that the cremasteric reflex cannot be provoked before the 
age of two weeks, while the reflex contraction of the cremasteric muscle only 
reaches sufficient strength to withdraw the testis from the scrotum at the age of 
six months. Retractility reaches its peak around the age of six years, whereupon it 
begins to decline. Around puberty the cremasteric reflex disappears altogether. 
Once over the pubic bone, the testis floats freely into the superficial inguinal 
pouch (Browne, 1938; Scorer, 1962; johnston, 1965; Flach, 1977). From the super-
ficial inguinal pouch, where it can reside for lengthy periods, the retractile testis 
can be manipulated into a stable intrascrotal position, while it is also capable of 
descending spontaneously at anytime. The retractile testis is never found in front 
of the pubic bone as that is not a stable position. Apart from its hypermobility, the 
retractile testis is entirely normal. Figure 6.1. is a schematic presentation of the 
retractile testis. 
During the period under study (October 1982 to April 1985) a total of 660 
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Figure 6.1. Schematic presentation of the retractile testis. 
prepuberal boys with either unilateral or bilateral undescended testes were 
referred to us for treatment (figure 6.2.). In 217 of them (33%) we diagnosed 
retractile testis, generally at the very first examination, though sometimes only 
after repeated examinations. It is important to note that all 660 boys had pre-
viously been examined by their general practitioner and/or school physician and 
referred with a diagnosis of undescended testis. None of the boys in whom we 
diagnosed a retractile testis were operated upon; they were just told to come 
back for annual checkups. 
In the group of boys with retractile testes, there were 24 whom we first saw 
when they were 10-11 years old. In 20 of them we found both testes in a scrotal 
position around age 12 with the cremasteric reflex no longer capable of withdraw-
ing the testis from the scrotum. For the other boys the duration of the follow-up 
was too short at the conclusion of the study period to allow for an examination at 
the age of puberty. 
It is generally assumed that retractile testes do not require treatment as these 
testes will be permanently intrascrotal around puberty. However, some authors 
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Figure 6.2. Division between boys with retractile testes (n = 217) and boys with undescended testes 
(n = 443) in different age groups. 
have described previously retractile testes that were in a permanent nonscrotal 
position after a number of years, requiring surgical intervention (Villumsen and 
Zachau, 1966; Privat, 1978; Atwell, 1985). Atwell suggested a possible cause for this 
testicular ascent. In a number of cases where the testis had ascended, he would 
find an open processus vaginalis at operation. It seemed feasible that in the 
course of further growth of the abdominal wall, for example, this open processus 
vaginalis had gradually become part of the peritoneum thereby lifting up the 
testis (figure 6.3.). 
We did not (yet) see permanent ascent of a testis diagnosed as retractile, but 
here again we must stress that the follow-up period never exceeded two years. In 
this connection it is interesting to note that 5 of 443 boys in whom we diagnosed 
incompletely descended testes had been examined years before by an experi-
enced paediatric surgeon, who diagnosed retractile testes (three bilateral, two 
unilateral). In one of these five boys, the right testis was palpable in the external 
inguinal ring though incapable of manipulation down to the scrotum, while the 
left testis had assumed a high scrotal position. At operation of the right testis, we 
found a wide open processus vaginalis with adhesions and folds of connective 
tissue at the transection of processus vaginalis to peritoneum. This might well 
account for the ascent of the testis as it was lying in a processus vaginal is which no 
longer extended down to the scrotum (figure 6.4•. and 6.4b.). The aetiology of 
these peritoneal adhesions is not clear. 
In conclusion, we can safely say that retractile testes generally require no 
treatment, although a regular checkup, preferably once a year, up to the age of 
puberty is imperative. We have found that a simple explanation of the need for 
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Figure 6.3. Schematic presentation of open processus vaginalis becoming part of the parietal 
peritoneum with resultant shortening of the cord and testicular ascent (Modified from 
Atwell, 1985). 
Figure 6.43 • Spontaneous testicular position in a 10 year old boy with previously descended testes. 
Line indicates position of right testis. 
238 
Figure 6.4b. Exploration of the right inguinal canal revealed wide open processus vaginal is with 
adhesions and folds (arrow) of the peritoneum. 
such regular checkups will prevent any anxiety the boy or his parents may feel 
when told to come back once a year. 
6.3. SURGICAl MANAGEMENT OF THE IMPALPABLE TESTIS 
6.3.1. Introduction 
The impalpable testis by the simplest definition is a testis that is not palpable by 
the examiner. Testes are impalpable when they are lying intra-abdominally or 
high in the inguinal canal and never emerge through the external inguinal ring, 
or when they are atrophic or absent (Browne, 1938). In a review of the literature, 
levitt and coworkers (1978) reported that the incidence of impalpable testes is 
approximately 20 per cent of the undescended testis populations. 
The surgical management of the palpable testis has since long been a routine 
surgical procedure, but for the nonpalpable testis the surgical management 
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remains controversial. Hinman (1979) advocates removal of high-lying testes 
(orchidectomy), while Redman (1980) argues for treatment (orchiopexy). The 
reason for these completely opposing views lies in the fact that impalpable testes 
differ in some ways from either descended or palpable, undescended testes. For 
example, impalpable testes are often comparatively smaller and histologically 
divergent (Mack, 1961; Nistal et al., 1980). A partial or completely separated 
epididymis, as described in the previous chapter (5.4.1.c.) is a frequent finding. If 
there is total separation of epididymis and testis in bilaterally undescended, 
high-lying testes, this condition greatly reduces the chances of fertility, which are 
limited anyway in boys with such an abnormal testicular position (Scorer and 
Farrington, 1971; Marshall and Shermeta, 1979; Kroovand and Perlmutter, 1981; 
Heath et al., 1984) (see 5.3.1.). With intra-abdominal or high-lying, inguinal testes, 
there is an increased risk of carcinoma in situ or even a real germ cell tumour (see 
5.3.2.). Bringing the impalpable testis to the scrotum frequently involves a tech-
nically complicated surgical intervention due to the large distance that often has 
to be bridged, while the functional and cosmetic result is rather poor (Gibbons et 
al., 1979; Smolka et al., 1983). 
This chapter describes the author's own experience with the treatment of boys 
with unilaterally or bilaterally undescended testes that are lying intra-ab-
dominally or high in the inguinal canal. The results are compared with literature 
data. The following questions will be dealt with: 
- What are the indications for treatment of impalpable testes? 
- How should impalpable testes be treated? 
6.3.2. Diagnostic evaluation of the impalpable testis 
In deciding what type of diagnostic examination is required before surgical 
intervention for impalpable testis is initiated, one should distinguish between 
unilateral and bilateral impalpable testis. Hormonal evaluation is essential in boys 
with bilateral impalpable testes, to ensure the presence of testicular tissue. 
Normal basal serum gonadotropins- FSH and LH- and an appropriate increase in 
serum testosterone over basal values after stimulation with HCG (1,500 IU) 
denote functioning testicular tissue and mandate further therapy. In contrast, 
elevated basal levels of FSH and LH in association with failure of testosterone 
elevation over basal levels after HCG stimulation, denote an absence of func-
tioning testicular tissue. These endocrine findings in a normal phenotypic male 
subject with a normal46 XY karyotype without palpable Mullerian structures on 
rectal examination, establish the diagnosis of congenital bilateral anorchism or 
vanishing testis syndrome (see 5.4.1.b.). Surgical exploration is not necessary for 
confirmation of this syndrome. Hormonal evaluation is pointless in boys with 
unilateral impalpable testis. The presence of one normally descended testis with 
normal hormonal function, makes it impossible to determine whether this is a 
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case of anorchia or vanishing testis, or rather an existing testis which is merely not 
palpable. 
The last decade has witnessed an incrasing emphasis on evaluations to ascertain 
pre-operatively the position of the impalpable testis. The inference is that when 
the testis is impalpable pre-operatively, a fruitless exploration of the inguinal 
canal may herald a frustrating search for an elusive gonad. Selective gonadal 
arteriography and venography have been proposed to localize the position of 
impalpable testes pre-operatively as an aid in surgical management (Domellof et 
al., 1978; Rubin and Gershater, 1981; Pommerville et al., 1982; Khan et al., 1982). 
However, these examinations are definitely not recommended as routine diag-
nostic procedures, because both arteriography and venography are invasive 
examinations with an inherent risk of complications (lesion of femoral artery or 
vein), while the interpretation of the images achieved remains difficult due to 
anatomical variations of the testicular vessels (Harrison, 1949). The information 
gained from these procedures must therefore be seen in the light of their limited 
accuracy and invasive nature. Computerized tomography and ultrasonography 
are not very invasive procedures, which are easy to reproduce. However, these 
methods are not very dependable for visualizing the impalpable testis (Green, 
1985; Malone and Guiney, 1985; Wright, 1986).1n contrast, laparoscopy has been 
found to demonstrate intra-abdominal testes accurately and to visualize the 
spermatic vessels and vas deferens entering the inguinal ring (Scott, 1982; Lowe et 
al., 1984; Boddy et al., 1985; Manson et al., 1985). Laparoscopy will also demon-
strate blind-ending vessels within the abdomen (Silber and Cohen, 1980). How-
ever, laparoscopy is certainly invasive, while the findings are often difficult to 
interpret despite the fact that it is not a difficult procedure for an expert surgeon 
to perform. 
The main argument against performing any one of these diagnostic examina-
tions routinely lies in the fact that surgical exploration will still be required. None 
of these methods are capable of providing conclusive evidence of testicular 
absence, so that at least in these cases surgery could be circumvented (Sheldon, 
1986). Besides, this would only involve a small percentage of the impalpable 
testes, as surgery generally does reveal a testis, albeit sometimes an atrophic one. 
Table 6.1. gives a summary of literature data concerning 337 impalpable testes. 
Table 6.1. Peroperative position of 337 impalpable testes; number(%) of testes. 
total 
peroperative position 
of intra- inguinal outside 
authors (year) testes absent abdominal canal ing. canal 
Redman ( 1 960) 114 6 ( 5 ) 19 (17 ) 64 (74) 5 ( 4) 
Smolka et al (1963) 60 17 (20 ) 44 (56 ) 15 (19) 4 ( 5) 
Rajfer et al (1963) 6 1 (12.5) 1 (12.5) 2 (25) 4 (50) 
Malone and Guiney (1965) 14 2 (14 ) 7 (50 ) 5 (36) 0 ( OJ 
Manson et: al (1965) 17 1 ( 6 ) 5 (29 ) 9 (53) 2 (12) 
Wright ( 1 966) 104 29 (28 ) 34 (33 ) 34 (33) 7 ( 6) 
Total 337 56 (17 ) 110 (33 149 (44) 22 ( 6) 
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Surgery revealed testicular absence in only 56 (17%) of these cases, which means 
that regardless of the type or invasiveness of pre-operative diagnostic examina-
tions, surgical intervention was definitely required in 281 cases, amounting to 
83%. In actual fact this percentage is even higher, because the 56 cases of 
testicular absence included a number of so-called vanishing testis whereby 
testicular vessels and vas deferens do reach the inguinal canal through the 
annulus intern us, but neither laparoscopy nor venography can provide conclu-
sive evidence for or against the presence of a testis in the inguinal canal. This 
means that surgical exploration remains mandatory. A primary surgical approach 
to the impalpable testis has the added advantage that in most cases a surgical 
exploration will provide both diagnosis and therapy, because orchiopexy can 
generally be performed rightaway. Consequently, surgical exploration is the only 
correct method of diagnostic evaluation of the impalpable testis. 
Hormonal treatment of the impalpable testis is pointless, as demonstrated 
extensively in chapter 4. Therefore, we agree with Levitt et al. (1978) and Redman 
(1980), that an inguinal skin incision is the simplest, most cosmetic and most 
direct approach in most cases of impalpable testes. The degree of exposure is 
striking. The retroperitoneal space can be visualized from the base of the bladder 
to just below the lower pole of the kindney. The peritoneum may be opened 
widely for intraperitoneal exploration. The following conditions may be 
revealed: 
- Extensive extraperitoneal and intraperitoneal exploration demonstrate the 
absence of either testicular or funicular structures. This finding is very rare 
(Levitt et al., 1978). 
- There is only a blind-ending vas deferens, in which case intraperitoneal 
exploration is still required to exclude a higher-lying testis (Kogan et al., 1986). 
- Testicular vessels with a vas deferens are located in the inguinal canal or at the 
level of the annulus intern us; these structures usually end in a tissue remnant 
consisting of epididymis (Kogan et al., 1986). This is a case of "vanishing testis" 
(see 5.4.1.b.). 
- The testis is located intra-abdominally or high in the inguinal canal, in which 
case there is often a partial or complete separation of testis and epididymis, 
while the testis is obviously smaller and softer than the contralateral, descend-
ed testis. 
The surgical possibilities depend on the explorative findings. If the exploration 
reveals testicular absence, provided this is a case of "vanishing testis", a scrotal 
orchiopexy will have to be performed on the contralateral testis, in order to 
prevent torsion of this solitary testis. This operation is not indicated in case of uni-
lateral anorchia. 
Indications for orchidectomy are not easy to define. Unilateral testicular 
atrophy associated with anatomical abnormalities of epididymis and vas deferens 
may be such an indication, whereby the extent of the abnormality and the 
ultimate length of the testicular vessels will be the deciding factors. If the testis is 
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incapable of being brought to the scrotum, e.g. because of insufficient funicular 
length, orchidectomy may be indicated to prevent the development of car-
cinoma. Bilateral orchidectomy to prevent malignant degeneration is obviously 
unacceptable. In boys with two impalpable testes, all attempts should be made to 
conserve hormonal function. Sparing hormonal function is paramount and 
should even prevail over the wish to achieve a scrotal position should this be 
feasible. In case of bilaterally impalpable testes, it may be necessary to leave at 
least one testis in a subcutaneous position without damage to the vascularization, 
to ensure normal hormonal function. In case of unilateral impalpable testis, 
the mentality and age of the boy also play a part in a decision for or against 
orchidectomy. 
It is essential that all possibilities are fully discussed with the boy and his 
parents, before surgery takes place. Surch pre-operative consultation should 
include mention of a testicular prosthesis in case orchiopexy is not feasible. It is 
generally advisable not to insert a prosthesis before the age of puberty. A tes-
ticular prosthesis of adult dimension can then be inserted rightaway and, what's 
more important, the motivation will come from the boy himself and not merely 
from the parents. 
Fortunately, it appears that the majority of the impalpable testes are capable of 
being brought well into the scrotum (Gross and jewett, 1956; Redman, 1980; 
Wright, 1986). Table 6.2. gives the results of surgical treatment of impalpable 
testes carried out by the author. Between April1982 and April1985, a total of 68 
prepuberal boys with 84 impalpable testes were operated upon. Eighteen testes 
(22%) appeared to be absent, while 38 testes (45%) could be placed in a scrotal 
position with a standard orchiopexy after Schoemaker (see 6.5.3.d. for a descript-
ion of this technique). A special surgical technique was required for 28 testes 
(33%), involving orchidectomy in two cases, but succeeding in a scrotal position 
for another 18 testes. (The number of cases listed for the staged procedure only 
include cases where both first and second operation were carried out by the 
author). In the following paragraphs the special surgical techniques will be dealt 
with extensively, as well as the indications for such techniques and the subse-
quent results. 
Table 6.2. Results and type of surgical correction of 84 impalpable testes in 68 prepuberal boys; 
number of testes (number of boys). 
surgical procedure 
exploration standard staged postoperative 
testis archie- Fowler- incl.orchi- micro- condition/position 
absent pexy Stephens dectomy vascular of testis total 
16 0 0 2 0 no testis 20 
0 0 3 0 3 atrophic testis 6 
0 0 0 2 0 outside ing. canal 2 
0 B 2 2 
" 
high~ scrotal 16 
0 30 
" 
0 6 low scrotal '10 
16 [16) 36 [26) g [B) 6 ['I) 13 [2) total BLJ [66) 
243 
6.4. SPECIAL SURGICAL PROCEDURES FOR IMPALPABLE TESTES 
For a number of impalpable testes, particularly the intra-abdominal ones, a 
scrotal position can only be achieved by means of a special surgical technique. 
The author's own experience with a number of these techniques and the results 
are presented below, with reference to the literature. 
6.4.1. Experience with Fowler-Stephens procedure 
a. Introduction 
The principle of orchiopexy with testicular vessel transection (Fowler-Stephens 
procedure) has been dealt with in chapter 5 (5.5.3.). A special anatomical situation 
must be present to permit a satisfactory performance of this technique. In such a 
situation, the testis itself is usually located in the abdomen or high in the inguinal 
canal, while the epididymis and vas deferens often extend caudally past the 
annulus extern us ("long loop vas and epididymis"). Although the main vascular 
pedicle to the testis is short, a secondary vascular loop emerges from the deep 
epigastric vessels with a lot of branches entering the posterior wall of the open 
processus vaginal is. This vascular network creates a rich collateral circulation for 
the testis (figure 6.5.). Following localization of the testis, vas and epididymis, the 
spermatic vessels are mobilized high through the posterior peritoneum without 
disturbing the medial blood supply along the vas. A bulldog clamp temporarily 
occludes the spermatic vessels high above the testis and sometimes a number of 
the collateral vessels are ligated. The colour of the testis is observed for several 
minutes and a small incision may be made in the tunica albuginea of the testis to 
aid assessment of the adequacy of the collateral blood supply (figure 6.6.). 
Provided the circulation appears intact, the testicular vessels are ligated high 
above the testis and a wide tongue is created of medially based peritoneum 
containing the vas and the perivasal collateral blood supply. 
b. Results of Fowler-Stephens procedure 
In the period April 1982 - April 1985, nine intra-abdominal or high-lying, 
inguinal testes were brought into the scrotum by the author applying the Fowler-
Stephens procedure. Table 6.3.lists the results of these operations. There were six 
cases with an obvious "long loop" vas deferens and epididymis with extensive 
collateral vascularization. In the other three cases there was no "long loop" vas or 
epididymis, but the epididymis was almost completely separated from the testis. 
The results of these nine operations clearly demonstrate that a "long loop" 
anatomy, coupled with adequate collateral circulation between vas deferens, 
epididymis and testis, is essential for the persistence of a good testicular vasculari-
zation. Only one of the six testes with this anatomical structure appeared to have 
become atrophic after at least six months had elapsed. In contrast, two of the 
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1. testis 
4 2. epididymis 
3. vas deferens 
4. testicular vessels 
5. deferential vessels 
5 
a, b, divided vessels 
Figure 6.5. Peroperative photograph of "long loop" vas, showing collateral circulation between 
testicular and vasal vascularization. 
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1. compressed testicular vessels 
2. testis biopsy 
3. vas deferens 
4. external annulus 
5. internal annulus 
6. a. deferentes 
a-d collateral circulation 
between deferential 
and testicular vessels 
6 
5 
2 
3 
4 
Figure 6.6. Schematic presentation of Fowler-Stephens procedure. After compression of the 
testicular vessels, several collateral vessels (a, b, c, d) across the major long loop ofthe vas 
deferens can usually be divided. Provided bleeding is continuous, it is safe to divide the 
testicular vessels whereby adequate length can be achieved. 
Table 6.3. Results of Fowler-Stephens procedure; number of testes (number of boys). 
anatomical 
structure 
"long loop" vas and epididymis 
normal vas and epididymis 
Total 
total 
6 (5) 
3 (3) 
g (B) 
results >6 months postoperative 
normal testis 
atrophic 
high scrota I low scrotal testis 
1 (1] lj (3) 1 (1) 
1 (1) 0 (OJ 2 (2) 
2 (2) lj [3) 3 (3) 
three testes without a "long loop" anatomy had atrophied as a result of insuf-
ficient vascularization. In conclusion, the Fowler-Stephens procedure proved a 
good surgical technique for the high-lying, impalpable testis associated with a 
"long loop" vas deferens and epididymis. 
c. Discussion 
The concept of dividing the vascular pedicle of the testis is not new, having 
been performed by Bevan as early as 1903. Bevan considered it a "radical but 
perfectly safe" procedure, and noted no evidence of interference with testicular 
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position. In 1910, Moschcowitz described the long loop vas variant with transec-
tion of the vessels as a safe procedure for undescended testes. Over the years, this 
procedure fell into disrepute because of poor long-term results (MacCollum, 
1935). Interest in the maneuver of testicular vessel division was revived by 
Fowler and Stephens in 1959. They ligated the spermatic vessels in 12 patients with 
high-lying undescended testes and obtained good anatomic results in 8 of them. 
There seem to be two reasons for the present success with this procedure in 
contrast to the poor experience in the past. The first of these lies in the recogni-
tion of anastomoses between the vasal and spermatic arteries within the sperma-
tic cord and in the region of the epididymis. The second reason lies in the current 
practice of high ligation of the spermatic vessels, above the point where they 
diverge from the vas, avoiding damage to collateral channels. 
In 1972, Clatworthy and coworkers reported their experience with the Fowler-
Stephens procedure in 32 patients. These patients could be divided into two 
groups. In the first group, a premeditated Fowler-Stephens procedure resulted in 
an 85% success rate (18 of 21). All 7 high inguinal testes survived, while only 3 of 14 
intra-abdominal testes atrophied. In the second group of patients, the Fowler-
Stephens procedure was carried out after an attempt to bring the testis down by 
mobilizing the cord had failed. The success rate for this group was much lower, 
amounting to 54% (6 of 11). Their results exemplify the fact that the cord should 
not be dissected before spermatic vessel division. 
Datta and coworkers (1977) achieved a satisfactory intrascrotal position of the 
testes by dividing the spermatic vessels in three boys with unilateral undescended 
testes. They recommended a postoperative scrotal scan to determine the ade-
quacy of testicular circulation. Gibbons and coworkers (1979) stressed the impor-
tance of creating a wide pedicle of peritoneum on either side of the vas to 
preserve the precariously delicate vasal structure. 
d. Indications for Fowler-Stephens procedure 
Most authors that reported their experience with the Fowler-Stephens proce-
dure concluded that its performance must be "premeditated" and not a "sal-
vage" attempt. This is something which we can wholeheartedly agree. Analysis of 
our own results demonstrate that for a successful outcome it is essential that the 
decision to carry out the Fowler-Stephens procedure is taken early in the course 
of dissection, since retroperitoneal dissection damages the perivasal circulation. 
The "long loop" anatomy must be present, because this means there is a good 
collateral circulation so that the testicular vessels may safely be divided. The 
decision to divide the testicular vessels must be taken before further mobilization 
of processus vaginalis and peritoneum is initiated, to prevent damage to the 
testicular vascularization. In the absence of a "long loop" vas deferens and 
epididymis, there is a very real risk that division of the testicular vessels will result 
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in testicular atrophy and consequently, the Fowler-Stephens procedure should 
not be carried out. 
6.4.2. Experience with staged procedure 
a. Introduction 
Judging from literature data, one would say that the results of the planned, 
staged orchiopexy are not disappointing. Table 5.1. (see 5.5.2.) shows that 149 of 
175 (85%) staged operations performed by various authors were successful in that 
the undescended testis could be brought into the scrotum at the second opera-
tion. 
b. Results of staged procedure 
In the period April1982- April1985, a second-stage procedure was carried out 
15 times in ten prepuberal boys. In six boys (nine testes) the initial operation was 
carried out elsewhere by another surgeon, resulting in seven testes in a subcuta-
neous position outside the inguinal canal and two testes in the inguinal canal. In 
the other four boys (six testes), both operations were carried out by the author, 
with the first operation resulting in six testes lying in a subcutaneous position 
outside the inguinal canal. In all cases, the second operation was carried out at 
least 12 months after the first one. Table 6.4. gives the final results of these 15 
staged operations (6 of them were also listed in table 6.2.). Ten testes were 
successfully brought into a high or low scrotal position. In one bilateral cryptor-
chid, neither testis was capable of being brought into the scrotum even at the 
second operation. Both testes were affixed in a subcutaneous position outside 
the inguinal canal. Microvascular testis transplantation may still be carried out in 
this boy at a later stage. Three boys had one testis each removed at the second-
stage operation, because these testes were considerably smaller than the contra-
lateral, descended testes and could not possibly be brought to the scrotum 
without severe traction to the testicular vessels. 
c. Discussion 
Dividing the boys that underwent staged procedures into two groups, with the 
boys that had both operations performed by the author in one and the remainder 
Table 6.4. Results of 15 "second-stage" testicular operations; number oftestes (number of boys). 
first stage orchi- outside high low 
operation total dectomy ing.canal scrotal scrotal 
performed elsewhere 9 ( oJ 1 [1) 0 [OJ 1 (1) 7 (4J 
performed by author fj ( 4J 2 [2J 2 (1) 2 (1 J 0 (OJ 
Total 15 (10J 3 [3J 2 (1) 3 (2J 7 (4J 
248 
in the other group, has a marked effect on the results. For the group of boys that 
underwent the first operation elsewhere, the results seem to be much better. 
Eight of nine undescended testes first explored by another surgeon could be 
brought into the scrotum at the second operation. At this second operation, it 
always proved possible to carry out extensive retroperitoneal mobilization of the 
funiculus coupled with dissection of the processus vaginalis and thereby gain 
sufficient funicular length for a scrotal fixation of the testis without undue 
traction. In this respect it must be stressed that at the first operation of these 
high-lying testes the funiculus was obviously only partially mobilized if at all! We 
may safely assume that a second operation would not have been necessary if 
extensive funicular mobilization had taken place at the initial exploration. In 
contrast, in the six cases where both operations were carried out by the author, 
the first operation involved maximal retroperitoneal funicular mobilization and 
medialization. The results illustrate clearly that the gain in funicular length at the 
second operation is minimal. Not a single testis could be brought low into the 
scrotum. Two testes had to be left in a subcutaneous position outside the inguinal 
canal and orchidectomy was carried out twice (against one orchidectomy in the 
other group). Scarring with connective tissue formation around the testis and 
funiculus generally complicated the freeing of these structures and effectively 
inhibited any gain in funicular length. 
A critical evaluation of the published series of successful staged procedures 
frequently show that patient selection or the extent of funiculolysis at the first 
operation were largely responsible for the success of the second operation. For 
example, it appears that a number of the second-stage procedures described by 
Persky and Albert (1971) were carried out in patients with an iatrogenically 
undescended testis secondary to an earlier operation for inguinal hernia. It stands 
to reason that dissection ofthe funiculus would return the testis to the scrotum in 
these cases. Firor (1971) goes so far as to describe retroperitoneal dissection of the 
funiculus as something that is only required at the second operation! In 1975 
Corkery introduced a new technique whereby the funiculus is wrapped in a 
(ell ow sheet following funicolysis at the first operation, to prevent the formation 
of connective tissue around the funiculus and thereby simplify the second 
operation. However, for all six patients he operated on in this way, Corkery 
describes the teflon sheet as enveloping, apart from the testis itself, only the part 
of the funiculus that lies in the inguinal canal and not the retroperitoneal part of 
the funiculus. Consequently, it seems likely that the gain in funicular length 
achieved at the second operation, was the result of retroperitoneal funicular 
mobilization first carried out at that second stage. In their report of 60 staged 
procedures, Kiesewetter and coworkers (1981) describe as many as 28 second-
stage operations of initially intrascrotal testes that had returned to a subcutaneous 
position in the inguinal area in the course of time. Here again, we wonder if the 
first operation included sufficient funiculolysis. 
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d. Indications for a staged procedure 
Good results of a second-stage procedure are generally due to incomplete 
funiculolysis being carried out at the first operation. In our group of patients that 
had both operations performed by the author, the initial procedure did involve 
maximal retroperitoneal funiculolysis. In those cases the second operation pro-
vided practically no gain in funicular length and therefore the results were 
disappointing. Although these results are based on a small number of patients, we 
believe with Redman (1976) that "there is still no proofthat later surgical manipu-
lation of the testis allows the spermatic cord structures to resume again their 
elongation for the testicular descent". 
In summary 
A staged procedure is only indicated in case of an acquired high position of the 
testis, generally secondary to improperly executed, surgical correction of ingui-
nal hernia; or incomplete mobilization of the funiculus at the initial surgical 
exploration. If the testis can be manipulated past the annulus extern us all the way 
to the scrotal entrance before the second operation, there is a particularly good 
chance that this second operation will succeed in bringing the testis low into the 
scrotum. If the first operation involved extensive funiculolysis without this result-
ing in sufficient funicular length to bring the testis into the scrotum, then a 
"second-stage procedure" is pointless, unless this procedure involves autotrans-
plantation of the testis employing microsurgical, vascular anastomoses (see 
6.4.3.). 
6.4.3. Experience with microvascular orchiopexy 
In recent years, reports of orchiopexy with revascularization of the autotrans-
planted testis have appeared in the literature with increasing fequency (table 5.3., 
see 5.5.4.). In 1984, we published our own results with the microvascular tech-
nique and its application for the high-lying, undescended testis. The full text is 
reproduced below, with permission from the publishers. 
a. MICROVASCULAR SURGICAL ORCHIOPEXY IN THE TREATMENT 
OF HIGH-LYING UNDESCENDED TESTES 
H. Garibyan1, F.W.j. Hazebroekz, J.A.R. Schulkes3, j.C. Molenaar2, and N.F. Daib-
hoiwala1 
1 Department of Urology, Academic Medical Centre, University of Amsterdam; 2 Department of 
Paediatric Surgery, Sophia Children's Hospital, Erasmus University f Rotterdam; 3 Department of 
Psychiatry, Free University of Amsterdam, The Netherlands. 
British Journal of Urology (1984), 56,326-329 
© 1984 British Association of Urological Surgeons 
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Summary 
Extensive laboratory experiments in animals have led us to believe that auto-
transplantation of the testis in the human is feasible. To date, nine of our patients 
(aged 4-13 years) with undescended intra-abdominal testes have undergone 
autotransplantation. Using a microvascular surgical technique to anastomose the 
testicular vessels to the inferior epigastric vessels, it has been possible to place the 
testis in a scrotal position in every case. No postoperative complications have 
been noted. Follow-up varied from 9 to 18 months and no atrophy of the testis 
was observed in this period. Doppler investigations on all of the transplanted 
testes continue to demonstrate good arterial flow. The aim of surgery on the 
undescended testis is not only to increase the chances of fertility and to diminish 
the possibility of malignanttransformation but also, more importantly perhaps, to 
prevent possible abnormal psychosexual development in the child. 
Introduction 
Approximately 9% of impalpable testes are located intra-abdominally or are 
absent (Scorer and Farrington, 1971). In 5% of such cases conventional surgical 
methods will not enable the testis to be brought into the scrotum. Several 
operative techniques to solve this problem have been reported. Some of the 
better known are staged orchiopexy and division of the spermatic vessels (Fowler 
and Stephens, 1959). Although good results have been achieved with these 
techniques, the number of abortive attempts leading to testicular atrophy is 
considerable. A review of our cases 6 months after division of the spermatic 
vessels revealed that testicular atrophy was present in 50%. 
In 1976 Silber and Kelly described autotransplantation of an intra-abdominal 
testis using a microvascular surgical technique. Subsequently, other authors have 
also reported success using this method (Giuliani and Carmignani, 1983; O'Brien 
et al., 1983; Upton et al., 1983). Interest in organ and tissue transplantation has 
increased dramatically and microsurgical techniques have advanced so rapidly 
that it is now possible to anastomose blood vessels with a diameter of 0.5 mm 
(Acland, 1972; Hayhurst and O'Brien, 1975). These developments prompted us to 
attempt experimental microvascular orchiopexy in dogs. The results were re-
viewed by histological examination of the testes, plasma testosterone levels and 
patency of the anastomoses by angiographic studies (Garibyan, 1981). Having 
obtained sufficient technical expertise and continued success with the auto-
transplanted canine testis, we carried out the procedure in the human. 
Patients and methods 
Nine patients with unilateral intra-abdominal testes (age range 4-13 years) were 
operated upon. A higher than normal inguinal incision was made to avoid injury 
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to the epigastric vessels. Depending on the position of the testis, it was approach-
ed either intraperitoneally or retroperitoneally. The testis, epididymis, vas 
deferens and testicular vessels were first inspected and the vessels dissected free 
of the surrounding structures to the level of the lower pole of the kidney. The 
epigastric vessels were then isolated and the vein and artery cleanly divided 
under the operating microscope. Thereafter the testicular vessels were divided as 
high as possible and ligated proximally. The testicular artery and vein were 
anstomosed to the respective epigastric vessels under the microscope, avoiding 
any tension on the anastomoses. When great disparity in diameter between two 
vessels existed, spatulation of the end of the smaller vessel facilitated proper 
tension-free approximation. The diameter of the testicular vein varied from 0.8 to 
1.4 mm and that of the artery from 0.5 to 0.9 mm. An end-to-end anastomosis was 
carried out under the operating microscope using a magnification of x5 and a 
zoom magnification of x25. A BV-6 or BV-4 needle and 10/0 atraumatic, inter-
rupted, monofilament nylon sutures were used. The arterial anastomosis was 
completed first in order to limit the warm ischaemia time to a minimum. In order 
to obtain an intrascrotal testis it was sometimes necessary to mobilise the vas defe-
rens, together with the surrounding peritoneum, as far as the posterior aspect of 
the bladder. The testis was fixed in the usual manner in a subcutaneous pouch as 
shown in figures 6.7. and 6.8. (figures 1 and 2 in original article). Details of the 
patients are summarised in table 6.5. (the only table in the original article). In 
seven patients the inguinal canal had been explored before the testis was trans-
planted and the testis identified as lying proximal to the inguinal ring or intra-
abdominally. In the other two patients laparoscopy was undertaken before 
transplantation and the presence of the testis confirmed. Operating time varied 
from 21j2 to 4 h and the warm ischaemia time varied from 30 to 40 min. Post-
operatively, patients were kept in bed for a day and thereafter were gradually 
mobilised. Prophylactic antibiotics were not administered and no wound infec-
tions or other complications occurred. Hospitalisation varied from 5 to 7 days. 
Results 
Using this technique all testes could be brought into the scrotum. During the 
follow-up period, lasting from 10 to 18 months, no atrophy of the testis was 
encountered on clinical examination. However, in two patients a high scrotal 
testis was present because of a short vas deferens and in one patient residual 
induration of the spermatic cord persisted for as long as 6 months post-
operatively. The testicular vessels are regularly checked by the Doppler flow 
technique and normal pulsations have been recorded to date. 
Discussion 
The procedure of testicular autotransplantation with microvascular anastomo-
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INF. EPIGASTRIC VESSELS 
Figure 6.7. Diagram of a high-lying 
undescended testis. 
Ill 
TESTICULAR VEsSELS 
Figure 6.8. Diagram of a testicular 
autotransplantation. 
sis is feasible and, while the immediate results appear to be good, the long-term 
results are still awaited. Our experience has convinced us that this procedure has 
a greater potential for success than vascular pedicle division or a staged orchio-
pexy. Microvascular techniques require considerable training and expertise. 
Consequently, testicular autotransplantation will probably have to remain for the 
foreseeable future a prerogative of specialised surgical centres. 
The aim of surgery on the undescended testis is not only to increase the 
chances of fertility at a later date and to diminish the possibility of malignant 
transformation but also, more importantly perhaps, to prevent possible abnormal 
psychosexual development in the child. Several publications on the psycholog-
ical effects of cryptorchidism on young children and pre- and post-pubertal 
adolescents with untreated non-descended testes have revealed that these 
patients suffer from psychological symptoms and disorders such as hyperactivity, 
learning difficulties, accident proneness, indecision, fear, immaturity, depres-
sion, passivity, a poor self-concept and confusion about body image and psycho-
sexual identity (Bios, 1960; Yazmajian, 1966; Cytryn et al., 1967; Manley, 1982). The 
chances of emotional instability are greatly increased with the absence of a father 
figure as a suitable object of identification, if the mother is dominant or if the 
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Table6.5. Results of testicular autotransplantation. 
Patient Age at Side Operation Follow-up Doppler Remarks 
no. operation time location and control of 
(years) (hours) condition of testicular 
the testis vessels 
Sir R 4 18 months ++ Unsuccessful conventional 
normal exploration 2 years previously 
2 II R 4 15 months ++ Long loop vas 
normal 
12f,- R 3! 14! months ++ Unsuccessful conventional 
high scrotal exploration 3 years previously 
normal 
4 R 4 12! months ++ 
normal 
llir R 12 months + 
indurated 
sperm. cord 
9f,- L 12 months ++ 
normal 
9-b L 2! 11 months ++ 
high scrotal 
normal 
3f, L !OJ- months ++ 
normal 
!Of, R 2l: 10 months ++ Contralateral atrophic testis 
normal after earlier orchiopexy with 
ligation of testicular vessels 
parents try to hide their fears about the future development of their son under a 
cloak of secrecy and false pretences. 
In view of the profound impactthat cryptorchidism may have on an individual 
patient, medical intervention appears to be indicated about the third year of life, 
before the condition exercises its pathogenic influence and the child becomes 
aware of his anatomical aberration by comparison with his peers, and before the 
external genitals play a major part in the enhancement of body image and 
psychosexual identity. 
When treatment of cryptorchidism takes place at a later age, almost inevitably a 
combination of anatomical correction and intensive psychotherapy is required 
(Bios, 1960). 
Thus, restoration of normal anatomy in every case of cryptorchidism deserves the 
highest priority and in order to achieve this goal every improvement in surgical 
technique in the treatment of the undescended testis deserves to be imple-
mented. 
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· b. Recent evaluation of the results of microvascular orchiopexy 
In the period 1982-1985, microvascular orchiopexy was carried out on 13 testes 
in 12 patients, including the patients mentioned above. Among the additional 
three boys, there was one with bilateral intra-abdominal testes. Initially, we 
limited the performance of microvascular orchiopexy to boys with unilateral 
high-lying testis. We first wanted to acquire sufficient expertise with this new 
modality, before tackling the bilateral condition. In this first attempt, the boy 
underwent two separate operations, one for each high-lying testis, with an 
interval of eight months. 
A follow-up examination of all12 boys was carried out in April1985. The clinical 
results of the 13 autotransplantations are given in table 6.6. In patient number 5, 
residual induration of the spermatic cord persisted for six months postoperatively 
(table 6.5., see 6.4.3.a.), which may have been secondary to a haemorrhage in the 
funicular region. This testis was now obviously atrophic. In patients 4, 8 and 11, 
the transplanted testis had likewise atrophied. Regarding patient number 2, the 
transplanted testis was well palpable 19 months postoperatively, but obviously 
lagged behind in growth compared with the contralaterat normally descended 
testis. The transplanted testis of patient number 12 had a volume of 2 ml about six 
months postoperatively, but at the follow-up examination 12 months later, the 
volume appeared to be reduced to approximately 1 ml, even though the testis 
was still palpable high in the scrotum. This reduction in testicular volume is a clear 
sign of partial atrophy. Discounting this testis, 4 of 13 transplanted testes (31%) 
have become completely atrophic. 
A closer look at the group of patients whose testes eventually atrophied after 
transplantation, clearly shows a connection between the occurrence of testicular 
atrophy and age at operation. With only one exception, all patients that were 
operated on under the age of seven years, suffered at least partial testicular 
atrophy. In the testes that had atrophied completely, pulsations in the testicular 
vessels were not longer audible, and therefore it seems likely that a disturbance of 
the circulation caused this testicular atrophy. The results also show that the 
transplanted testis may atrophy after some time has elapsed, i.e. longer than a 
year after the operation, as happened in patients 4 and 8. Consequently, it is no 
mere coincidence that the published series of microvascular testis transplantation 
with a long follow-up period (MacMahon et al., 1980; O'Brien et al., 1983; Upton 
et al., 1983) show a lower rate of ultimate success than the series with a shorter 
follow-up period (Martin and Salibian, 1980; Shioshvili, 1985). 
c. Indications for microvascular orchiopexy 
Long-term studies following microvascular testis transplantation are still lack-
ing and therefore the indications for this intervention can only be given with 
reservations. At this stage, the "success" of this rather new modality can only be 
judged from the postoperative position, volume and consistency of the trans-
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Table6.6. Results of testicular autotransplantation including recent operations. 
follow-up Doppler testis 
age at operation location. control of volume 
patient operation time condition of testicular [mil 
no. [years) side [hours) the testis vessels R L remarks 
5 5112 
32 months 
R 
" 
low scrotal 2 2 
normal 
1g months R testis small. 
2 11 R 
" 
low scrotal 3 11 
normal well palpable 
12 Bt12 3 1/2 
2g months 
3 R high scrotal 2-3 3 
normal 
6 7112 
26 months atrophic testis after 
" 
R 
" 
<1 2 
>12 months 
atrophic 
3112 
26 months atrophic testis after 
5 11 R 3 2-3 <1 indurated sperm. cord 
atrophic 
9 Bt12 
12 months after 12 months patient 
6 L 3 low scrotal 2-3 2-3 
"lost" for follow-up 
normal 
9 3'12 2 1t2 
25 months 
7 L high scrotal 3 3 
normal 
3 5'12 
22 months atrophic testis after 
B L 3 + 2 <1 
atrophic 15 months 
10 "'12 2 1t2 
23 months 
9 R low scrotal 2 2-3 
normal 
1B months bilateral intra-
10 12 R 3 low scrotal 6 ? abdominal testes 
normal R testis operated first 
12 a,12 2 1'2 
10 months L testis small 
10 L high scrotal + 6 3-'1 
normal compared to R one 
" 10/12 
B months atrophic testis after 
11 L 3 2 <1 
atrophic 3 months 
3 1'2 12 months 
after 6 months: 
12 5 R high scrotal + + 1-2 2 R testis 1 ml 
planted testis. The author's own experience with this operation and follow-up 
examination coupled with the aforementioned literature data, suggest the follow-
ing indications for the performance of microvascular orchiopexy: 
1. Bilateral high-lying testes- Microvascular orchiopexy is primarily indicated 
for patients with bilaterally undescended testes that are incapable of being 
brought to the scrotum with conventional orchiopexy. The alternative would 
be bilateral orchidectomy, which is obviously unacceptable. The two testes 
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should never be transplanted at one and the same operation, because of the 
risk of testicular atrophy. If this occurs in the one testis that is transplanted, 
the contralateral, also high-lying testis can still be treated "conservatively" 
(e.g. affixing the testis in a subcutaneous position outside the inguinal canal) 
in order to prevent castration of the patient. 
2. Second-stage operation- A second indication for this modality concerns the 
"second-stage operation" whereby the previously operated testis is still in-
capable of being brought to the scrotum. This depends on the extent of 
funiculolysis carried out at the first operation. If the funiculus has not been 
completely mobilized at the initial operation, a high funiculolysis at this 
second stage usually results in sufficient funicular length to achieve intra-
scrotal testis fixation without undue tension to the spermatic cord. However, 
microvascular anastomoses may still be required in some cases to achieve a 
scrotal position of the testis, for example when the mobilization of the 
funiculus at the first operation has been so complete that no further gain in 
length can possibly be obtained at the second operation. 
3. Unilateral high-lying testis- Indications for microvascular transplantation of 
the unilateral high-lying testis are very limited. If exploration reveals a testis 
that clearly lags behind in growth compared with the normally descended, 
contralateral testis, or if there are obvious, macroscopic signs of a loss in con-
tinuity between the testis and the epididymis, orchidectomy will be the 
proper treatment. If the macroscopic appearance of testis and epididymis is 
normal, particularly regarding testicular shape and size, then microvascular 
transplantation is justified. The psychosexual aspect is important and the 
situation should be weighed carefully and individually for each patient. 
4. Age at operation- Microvascular testis transplantation should at best not be 
carried out before the age of seven years (or even later in a boy that is small 
for size) when the diameter of the testicular vessels is such that the chance of 
a successful anastomosis is good. The ultimate results of testicular trans-
plantation carried out at an early age, have been poor and there seems to be 
no pressing indication for an early performance. Histological investigation 
has revealed that any abnormalities that are present when the boy is two years 
old remain unchanged practically up till the age of puberty (Hedinger, 1982). 
In summary 
If a standard orchiopexy carried out at an early age results in insufficient 
funicular length to bring the testis to the scrotum without causing tension (this is 
particularly rare at an early age), then the testis should be fixed in a subcutaneous 
position to be followed by microvascular testis transplantation when the boy is at 
least seven years old. It is imperative that a boy who has undergone autotrans-
plantation of one or both testes be followed for an extended period of time, at 
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least until a few years have elapsed after the onset of puberty. Regular checkups 
(1-2 times per year) are particularly essential in the peri puberal period, because in 
those years it wi II become apparent whether the growth ofthe transplanted testis 
is normal. If the growth of the transplanted testis lags behind in the presence of a 
normal contralateral testis, the abnormal testis had best be removed, whereupon 
a prosthesis may be inserted. Obviously such a decision can only be taken after 
extensive consultation with the boy and his parents. 
6.5. SURGICAL TREATMENT OF CRYPTORCHID BOYS AFTER UNSUCCESS-
FUL HORMONAL TREATMENT (LHRH NASAL SPRAY) 
6.5.1. Introduction 
Our double-blind, placebo-controlled study of the efficacy of LHRH nasal 
spray revealed a rate of success of only 18% for this hormonal treatment (see 
chapter 4). Consequently, the intranasal administration of LHRH seems to have a 
limited role in the treatment protocol for boys with undescended testes. Surgical 
treatment, consisting of orchispexy following funiculolysis, will still be required in 
most cases. Several workers (Illig et al., 1977; Hadziselimovic, 1982; Karpe et al., 
1983; Vander Meijden, 1984; Schwartz et al., 1985; Wit et al., 1985) have reported 
their findings at operation of boys that were treated unsuccessfully with LHRH. 
Only some of these authors (Karpe et al., 1983; Van der Meijden et al., 1984; 
Schwartz et al., 1985) ascribed the failure of hormonal treatment to the anato-
mical anomalies they found at surgery. Provided these anatomical anomalies are 
not too extensive, surgical treatment will usually be successful, resulting in a 
stable intrascrotal position of the testis. 
In the last few decades several publications have appeared concerning the 
functional results and complications of surgical treatment of cryptorchidism. 
Some large studies, notably those carried out by Gross and Replogle (1963), Daum 
et al. (1969), Cywes et al. (1979), and Lynch et al. (1982), include a follow-up period 
of 10-20 years after orchiopexy usually performed when these boys were over six 
years old. However, the recommendation of recent years has increasingly been 
to treat boys with undescended testes at an earlier age, preferably after the 
second year of life. As this treatment will generally involve surgery, more insight is 
required into the results and complications of orchiopexy carried out in younger 
children. 
The foregoing prompted a prospective study aiming to answer the following 
questions: 
1. Would surgery reveal anatomical anomalies in the boys whose testes did not 
descend despite two courses of LHRH nasal spray, which would explain the 
failure of hormonal treatment? 
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2. What is the postoperative course after orchiopexy and what postoperative 
complications may occur? 
3. What are the obvious results, as regards position and volume of the testis, 
immediately after orchiopexy and four months later? 
4. Would age at orchiopexy influence the answers to questions 2 and 3? 
6.5.2. Patients and methods 
The study population included none other than boys from our double-blind, 
placebo-controlled study of the efficacy of LHRH nasal spray in whom this 
treatment had failed. During the study period (August 1983 - April 1985) 170 
cryptorchid boys underwent surgery. Divided into the same three age groups as 
for the hormonal study (table 6.7.), there were 36 boys in group A (1-2 years), 72 in 
group B (2-6 years) and 62 in group C (6-12 years). There were 144 unilateral 
cryptorchids (69 rightsided, 751eftsided) and 26 bilateral cryptorchids (table 6.8.). 
The definitive protocol for this study was based on the evaluation of data from 
our pilot study (see 4.2.), which included registration of the most relevant normal 
and abnormal anatomical findings at orchiopexy. Various criteria played a part in 
the protocol. Significant differences were determined with the chi-square test. 
Table 6.7. Age division for 170 boys undergoing surgery after unsuccessful LHRH therapy. 
mean age and 
standard deviation 
age group boys at admission at surgery 
A (1-2 yrs) 36 1.5 ~ 0.3 2.1 ~ 0.'1 
B (2-6 yrs) 72 '1.1 ~ 1.1 '1.6 ~ 1.'1 
c (6-12 yrs) 62 6.5 ~ 1.5 g_z ~ 1.5 
Total 170 5.2 ~ 3.0 5.6 ~ 3.1 
Table 6.8. Laterality of cryptorchidism in 170 operated boys; number(%) of boys per age group. 
boys A B c 
unilateral R 69 ('11) 10 31 26 
unilateral L 75 (Ljlj) 21 31 23 
bilateral 26 (15) 5 10 11 
total 170 ( 100) 36 72 52 
a. Registration of most caudal testicular position immediately preceding 
surgery 
Immediately preceding the operation, the patient was examined under gener-
al anaesthesia and the most caudal position achieved with manipulation was 
defined as described in chapter 2 (2.3.2.b.): 
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- testis impalpable; 
- testis intermittently palpable (emergent inguinal position); 
- testis palpable outside inguinal ring; 
- testis palpable in scrotal entrance; 
- testis palpable high in scrotum. 
If the testis proved capable of manipulation into a stable scrotal position, albeit 
high, the operation was cancelled. 
b. Registration of peroperative testicular position 
Location of testis at operation was defined as follows: 
- testis absent: this could be a case of true anorchia whereby intraperitoneal 
exploration might reveal a blind-ending vas deferens or a funicular remnant, 
usually lying in the inguinal canal or just inside the annulus intern us ("vanish-
ing testis"); 
- intra-abdominal testis: the testis lies cranial to the annulus internus of the 
inguinal canal and is only located after opening the peritoneum; 
- testis in inguinal canal: the testis lies caudal to the annulus intern us, but cranial 
to the external annulus of the inguinal canal; 
- testis in external annulus: the testis lies in or just outside the annulus extern us 
and is located at exploration of the subcutaneous tissues caudal to the still 
unopened inguinal canal; 
- testis in superficial inguinat ectopic position: the testis is lying on the aponeu-
rosis of the external abdominal muscle under the subcutaneous fascia of 
Scarpa and is located at exploration of the subcutaneous tissues outside the 
inguinal canal. 
Scrotal entrance is not a stable testicular position, merely the result of testicular 
manipulation towards the scrotum. Consequently, no testis would be found in 
the scrotal entrance at operation. 
c. Registration of anatomical findings 
Processus vagina/is peritonei - the appearance of the processus vaginalis was 
defined as follows: 
- wide open- the testis can move freely in the open processus vaginalis, ranging 
from the most caudal position to intra-peritoneal; 
- slightly open- there is an open communication between the peritoneal cavity 
and that part of the processus vaginalis immediately surrounding the testis 
which always remains open, the tunica vaginalis; 
- closed -the processus vaginal is has been obliterated and instead of an open 
communication between peritoneal cavity and tunica vaginalis, there is 
merely a fibrous band alongside the funiculus. 
Epididymis- description of the epididymis was based on a modification of the 
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combined classification of Scorer and Farrington (1971L Marshall and Shermeta 
(1979) and Heath et al. (1984): 
- epididymis absent; 
- normal epididymis, caput and tail are firmly attached to the testis; 
- partial separation of epididymis, the epididymis extends more than twice the 
length of the testis, the head is normally attached, but the tail may be unat-
tached; 
- complete separation of epididymis, there is a macroscopical, total separation 
of the head of the epididymis and the testis, while the tail is lying free; 
- long-loop epididymis and vas deferens, the epididymis and vas are extended 
in a caudal direction (sometimes reaching the scrotum), while the testis is 
located in the inguinal canal or in the abdomen. 
Vas deferens- regarding the vas deferens, registration focused on any disrup-
tion of vasa-vasal or vasa-epididymal continuity. 
Testicular volume- after opening the tunica vaginalis, the volume of the testis 
was measured and registered in ml with a Prader orchiometer (see 2.3.1.) using 
the following scale: 1, 1, 11j2, 2, 21j2, 3 and> 3 mi. 
Cubernacular remnant- a gubernacular remnant was identified during surgery 
by pulling funiculus, testis and epididymis gently in a cranial direction at a point 
where these structures are still surrounded by the tunica vaginalis. If this traction 
resulted in an obvious shrinking of scrotal skin, an identifiable gubernacular 
remnant was registered. 
Cremaster muscle- we decided against a systematic description of the course 
of the cremaster muscle. The pilot study had revealed such a wide divergence in 
size and course of the individual cremasteric fibres that classification was hardly 
feasible. 
d. Surgical procedures and registration of results 
All operations were carried out by one and the same surgeon (F.H.). If there 
was a chance that no testis would be found at surgery, the boy and his parents 
were so informed beforehand. They were also told rightaway that if this suspicion 
proved correct, no testicular prosthesis would be inserted at this operation, as this 
could always be done at a later stage, even after the onset of puberty. Depending 
on the findings at operation, one of the following procedures was carried out: 
- orchidectomy or excision of funicular remnant; 
- funiculolysis and orchiopexy, consisting of: 
- standard orchiopexy with fixation of testis in a scrotal pouch (Schoemaker 
technique as described under 6.5.3.d.L or 
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- subcutaneous fixation of testis outside the inguinal can at or 
- orchiopexy with transection of the testicular vessels (Fowler-Stephens 
technique as described under 5.5.3. and 6.4.1.), or 
- microvascular testis transplantation (Silber technique as described under 
5.5.4. and 6.4.3.). 
All stitching was done with resorbable sutures. The inguinal incisions were 
closed intracutaneously with continuous sutures, while the scrotal incisions were 
closed transcutaneously with interrupted sutures. 
Special forms, specifically designed for this purpose, were used to register 
surgical findings and results related to type of surgical intervention performed in 
each individual patient. A sample form is included in the appendix to chapter 2. 
e. Registration of postoperative complications 
Only complications that occurred within the first two weeks after operation 
were registered as postoperative complications. 
Wound infections- these were divided into three subsets: 
- redness and swelling of the wound, no pus visible; 
- pus visible in the wound; 
- other complications (haematoma, dehiscence, etc.). 
Duration of hospital stay- for a standard orchiopexy, hospital stay usually lasted 
from admission on the day before the operation to discharge on the morning 
after. The number of times that a longer stay in hospital was required was duly 
registered. For a "nonstandard" orchiopexy, the duration of hospital stay varied 
and as such was not included in the evaluation. 
f. Registration during follow-up period 
All surgical patients were recalled for a follow-up examination at least four 
months after the surgical intervention. This examination served mainly to register 
testicular volume and position, enabling a comparison with the peroperative 
registration of these parameters. 
6.5.3. Results 
a. Most caudal testicular position immediately preceding surgery 
Not one single testis of this study population was capable of manipulation into 
a stable scrotal position at the final pre-operative examination under general 
anaesthesia. Consequently, all170 boys (with 196 undescended testes) under-
went surgical intervention, during which no evidence was found of any effect of 
the earlier hormonal treatment. The most caudal position achieved immediately 
preceding the operation is listed per age group in table 6.9. 
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Table 6.9. Most caudal position of testis before operation; number(%) of testes per age group. 
A+B+C A B c 
not palpable 29 ( 15) 7 17) 15 ( 18) 7 ( 10) 
emergent inguinal 9 ( 'I) 2 5] 
" 
( 5] 3 ( 'I] 
external annulus 115 ( 59] 28 68] 55 ( 67] 32 ( '1'1] 
scrotal entrance 39 ( 20] 'I 10] 7 ( 9] 28 ( 38] 
high scrota I 'I ( 2] 0 OJ 1 ( 1] 3 ( 'I] 
Total 196 (100] '11 (100] 82 ( 100] 73 (100] 
b. Peroperative testicular position 
Table 6.10. gives the testicular position found at operation per age group. The 
testis was absent in 15 cases, including seven cases of (unilateral) true anorchia, 
and eight "vanishing testes". Regarding the testes that were present, there was a 
lack of even distribution for the three age groups as far as location was concerned. 
Group A had a higher percentage of testes in the inguinal canal than either B or 
C (34% vs 26% or 16%), while there were comparatively more testes in a superficial 
inguinal, ectopic position in group C, than in either A orB (40% vs 27% or 24%).1n 
contrast, the testes located in the annulus externus, outside the inguinal canal, 
did not show a clear difference between the age groups. The number of testes 
located intra-abdominally was too small for a comparison between age groups, 
although group C had by far the lowest percentage. 
Table 6.10. Peroperative testicular position; number(%) of testes per age group. 
A+B+C A B c 
anorchia 7 ( 'I] 2 ( 5] 3 ( 'I] 2 ( 3] 
funicular remnant 8 ( 'I] 2 ( 5] 'I ( 5] 2 ( 3] 
intra-abdominal 8 ( 'I] 2 ( 5] 5 ( 6] 1 ( 1] 
inguinal canal '17 ( 2'1) 1'1 ( 3'1] 21 ( 26) 12 ( 16] 
external annulus 66 ( 3'1) 10 ( 2'1] 29 ( 35] 27 ( 37] 
superficial inguinal 60 ( 30) 11 ( 27] 20 ( 2'1] 29 ( '10] 
ectopia 
Total 196 ( 100) '11 (100) B2 (100) 73 (100] 
c. Anatomical findings 
Processus vagina/is - table 6.11. lists the condition of the processus vaginalis 
found at operation per age group. There were significant differences between 
the three groups. A wide open processus vaginalis was found far more frequently 
in age groups A and B (54% and 56%) than in group C (26%). The processus 
vaginalis was obliterated in 47% of the testes in group C, but a closed processus 
vaginal is was significantly less frequent in the younger age groups (17% in A and 
20% in B). 
Epididymis- as shown in table 6.12.a., an abnormal epididymis was significantly 
more frequent in the groups A and B (58% and 56%) than in group C (25%). 
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Table 6.11. Condition of processus vaginalis in relation to number (%) of undescended testes per 
age group. 
A+B+C A B c 
wide open B7 ( 'I'll 22 ( 5'1] '16 ( 56) 19 ( 26) 
slightly open 52 ( 27) 12 ( 29) 20 ( 2'1) 20 ( 27) 
closed 57 ( 29) 7 ( 171 16 ( 20) 3'1 ( '171 
Total 196 (100) '11 (100) 62 (100) 73 (100) 
Table 6.12•. Condition of epididymis in relation to number (%) of undescended testes per age 
group. 
A+B + c A B c 
absent 15 B) 
" 
10) 7 9) 
" 
51 
normal 93 '171 13 32) 29 35) 51 70) 
abnormal BB '15) 2'1 56) '16 56) 16 25) 
Total 196 (100) '11 (100) B2 (100) 73 (100) 
Table 6.12b. Type of epididymal anomaly in relation to number(%) of undescended testes per age 
group. 
A+ B + C A B c 
absent 15 B) 
" 
( 10) 7 9) 
" 
5) 
normal 93 '171 13 ( 32) 29 35) 51 70) 
partial separation 66 3'1) 20 ( '19) 3'1 'Ill 12 17) 
complete separation 12 6) 3 ( 7) 5 61 
" 
51 
long loop 10 5) 1 ( 2) 7 9) 2 3) 
Total 196 (100) '11 (100) 62 (100) 73 [100) 
Figure 6.9. Epididymal deformities. Relation between testis and epididymis: normal. 
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Figure 6.10. Epididymal deformities. Relation between testes and epididymis: partial separation. 
Figure 6.11. Epididymal deformities. Relation between testis and epididymis: complete separation. 
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Table 6.12.b. shows the diversity of epididymal abnormalities found at surgery, to 
some extent depicted in figure 6.9., 6.10. and 6.11. 
Vas deferens- no disruption of vaso-vasal or vasa-epididymal continuity was 
ever found. 
Testicular volume- a testicular volume exceeding 2 ml was comparatively more 
frequent in group C than in the groups A and B (table 6.13.). Markedly divergent 
testicular volumes as seen in compensatory testicular hypertrophy, were never 
registered. 
Gubernacular remnant- here again, age group C differed from the other two 
age groups; the percentage of an identifiable gubernacular remnant amounted 
to 45% in age group C, against 22% in group A and 24% in group B (table 6.14.). 
Table6.13. Testicular volume; number(%) oftestes per age group. 
A+B+C A B c 
absent 15 [ B) 4 [ 10) 7 [ B) 4 [ 5) 
< 1 ml 9 [ 4) 4 [ 10) 3 [ 4) 2 [ 3) 
1 ml 17 [ 9) 7 [ 171 9 [ 11) 1 [ 1) 
1.5 ml 90 [ 46] 23 [ 56) 46 [ 56) 21 [ 29) 
2 ml 55 [ 2B) 3 [ 7) 14 [ 17) 3B [ 52) 
2.5 ml 10 [ 5) 0 [ 0) 3 [ 4) 7 [ 10) 
Total 196 [100) 41 [ 100) B2 [100) 73 [100) 
Table 6.14. Presence ofgubernacular remnant in relation to number(%) of undescended testes per 
age group. 
A + B + C A B c 
identifiable 62 [ 32) 9 [ 22) 20 [ 24) 33 ( 45) 
not identifiable 134 [ 6B) 32 [ 7B) 62 [ 76) 40 [ 55) 
Total 196 (100) 41 (100) B2 [100) 73 (100) 
Cremaster muscle - a clear distinction of individual fibres of the cremaster 
muscle was only possible if the testis had passed the inguinal canal. While these 
fibres could usually be distinguished surrounding a testis in the annulus extern us, 
they were particularly conspicuous in case of superficial inguinal ectopia. The 
cremasteric fibres surrounding such a testis were markedly divergent in size and 
fanned out over the tunica vaginalis along the distal part of the funiculus. A 
systematic registration of these fibres was not feasible because of dissimilarity in 
course as well as development. 
d. Surgical procedures and rates of success (table 6.15.) 
Except for a strongly developed vena cremasterica, there were no particular 
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Table 6.15. Results of operation in relation to procedure; number(%) of undescended testes per age 
group. 
A+B+C A B c 
anorchia 7 [3.5) 2 [ 5) 3 [ 'I) 2 [ 3) 
no therapy 
excision B [ 'I) 2 [ 5) " [ 5) 2 [ 3) funicular remnant 
standard orchiopexy 
'16 23) 15 36) 16 22) 13 18) high scrotal 
standard orchiopexy 130 66) 20 qg) 55 671 55 75) low scrotal 
Fowler Stephens 2 [ 1) 0 [ OJ 1 [ 1) 1 [ 1) high scrotal 
testis fixation 2 [ 1) 2 [ 5) 0 [ OJ 0 [ 0) 
outside inguinal canal 
microvascular 1 [0.5) 0 [ 0) 1 [ 1) 0 [ 0) testis transplantation 
Total 1g6 [100) '11 [100) 82 [100) 73 [100) 
Figure 6.12. Macroscopical aspect of funicular remnant. 
features that either facilitated or complicated operation. Orchidectomy was 
never performed. In the seven cases of true anorchia, surgery merely consisted of 
extensive intraperitoneal and extraperitoneal exploration. A funicular remnant 
was identified and excised in the eight cases where the testis had vanished. Figure 
6.12. is a macroscopic presentation of such an excised funicular remnant. The vas 
deferens and testicular vessels ended blindly in these tissue remnants. Microscop-
ically, the remnants consisted mainly of epididymis and connective tissue with 
calcifications, in the absence of any testicular tissue. These histological findings 
support the hypothesis that a "vanishing testis" is secondary to torsio testis 
occurring at a very early age, possibly even ante natally. In order to prevent torsion 
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Figure 6.13. Standard orchiopexy after Schoemaker. 
A. After routine orchiopexy via an inguinal approach, a scrotal pouch is created between the tunica 
dartos and the scrotal skin. 
B. With two catgut retentionsutures the tunica dartos is secured and a small incision is then made 
between these sutures, so that the assisting finger becomes visible. A clamp is passed through 
this opening which pushes the finger away and then becomes visible in the wound. 
C. This clamp carefully takes hold of the tunica albuginea of the testis. Subsequently the testis is 
pulled down through the scrotal opening. 
D. After the catgut retentionsutures are stitched to the membranous layer covering the testis, two 
small one-pronged retractors are placed in the corners of the scrotal wound and the testis is 
placed in the space between the tunica dartos and the scrotal skin. 
E. The scrotal skin is closed with a few thin catgut sutures. Closure ofthe fascia ofthe inguinal canal 
and the subcutaneous fascia with polyglycolic acid sutures. The skin of the inguinal incision is 
closed with a continuous intracuticular polyglycolic acid suture. 
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of the single remaining testis, the contralateral, fully descended testis was attach-
ed to the tunica dartos (window orchiopexy) in all eight boys. 
In the 181 operations that did reveal a testis, the funiculus was first dissected 
free from the processus vaginalis, to obtain sufficient funicular length for an 
intrascrotal fixation of testis. This was followed by funiculolysis, which was gener-
ally extensive and except for the ectopic testes reached a high retro-peritoneal 
level. In case the testis was ectopic, there were obvious fibrous connections 
(gubernacular remnants) between on the one hand tunica vaginalis and caudal 
epididymis, and on the other hand pubic bone and scrotal entrance. Dissection 
of these fibrous connections, together with Scarpa's fascia and cremasteric fibres 
usually sufficed. If the processus vaginal is had not been obliterated, this also had 
to be dissected. Dissection oft he cremasteric fibres added very little to the length 
of the funiculus. 
A standard orchiopexy with fixation of the testis in a scrotal pouch according to 
Schoemaker (figure 6.13.) was performed on 176 testes (89% of total number), 
resulting in a low scrotal position for 130 testes (66%) altogether. A non-standard 
technique was required in three cases, twice consisting of Fowler-Stephens 
procedure and once of microvascular testis transplantation, all resulting in a high 
scrotal position. In one three year old bilateral cryptorchid, it proved impossible 
to get sufficient funicular length to achieve a scrotal position for either testis and 
therefore these testes were affixed subcutaneously outside the inguinal canal. 
Further descent would be attempted at a second-stage operation some time in 
the future. 
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6.5.4. Relationship between peroperative testicular position and other findings 
By means of cross-sectional tables, we looked for any relationship between the 
peroperative testicular position and the diverse findings. For clarity's sake, we did 
not differentiate per age group in these cross-sectional tables. 
a. Peroperative testicular position in relation to most caudal position imme-
diately preceding operation (table 6.16.) 
Cross-referencing the most caudal testicular position immediately preceding 
operation with the position found at surgery, supplied information regarding the 
mobility of these undescended testes. It appeared that the 47 testes located in the 
inguinal canal were rather mobile; 3 testes had even been capable of manipula-
tion to the scrotal entrance, while 30 had been palpated in the annulus extern us 
preceding surgery. These 30 testes were found to be lying very close to the 
annulus externus, which explains the pre-operative finding. The remaining 14 
testes were located high in the inguinal canal, approximating the annulus inter-
nus and these testes had at best been intermittently palpable. The tunica vaginalis 
of all47 testes ended at the level of the annulus extern us. 
Of the 66 testes located in the annulus externus, 51 had not been capable of 
descending further than this exit of the inguinal canal before the operation. 
Thirteen of these testes had been manipulated to the scrotal entrance and two 
even high into the scrotum. For 52 testes the distal part of the tunica vaginal is was 
found at the level of the pubic bone. In 12 cases it extended towards the scrotum, 
although never reaching deep into the scrotum. The 60 testes that were located in 
a superficial inguinat ectopic position appeared to be very mobile; for 25 of these 
testes mobility extended to the scrotal entrance. The scrotal entrance itself was 
never obstructed in these cases; it appeared that the tunica vaginal is enveloping 
the rather mobile testis was the hampering factor. This was due to the fact that the 
tunica vaginal is ended at best right at the scrotal entrance over the os pubis, never 
extending to the bottom of the scrotum. Regarding the remaining 35 ectopic 
testes, surgery revealed a narrowing, sometimes even an actual obstruction, of 
the scrotal entrance. This was caused by Scarpa's fascia, which was stretched 
Table 6.16. Peroperative testicular position in relation to most caudal position before operation; 
number of testes. 
most caudal testis position before operation 
not emergent external scrotal high 
peroperative testicular position total palpable inguinal annulus entrance scrotal 
anorchia 7 7 0 0 0 0 
funicular remnant 8 7 1 0 0 0 
intra-abdominal B 7 0 1 0 0 
inguinal canal 47 8 6 30 3 0 
external annulus 66 0 2 qg 13 2 
superficial inguinal ectopia 60 0 0 35 23 2 
Total 196 29 9 115 39 
" 
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tautly across the os pubis in its superficial course, leaving no room for the 
subcutaneously located testis to move to the scrotum. Instead of being contin-
uous with the tunica dartos, which would be the normal course, Scarpa's fascia 
frequently ended at least partially at the os pubis, causing an obstruction or at 
least a narrowing of the scrotal entrance. This anatomical anomaly was frequently 
found in association of another abnormality, viz. a gubernacular remnant extend-
ing like a cord from the epididymis and testis to end on the os pubis or in the 
scrotal entrance also hampering testicular descent. 
The registration of a most caudal position outside the inguinal canal (in the 
annulus externus) for one of the eight testes located intra-abdominally, was 
obviously based on a faulty observation. 
b. Peroperative testicular position in relation to condition of processus vagi-
na/is (table 6.17.) 
Four of eight testes located intra-abdominally were associated with a wide 
open processus vaginal is which extended into the inguinal canal. No such exten-
sion was found in the other four cases. All47 testes located in the inguinal canal 
were floating rather freely in a wide open processus vaginalis, the most caudal 
part of which was always found at the level ofthe annulus extern us. As mentioned 
in section 6.5.3.c., there was a clear correlation between age and frequency of this 
testicular position: age group A> B >C. Over half (35 of 66) the testes located 
outside the inguinal canal, in the annulus externus, were also surrounded by a 
wide open processus vaginalis. In the remaining 31 cases the processus vaginal is 
had at least partially been obliterated. With one exception, all testes that had 
passed the inguinal canal and were located in a superficial inguinal, ectopic 
position, were associated with a slightly open or completely obliterated proces-
sus vaginalis. A slightly open processus vaginal is was particularly frequent in age 
group A; the processus vaginalis was either slightly open or completely obliterat-
ed in age group B, while in age group C the processus vaginalis was always 
obliterated. 
Table 6.17. Peroperative testicular position in relation to condition of processus vaginalis; number 
of testes. 
processus vaginalis 
wide slightly 
peroperative testicular position total open open closed 
anorchia 7 0 0 7 
funicular remnant B 0 B 0 
intra-abdominal B 
" 
0 
" inguinal canal '17 '17 0 0 
external annulus 66 35 19 12 
superficial inguinal ectopia 60 25 3'1 
Total 196 87 52 57 
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c. Peroperative testicular position in relation to condition of epididymis 
As mentioned in section 6.5.3.c., anomalies of the epididymis were often 
noted. The frequency in relation to testicular position (table 6.18.) amounted to 
six out of eight (75%) intra-abdominal testes, 40 out of 47 (85%) testes located in 
the inguinal canat and 37 out of 66 (56%) testes located in the annulus extern us. In 
contrast, only five out of 60 (8%) testes in a superficial inguinal, ectopic position 
were associated with an abnormal epididymis. 
Table 6.18. Peroperative testicular position in relation to condition of epididymis; number oftestes. 
epididymis 
partial complete long 
peroperative testicular position total absent normal separation separation loop 
anorchia 7 7 0 0 0 0 
funicular remnant B B 0 0 0 0 
intra-abdomina I B 0 2 4 0 2 
inguinal canal 47 0 7 26 B B 
externa I annu I us BB 0 2g 31 6 0 
superficial inguinal ectopia 60 0 55 5 0 0 
Total 1g6 15 g3 66 12 10 
d. Association of abnormal epididymis and open processus vagina/is 
It appeared that an abnormal epididymis was often associated with a wide open 
processus vaginalis (table 6.19.). This association was found most frequently when 
the testis was located in the inguinal canaL 
Table 6.19. Condition of epididymis in relation to condition of processus vaginal is; number oftestes. 
processus vaginalis 
wide slightly 
epididymis total open open closed 
absent 15 0 B 7 
normal g3 12 34 47 
partial separation BB 53 10 3 
complete separation 12 12 0 0 
long loop 10 10 0 0 
Total 1g6 87 52 57 
e. Peroperative testicular position in relation to testicular volume (table 6.20.) 
Relatively the largest testicular volume (2 ml and over) was registered for testes 
lying outside the inguinal canaL These testicular locations (annulus extern us and 
superficial inguinal ectopic) were most frequent in age group C. 
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Table6.20. Peroperative testicular position in relation to testicular volume; number of testes. 
testicular volume 
peroperative testicular position total absent <1 ml 1 ml 1.5 ml 2 ml 2.5 ml 
anorchia 7 7 D D D D D 
funicular remnant B B D D D D D 
intra-abdominal B D 2 1 4 1 D 
inguinal canal 47 D 3 5 32 7 2 
external annulus 66 D 3 5 37 18 
superficial inguinal ectopia 60 D 6 17 29 7 
Total 196 15 9 17 90 55 1D 
f. Peroperative testicular position in relation to gubernacular remnant (table 
6.21.) 
With one exception, a gubernacular remnant was only identifiable if the testis 
had passed the inguinal canaL For 61 out of 126 testes located outside the inguinal 
canat it proved possible to mobilize a distinct gubernacular remnant 
Table 6.21. Peroperative testicular position in relation to gubernacular remnant; number of testes. 
gubernacular remnant 
identifiable 
peroperative testicular position total yes no 
anorchia 7 D 7 
funicular remnant B D B 
intra-abdominal B D B 
inguinal canal 47 1 46 
external annulus 66 22 44 
superficial inguinal ectopia 60 39 21 
Total 196 62 134 
g. Peroperative testicular position in relation to success of surgical interven-
tion 
Table 6.22. shows the relationship between peroperative testicular position 
and result of diverse surgical procedures. Excluding the 15 cases where surgery 
revealed absence of testis, all but two testes became intrascrotaL These two testes 
(see section 6.5.3.d.) had been intra-abdominaL The remainder of the intra-
abdominal testes were successfully fixed in the scrotum, once requiring dissec-
tion of testicular vessels (Fowler-Stephens procedure) and once requiring micro-
vascular transplantation. All 47 testes located in the inguinal canal were fixed in a 
predominantly low scrotal position. Dissection of testicular vessels was required 
for one of these testes, resulting in a high scrotal position. The majority (50 of 66) 
of the testes located outside the inguinal canal, in the annulus externus, were 
successfully placed in a low scrotal position without causing funicular traction. 
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For the remaining 16 testes, the result was a high scrotal position. The result was 
even better for the testes located in a superficial inguinal, ectopic position; a low 
scrotal position was achieved in all but five of these testes. 
Table 6.22. Peroperative testicular position in relation to surgical procedure and results; number of 
testes. 
surgical procedure and result 
Fowler- microvasc. fixation 
peroperative excision standard orchiopexy 
Stephens transpl. 
outside 
location exploration funicular high loW high high inguinal 
of testis total only remnant scrotal scrotal scrotal scrotal canal 
anorchia 7 7 0 0 0 0 
vanishing testis B 0 B 0 0 0 
intra-abdominal B 0 0 3 1 1 2 
inguinal canal 47 0 0 22 24 1 0 0 
external annulus 66 0 0 16 50 0 0 0 
superf. ing. ectopia 60 0 0 5 55 0 0 
total 196 7 B 46 130 2 2 
6.5.5. Postoperative course 
a. Wound-related complications 
Complications in connection with wound healing occurred in 9 of the 170 (5%) 
operated boys (table 6.23.). Three boys, two with a one-sided operation, one 
two-sided, had excessive swelling of the wound which was red and painful. Even 
so, wound healing proceeded normally. Wound healing was disturbed in six 
cases, secondary to wound dehiscence in one boy, and to wound drainage in five 
other boys. Wound drainage was required because of an abscess in three of these 
boys and to haematoma in the other two. All these wound-related complications 
occurred in the inguinal incisions. The scrotal incisions all healed without distur-
bance. 
Table 6.23. Wound-related complications; number of testes per age group (number of boys). 
Wound related complications 
Redness and wound swelling 
Pus visible in wound 
Haematoma 
'Wound dehiscence 
Tot;> I 
*in one boy 
b. Duration of hospital stay 
A+B+C 
" [3) 
3 (3) 
2 (2] 
1 [1) 
10 (9) 
A 
1 
2 
1 
B c 
All but two of the 170 boys that underwent a testicular operation left the 
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hospitat in an ambulatory condition, the day after the operation. The longer 
hospital stay of the other two boys was caused by wound-related complications. 
Dehiscence of the wound occurred in one of them, while the other one develop-
ed haematoma on one side and therefore it took longer for him to be ambulatory. 
However, both boys were released from hospital within four days after surgery. 
6.5.6. Follow-up period 
Within the study period it was possible to re-examine 141 (83%) ofthe 170 boys, 
from four to ten months after the operation. All but the boys in whom surgery 
had revealed an absence oftestis, were recalled for a checkup. Figure 6.14. gives, 
side by side, the position of the testis achieved at operation and the position 
noted at least four months postoperatively. At this follow-up examination, it 
appeared that 5 (4%) of the 114 testes that were surgically placed low in the 
scrotum, had now assumed a position high in the scrotum, while one testis was no 
longer in the scrotum, but palpable in the inguinal region instead. It was even 
more remarkable, that 25 (51%) of the 46 testes placed high in the scrotum at 
orchiopexy, were now obviously low in the scrotum. The two testes affixed 
outside the inguinal canal, remained well palpable in that same position. 
With the aid of Prader's orchiometer, the volume of the operated testes was 
measured at the follow-up examination and compared with the peroperative 
registration (figure 6.15.). Three (2%) of the 162 testes appeared to have become 
atrophic. A slight increase of testicular volume was noted in 15 testes, which can 
hardly be significant in view ofthefactthat at follow-up the volume was measured 
through the scrotal skin, which was not the case at operation. 
While neither the boys nor their parents were asked specifically what they 
thought of the hospital stay or the operation, it was remarkable that many of them 
told us of their own accord that they had gone through the whole experience 
with little discomfort. Particularly regarding the boys that were still very young at 
operation, the parents said that they had often been hard put to curb their son's 
activity when he came home from the hospital! 
TESTIS POSITION A B c A+B+C 
INGUINAL REGION • 0 1 00 
HIGH SCROTAL 8@ 
7 0 LOW SCROTAL 8 08 
Figure6.14. Follow-up findings; testicular position immediately after • and 4-10 months after 
0 orchiopexy; number of testes per age group. 
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Figure 6.15 Follow-up findings; testicular volume immediately after e and 4-10 months after 0 
orchiopexy; numer of testes per age group. 
6.5.7. Discussion 
We found various anatomical anomalies that might explain the failure of 
testicular descent and which might also account for the failure of hormonal 
treatment. These anomalies can be summarized as follows: 
1. An underdeveloped processus vagina lis extending no further than the annu-
lus extern us. This was found in 55 of the 196 testicular operations, concerning 
47 testes in the inguinal canal and all eight intra-abdominal testes. The 
associated epididymal anomalies and the lack of obliteration of the processus 
vaginalis often found in these cases, demonstrate a true disruption of the 
developmental process of testicular descent. 
2. Testes lying in the annulus externus or on top of the inguinal canal in 
association with: 
- a mechanical obstruction (gubernacular remnant or abnormal course of 
Scarpa's fascia); this was the case in 35 of the 60 testes found in a superficial 
inguinal, ectopic position; 
- a tunica vaginal is ending cranial to the scrotal entrance; the tunica vaginal is 
of 52 of the 66 testes located in the annulus extern us ended at the distal level 
of the os pubis. 
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If we include the 15 explorations revealing the absence of a testis, then we come 
to a total of 157 of the 196 testicular operations (80%), whereby anatomical 
anomalies were found that would explain the failure of testicular descent, let 
alone failure of LHRH treatment. It is difficult to find an answer to the question 
which now arises, whether the other 39 operations were justified. Would these 39 
testes have descended of their own accord at the onset of puberty? The retro-
spective evaluation of previous testicular position (see 4.3.5.) revealed that some 
ofthese testes had at one point been observed in a scrotal position. However, this 
information was received after the operation had been carried out, while none of 
these testes could possibly have been described as retractile at the pre-operative 
examination. Even under general anaesthesia, these testes could not be manipu-
lated into a stable scrotal position. That finding certainly justified surgery! 
6.5.8. Conclusions 
The questions posed in the introduction may be answered as follows: 
1. In 80% of the testicular operations, surgery revealed anatomical anomalies 
that explain the failure of LHRH treatment. The most common of these 
anomalies was incomplete development of the processus vaginal is, in that it 
did not extend into the scrotum, and an abnormal course of the subcuta-
neous fascia of Scarpa, which caused partial or complete obstruction of the 
scrotal entrance, preventing testicular descent into the scrotum. The latter 
anomaly was often found in association with a gubernacular remnant which 
also formed an obstruction to testicular descent. 
2. For most of our 170 patients the postoperative course was uncomplicated. 
Wound-related complications occurred in 10 of the 196 operations carried 
out (5%), usually secondary to infection. The wound-related complications 
had no effect on subsequent position or volume of the testis (Infection of the 
wound never caused testicular atrophy). 
3. In 179 of the 196 operations the testis could be placed in either a high (49) or 
low (130) scrotal position. At the follow-up examination (4-10 months post-
operatively), it appeared that two per cent of the operated testes had atro-
phied. Approximately half the number of testes that had been affixed high in 
the scrotum were found in a low scrotal position at follow-up. 
4. The age at which orchiopexy was carried out did not influence the operative 
results as regards position or volume of testis, postoperative complications, 
or the incidence of testicular atrophy. Particularly where the younger boys 
were concerned, neither the boys nor their parents had experienced any 
hardship in connection with the operation. 
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GENERAL DISCUSSION OF SURGICAL ASPECTS AND 
TREATMENT OF CRYPTORCHIDISM 
REGARDING RETRACTilE TESTES 
The consensus of opinion is that retractile testes do not require any treatment, 
because these testes assume a permanent intrascrotal position around puberty. 
Consequently, no follow-up would be required for a boy with a retractile testis 
(Woolley, 1979; Schoorl, 1982; Hirasing et al., 1982; Snick, 1984). However, there 
are clear indications that this supposition is not always correct. Villumsen and 
Zachau (1966), Privat (1978) and Atwell (1985) all noted that some testes that had 
been in a scrotal position, albeit retractile, were no longer in the scrotum after a 
number of years. Wyllie (1984) reported that 42 testes out of 100 that he himself had 
diagnosed as retractile, did require surgery five years later when a follow-up 
examination revealed that these testes had ascended. He also found that the 
volume of 27 of these 42 testes had decreased. He did not mention the surgical 
findings. Atwell was the only one to describe a possible cause of this testicular 
ascent. In a number of cases where the testis had ascended, he would find an open 
processus vaginalis at operation. It seemed feasible that in the course of further 
growth of the abdominal wall, for example, this open vaginal process had gra-
dually become part of the peritoneum thereby lifting up the testis. 
Boys with retractile testes do not require treatment, but they should be followed 
until puberty as their retractile testes may fail to assume a permanent scrotal 
position. 
REGARDING IMPAlPABlE TESTES 
Impalpable testes are testes that are either located in the abdomen or in the 
inguinal canal. Histologically, these testes are generally more markedly divergent 
from normally descended testes than the undescended testes that have passed the 
inguinal canal. In contrast, hormonal function of the impalpable testis is usually 
normal. In case of bilateral impalpable testes, the presence of testicular tissue 
should first be ascertained by means of an HCG test, before surgical exploration is 
initiated. 
Hormonal treatment of impalpable testes is pointless. 
An immediate surgical approach has the advantage of having a diagnostic as well 
as a therapeutic function. Orchiopexy can generally be carried out at the initial 
surgical exploration. Inguinal exploration is clearly preferable to various nonsur-
gical, but frequently invasive, diagnostic evaluations that have been proposed in 
the literature, for the following reasons: 
Inguinal exploration enables a more efficient examination of the anatomical 
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structures, while the peroperative findings enable a justified decision for orchio-
pexy or orchidectomy. 
Inguinal exploration is much more economical than, for example, CT-scanning, 
angiography or laparoscopy, because these procedures generally do not render 
an inguinal exploration dispensable. 
The impalpable testis can generally be brought into the scrotum with a standard 
orchiopexy, provided the funiculus is extensively mobilized and medialized. A 
special surgical technique is seldom required. 
Orchiopexy with transection of the testicular vessels (Fowler-Stephens procedure) 
is only indicated in the presence of a "long loop" vas deferens and epididymis. 
Sometimes orchiopexy has not resulted in a scrotal position of the testis, requir-
ing a second operation. It may be that the initial operation did not include 
(sufficient) retroperitoneal mobilization of the funiculus. In that case the second 
operation should include extensive funiculolysis, which generally results in a 
scrotal position of the testis. 
A second-stage, conventional orchiopexy is only indicated if there is uncertainty 
regarding the extent of the funiculolysis carried out at the first operation. 
lfthe first operation did include adequate retroperitoneal mobilization without 
resulting in a scrotal position of the testis, then the second-stage procedure should 
involve autotransplantation of the testis. 
A second-stage procedure is pointless, unless microvascular techniques can be 
employed to transplant the testis at the second operation. 
Employing these microvascular techniques is also indicated in case of bilateral 
impalpable testes, whereby it is essential to operate one testis to begin with. Once 
that operation has proved successful, the same procedure should be carried out 
on the contralateral high-lying testis. If the first operation has resulted in testicular 
atrophy, then the contralateral testis should be left in an undescended (subcuta-
neous inguinal) position. 
In case of bilateral impalpable testes, hormonal function should always prevail 
over the achievement of a scrotal position of the testis. 
In agreement with the literature, we had relatively poor results with autotrans-
plantation of the testis in very young boys. When the boy was under seven years of 
age at the time of operation, the autotransplanted testis seemed more prone to 
atrophy. 
It is safer to carry out a microvascular orchiopexy after the seventh year of life. 
No clear indications can be given for orchidectomy. Such an intervention 
requires an individual approach; there are no general guidefines. A combination 
of various factors, such as psyche and age of the patient, extent of testicular 
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atrophy, continuity of epididymis and testis, length of the testicular vessels, will 
indicate whether orchidectomy should be performed. 
There are no guidelines for the decision to carry out an orchidectomy, but bilateral 
orchidectomy should be avoided at all cost. 
If orchidectomy has taken place, a testicular prosthesis may be inserted. Here 
again, there are no guidelines, although it seems preferable to wait until the boy 
has reached puberty. An adult-sized prosthesis can then be inserted rightaway and 
the boy himself can be involved in the decision. 
The treatment protocol for prepuberal boys with impalpable undescended testes 
is schematically presented in figure A. 
ATROPHY 
INTRA-ABDOMINAL OR 
HIGH INGUINAL UNILATERAL 
Figure A. Schematic presentation of surgical protocol for boys with impalpable testes. 
REGARDING SURGICAL TREATMENT OF UNDESCENDED TESTES IN GENERAL 
The anatomical anomalies found in this study should be viewed in the light of 
the normal process of testicular descent (chapter 1). Even though the mystery 
surrounding testicular descent has not been cleared up completely, several factors 
have been established. The epididymis plays a major part in testicular descent as 
demonstrated extensively by Hadziselimovic (1983c), Mininberg and Schlossberg 
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(1983), while the important role of hormonal influences has also become obvious 
(Wensing et al., 1980; Hadziselimovic, 1982). In his embryological study, Back-
house 1981) demonstrated that testicular descent can only proceed without 
disruption if the processus vaginalis extends into the scrotum (see 1.3.2., figure 
1.5.). 
Testicular descent requires ingrowth of the processus vaginal is into the guberna-
culum, which is a mesenchymal mass filling the scrotum. 
Once the testis has descended, the gubernaculum goes into regresssion (Wen-
sing et al., 1980). The actual descent of the testis occurs during the last few months 
of fetal development. It is unlikely that this process would repeat itself after birth 
under influence of hormonal stimulation. For this reason, it is not likely that an 
undescended testis, particularly one located in the annulus extern us with incom-
plete extension of the processus vaginalis, would assume a scrotal position as a 
result of LHRH treatment. Depending on the age of the child, the testis would have 
to traverse a distance of 4-8 em caudally to reach the scrotum (Scorer and Farring-
ton, 1971), while the development of the processus vaginalis and responding 
gubernaculum regression would have to occur anew. In laboratory animals with 
undescended testes, no such extension of the processus vaginal is nor gubernacu-
lar reaction was ever noted as a result of LHRH treatment (Wensing and Colen-
brander, 1986). 
Considering the important part played by the epididymis in testicular descent, it 
is not surprising that epididymal anomalies are often found in boys with disruption 
of testicular descent. In our patient series, epididymal anomalies amounted to 
45%, which correlates well with the incidence of 32-66% reported for other studies 
(Marshall and Shermeta, 1979; Mininberg and Schlossberg, 1983; Heath et al., 
1984.). Heath and coworkers found a wide open processus vaginalis in association 
with 21 of their 28 cases of epididymal anomalies (75%).1n our series this amounted 
to 88% (75 of 88 cases). 
The fact that the processus vaginalis remains open does not necessarily imply a 
disturbance of testicular descent. 
Completely descended testes may be associated with various forms of hydro-
cele, which may be secondary to local anatomical relations (e.g. wide annulus 
extern us). Noting and documenting epididymal anomalies at orchiopexy is essen-
tial in connection with fertility disorders that may appear later, possibly due to the 
lack of attachment between testis and epididymis. Microsurgical repair of the 
disrupted continuity between testis, epididymis and vas deferens may be required 
to improve the potential for fertility and in that case a record of anatomical 
structures will be invaluable (Heath et al., 1984). 
In case of bilaterally undescended testes, it is particularly important to document 
the extent of attachment between testis and epididymis to facilitate subsequent 
surgical repair that may be required to enhance fertility. 
Another aspect that warrants further discussion is the uneven distribution ofthe 
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diverse testicular positions found at operation. In age group A (1-2 years), we 
found significantly more testes in the inguinal canal than in the older boys (A> B > 
C), while a superficial inguinal, ectopic location was significantly more frequent in 
age group C (6-12 years) than in the younger boys (A< B <C). Age group B was 
obviously the intermediary between A and Cas far as peroperative testis location 
was concerned. There are various possible explanations for the divergence in 
testicular position related to age group: 
1. The divergence may be due to the manner of patient selection. The patients 
were not randomly assigned to diverse age groups; classification was subject 
to the pattern of referral of the general practitioners. 
2. A testis which is at best intermittently palpable will be noticed at an earlier age. 
Consequently, chances are that referral will take place at a relatively young 
age. This may be the reason that so many testes were found in the inguinal 
canal in age group A. 
3. It may well be that a testis which is initially located low in the inguinal canal, is 
pushed out ofthe inguinal canal and permanently into the annulus extern us as 
a result of a toughening of the abdominal wall in the course of further 
development (possibly followed by obliteration of the processus vaginalis). 
This may explain the number of testes that are initially located in the inguinal 
canal but assume a lower position with passage of years. In these cases an 
incomplete development of the processus vaginal is would prevent complete 
descent into the scrotum. 
4. A superficial inguinal, ectopic testicular position was found in all three age 
groups secondary to a partial or complete obstruction at the level of the scrotal 
entrance. The fact that this testicular position was found more frequently in 
age group C than in the younger boys may be due to the following reasons: 
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- a testis which is initially located in the annulus externus may, in the course 
of a few years, be "pushed" out and on to the inguinal canal as a result of 
growth of the abdominal wall on the one hand and the abnormal anatom-
ical relations of Scarpa's fascia cranio-lateral from the annulus externus 
on the other hand (figure B). This would explain the increased number of 
testes located in a superficial inguinal, ectopic position in the older age 
group. 
- a retractile testis is often located in the "subcutaneous inguinal pouch". It 
might well be that a testis with a tendency to move to this "pouch" may 
eventually find the way to the scrotum blocked. As a result of further 
growth of the various structures in the course oftime, the scrotal entrance 
may have become relatively more narrow making passage less easy. Alter-
natively, the distal part of the tunica vaginalis of this initially retractile testis 
may to some extent have collapsed, as a result of which the testis (which has 
meanwhile also increased in size) cannot return to the scrotum through 
the tunica vaginalis. This premise furnishes an explanation for the apparent 
ascent of the testis. 
cranial 
~ 
=~~~ 
~ 
--- -
caudal 
1. Scarpa's fascia 
2. testis 
3. external annulus 
4. spermatic cord 
5. pubic bone 
Figure B. Path of testicular ascent from external annulus into a superficial inguinal, ectopic position. 
5. The occurrence of testicular ascent as a result of the extension of the processus 
vaginal is which has become continuous with the peritoneum, may also furnish 
an explanation for more testes being found subcutaneously outside the ingui-
nal canal in age group C. 
Few studies reported in the literature include a description of peroperative 
testicular position. Thorup and coworkers (1984) registered the peroperative tes-
ticular position in a number of boys that underwent surgery at various ages. In 
agreement with our study, he also found more testes in a superficial inguinal, 
ectopic position in the older boys, but he did not suggest an explanation for this 
finding. Privat (1978), Wyllie (1984) and Atwell (1985) described the ascent of 
initially intrascrotal testes. 
The ultimate aim of surgical treatment, a scrotal position for the undescended 
testis, was achieved in this series of operations with few exceptions. Excluding the 
15 absent testes, 179 of 181 undescended testes were successfully affixed high or 
low in the scrotum. This rate of success corresponds with similar good results of 
other large series of orchiopexies reported in the literature (Gross and Replogle, 
1963; Daum, 1969; Cywes et al., 1979; Mengel and Hecker, 1979; Lynch et al., 1982; 
Thorup et al., 1984). A standard orchiopexy was carried out in most cases. It would 
actually be better to talk of orchiofunicolysis followed by orchiopexy, rather than 
just orchiopexy, to illustrate the essential step preceding the fixation of the testis in 
the scrotum, consisting of mobilization of the funiculus (Molenaar, 1982). Particu-
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larly for testes located in the inguinal canal or higher, extensive mobilization ofthe 
funiculus is essential for a sufficient gain in length. If the testis is located subcuta-
neously, outside the inguinal canal, funiculolysis up to the annulus internus will 
usually result in sufficient funicular length for testis fixation in the scrotum without 
traction (Prentiss, 1960; Odiase et al., 1982). This procedure is shown schematically 
in figure C. 
A correctly executed orchipexy includes adequate funiculolysis, whereby the 
funiculus is first teased free from the processus vaginal is and then mobilized as far 
as possible retroperitoneally to, enable a medial replacement and to gain enough 
funicular length for the testis to be affixed inside the scrotum. 
The number of infections and other wound-related complications amounted to 
only five per cent (10 out of 196 operations). A close scrutiny of these complica-
tions does not lead to stringent, preventive measures. Infection ofthe wound had 
no effect on the vitality of the testis, as the follow-up examination never revealed 
atrophy of a testis whereby wound healing had been complicated. Altogether, 
testicular atrophy amounted to two per cent (3 out of 163), corresponding with 
2-3% reported by other workers (Snijder and Chaffin, 1955; Gross and jewitt, 1956; 
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Figure C. Schematic presentation of orchiopexy including funiculolysis. 
284 
Hecker, 1976; Mengel, 1979). Wound infection and other wound-related com-
plications occurred in all age groups, so that there could not have been a connec-
tion with e.g. urine or faeces contamination which would be a frequent occur-
rence in the younger age group. 
None of the patients, nor their parents, experienced any hardship connected 
with the operation or the hospital stay. This was particularly so for the younger 
boys. Coupled with the good results of the operation in the younger boys, this 
shows that: 
A standard orchiopexy may safely be carried out at a very young age. 
Regarding the technical aspect of the operation, the younger the child, the 
more difficult the surgical intervention (Scholtmeijer, 1983). 
For our patient series, the age at which surgery was carried out had no effect on 
the results. Our conclusion regarding the safety of performing orchiopexy in 
young infants is justified, despite the fact that our follow-up period was rather 
short (4-10 months). It remains to be seen whether the fertility of boys that 
underwent surgery at a very young age, is better than that for boys that were 
operated on when they were older. 
No evidence has emerged from the literature indicating that surgery at a very 
young age would enhance the potential for fertility. 
Orchiopexy in a very young child demands a great deal of surgical expertise. The 
funicular structures are very vulnerable at an early age, while the processus 
vaginalis is frequently wide open and very thin, complicating its required dissec-
tion from a long stretch of the funiculus without damage to the testicular vessels 
and the vas deferens. 
The results of these series of operations have meanwhile occasioned a change in 
our protocol. We feel confident in reducing the duration of hospital stay to a 
minimum. Boys with an undescended testis that is well palpable are even under-
going surgery on a day-care basis. Rather than causing any problems, this seems to 
enhance recovery. 
Orchiopexy requires only a short stay in hospital. Recovery will proceed much 
better at home. 
We have also learned from these studies that the inability to place a testis low in 
the scrotum at surgery, is no cause for concern. Follow-up examination revealed 
that a number of testes that had been affixed high in the scrotum, had assumed a 
low scrotal position of their own accord. 
A testis placed high in the scrotum at surgery may subsequently assume a low . 
scrotal position of its own accord. 
Finally, it is important to mention that, in case exploration reveals a "vanished 
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testis", the contralateral testis should be affixed on the tunica dartos to prevent 
torsion of that single remaining testis. This is because the possibly antenatal 
occurrence of torsio testis may have caused the vanishing of the "undescended" 
testis (Abeyaratne et al., 1969). At contralateral exploration in 13 boys with a 
unilateral vanished testis, Harris et al. (1982) found an abnormally loose attachment 
between testis and epididymis (bell-clapper deformity) in 11 of these boys. This 
anatomical anomaly is associated with an increased risk of torsio testis (Bellinger, 
1985). Window orchiopexy, as described by Morse and Hollobaug in 1977, is a 
good technique for affixing the solitary testis transscrotally. 
In case of a "vanished" testis, the contralateral testis should be affixed on the tunica 
dartos to prevent subsequent torsion of that single remaining testis. 
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CHAPTER7 
GENERAL CONCLUSIONS AND GUIDELINES FOR THE FUTURE 
7.1. INTRODUCTION 
As outlined in the first chapter of this dissertation, we have carried out a joint 
endocrinological and surgical investigation of the entity of cryptorchidism. The 
paediatrician and the paediatric surgeon have each argued their case and now the 
time has come for the summing up. WHY did we carry out such an extensive 
review of the literature? HOW did we apply literature data to our clinical studies? 
And finally, WHEN did we begin to find answers to the questions that embodied 
our motivation? 
An extensive review of the literature was required in the first place to enable 
presentation of a clear profile of the anatomy, physiology, and pathophysiology of 
testicular descent. Secondly, a critical study of the literature would throw light on 
the implications of a disturbance of testicular descent indicating the need for, and 
possibly the type of treatment. Lastly, the data gleaned from the literature would 
form a basis for comparison with out findings. Coming through a maze of agree-
ment and, at times, disagreement with the literature, we finally saw our way clear 
to translate our findings into a protocol for nonscrotal testes as well as proposals for 
the future. 
7.2. WHY SHOULD CRYPTORCHIDISM BE TREATED? 
Boys with unilateral or bilateral undescended testes should be treated for the 
following reasons: 
- There is a definite connection between a disturbance of testicular descent and 
infertility. The risk of infertility is that much greater if both testes are undescend-
ed. The location of the undescended testis also influences the potential for 
fertility. Intra-abdominal testes have far less chance of fertility than, for example, 
testes lying subcutaneously in the inguinal region. 
- Normal anatomical relations of the genitalia are extremely important for an 
undisturbed psychosexual development of the boys concerned. 
- A testicular tumour, albeit a rare occurrence, is more frequently found in an 
undescended than in a normally descended testis. Bringing the testes into a 
scrotal position renders the previously undescended testis more accessible for 
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examination, instantly revealing a tumour that might occur just the same, which 
could then be treated without delay. 
7.3. HOW SHOULD CRYPTORCHIDISM BE TREATED? 
Before any kind of treatment can be initiated, the proper diagnosis has to be 
made. To reach the proper diagnosis, the cryptorchid boy has to be examined at 
least twice, following the procedure described in chapter 2. The type oftreatment 
depends to a large extent on the diagnostic findings. The results of our study of 
the efficacy of LHRH nasal spray show that this hormonal treatment may be 
successful for undescended testes that have emerged from the inguinal canat 
although a placebo effect cannot be excluded. It appeared that the rate of success 
was highest for low-lying testes capable of manipulation to the scrotal entrance or 
even lower, at physical examination. In our patient series such low testicular 
positions were most prominent in boys with an age range of 6 to 12 years. LHRH 
therapy seemed to be least successful in the younger boys, which may be due to 
the fact that a low testicular position was relatively less frequent in the younger 
age groups. Our dosage schedule for LHRH administration consisted of: one puff 
(200 J.tg) in each nostril three times a day before meals for a period of four weeks; 
four weeks respite; another four weeks of LHRH administration if required. Data 
on lengthy follow-up periods for LHRH treatment being scarce, we feel the 
successfully treated boys should have regular checkups, say once a year, until 
they have reached puberty. 
If hormonal treatment is indicated, we feel LHRH is preferable to HCG treat-
ment, for the following reasons: 
- The administration of LHRH nasal spray is less invasive and therefore less 
burdensome for the child than the intramuscular HCG injection. 
- With LHRH nasal spray there are fewer side effects during treatment. 
- The percentage of success is similar for either modality. 
We have no personal experience of HCG treatment following unsuccessful 
LHRH therapy. However, comparing the results of these two modalities as well as 
the factors contributing to the success of either modality (see chapter 4), the 
chances of HCG treatment succeeding where LHRH therapy has failed seem very 
slim. 
Our patients that did not have testicular descent with LHRH therapy under-
went surgical treatment. In most cases, surgery revealed anatomical anomalies 
which had prevented testicular descent and would account for the failure of 
hormonal treatment. This fact also argues against any attempt to achieve testicu-
lar descent with HCG treatment after failure of LHRH therapy. 
There are cases where hormonal treatment of any kind is doomed to fail, 
demonstrating clearly the paramountcy of a proper diagnosis. The child should 
be examined by someone with an anatomic insight of the inguinal region, not 
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only to distinguish between a retractile and a truly undescended one, but even 
more so to differentiate: 
- an ectopic testis, which always lies subcutaneously and is therefore palpable. 
Hormonal treatment is pointless; ectopic testes have to be surgically correct-
ed. 
- a testis that is intermittently palpable; lying in the inguinal canal this testis will 
emerge with gentle manipulation. This testis needs surgical intervention. 
- a testis that will not emerge from the inguinal canal, remaining impalpable; 
this testis may lie high in the inguinal canal or intra-abdominal and always 
requires surgical treatment. 
We feel the method of choice for locating the impalpable testis is inguinal 
exploration. This method has the advantage that orchiopexy can generally follow 
immediately upo~ location of the testis at the same operation. Special surgical 
procedures may be required in some cases, for example, if inguinal exploration 
reveals an intra-abdominal testis, microvascular orchiopexy may be required. 
Our results indicate that this type of operation had best be carried out after the 
seventh year of life. 
Naturally, all these operations should only be carried out by surgeons that are 
familiar with dissection of the fragile structures in the inguinal region of young 
children; in other words, paediatric surgeons or paediatric urologists. 
7.4. WHEN SHOULD CRYPTORCHIDISM BE TREATED? 
A proper diagnosis is an essential element in determining the time of treat-
ment. It is also important to have complete medical records of the patient; 
documentation of previous testicular positions should be available (supplied by 
well-baby clinics and school medical officers, etc.). These data together with the 
age of the boy will decide the timing of treatment. 
Boys referred for unilateral or bilateral undescended testes before the second 
year of life 
Provided a definite diagnosis has been reached, the best time for initiating 
treatment is when the boy is approximately two years old. There is no real proof 
that early treatment is the best course of action, but there are a number of factors 
that argue against suspension of treatment: 
- The younger the child, the easier it is to diagnose truly undescended testes, 
because the retractility of the cremaster muscle is less pronounced. In other 
words, the shorter the interval between birth and moment of referral, the less 
likely the chance of a retractile testis being diagnosed as undescended. Apart 
from that, documentation of previous testicular position, e.g. at birth, is more 
likely to be available, the younger the child. 
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- Delayed, spontaneous descent is extremely unlikely to occur after the first 
year of life. 
- After the second year of life, obvious histological changes occur in the 
germinal epithelium of the undescended testis. It is not yet known to what 
extent these changes are reversible. 
- Early placement of the testis in the scrotum reduces the negative effect that a 
higher temperature may have on potential fertility. 
- There are indications that testicular tumours occur less frequently in initially 
nonscrotal testes that are operated on at an early age. 
- Early treatment is also preferable from a psychological point of view, because 
the anomaly in the genital region will have been corrected before the boy 
himself discovers that he is "different". This reduces the risk of a disturbance 
of the boy's psychosexual development. 
Boys that are referred for unilateral or bilateral undescended testes after the 
second year of life 
If the boy is over two years old (but still prepuberal) upon referral, there are few 
pressing reasons for initiating immediate treatment. Histological investigation of 
the germinal epithelium of undescended testes at various stages of development, 
has revealed that the changes are not progressive. The reduction in the number 
of spermatogonia per tubule stabilizes after the second year of life and no further 
decrease is likely to occur (see figures 5.2. and 5.3.). Consequently, the timing of 
treatment for the age period past two years to puberty, can be adapted to 
personal circumstances, such as scholastic achievement; family situations; the 
extent to which the boy and his parents are able to cope, psychologically, with his 
physical abnormality. 
Suspending treatment will provide more time to ensure that the proper diag-
nosis has been reached. In this age period it may be difficult to differentiate 
between a retractile and a truly undescended testis. 
Regardless of the time of referral, microvascular orchiopexy had best be 
carried out after the seventh year of life (see 7.3.). 
7.5. PROTOCOl FOR THE TREATMENT OF NONSCROTAl TESTES 
Based on the results of our studies, we have drawn up a protocol for the 
treatment of boys with nonscrotal testes. This protocol is schematically presented 
in page 333 (foldout), which requires some elaboration. 
During the diagnostic phase, the boy should be examined several times (at least 
twice) by the same examiner, following the proper procedure as defined in 
chapter 2. A number of questions have to be answered before proceeding on to 
the treatment phase. Following the treatment phase, or if treatment can be 
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dispensed with, a decision has to be taken regarding the follow-up phase. The 
questions that have to be answered are: 
1. Is the testis truly undescended or retractile? A testis that can be manipulated 
into a stable scrotal position is retractile. Although the retractile testis re-
quires no treatment, we feel that a follow-up phase is essential. The boy 
should have an annual checkup until he reaches puberty, because testicular 
ascent may occur. 
2. If the testis is truly undescended, the question arises whether there are other, 
associated anomalies. The cryptorchid boy requires a complete workup. In 
case of chromosomal or dysmorphic syndromes, treatment of cryptor-
chidism will depend on the prognosis for this associated anomaly. Life expec-
tancy will play an important part in the decision. In case of inguinal hernia, 
surgical treatment is indicated for both unilateral and bilateral undescended 
testes. 
3. If the cryptorchid boy is otherwise normal, the question is whether there are 
any signs of the onset of puberty. If so, surgical treatment should be carried 
out without delay, regardless of laterality of the undescended testis. 
4. If the cryptorchid boy is prepuberat the question concerns the treatment of 
choice. The most caudal position to which the testis can be manipulated 
figures very prominently in this decision. Impalpable testes cannot be mani-
pulated and always require surgery. In case of bilateral impalpable testes, an 
HCG test has to be carried out before surgery is initiated. A positive test 
indicates functioning Leydig cells, excluding a total absence of testicular 
tissue. In case of intermittently palpable, or ectopic testes, surgical treatment 
is also indicated. If the testis has emerged from the inguinal canal and can be 
manipulated to a lower position, hormonal treatment may be considered 
(preferably consisting of LHRH nasal spray). If this hormonal treatment fails to 
induce complete testicular descent, surgical treatment should be carried out 
without too much of a delay. 
A follow-up phase is required for all successfully treated boys, regardless of 
type of treatment. For the boys that had complete testicular descent with hormo-
nal treatment, this is necessary because experience with LHRH nasal spray is still 
short-lived. For the surgically treated boys, this is necessary to assess short-term as 
well as long-term results of the operation. 
We have not come to a definite decision regarding the expediency of a repeat 
course of LHRH nasal spray in case of a "relapse". If the undescended testis did 
assume an intrascrotal position or at least became retractile with hormonal 
treatment but has subsequently returned to its undescended position, suspen-
sion of treatment until puberty seems justified. 
The schematic presentation of the treatment protocol does not include any 
indication oftiming of treatment. This aspect has been dealt with extehsively in 
section 7.4. The extent to which previous documentation of testicular position 
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should play a part in the treatment protocol will be discussed in the next section, 
dealing with proposals for the future. 
In summary 
Ifthe boy is under two years old at referral, treatment should take place around 
age two. If he is over two years old, there is no urgency and treatment may be 
suspended, subject to personal circumstances. For a boy that is over two years 
old, it is more important to allow sufficient time for a proper diagnosis. 
7.6. PROPOSALS 
Our clinical studies may have answered the questions that motivated our 
investigation, but in the process our findings have raised new questions, such as: 
Should all prepuberal boys with undescended testes be treated or would a 
"wait-and-see" approach be the wiser course in some cases? 
Consideration of previous documentation of testicular position enables differ-
entiation between testes that have never had a scrotal position and testes that 
have at one point been intrascrotal or at least retractile, even though the present 
position is definitely nonscrotal. At this point in time, we are unable to state 
categorically one way or the other whether the latter group of testes should be 
treated, or whether it would be better to wait and see if these testes will assume a 
scrotal position of their own accord after the onset of puberty. 
Our retrospective evaluation of previous testicular positions (see 4.3.5.) has 
revealed positive information for a large number (43%) of boys that had complete 
testicular descent with LHRH treatment. In other words, their undescended 
testes had at one point been documented as intrascrotal or retractile. This 
percentage was very much lower (17%) in the group of boys that did not have 
testicular descent with hormonal treatment. Considering the fact that the major-
ity of the success group consisted of boys whose undescended testes could be 
manipulated to at least the scrotal entrance, it may well be that anyone of this 
group, given positive information, need not have been treated. Extensive, longi-
tudinal investigation would be required to settle this issue conclusively. Conse-
quently, we have been conducting another clinical study from the beginning of 
1985, whereby boys with undescended testes that can be manipulated to the 
scrotal entrance and whose history reveals previous documentation of a scrotal 
position or retractility of the undescended testis, are not treated but followed 
closely until the age of puberty. At the time of writing, there are some slight 
indications that this "wait-and-see" approach is correct, but it is definitely too 
early to draw any conclusions. 
The results of LHRH therapy coupled with those of the retrospective evaluation 
have shown that a large percentage of success concerns testes that have previous-
ly been retractile or intrascrotal, whereby subsequently a (transient?) ascent has 
occurred. This has raised the question whether the LHRH therapy affects the 
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cremaster muscle. To investigate this aspect, we have recently started an inves-
tigation of the feasibility of binding sites in the cremaster muscle for LHRH, 
gonadotropins, or androgens. 
In conclusion, we wantto stress the paramountcy of a proper physical examina-
tion and consequently the proper diagnosis, amiqst all questions that may remain 
unresolved concerning cause and effect of undescended testes. Proper examina-
tion and diagnosis, coupled with proper documentation of this diagnosis, may 
prevent needless treatment. As early as 1938, Sir Denis Browne said it all in his 
inimitable, tongue-in-cheek way: 
"There are few conditions upon which more contradictory diagnosis and 
advice can be obtained from the medical profession than those which fall into the 
vague and elastic category of "undescended testicle". I know a parent who was 
told that her son's testicles: 
a. Needed immediate operation if he were not to be practically a eunuch (A 
surgeon of great experience). 
b. Should be left for five years to see what happened (Another reputable sur-
geon). 
c. Should be treated by hormone injections (A physician). 
d. Should on no account be operated upon, as the operation invariably failed 
(The family general practitioner). 
e. Were normal (Myself). 
f. Were held up owing to a displaced vertebra (An osteopath.). 
it is hardly necessary to say that the last diagnosis and the treatment that followed 
are now held responsible for the present obviously satisfactory condition of 
affairs." 
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NONSCROT AL TESTIS 
CHROMOSOMAL BOYS NITH ASSOCI A TED UNDESCENDED 
OR DYSMORPHIC 1--------,.1 ANOMALIES 1--------1 TESTIS 
RETRACTILE 
TESTIS SYNDROMES * 
INGUINAL HERNIA 
INGUINAL REGION 
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EXPLANATION OF PATIENT GROUPS. AGE PERIODS AND SYMBOLS IN FIGURES AND TABLES 
Group I 
Group II 
Group Ill 
boys that stayed cryptorchid in the first year of life 
.A. unilateral 
ll.. bilateral 
boys with spontaneous testicular descent in the first year of life 
• unilateral 
[] bilateral 
13 hemi-descent (descent of one testis in case of bilateral cryptorchidism] 
boys born with normally descended testes 
0 control subjects 
Age period X approximately 3 months of age. range: BD-126 days 
Age period Y approximately 6 months of age. range: 169-236 days 
Age period Z approximately 12 months of age. range: 33o-q1o days 
